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The aim of this study was to identify, and assess, one or more Theileria
annulata sporozoite antigens as potential non-infective vaccine material for
tropical theileriosis.
Theileria annulata was described with particular reference to literature
concerning characteristics of the sporozoite stage, immunity and immunisation.
The application of biotechnology to the production of recombinant DNA vaccines
was reviewed and relevant examples were detailed.
Antisporozoite monoclonal antibodies (Mabs) were screened for their ability
to inhibit sporozoite invasion of peripheral blood mononuclear cells in vitro.
Two Mabs, 1A7 and 4B11, were shown to possess significant inhibitory activity.
Strong sporozoite blocking activity was also detected in hyperimmune bovine sera,
antisporozoite rabbit serum and sera from calves exposed to irradiated sporozoites.
■labs 1A7 and 4B11 both identified epitopes on the sporozoite surface. Mab 4B11
recognised a 17-20 kilodalton (kdal) antigen while the epitope detected by Mab 1A7
resided on several members of a group of proteins, of approximate molecular weights
35, 72, 63 and 54 kdal, believed to result from the processing of a high molecular
weight precursor. Certain of the above polyclonal sera also recognised one or
aoth of these epitopes.
In order to obtain material for immunisation trials,the gene sequence coding
for the sporozoite epitope recognised by Mab 1A7 was cloned into the vector, \ gtl 1 ,
and expressed in Esherichia coli (_E. coli) . Two recombinant phage clones, Agtll-
3R1 and \ gt11-SR2, containing this gene sequence were obtained. Analysis of the
330 base pair DNA sequence cloned inXgtll-SRl showed that three copies of the
sequence were present in Eco Rl digested genomic DNA from uncloned parasite material
/■/hile DNA from cloned parasite contained a single copy. Expression of the gene
sequence was stage-specific, occurring only in sporoblast and sporozoite stages.
The recombinant DNA cloned in\gtll-SRl and Agtll-SR2 was expressed in Eh coli
as B-galactosidase fusion proteins of 135 and 147 kdal respectively. These proteins
reacted specifically with Mab 1A7 and also with antisporozoite rabbit serum and
aertain sera from calves exposed to live or irradiated sporozoites. Mice, rabbits
and calves were immunised with the 135 kdal protein from Xgtl1-SRI. Rabbits and
aalves developed a strong antibody response to this protein and the antibodies produ¬
ced also recognised the native sporozoite epitopes, showing an identical pattern
af reactivity to that seen with Mab 1A7. Significantly, the\gtll-SRl sera neutral¬
ised sporozoite infectivity very effectively _in vitro, while control sera failed
ao do so. On challenge with live virulent sporozoites, the calves immunised with
:he Agtl 1 -SRI protein became infected and underwent clinical reactions which were
lot significantly different from those observed in control B-galactosidase immunised,
ar unimmunised, calves. Discussion of these results concentrated on whether this
failure to stimulate protective immunity reflected an inadequate method of antigen
presentation, or whether antisporozoite immunity alone is insufficient to protect
atherwise fully susceptible calves.




The aim of this study was to identify potentially protective
antigens of the infective, sporozoite, stage of Theileria annulata
and to clone the relevant gene(s) to obtain one or more of these
antigens as a recombinant protein with which to perform immunisation
trials.
Theileria annulata and the disease it causes, tropical theil-
eriosis, were described with particular reference to literature
concerning characteristics of the sporozoite stage, immunity and
immunisation. The application of biotechnology to the production of
recombinant DNA vaccines was reviewed and relevant examples were
detailed.
To this end, antisporozoite monoclonal antibodies (Mabs) were
raised and those giving positive fluorescence of formalin fixed
sporozoites by the indirect fluorescent antibody test (IFAT) were
selected. Nineteen such Mabs were screened for the ability to
neutralise sporozoite infectivity for bovine peripheral blood mono¬
nuclear cells in vitro. Two antisporozoite Mabs, 1A7 and 4B11,
which demonstrated surface immunofluorescence of live sporozoites,
exhibited a significant degree of sporozoite inhibition. These were
chosen for further investigation. The in vitro assay was also used
to detect sporozoite neutralising activity in hyperimmune bovine
sera, sera from calves exposed to irradiated sporozoites and serum
from rabbits on which infected ticks had fed.
Using SDS-PAGE Western blotting, Mabs 1A7 and 4B11 were shown
to identify different epitopes on the sporozoite surface. Mab 1A7
specifically recognised an epitope present on several sporozoite
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proteins of approximate molecular weights 85, 72, 63 and 54 kilo-
daltons (kdal) in Western blots. This was believed to reflect pro¬
cessing of a high molecular weight precursor. Mab 4B11 recognised
a low molecular weight protein of 17-20 kdal, also located on the
sporozoite surface. Some immune bovine sera and antisporozoite
rabbit serum also detected these two sporozoite epitopes.
Large amounts of one of the epitopes were made available as
a recombinant protein by cloning and expressing the relevant theil-
erial gene fragment in Escherichia coli (_E. coli) . To achieve this
a Agtl 1 expression library, constructed using genomic DNA from _T.
annulata piroplasm DNA, was screened with Mabs 1A7 and 4B11. Two
recombinant clones,A gtl1-SR1 and Xgtll-SR2, were obtained, both of
which contained the gene sequence coding for the epitope recognised
by Mab 1A7. The theilerial DNA insert of clone Agtl1-SRl was 330
base pairs in size and hybridised to three DNA bands in EcoRl digested
genomic DNA from an uncloned parasite stock. These bands were segre¬
gated to single copies of the gene sequence in the DNA from cloned
parasite material. Northern blot analysis using RNA from infected
tick salivary glands showed expression of theAgtll-SRl insert to be
stage specific, occurring only in sporoblast and sporozoite stages
and not in macroschizonts or piroplasms, nor in uninfected tick sali¬
vary glands.
The recombinant DNA cloned inAgtll-SRl and\gtll-SR2 was
expressed in _E. coli as B-galactosidase fusion proteins of 135 and
147 kdal respectively. These proteins reacted specifically with Mab
1A7 and also with antisporozoite rabbit serum and certain sera from
calves exposed to live or irradiated sporozoites. Immunisation trials
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using the purified 135 kdal protein from Agtl1-SRl, were performed
in mice, rabbits and calves. Inoculation of rabbits and calves with
this fusion protein combined with Freund's adjuvant elicited a strong
and specific antibody response. These antibodies alpo recognised the
native sporozoite epitope when assessed by IFAT and Western blotting,
the latter revealing exactly the same multiple reactivity of sporo¬
zoite proteins with anti \gtll-SRl sera as observed with Mab 1A7.
Significantly, the same sera also neutralised sporozoite infectivity
in vitro very effectively, while control sera failed to do so. On
challenge with live virulent sporozoites, the calves immunised with
theXgtll-SRl protein became infected and underwent clinical reactions
which were not significantly different from those observed in control
B-galactosidase immunised or unimmunised calves. Discussion of these
results concentrated on whether this failure to stimulate protective
immunity reflected an inadequate method of antigen presentation, or
whether antisporozoite immunity alone is insufficient to protect
otherwise fully susceptible calves.
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1.1. INTRODUCTION
Tropical theileriosis is a tick-borne haemoprotozoan disease
threatening an estimated 250 million cattle in the Mediterranean
littoral, North Africa, the Middle East, the Indian subcontinent
and central Asia (Purnell, 1978; Robinson, 1982). The disease is
caused by Theileria annulata, a protozoan parasite transmitted by
ticks of the genus, Hyalomma (Dschunkowsky and Luhs, 1904), and acts
as a major constraint on livestock production and improvement in
many developing countries.
This constraint arises particularly where exotic cattle are
being introduced in attempts to upgrade local beef or dairy stock.
These cattle appear to be more susceptible to theileriosis than
indigenous breeds,suffering higher mortality and more severe clinical
signs (Yousif, 1969) . In order to give these livestock improvement
programmes a chance of success, the cattle need to be protected from
theileriosis as well as from other tick-borne diseases such as
babesiosis and anaplasmosis. This can, in a properly planned and
managed system, be achieved using one of two principles; either the
cattle can be protected from exposure to the disease agent through
control of the tick vector and cattle movement regulations or they
can be allowed to develop active immunity. In the latter case, if
loss of animals and production is to be avoided, either the exposure
to the parasite must be deliberate and controlled, through vaccination,
or chemotherapy needs to be used to treat clinical cases as they arise.
However, when considering the quality of surveillance that would be
required to recognise and treat cases early enough, together with the
high cost of theilericidal drugs, chemotherapy should ideally be
reserved for use in the event of breakdown of other control methods.
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Routine or strategic use of acaricides to control tick numbers
is a well established method of limiting tick damage and the impact
of tick-borne disease but suffers from concern about the development
of tick resistance to acaricides (Young, Groocock and Kariuki, 1988).
Also, a state of enzootic instability may result in which fully sus¬
ceptible cattle exist in an area where tick-borne disease agents are
endemic in the tick population (Lawrence and Norval, 1979) . There¬
fore, any interruption to a tick dipping regime, whether through
shortage of acaricide, political unrest, damage to equipment or
simply inefficient implementation, can result in heavy losses in
cattle suddenly exposed to infected ticks (Lawrence, Foggin and
Norval, 1980).
Thus, the creation of cattle immune to tropical theileriosis
in such a way that clinical disease is avoided and long term field
challenge can be resisted is of paramount importance in limiting the
effects of this disease in an otherwise susceptible cattle population.
Cattle recovering from tropical theileriosis either naturally
or through drug treatment are immune to homologous challenge (Sergent,
Donatien, Parrot and Lestoquard, 1945; Neitz, 1957). This immunity
is believed to be mainly due to the action of genetically restricted
cytotoxic T cells on schizont-infected lymphocytes (Preston, Brown
and Spooner, 1983). However, with repeated exposure to sporozoites,
an antibody mediated response develops which is directed against the
sporozoite stage as shown by the fact that hyperimmune bovine serum
blocks sporozoite infectivity for lymphocytes very effectively in
vitro (Gray and Brown, 1981; Preston and Brown, 1985) and it is
likely that this humoral mechanism plays a significant role in main¬
taining immunity.
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Two methods of immunisation against theileriosis have been
developed, both of which involve deliberately infecting cattle with
live parasites. One, the infection and treatment method, involves
inoculation of live sporozoites with simultaneous chemoprophylaxis
to limit the clinical reaction and permit the subsequent development
of immunity (Radley, 1981) . The other method of immunisation, which
has been widely applied in the Middle East, USSR, China and, more
recently, India, Turkey and North Africa, is achieved by infecting
cattle with attenuated Theileria annulata macroschizont-infected
cells from in vitro cultures (Pipano and Tsur, 1966).
Both these methods of vaccination depend upon establishing
active infection in the bovine host (Pipano, 1977) and thus incur
the risks of causing clinical disease and carrier status and the
problems of handling live parasite material under tropical conditions.
For these reasons, which have been emphasised by Doherty and
Nussenzweig (1985) for Theileria parva, the cause of East Coast fever,
efforts are being made to find alternative non-infective immunising
material. To date, neither Theileria annulata schizont-infected cells
killed by freeze drying and sonication (Pipano, Goldman, Samish and
Friedhoff, 1977) nor plasma membranes prepared from Theileria parva
parasitised lymphoblastoid cells (Emery, Morrison and Jack, 1986)
have met with convincing success and more defined approaches have been
adopted. For Theileria annulata, attention has so far been focussed
particularly on the schizont-infected lymphocyte (Shiels, McDougall,
Tait and Brown, 1986a; Preston, McDougall, Wilkie, Shiels, Tait and
Brown, 1986) and, for Theileria parva, on the sporozoite stage (Musoke,
Nantulya, Rurangirwa and Buscher, 1984; Dobbelaere, Spooner, Barry
and Irvin, 1984) .
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With the exciting recent advances in biotechnology and their
widespread implementation in research on all important disease agents
of man and animals, new strategies for vaccine development have
emerged. The aim of the work described in this thesis was to apply
one of these strategies to the development of a subunit vaccine from
the infective, sporozoite stage of Theileria annulata. The rationale
adopted was similar to that behind much of the current work on the
sporozoite stage of Plasmodium species, in particular of Plasmodium
falciparum, the cause of perhaps the most important form of human
malaria (Zavala, Tarn, Cochrane, Quakyi, Nussenzweig and Nussenzweig,
1985).
First, the thesis describes how hybridoma technology was applied
to the identification of individual sporozoite antigens and then how
the resulting antisporozoite monoclonal antibodies were screened for
the ability to mimic hyperimmune bovine serum in blocking sporozoite
invasion of lymphocytes in vitro. Monoclonal antibodies with a
significant degree of blocking activity were selected and used to
characterise the sporozoite antigens they recognise. One priority
was then to obtain these proteins in sufficient quantities for immun¬
isation experiments. To this end, a genomic DNA library of Theileria
annulata was screened with the monoclonal antibodies resulting in the
isolation of a recombinant expressing one of the relevant sporozoite
epitopes. Following analysis of the recombinant DNA and the recombinant
protein expressed, the protein was used in preliminary immunisation
trials in mice, rabbits and calves. In this way, the potential of
this particular sporozoite recombinant protein as vaccine material
for tropical theileriosis was assessed.
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1.2. THEILERIA ANNULATA AND TROPICAL THEILERIOSIS
1.2.1. The parasite
Two scientists taking part in a rinderpest control programme
in, what was then, Southern Russia, noticed and investigated a fatal
disease afflicting the Transcaucasian cattle of the region and first
described the parasite now known as Theileria annulata (Dschunkowsky
and Luhs, 1904). Observing the round or oval shape of this parasite
and comparing it with that seen by Koch (1903a) in East Coast fever
and described as Piroplasma parvum by Theiler (1904) , they named it
Piroplasma annulatum. Bettencourt, Franca and Borges (1907) proposed
that Piroplasma annulatum and Piroplasma parvum be placed in a new
genus, Theileria, on the basis of the distinctive shape of their
erythrocytic stages. The existence of a schizont stage in several
organs was revealed (Dschunkowsky and Luhs, 1909) and du Toit (1918)
used this characteristic to define members of the Theileria genus.
This definition stands today and all members of the Theileria genus
have an exoerythrocytic stage which multiplies by schizogony in
lymphoid mononuclear cells or cells from which they derive (Barnett,
1968). This distinguishes them from the closely related Babesia
parasites which, if the controversially placed Babesia equi (Laveran,
1901) is overlooked, multiply exclusively during an erythrocytic
stage.
Levine (1988) gives an up-to-date formal classification of







Theileria annulata (T_. annulata) is synonymous with T. dispar
and Gonderia annulata in the major reviews of this species by Sergent
et al. (1945) and Neitz (1957) respectively.
The most important species of Theileria infecting cattle are
listed in Table 1 together with their main features. Detailed accounts
of these species are given by Barnett (1968), Uilenberg (1981a and b)
and Uilenberg, Peri^, Lawrence, de Vos, Paling and Spanjer (1982).
Hereon this review concentrates on T_. annulata, the species
studied in this thesis, with reference to T. parva, the cause of
East Coast fever (ECF, Theiler, 1904), where research on this para¬
site has contributed to the understanding and knowledge of T. annulata
and tropical theileriosis.
Until Sergent, Donatien, Parrot and Lestoquard (1931) effected
biological transmission of T. annulata using the two host tick,
Hyalomma detritum (syn. Hyalomma mauretanicum), its natural mode of
transmission was unknown. By this time there were reports' of bovine
theileriosis distinct from ECF from numerous countries in Africa,
Asia and Europe as summarised by Neitz (1957) .
The demonstration of Hyalomma ticks as the natural vector and
evidence from cross immunity trials (Adler and Ellenbogen, 1935, 1936;
Sergent, Donatien, Parrot and Lestoquard, 1937; Sergent, Parrot,
Lestoquard and Delpy, 1939a) indicating an immunological relationship
between different isolates, led to the conclusion that the same para¬
site was involved in all three continents. The distribution of
endemic theileriosis is therefore largely determined by that of its
vector tick, Hyalomma, (Robinson, 1982) and is now known to exist in
a wide geographic .belt extending from Southern Europe and Northern

































































































Africa through the Middle East to South USSR and the Indian sub¬
continent (Purnell, 1978).
Domestic cattle both of Bos taurus and Bos indicus types are
most commonly affected by T. annulata infection with domestic water
buffalo (Bubalus bubalis) also being susceptible (Dhar, Bhattacharyulu
and Gautam, 1973). There are isolated reports of other members of
the family Bovidae becoming infected, namely the North American bison
(Bison bison) and Tibetan yak (Bos grunniens) (Barnett, 1977) , but
no wild Bovidae are known to act as reservoirs of infection (Uilenberg,
1976). Although numerous attempts have been made to infect laboratory
species with T. parva in particular (Dschunkowsky and Luhs, 1904;
Brocklesby and Vidler, 1961, 1962; Guilbride, 1963) these have not
met with success and there is no true laboratory animal model for
Theileria species.
Transmission of theileriosis by the vector tick has been exten¬
sively reviewed (Sergent et. _al_. , 1945; Barnett, 1968; Robinson, 1982).
Only the essential features of natural transmission of T. annulata
are detailed below.
Ticks becoming infected by engorging on a patently infected
animal will transmit infection in the following instar, but there
is no persistence of infection from one tick generation to the next.
Thus, transmission is transtadial but not transovarial.- The Hyalomma
species thought to be active vectors in the field may be classified
according to the number of different hosts they feed on in one gene¬
ration. Given that there are three in stars per generation, there
are one host (Hyalomma scupense, Markov, 1962), two host (Hyalomma
detritum, Sergent et al., 1931), two or three host (Hyalomma
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dromedarii, Tselishcheva, 1940) and three host (Hyalomma anatolicum,
Kornienko and Shmyreva, 1944) ticks. The relative importance of
these different species in transmitting theileriosis and the season¬
ality of disease outbreaks in part reflects this variation in the
tick's biology. Transmission depends on an immature stage engorging
on an infected bovine host, dropping off, moulting and reattaching
to a fresh susceptible bovine host within a single generation
(Robinson, 1982). In two host ticks, larvae or nymphs become in¬
fected on the first host before attaching to the second host and
transmitting infection as the adult. Three host ticks can transmit
infection as either nymphs or adults as they use a fresh host for
each blood meal (Arthur, 1962; Robinson, 1982) . The situation is
complicated by the fact that any of these tick stages may feed on
non-susceptible hosts. Sergent, Donatien, Parrot and Lestoquard
(1936) were first to notice that three host ticks infected as larvae
and then engorging as nymphs on a non-susceptible host were still able
to transmit infection in the adult stage. This was confirmed by
Bhattacharyulu, Chaudhuri and Gill (1975) who fed infective nymphs
on a rabbit and found that the resultant adults were still infective.
Adding to the complexity of transmission pattern is the observation
that male adults may interrupt feeding to change hosts so making it
possible for one tick to infect more than one host in the same season
(Sergent et. _al. , 1945) . To explain how Hyalomma scupense, a one host
tick, has been incriminated as a vector, Markov (1962) proposed that
unfed adults migrated between animals.
Regardless of the above variables, two features of the trans¬
mission of T. annulata are clearly of particular interest with regard
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to this study. Firstly, experiments by Sergent et al. (1936) showed
the moulting process of the tick to be essential for the parasites
ingested in the previous instar to develop and become infective.
Secondly, until recently the belief that an initial feeding period
of one to three days was required before ticks were able to transmit
theileriosis was widely held (Sergent et _al. , 1936; Gautam, 1978;
Samish and Pipano, 1978; Singh, Jagdish, Gautam and Dhar, 1979).
Whilst this is an important feature and indicates that the parasite
requires a period of maturation to its infective form, the stimulus
of a blood meal is not an absolute requirement. Mazlum (1969)
reported transmission of T. annulata by crushed infected Hyalomma
dromedarii which were unfed. Work by Samish (1977 a and b) to
investigate this observation indicates that high temperatures and
humidity levels can substitute for this initial period of feeding.
1.2.2. Importance
Tropical theileriosis has long been recognised as a tick-borne
disease of particular importance where the improvement of local dairy
and beef breeds is being attempted in tropical and subtropical areas
infested with the parasite (MacHattie, 1935; Sergent et ad., 1945).
Exotic breeds have been and are being imported into such areas
to improve the genetic potential of the indigenous stock and tropical
theileriosis frequently takes its toll of these and their crossbred
progeny. At best, theileriosis makes it essential for certain disease
control measures to be instituted and diligently practised; at worst
it can have devastating effects on a livestock improvement programme
even leading to its failure. In the early 1920s for example, 16
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Ayrshire bulls were imported into Iraq to obtain high yielding cross¬
bred milking cows (MacHattie, 1935). In the absence of any prevent¬
ive measures against tick-borne diseases at dairies, the crossbred
calves succumbed to theileriosis with 60% of the calf crop dying
within three months of birth and those surviving having shown signs
of infection and consequently retarded early growth. This was no
isolated report; Rafyi and Maghani (1962) and Purnell (1978) describe
the serious threat posed by T. annulata in Iran and Turkey respect¬
ively. Yousif (1969) recorded 44% of adult Friesians imported into
Iraq becoming clinically infected where tick control was inadequate,
with 29% of these dying.
The World Bank funded "Operation Flood" in India is in jeopardy
because of the resistance being shown by farmers to the introduction
of crossbred animals which are central to the aim to increase milk
supplies. Part of this resistance is as a result of the greater
susceptibility of crossbreds to disease amongst which theileriosis
is one of the most important (Hashemi-Fesharki, 1988). Each mature
cow is worth 3,000 Rupees, if she dies the average farmer and his
family lose the equivalent of four months income, a vast sum compared
to the loss of one of his local cows or buffalo (Mergos and Slade,
1987). Until effective tropical theileriosis immunisation reaches
these areas one can understand the reluctance of these farmers to
take on such a risk. That India is committed to a strategy of cross¬
breeding is clear from the fact that, by 1987, 48 frozen semen
stations had been established allowing a total of 8.4 million insemin¬
ations with exotic semen annually and with plans to increase this
number (Acharya and Chatterjee, 1987).
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1.2.3. Life cycle
Detailed descriptions of bovine Theileria stages have been
given by Cowdry and Danks (1933), Reichenow (1940), Sergent _et al.
(1945) and Wilde (1967) while structural studies of tick stages of
T. parva were made by Cowdry and Ham (1932) and Reichenow (1940) ,
these were reviewed and updated for T_. annulata by Schein, Buscher
and Friedhoff (1975) and Schein and Friedhoff (1978). Together
these authors have contributed to the present understanding of the
life cycle which is illustrated in Figure 1 and summarised below.
Mature infective sporozoites are inoculated into the bovine
host in the saliva of a feeding tick where they enter mononuclear
cells. In vitro studies (Jura, Brown and Kelly, 1983) have shown
this invasion to occur within minutes and the fact that the parasites
cannot be detected at the site of a tick bite (Cowdry and Danks, 1933;
Wilde, 1967) suggests that entry into host cells is equally rapid
in vivo. Once interiorised, the sporozoite enlarges to form a
transient trophozoite stage which develops into a macroschizont
(Jura et al., 1983). At the same time, the infected cell becomes
transformed and begins to divide (Hulliger, Wilde, Brown and Turner,
1964). The interaction between parasite and host which results in
this disruption of normal cell growth control is poorly understood.
Recent work has revealed DNA sequences homologous to oncogenes in
the genome of T. annulata (Dyer and Tait, 1987); such oncogenes may
be responsible for stimulating cell division. Whatever the mechanism
operating the result is a fascinating example of subversion of the
immune system to the benefit of the parasite (Bloom, 1979) since the
macroschizont divides in synchrony with the mononuclear host cell
Figure 1 Life cycle of Theileria annulata
1 Sporozoites entering bovine host in tick saliva
2 Trophozoites in mononuclear cells
3 Macroschizonts in transformed mononuclear cells
4 Microschizont containing merozoites in trans¬
formed mononuclear cells
5 Piroplasms in erythrocytes
6 Gamogony cycle in tick gut cells
7 Kinetes in haemolymph
8 Sporogony cycle in tick salivary gland
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resulting in an exponential increase in the number of lymphoblastoid
cells, each of which is parasitised (Hulliger et al., 1964). This
phenomenon was only described fully by observing T_. parva infected
cells in in vitro cultures (Hulliger et aT., 1964). Similar observ¬
ations had been made _in vivo by Reichenow (1940) who had believed,
correctly, that the macroschizont nuclei divide by binary fission
and synchronous division of macroschizont and host cells had also
been described by de Martini and Moulton (1973a) in histopathological
sections of T. parva infected lymph nodes.
Macroschizont-infected cells disseminate around the body (de
Martini and Moulton, 1973b) and a proportion differentiate into
microschizonts (Jarrett, Crighton and Pirie, 1969). The host cell
is disrupted to release merozoites; the only bovine stage, other than
the sporozoite, found extracellularly. These merozoites are infective
for, and enter, erythrocytes and develop into piroplasms. Whilst
intraerythrocytic schizogony of T. annulata is commonly observed
(Conrad, Kelly and Brown, 1985) , rupture of infected erythrocytes
and subsequent reinvasion by the released piroplasms has not been
shown to occur (Conrad, 1983). It is this piroplasm stage which is
ingested by ticks as they take a blood meal.
The two main parasitic stages, macroschizont and piroplasm,
occurring in the bovine phase of the life cycle are responsible for
the clinical signs and pathology observed. In the early stages of
infection when piroplasm parasitaemia is low and there is minor
reduction in red blood cell count,calves die primarily of the effects
of the proliferating macroschizont-infected cells which have dissem¬
inated around the body (de Martini and Moulton, 1973b; Eisler, 1988).
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This uncontrolled mononuclear cell proliferation exerts a combination
of effects. Apart from impaired function and destruction of lymphoid
tissue, which is reflected clinically as a reduction in the number of
circulating white blood cells, major organs are affected such as the
lungs, liver, kidneys and adrenals which are infiltrated by parasit¬
ised lymphoblastoid cells as studied in T. parva infection by Steck
(1928), Cowdry and Danks (1933) and de Kock (1957). Calves infected
with T. annulata often survive the early stages of disease only to
succumb to the pathogenic effects of the piroplasm stage (Barrett,
1977). A high piroplasm parasitaemia, sometimes in excess of 90%,
may develop and is accompanied by a progressive reduction in red
blood cell count (Hooshmand-Rad, 1976) . The profound anaemia which
can result is often fatal (ibid).
The piroplasms ingested by the tick however, ensure the sur¬
vival of Theileria and the completion of the life cycle. Inside
the tick gut, the ingested erythrocytes lyse and the liberated piro¬
plasms develop into male and female gametes which fuse (Schein et_
al., 1975) . The resulting zygote invades cells in the gut wall
(Schein, Warnecke and Kirmse, 1977). Concurrently with the tick
moulting, motile kinetes are released into the haemolymph in which
they migrate to the salivary glands (Schein and Friedhoff, 1978).
The parasite enters and resides in acinar cells of the salivary gland
until sporogony occurs when mature sporozoites develop and pass into




Studies of the development of T. parva in the tick salivary
glands (Cowdry and Ham, 1932; Reichenow, 1940; Purnell and Joyner,
1968) have been complemented by similar work on T. annulata (Hadani,
Pipano and Dinur, 1969; Schein and Friedhoff, 1978) and show the two
parasites to behave in a very similar fashion. Kinetes invade
alveolar cells of the salivary gland acini immediately before the
tick moults when the alveolar cells are still immature. The kinete
rounds up and becomes multinucleate, steadily increasing in size and
number. Once this initial differentiation is complete and the
sporonts are formed, parasite development is suspended until sporo¬
gony is stimulated. Survival of Theileria in the salivary glands is
impressive; adult Rhipicephalus appendiculatus infected with T. parva
can still be infective after 18 months under natural conditions
(Young, Leitch, Dolan, Newson, Ngumi and Omwoyo, 1983). This obviously
increases the chance of successful transmission of Theileria.
Maturation and differentiation of the parasite within the sali¬
vary glands to generate vast numbers of infective sporozoites is
achieved by the process of sporogony and salivary gland activation
at the start of tick feeding is coincident with a rapid renewal of
parasite multiplication (Schein and Friedhoff, 1978). The infected
alveolar cells enlarge massively as the parasites within divide at
a tremendous rate and differentiate from sporoblasts to mature sporo¬
zoites, one sporont giving rise to thousands of sporozoites (Martin,
Barnett and Vidler, 1964).
Studies on T. parva-infected Rhipicephalus appendiculatus have
shown that it is between the second and third days of tick feeding
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that maximal parasite proliferation occurs as monitored by incorpor¬
ation of tritiated nucleic acid precursors into parasite DNA and RNA
(Dobbelaere, Irvin, Spooner and Ocama, 1983) . Active protein syn¬
thesis has been demonstrated to occur simultaneously by immunogold
labelling of a sporozoite surface antigen (Dobbelaere, Webster,
Leitch, Voigt and Irvin, 1985a). The same phenomenon undoubtedly
occurs in T. annulata-infected Hyalomma, probably a little earlier
after tick feeding has begun (Bhattacharyulu jet ad., 1975) .
Sporogony is essential for the maturation of the infective
sporozoites and is the time when the Theileria parasite different¬
iates and acquires the ability to recognise and invade bovine host
cells. This is thought to be achieved by the synthesis of function¬
ally important sporozoite surface proteins (Dobbelaere et al., 1985).
The stimulus for sporogony is not tick feeding per se since
high temperatures alone can stimulate the development of infective
sporozoites in both T. annulata (Samish, 1977a) and T. parva (Young,
Leitch and Omwoyo, 1979). Backless tick explants cultured _in vitro
also showed maturation of TL parva within the salivary gland when
cultured at 37°C although their infectivity was not confirmed (Bell,
1980). The common factor in those experiments which result in infect¬
ive ticks is that the temperature is raised to and maintained at
around 37°C. Unpublished preliminary work by Drs. Roger Hall and
Philip Mason has detected the presence of "heat shock" genes in the
Theileria genome. The temperature rise may activate these genes and
result in the expression of proteins which stimulate sporogony.
Friedhoff (1986) speculated that sporogony was the result of trans¬
formation of alveolar host cells at a molecular level in a manner
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similar to that proposed for transformation of host lymphocytes
by the macroschizont (Dyer and Tait, 1987). There is no evidence
that this is the case and, anyway, it is normal for acinar cells
of tick salivary glands to undergo major activation and trans¬
formation during feeding (Binnington, 1978).
An idea of the relative importance of high environmental temp¬
erature and humidity and tick feeding in stimulating sporogony in
the field was given by Young, Leitch and Mutugi (1984). They found
that although sporogony was effectively stimulated by high tempera¬
ture, parasites sometimes failed to complete sporogony in unfed
ticks, maybe because tick feeding supplies nutrients or salivary
gland changes essential to the process of sporogony. Nevertheless
sporogony occurring in unfed ticks has important epidemiological
implications since it may allow a tick to be infective as soon as
it attaches and before acaricides, which are the primary defence
against tick-borne diseases, can take effect.
1.2.5. Sporozoite entry into mononuclear cells
The precise interaction between T_. annulata sporozoites and
bovine mononuclear cells resulting in sporozoite entry has been
studied in vitro by Jura _et al_. (1983) . Whilst the mechanism would
be expected to be similar for different Theileria species, these
authors found some notable differences from those working on _T. parva
(Fawcett, Doxsey, Stagg and Young, 1982) . Both groups agreed that
the entry process was rapid, occurring within the first five minutes
of contact between sporozoites and cells. The T. annulata sporozoites,
averaging 0.9 |im in length, attached to target cells by their basal
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end while T. parva sporozoites made contact in any orientation.
Following initial contact, sporozoite and bovine cell membranes
became progressively more closely apposed and entry of both parasites
occurred by endocytosis involving an invagination of the host cell
membrane which remained intact. Jura (1984) believed this to be
an active, temperature dependent, energy requiring process in direct
contrast to Fawcett et al. (1982) who detected no reduction in in¬
vasion when the temperature was lowered to 1-2°C, suggesting that
the process was a passive one. In neither case did there appear
to be an obvious role in invasion for the pleiomorphic rhoptries
located at the apical end of the sporozoite. Immunoelectron studies
of sporozoite entry were performed using protein A-colloidal gold
conjugate to visualise a monoclonal antibody which binds to the T?.
parva sporozoite surface (Webster, Dobbelaere and Fawcett, 1985).
The results were very revealing; free sporozoites were labelled
but those inside cells were not and local areas of label were visible
on the surface of infected cells. Immunofluorescence using similar
material lent supporting evidence that the sporozoite surface coat
is shed during entry into the host cell (Dobbelaere et_ al_. , 1985a) .
Having gained entry to the host cell the Theileria parasite has
to avoid destruction by lysosomes which could fuse with the invagin-
ated portion of host cell membrane (Hirsch, 1972). It appears that
its survival is achieved through the action of micronemes within the
sporozoite which causes dispersal of the host cell membrane or para-
sitophorus vacuole, this suggestion is by inference from the observ¬
ation that the micronemes and host cell membrane disappear at the
same time (Fawcett et al., 1982).
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Although no specific receptor sites have been identified,
certain mononuclear cell subsets are markedly more susceptible to
infection with T. annulata than others; class II bearing cells, mono¬
cytes and B cells being highly susceptible (Spooner, Innes, Glass
and Brown, 1988). If this is due to selective sporozoite infecti-




Dschunkowsky and Luhs (1904) tried and failed to transmit T.
annulata artificially using infected blood. They repeated the attempt
using recipient cattle obtained from a theileriosis free area and were
successful (Neitz, 1957). This was the first indication that cattle
could resist infection with T. annulata.
Subsequently, cross-immunity trials were widely used to deter¬
mine the relationship of Theileria parasites involved in different
outbreaks of the disease (Sergent et a_l. , 1937; Adler and Ellenbogen,
1935, 1936). While there is no cross-immunity between T. annulata
and other Theileria species (Sergent et al., 1945; Neitz, 1957) but
strong immunity to homologous challenge in recovered cattle, the
cross-immunity between different T. annulata stocks is very variable.
Parasites isolated from within a geographic area can differ as much
from each other as from parasites originating from geographically
distinct regions (Sergent et al., 1937; Sergent et ab. , 1939a; Gill,
Bansal, Bhattacharyulu, Kaur and Singh, 1980) . T?. annulata stocks
have been shown to differ on the basis of glucose phosphate isomerase
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isoenzyme patterns (Melrose and Brown, 1979; Melrose, Brown and
Sharma, 1980) and schizont staining monoclonal antibody profiles
(Shiels, McDougall, Tait and Brown, 1986b). Similar monoclonal
antibody reagents detect antigenic diversity in T. parva isolates
(Pinder and Hewett, 1980; Minami, Spooner, Irvin, Ocama et al.,
1983) and DNA probes have also been produced which reveal diversity
at the level of the genome (Conrad, lams, Brown, Sohanpal and ole-
Moi Yoi, 1987; Allsopp and Allsopp, 1988) . However, none of these
three approaches have yet been able to predict cross-immunity and
so replace _in vivo cattle experiments.
Some features of the immunity engendered in recovered cattle
were revealed in a series of experiments by Sergent et ad. (1945)
using large numbers of cattle. The resistance to homologous chall¬
enge acquired after a single episode of infection did not break down
in the face of repeated challenge. However, in the absence of
challenge immunity began to decline after the first six months. They
also made the observation that immunity conferred by tick bite, in
other words by sporozoites, was stronger than that resulting from
the inoculation of blood, implying that life cycle stages before the
schizont are responsible for stimulating a component of the protect¬
ive immune response (Sergent, Donatien, Parrot, Lestoquard and Delpy,
1939b) . Pipano (1978) found the same to be true; adult dairy cows
immunised with schizonts and then challenged with sporozoites fre¬
quently suffered heavy clinical symptoms compared to cows immunised
with sporozoites before exposure to the same challenge. Perhaps
eliciting the same mechanism, Musoke _et ad. (1984) were able to
obtain cross-immunity against two T. parva stocks which normally
23
broke through the immunity stimulated by just a single dose of a
third stock. They achieved this by giving repeated inoculations
of sporozoites of the immunising stock before challenging with the
others. Their conclusion was that multiple exposure to sporozoites
may broaden the spectrum of immunity.
It is possible to transmit T. annulata by the inoculation of
blood taken from an animal in the early stages of a patent primary
infection (Sergent et a_l. , 1945; Tsur, 1965) and animals recovering
from infection established in this manner are immune to homologous
challenge. The sporozoite stage is therefore not essential to the
development of immunity although it may significantly modify the
immunity stimulated as mentioned above.
b) Humoral immune responses
An offshoot of attempts to find an effective treatment for ECF
led to field veterinarians in East Africa using immune serum in
passive transfer experiments. Robson, Yeoman and Ross (1961) set up
an experiment to try and confirm reports from Tanganyika that the
inoculation of serum from cattle in endemic areas into cattle with
ECF was curative (Garden, Tanganyika Territory Report; cited by
Robson et. aT. , 1961) . They immunised cattle by exposing them to
field challenge under tetracycline cover over a 28 day period.
Immune serum was transferred to 15 cattle and resulted in all
surviving exposure to the parasite. Other workers were not able to
repeat this (Wilde, 1967; Muhammed, Lauermann and Johnson, 1975) and
the possibility that effective serum levels of tetracycline had per¬
sisted could account for the results. To produce immune serum
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comparable to that used therapeutically in Tanganyika one would have
to feed vast numbers of infected ticks on experimental cattle since
animals in endemic areas are being challenged by several hundred
infected ticks each week. It is interesting to speculate that this
constant and long term sporozoite challenge may enhance the relative
importance of the humoral component of immunity. Earlier, Koch
(1903b) had claimed some degree of success in a trial treatment of
clinical ECF using serum from cattle immunised by blood inoculation
on four occasions but Theiler (1907) was unable to repeat this.
In response to the controversy surrounding the role of anti¬
bodies in immunity to Theileria infections, Muhammed et ad. (1975)
took advantage of the recently developed indirect fluorescent anti¬
body test (IFAT) used to diagnose exposure to Theileria infection
(Lohr and Ross, 1969; Pipano and Cahana, 1969; Burridge, 1971;
Burridge and Kimber, 1972) . They measured IFAT titres to T. parva
macroschizont and piroplasm antigens to ascertain that donor sera
had high antibody levels to these stages and that recipients had no
serological evidence of previous exposure to ECF, both being possible
reasons for the conflicting results obtained previously. They failed
to alter the course of T. parva infection in the recipients which
received serum before and on the day of infection with sporozoites.
No information was available on the antisporozoite antibody titres.
Uncertainty also surrounds the role played by maternal antibody
in colostrum digested by calves born to immune dams and early reports
conflict (Wilde, 1967). Burridge and Kimber (1973) demonstrated that
the majority of a group of immune cows produced colostrum containing
significant levels of antibody but only two of the eight calves
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feeding on this colostrum reflected this in a significant rise in
serum antibody levels. All eight calves were fully susceptible to
challenge (Cunningham, Urquhart, Brown, Burridge and Morzaria, 1988) .
Again only antischizont and antipiroplasm IFAT titres were measured.
There is still much interest in the possible role of colostral anti¬
body, particularly antisporozoite antibody, in protecting young calves
born to dams in areas where they are under constant tick challenge
and a research project in Muguga, Kenya is currently investigating
this particular question (A.S. Young, personal communication).
Antibodies reacting with the macroschizont and piroplasm stages
consistently develop in cattle exposed to Theileria infection (Burridge
and Kimber, 1972) and are useful in making the IFAT a reliable diag¬
nostic test. However, there is now enough evidence to conclude that
they do not play a role in protective immunity. Some of this evidence
comes from _in vivo work in which cattle immunised with extracted schi-
zont or piroplasm antigens develop antimacroschizont or antipiroplasm
antibody levels comparable to those of Theileria-immunised cattle but
remain susceptible to challenge (Wagner, Duffus and Burridge, 1974).
Complementary in vitro studies summarised by Wilde (1967) showed that
the infectivity and multiplication of T. parva schizont-infected cells
in culture were unaffected by exposure to immune serum even when com¬
plement was added (Hulliger, Brown and Wilde, 1965). Sera from cattle
immunised with sporozoites do not recognise the surface of either
schizont-infected mononuclear cells (Duffus, Wagner and Preston, 1978;
Creemers, 1982) or piroplasm-infected red blood cells (Hall, 1988)
which may explain why antibody does not appear to affect these stages
(Wilde, 1967; J. Glascodine, personal communication).
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All the experiments mentioned above once again failed to assess
levels of antisporozoite antibody in any form. This may have been a
significant omission; the role of antisporozoite antibody has been
under particularly close scrutiny since Gray and Brown (1981) reported
the ability of immune bovine serum to significantly neutralise T.
annulata infectivity for bovine mononuclear cells _in vitro. The same
activity was found in serum from T. parva immune cattle and became
more marked when cattle were challenged several times with large
numbers of infected ticks (Musoke, Nantulya, Buscher, Masake and Otim,
1982). Preston and Brown (1985) also found the sporozoite neutralis¬
ing activity of serum to increase after sequential T. annulata sporo¬
zoite challenge and showed that two independent inhibitory mechanisms
were operating; one reducing sporozoite invasion of cells and the
other retarding the transformation of trophozoite infected mononuclear
cells into proliferating macroschizont infected cells.
The sporozoite neutralising action of immune serum was effective
against homologous and heterologous T. annulata sporozoites but T.
parva immune serum had little effect on the infectivity of T. annulata
sporozoites (Gray and Brown, 1981).
More recently, two groups working on T. parva have each pro¬
duced an antisporozoite monoclonal antibody with similar ability to
neutralise sporozoite infectivity (Dobbelaere et al., 1984; Musoke
et al., 1984). Significantly, both monoclonals neutralised sporozoites
from a range of T_. parva stocks, some of which do not cross protect
in in vivo cross-immunity trials.
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c) Cell mediated responses
Evidence that cattle which recover from infection with material
containing schizont-infected cells are immune (Sergent et al., 1945;
Neitz, 1957; Tsur, 1965) and that antibody against the macroschizont
stage is not protective (Hulliger et al., 1965; Wilde et al., 1974)
led those working on immunity to Theileria to consider it likely that
cell mediated mechanisms, acting on the macroschizont or the macro¬
schizont infected cell, were responsible for protective immunity.
Emery (1981) strengthened this belief when he succeeded in
transferring immunity to ECF between calves by inoculating suscept¬
ible calves around the time of infection with syngeneic thoracic
duct lymphocytes harvested from their T. parva immune chimaeric twins.
The protection afforded by this cell transfer, while an exciting
result, gave little indication as to the nature of the effector
mechanisms. This aspect was being investigated for T. parva in vitro
using peripheral blood mononuclear (PBM) cells isolated from cattle.
Pearson, Lundin, Dolan and Stagg (1979) had demonstrated mixed
lymphocyte reactions in PBM from immune and non-immune cattle when
exposed to T. parva-infected cell lines _in vitro. Functional activity
was assayed in these responding PBM populations and only PBM from
ECF immune cattle were found to possess cytotoxicity directed against
T. parva transformed cell lines (ibid). Emery, Eugui, Nelson and
Tenywa (1981) and Eugui and Emery (1981) showed this cytotoxicity to
change from non-specific to specific with the development of immunity
such that immune cattle possess genetically restricted cytotoxic cells
which lyse autologous but not allogeneic infected target cells.
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Morrison, Goddeeris, Teale, Baldwin et al. (1986a) give a com¬
prehensive account of the current knowledge of cell mediated immune
mechanisms operating on T. parva macroschizont-infected cells on
which much of the work on immunity to T. annulata was based, as
reviewed by Hall (1988) .
Immunity to the macroschizont stage of T. annulata.appears to
be the result of the combined effects of three immune cell types,
two with cytotoxic and one with cytostatic activity. Cells from
cattle destined to recover from primary infection show two waves of
cytotoxic activity. The first exhibits BoLA restriction, where BoLA
defines the Class I bovine major histocompatibility complex (MHC) pro¬
file. Thus, these cytotoxic cells will kill infected cell lines which
are BoLA matched (i.e. have the same BoLA type as themselves) and not
those which are mismatched (Preston et al_. , 1983) . The second wave
of cytotoxic cells do not show BoLA restricted killing (ibid). Over
a more prolonged period, which includes the time when cytotoxic cells
are active, adherent cells exhibit cytostatic effects on macroschizont-
infected cells (Preston and Brown, 1988). This cytostasis is not BoLA
restricted and is mediated via a soluble factor. Preston and Brown
(1988) speculate that tumour necrosis factor (Cerami and Beutler,
1988) may be responsible and may also account for the inhibition of
transformation of trophozoite-infected cells by immune serum (Preston
and Brown, 1985; Hall, 1988) . The adherent cells secreting this factor
•/ are presumed to be macrophages. The identify of the cytotoxic cells
has been inferred primarily from their properties and also partly
by analysis using monoclonal antibody markers for specific cell types
(E. A. Innes , personal communication). Those showing BoLA restriction
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appear to be genetically restricted cytotoxic T cells, while the non-
restricted cytotoxic cells appearing later are probably natural killer
cells (Preston et ad. , 1983). On challenge, similar effector mechan¬
isms are activated. Cytostatic cells appear and show the same kin¬
etics as during primary infection (Preston and Brown, 1988) . The
cytotoxic cells appear a little earlier and again show two peaks of
activity. However, both peaks tend to consist predominantly of BoLA
restricted cytotoxicity (Preston _et ad. , 1983) . This reflects the
activation of memory cytotoxic T cells rather than natural killer cells
which do not become established in the immunological memory (Roitt,
Brostoff and Male, 1985).
These cytotoxic and cytostatic cells are assumed to recognise
either a parasite antigen or an altered host antigen on the surface
of the macroschizont-infected cell. Shiels et ad. (1986a) have raised
monoclonals to T. annulata-infected cell lines. One of these not
only reacts specifically with the surface of infected cells but also
mediates complement lysis of such cells (Preston _et al., 1986) . It
is not yet known if this antigen is recognised by bovine T cells.
The cell mediated immune responses to sporozoite, merozoite and
piroplasm stages have not been investigated. Eisler (1988) remarked
upon the appearance of large numbers of macrophages in the lymph node
draining the site of infection. These macrophages were present in
the lymph nodes of calves surviving the acute stages of infection,
whether or not the calves were destined to recover, and exhibited
marked erythrophagocytosis - both uninfected and infected erythrocytes
being ingested. Whether this represents a significant cell mediated re¬
sponse with relevance to protective immunity, akin to the role of
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macrophages in immunity to babesiosis (Losos, 1986) has yet to be
determined. The failure of immune serum to recognise the surface
of the piroplasm-infected cell suggests that opsonisation by anti¬
body is not a feature of antitheilerial immunity (Glascodine, personal
communication).
1.2.7. Immunisation
Present methods of immunisation against Theileria depend on
establishing active infection in the bovine host using either sporo-
zoites or schizont-infected cells (Pipano, 1977; Brown, Crawford,
Kanhai, Njuguna and Stagg, 1978; Radley, 1978).
Infected blood containing schizonts of a mild T. annulata
strain was being used very early on as a crude form of vaccination
(Sergent, Donatien, Parrot and Lestoquard, 1932). This meant that
there was little impetus for developing an alternative type of immun¬
ising material for tropical theileriosis (Brown, 1981). In contrast,
transmission of T. parva using infected blood proved highly inconsist¬
ent and was abandoned as a means of immunisation (Theiler, 1912;
Theiler and du Toit, 1929). Largely for this reason, most work on
immunisation methods involving sporozoites has been performed using
T. parva and, following the encouraging results using a blood vaccine
for T. annulata (Sergent et _al., 1932), methods using schizont material
have been developed in laboratories working on tropical theileriosis
(Tsur and Adler, 1965; Pipano and Tsur, 1966). In both instances,
immunisation is believed to be effected solely as a result of infection
of the animal.
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a) Immunisation with sporozoites
The principles of the infection and treatment method of immun¬
isation developed for ECF (Radley, 1981) can be applied to T. annulata
(Samish and Pipano, 1981). In this, cattle are deliberately infected
with virulent sporozoites and simultaneously treated chemoprophylact-
ically such that mild or inapparent infections result but immunity
is still able to develop (Radley, 1981) .
The achievement of a practical infection and treatment method
followed on from three important developments: infection of cattle
with ground up ticks (Theiler and du Toit,1929), the cryopreservation
of ground up infected tick suspensions allowing stocks of sporozoites
of proven and titrated infectivity to be stored (Cunningham, Brown,
Burridge and Purnell, 1973), and the observation that administration
of tetracyclines during the prepatent period of ECF limits the clini¬
cal reaction (Neitz, 1953). The considerable effort involved in
refining this method to its present state has been reviewed and
summarised by Brocklesby and Bailey (1965), Cunningham (1977), Purnell
(1977) and Radley (1981). The chemoprophylactic component still re¬
lies primarily on the use of tetracyclines usually given as a long
acting formulation of oxytetracycline (Terra LA, Pfizer) on day 0
or as a short acting preparation on days 0 and 3 or 4 after infection
(Gill, Bhattacharyulu, Kaur and Singh, 1978; Young et al., 1988).
More recently the discovery of a new series of theilericidal quinones;
menoctone (McHardy, Haigh and Dolan, 1976), parvaquone (Clexon, Well¬
come; McHardy and Morgan, 1981) and buparvaquone (McHardy, Wekesa,
Hudson and Randall, 1985), has made another group of compounds avail¬
able for chemoprophylaxis and chemotherapy of theileriosis (Dolan, 1981).
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There are good indications that T. annulata is also susceptible to
their effects (Brown and Masign, 1981; Taylor, 1985), buparvaquone
being particularly effective. The observation that the early use of
menoctone could block infection so effectively that no immunity
developed (McHardy et al., 1976) served as a warning that the timing
of the chemoprophylactic use of parvaquone and buparvaquone may have
to be delayed until several days after the inoculation of sporozoite
stabilate to permit effective immunisation (Dolan, 1981; Young et
al. , 1988) .
As part of a series of experiments with the tissues of T. parva-
infected ticks, inactivated sporozoites were administered with adju¬
vants. These caused no reaction to inoculation and left the recipient
cattle susceptible to ECF (Wilde, Brown, Hulliger, Gall and MacLeod,
1968). Subsequent to this and in the light of the success of those
working on malarial sporozoites, the effects of gamma irradiation on
the infectivity and immunogenicity of Theileria sporozoites were studied
(Cunningham, Brown, Burridge, Musoke, Purnell and Dargie, 1973; Purnell,
Burridge, Cunningham, Emu, Irvin, Ledger, Njuguna, Payne and Radley,
1974; Srivastava and Sharma, 1977; Singh, Jagdish and Gautam, 1979).
Irradiated malarial sporozoites have been used in similar experiments
with some success from an early date. Mulligan, Russell and Mohan
(1941) used ultraviolet light to irradiate avian malarial sporozoites
and obtained a substantial degree of protection against lethal chall¬
enge. More recently, others have successfully immunised animals with
the irradiated sporozoites of Plasmodium berghei (Nussenzweig, Vander-
berg and Most, 1969a) and Plasmodium knowlesi (Gwadz, Cochrane,
Nussenzweig and Nussenzweig, 1970).
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None of the in vivo experiments using either T. parva (Cunningham
et al. , 1973; Purnell est ad. , 1974) or T. annulata (Srivastava and
Sharma, 1977; Singh et al., 1979) irradiated sporozoites have shown
effects which cannot be explained simply as an effective reduction
in the number of infective sporozoites. There was no evidence of
true attenuation; thus cattle which were immune to challenge had all
shown evidence of infection establishing during immunisation while
those which were susceptible had not. However, studying the effects
of irradiation _in vitro, Brown (1981) reported that T. annulata
sporozoites irradiated at 640 Gy did lose the ability to transform to
macroschizonts although they still entered host cells. Those sporo¬
zoites exposed to lower doses of irradiation still infected and trans¬
formed bovine lymphoid cells but their ability to do so was impaired,
their infectivity being inversely proportional to the irradiation dose
used as suggested by the in vivo results.
b) Immunisation with macroschizonts or macroschizont-infected cells
While immunisation against ECF, based on the use of the T. parva
sporozoite infection and treatment method, is still in Its infancy,
T. annulata immunisation is being put into practice in many of the
countries where tropical theileriosis is endemic. This now involves
the inoculation of macroschizont-infected mononuclear cells taken from
in vitro cultured cell lines (Pipano, 1977). Long term passage of
such cell lines causes them to become attenuated such that their patho¬
genicity is markedly reduced but their infectivity is left unimpaired
(Pipano and Tsur, 1966; Hooshmand-Rad, 1973). When tissue culture
cells are inoculated, infection transfers from the donor cells to those
of the recipient (Wilde, Hulliger and Brown, 1966; Brown et al., 1978).
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This transfer to the cells of the animal being inoculated is believed
to be essential for the stimulation of protective immunity which
correlates with the knowledge that the cytotoxic T cells involved are
genetically restricted (Emery et al., 1981; Eugui and Emery, 1981;
Preston et al_. , 1983) . The mechanism of transfer of the macroschizont
from the cells of the inoculum to those of the new host is not yet
understood but it is seen that T. annulata transfers much more readily
than T. parva (Brown, 1981) . This inability of T. parva macroschizonts
to transfer efficiently is thought to be responsible for the poor
results observed when cattle are immunised against ECF with allogeneic
T. parva-infected lymphoblastoid cell lines, successful immunisation
only being obtained when large numbers of cells are inoculated (Brown
et _al.,1978; Brown, 1981). T. parva-infected cell lines which are
autologous (Buscher, Morrison and Nelson, 1984) or BoLA matched with
the recipient cattle (Dolan, Teale, Stagg, Kemp et al., 1984) esta¬
blish infection and subsequent immunity in a majority of animals when
only small numbers of cells are inoculated, comparable to the number
of T. annulata-infected cells required when the BoLA relationship
between the inoculated cells and the recipients is unknown (Pipano,
1981). Apart from the excessive number of cultured cells which would
be required to reliably infect most cattle with T. parva macroschizont
infected cells, this method of immunisation is not practical in the
field because inevitably a proportion of the immunised animals would
have a similar BoLA type to that of the donor cells resulting in lethal
infections establishing (Morrison and Buscher, 1983). Spooner et al.
(1988) suggests that this difference between T, parva and T. annulata
is because they infect different cell types; T. parva transforming T
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cells, B cells and null cells (Baldwin, Black, Brown, Conrad et al.,
1988) and T. annulata infecting Class II positive cells, monocytes
and B cells (Spooner et al., 1988) .
Immunity to tropical theileriosis stimulated by immunising with
attenuated allogeneic macroschizont-infected cells has two components;
one being antiparasite as described earlier, the other being antiBoLA
and consisting of cytotoxic T cells which recognise the allogeneic
donor cells as foreign (Innes, Millar, Brown and Spooner, 1988). In
an experiment involving challenge with the same material as used for
immunisation, cattle showed marked antiBoLA and minor antiparasite
responses (Innes _et aJ_. , 1988) . Evidence from this experiment and
another performed by Pipano et al. (1977) suggests that a graft re¬
jection phenomenon occurs when allogeneic cell lines are used to
immunise which can significantly (Innes et a_l. , 1988) or even totally
(Pipano _et a_l. , 1977) block parasite transfer to the recipient. This
has important implications, especially as this form of vaccination
is being widely adopted, since if revaccination becomes necessary
it may prove ineffective in boosting immunity to the parasite.
Another problem which may afflict vaccination campaigns depend¬
ent on macroschizont immunisation is that the immunity may be less
broad spectrum and less complete when subjected to tick challenge than
that afforded by an immunisation method based on the sporozoite- stage
(Sergent et al. , 1939b; Pipano, 1978 and Musoke _et al., 1984) .
As was the case for sporozoites, inactivated schizont material
has not stimulated protective immunity, whether crude (Wilde, 1967)
or purified to a greater or lesser degree (Wagner et al., 1874;
Pipano et al., 1977; Emery et al., 1986).
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c) Immunisation with piroplasms
The possibility of immunising cattle with piroplasms remains
relatively unexplored. Irvin and Gill (1981) point out that the
pathogenic effects of the macroschizont stage would not be prevented
and that such a vaccine would be similar to a malaria gamete vaccine
(Carter and Chen, 1976) since it would benefit the host population
more than it would benefit the individual. A vaccine based on the
piroplasm stage might prove more beneficial in reducing the severity
of T. annulata infection than T. parva because of the more severe
anaemia which occurs in the former (Barnett, 1968).
Wagner et _al. (1974) were unable to stimulate protective immun¬
ity in cattle immunised with extracted piroplasm antigen in spite
of the high antipiroplasm antibody titres they developed. Attempts
to immunise cattle using separated piroplasm-infected red blood cells
have only succeeded due to contamination of the immunising material
with schizont-infected mononuclear cells (Pipano, 1972).
There is no reported work on immunisation with the merozoite
stage of either T. annulata or T. parva, principally because of the
difficulty in obtaining reasonable quantities of this stage of the
parasite (Morrison, Lalor, Goddeeris and Teale, 1986b) .
37
1.3. RECOMBINANT DNA VACCINES
The production of recombinant DNA vaccines involves strategies
designed to prepare, select, clone and express individual genes or
gene fragments from pathogens of man and animals. The biotechnology,
developed within the last 15 years, has given rise to, perhaps, the
most dynamic and potentially rewarding of areas in the search for
novel methods of disease control. It involves the splicing of a
segment of foreign DNA into the DNA of a vector such as a bacterial
plasmid or double stranded DNA bacteriophage. The vector is then
transferred into a host cell where replication and regulated ex¬
pression of the foreign DNA occurs along with the DNA of the vector.
This provides a source of defined antigenic material and the basis
for a genetically engineered subunit vaccine.
1.3.1. Advantages
Whether it is worth attempting to develop a recombinant vaccine
depends on the characteristics of a particular pathogenic organism
and whether existing methods of immunisation are satisfactory. Thus
a vaccine like that for yellow fever virus which is safe, effective
and long lasting (WHO, 1957) is unlikely to be superceded by a sub-
unit vaccine. Even for those diseases where in the future a subunit
vaccine could supplement or replace an existing one with advantage
the changeover is likely to be slow; whole organism vaccines have a
time proven effectiveness.
The most powerful drive for developing a recombinant vaccine
is for diseases where there is no readily available method of immuni¬
sation. Hepatitis B is one such example. Since the virus cannot
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readily be grown in culture, the surface antigen of the virus used
as the vaccine had to be obtained from the plasma of chronic carr¬
iers making it both expensive and inaccessible (Arnon, Shapira and
Jacob, 1983) .
A closer analogy to the disease being examined in this thesis
is malaria. There is a pressing need for an effective vaccine for
malaria and intensive research is in the process of producing and
testing recombinant proteins which represent antigens from different
stages of the life cycle (Howard, 1987) .
Development of a recombinant vaccine may allow a novel appli¬
cation in the control of a disease for which a more conventional
vaccine is also used. The recombinant vaccinia virus vaccine for
rabies, in which the immunogenic surface glycoprotein of the rabies
virus has been inserted into the genome of the vaccinia virus, is
effective by oral administration. The vaccinia virus replicates in
tonsillar tissue and the amplified expression of the rabies virus
glycoprotein is sufficient to stimulate high neutralising antibody
titres in the mammalian host which are protective on challenge with
street rabies virus (Blancou, Kieny, Lathe, Lecocq et al., 1986).
Effective immunity provided by oral dosing is unique to this form
of rabies vaccine and means that it could be used to immunise wild¬
life and so help prevent the spread of rabies.
The use of whole and particularly, live organisms as vaccines
can sometimes cause individual cases, or even outbreaks, of clinical
disease. This can occur through mutations of the genotype as in the
reversion to virulence of attenuated live oral poliovirus vaccines
(Kew, Nottay, Hatch, Nakano and Obijeski, 1981). Much too often
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foot and mouth disease outbreaks have followed the use of batches
of incompletely inactivated virus tovaccinatecattle (FAO, 1981).
This is a risk for many vaccines and, since the starting material
for their manufacture is a live, fully virulent, organism, any
laboratory involved in their production is a potential source of
infection. Escapes do occur, foot and mouth disease virus again
being an example where this has occurred (FAO, 1981) .
The motivation behind the production of a recombinant vaccine
for foot and mouth disease has, therefore primarily been the need
for a safe vaccine since the existing vaccine is efficient and cheap
(Pereira, 1981). In fact, researchers have moved on from recombin¬
ant foot and mouth disease proteins to synthetic peptides represent¬
ing portions of the immunogenic viral protein 1. One such peptide,
when coupled to keyhole limpet haemocyanin and mixed with adjuvant,
given on a single occasion to guinea pigs, stimulated neutralising
antibody and protected them from challenge with live foot and mouth
disease virus (Bittle, Houghton, Alexander, Shinnick et al., 1982).
As mentioned for poliovirus, mutations can occur during repli¬
cation of the attenuated vaccine organism. This is believed to be
a possible origin of canine parvovirus which may have resulted from
a batch of feline enteritis vaccine in which a mutation had occurred
to change the host specificity of the virus (McCandlish, 1979).
These points are of direct relevance to vaccination against
theileriosis. Even when properly attenuated, inoculation of schizont
infected cells and the establishment of infection in the recipient
can cause clinical reactions in some individuals (Pipano, 1977) . In
the infection and treatment method, clinical reactions are more common,
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their frequency being related tb the parasite stock and the chemo-
prophylactic regime adopted (Radley, 1981). Both methods of immun¬
isation can result in the carrier state where immunised animals
harbour low numbers of piroplasms (Sergent et al., 1945; Barnett,
1977; Radley, 1981) . Carrier animals would not result from the
use of a recombinant vaccine assuming the immunity it stimulated
was strong enough to prevent infection reaching the piroplasm stage
on challenge. The carrier state is of concern because it makes
parasite available for the infection of ticks (Barnett, 1968) .
Situations where this matters would arise if immunised animals were
moved to theileriosis free areas which have the tick vector, or
if use of vaccine introduced new parasite stocks into an area and
immunity to local stocks was not cross-protective. This could put
unimmunised cattle at risk (Radley, 1981). Thus an effective recom¬
binant vaccine would be safer for both immunised and non-immunised
stock.
Other deleterious effects of using live vaccines which would
be avoided if a recombinant one was available, include allergic
reactions, immunosuppression and possible contamination with other
infectious agents. The inoculation of material derived from another
animal can cause reactions, particularly if repeated. Schizont
infected cells constitute such material and Ouhelli, Innes, Walker,
Brown et al. (1988) show that cattle immunised with 10® T. annulata
infected allogeneic cells underwent an early temperature rise which
was not seen in cattle receiving BoLA matched infected cell line.
The possibility of a graft rejection type of response to repeated
schizont immunisation has been discussed.
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Rinderpest vaccine has been suspected of causing immuno¬
suppression at the time of immunisation. While this was certainly
a problem with the goat-adapted virus vaccine, the tissue culture
derived vaccine employed now is much safer (Rossiter and Kariuki,
1987) although some still suspect the rinderpest vaccine virus
could interfere with the development of immunity to other vaccines
given at the same time (Jeggo, Wardley and Corteyn, 1987). In view
of the fact that the Theileria parasite infects and destroys cells
of the immune system, the use of vaccines which establish active
infection in the host may bring Theileria under suspicion as a
potential immunosuppressive agent.
The presence of contaminating infectious agents in the cells
or medium of a vaccine such as that used for T. annulata must be
checked for rigorously.
The use of recombinant DNA technology makes the task of pro¬
ducing and testing individual antigens easier in that large quanti¬
ties of recombinant protein are available for purification. An
antigen produced as a recombinant protein can be defined at the level
of both the DNA and the amino acid sequence which can yield valuable
information about both the protein and the immune response it elicits
(Bachrach, 1982) .
Lastly, the stability of a recombinant vaccine would make the
practicalities of storage, delivery and administration significantly
easier than the strict requirements for present Theileria vaccine
material and its limited life once resuscitated from storage in
liquid nitrogen (Brown, 1983).
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1.3.2. Hybridoma technology
Hybridoma technology and monoclonal antibody production are
subjects for review in their own right. With the advent of mono¬
clonal antibody technology, a powerful tool for the identification,
isolation and assessment of antigens, particularly parasite anti¬
gens, was made available. The progress towards the production of
recombinant proteins as potential vaccines has been greatly facili¬
tated by the use of monoclonal antibodies. For this reason, a
brief review of the techniques involved in their production is
included here.
The development of cell fusion techniques (Harris and Watkins,
1965) enabled Ktthler and Milstein (1975) to produce hybridoma cell
lines by fusing spleen cells from immunised mice with murine myeloma
cells using inactivated Sendai virus. The standard technique for
cell fusion in hybridoma technology follows the same principles but
uses polyethylene glycol as the fusing agent (Goding, 1980). To
ensure that only hybrids grow following cell fusion a strategy
devised by Littlefield (1964) is followed in which the myeloma cell
line used is a mutant lacking the enzyme, hypoxanthine guanine
phosphoribosyl transferase (HGPRT). After fusion, the cells are
grown in hypoxanthine-aminoptermin-thymidine (HAT) medium (Szybalska
and Szybalski, 1962) which contains the folic acid antagonist, amin-
opterin. In the presence of aminopterin, the mutant myeloma cells
are unable to use salvage pathways to synthesis purines and they die.
However, if fused with spleen cells, which possess HGPRT, the result¬
ing hybrids can survive in HAT medium. Unfused spleen cells die
naturally after several days in culture (Goding, 1980).
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Since 1979, myeloma cell lines such as X63-Ag-8 clone 653
(Kearney, Radbruch, Liesengang and Rajewsky, 1979) have been avail¬
able. These are unable to synthesise or secrete their own immuno¬
globulin chains. Thus, antibodies secreted by hybridomas established
using these myeloma cells, derive only from stimulated spleen cells.
Once hybridomas secreting the desired antibodies have been identi¬
fied they are cloned (Goding, 1980; Oi and Herzenberg, 1980) to
obtain cell lines, each of which secretes unlimited quantities of
monoclonal antibody which, by definition, is specific for a single
antigenic determinant.
Pearson, Pinder, Roelants, Kar, Lundin, Mayor-Withey and
Hewett (1980) describe the application of the above technology to
the derivation and detection of antiparasite monoclonal antibodies,
in particular to Trypanosoma and Theileria species. Monoclonal anti¬
bodies have been raised against most parasitic protozoa and tend to
fall into two categories; those useful in diagnosis and detection
of antigenic diversity and those used to attempt to identify pro¬
tective antigens. Monoclonals of the former type have proved useful
in characterising different isolates or stocks of Plasmodium falci¬
parum (McBride, Walliker and Morgan, 1982; Knowles, Davidson, McBride
and Jolley, 1984) , Leishmania braziliensis (McMahon, Pratt, Bennett
and David, 1982) , Theileria parva (Pinder and Hewett, 1980; Minami,
Spooner, Irvin, Ocama, Dobbelaere and Fujinaga, 1983), Theileria
annulata (Shiels, McDougall, Tait and Brown, 1986b) and others.
There are numerous examples of monoclonal antibodies raised
against parasite antigens which may play a role in stimulating pro¬
tective immunity (Gamble, 1987). The beauty of this approach is that
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the functional antiparasite activity of antibody, which by definition
is known to interact with a single parasite molecule to exert its
effects, can be assessed using in_ vivo or in vitro techniques. In
this manner, some prediction can be made of the likelihood of a
particular parasite antigen being a useful candidate as a vaccine.
To give a few examples; monoclonal antibodies have been sel¬
ected which identify stage specific antigens of the malaria parasite.
Amongst those recognising the sporozoite stage are some of parti¬
cular interest which neutralise sporozoite infectivity (Yoshida,
Nussenzweig, Potocnjak, Nussenzweig and Aikawa, 1980). Antigens on
the blood stages of Plasmodium falciparum have been identified by
monoclonals which inhibit parasite multiplication (Saul, Myler,
Schofield and Kidson, 1984) . Affinity purification of a major sur¬
face antigen (p 190) of late blood stages of this parasite was made
possible using a monoclonal antibody (Hall, Hyde, Goman, Simmons
et al., 1984). Subsequent immunisation trials using the purified
protein suggested that p 190 can protect monkeys from falciparum
malaria (ibid). Antigamete monoclonal antibodies raised against
Plasmodium gallinaceum are able to block transmission of malaria
by suppressing the infectivity of the parasites to Aedes aegypti
mosquitoes (Kaushal, Carter, Rener, Grotendorst et al., 1983) .
Similar work has yielded useful monoclonals against other
protozoan parasites which show the ability to inhibit infective
stages from entering their target cells, as described for the sporo-
zoites of Eimeria tenella (Danforth, 1983) , Eimeria bovis (Whitmire,
Kyle, Speer and Burgess, 1988) and Theileria parva (Musoke et al. ,
1984; Dobbelaere et al_. , 1984) or the Babesia divergens merozoite
(Winger, Canning and Culverhouse, 1987) .
*
1.3.3. Development of recombinant vaccines for malarial sporozoites
and hepatitis B virus
Ideally, the choice of vector and expression system results in
the production of a recombinant protein possessing the same bio¬
chemical characteristics, and therefore potentially the same immuno¬
genic and protective properties, as the native molecule. The like¬
lihood of this being achieved, using any one strategy, is hard to
predict and is best described with reference to two examples. These
detail the development of potential malaria sporozoite and hepatitis
B vaccines.
a) Malarial sporozoites
Monoclonal antibodies which recognise the circumsporozoite
(CS) protein of the infective, sporozoite, stage of malaria may block
sporozoite infectivity in vitro (Hollingdale, Zavala, Nussenzweig
and Nussenzweig, 1982) and _in vivo (Potocnjak, Yoshida, Nussenzweig
and Nussenzweig, 1980) . This circumsporozoite protein has been shown
to possess a single immunodominant region in which different mono¬
clonal antibodies raised against the sporozoite surface react with
identical epitopes. These monoclonals also inhibit the subsequent
binding of polyclonal antisera from mice and man immunised with
irradiated sporozoites, indicating that they also recognise this
region (Zavala, Cochrane, Nardin, Nussenzweig and Nussenzweig, 1983).
The CS proteins from different Plasmodium species are structurally
similar and are not glycosylated (Santoro, Cochrane, Nussenzweig,
Nardin et al., 1983).
Analysis of the CS protein after its synthesis as several sub-
unit peptides revealed that a sequence of eight amino acids form the
4
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epitope (Schlesinger, Cochrane, Gwadz, Godson et al., 1984). Since
short peptide regions were found to contain the relevant epitope,
complex folding of the molecule was unlikely to be a requirement
for epitope formation. This feature, together with the absence of
glycosylation, made expression in E. coli likely to be successful.
These indications were subsequently found to be correct and the gene
coding for the circumsporozoite protein from several Plasmodium
species has been cloned and expressed in E_. coli (Ellis, Ozaki,
Gwadz, Cochrane et al., 1983; Enea, Arnot, Schmidt, Cochrane et al.,
1984a; Young, Hockmeyer, Gross, Ballou et al., 1985) . The whole CS
gene from Plasmodium knowlesi and Plasmodium falciparum has been
cloned and sequenced (Ozaki, Svec, Nussenzweig, Nussenzweig and
Gordon, 1983; Dame, Williams, McCutchan, Weber et al., 1984; Enea,
Ellis, Zavala, Arnot et al., 1984b). These groups have shown the
CS protein to consist of multiple tandem repeats in the amino acid
sequence such that, when expressed, about half of each CS molecule
consists of epitope repeats. It is therefore not surprising that
this epitope shows such strong immunogenicity (Nussenzweig and
Nussenzweig, 1984).
The expressed recombinant peptides of the Plasmodium falciparum
CS protein are of particular importance because of their potential
use as a vaccine for human malaria. When it was revealed that, if
the whole CS protein was expressed in E. coli, the expressed product
was unstable (Dame et al., 1984; Young et al., 1985), gene fragments
were introduced into plasmid vectors which, on expression in E. coli,
yielded recombinant proteins which corresponded to peptide repeats
containing the CS epitope. These were found to be immunogenic in
4
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mice and the polyclonal non-specific sera raised were shown to
block sporozoite invasion of human hepatoma cells in vitro (Young
et al. , 1985; Mazier, Mellouk, Beaudoin, Texier et al., 1986).
Subsequent immunisation trials in human volunteers have only achieved
low levels of antibody and partial protection has only been engen¬
dered in individuals repeatedly inoculated with high doses of the
recombinant protein (Ballou, Sherwood, Neva, Gordon et al., 1987).
Whether this reflects the fact that antibody to the CS protein is
not alone sufficient to protect humans from malaria or whether the
current developments in antigen presentation (Que, Cryz, Ballou,
Fhrer et_ a_l. , 1988) will overcome these difficulties remains to be
seen.
b) Hepatitis B virus
In order to obtain the immunogenic surface antigen of hepatitis
B virus (HBsAg) it was necessary to extract it from the plasma of
hepatitis B virus carrier donors which was both expensive and labor¬
ious , requiring careful monitoring of vaccine material to ensure that
no live virus was present (Tiollais, Charnay and Vyas, 1981). There
was, therefore, considerable drive for the production of an alterna¬
tive means of producing HBsAg. The native HBsAg from plasma occurs
as spherical or tubular 22 nm particles formed through complex fold¬
ing of the molecule (Tiollais et al., 1981) . This, and the presence
of glycoprotein, made it appear that complex post-translational
modification would be required to obtain anything resembling the
native HBsAg and retaining its properties. In spite of the fact that
no such post-translation modification will occur in E. coli, several
4
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groups used this expression system to clone and express genes
from the hepatitis B virus. As predicted, E. coli has not been
selected as the expression system for production of recombinant
HBsAg for vaccine purposes. Yields were found to be low (Pumpen,
Kozlovskaya, Borisova, Bichko et a_l. , 1984) and the conventional
determinants recognised on native HBsAg which are related to pro¬
tective immunity, were not recognised on the HBsAg expressed from
_E. coli, presumably because of the absence of structural changes
and glycosylation (Fujisawa, Ito, Ikeyama and Kikuchi, 1985). How¬
ever E. coli was not abandoned as an expression system for hepatitis
B virus. The core antigen of the virus has been expressed fused to
B-galactosidase in E. coli (Cohen and Richmond, 1982). The expressed
product forms particles equivalent to 27 nm core particles isolated
from the human liver (ibid). These recombinant core particles are
immunogenic in laboratory animals and may well be of diagnostic value
(Stahl, MacKay, Magazin, Bruce and Murray, 1982). Of interest regard¬
ing HBsAg expressed in _E. coli is the disclosure that, although the
recombinant protein does not contain the protective epitopes of the
native HBsAg, it does bear epitopes on another region of the protein
which enables the HBsAg to bind human serum albumin (Fujisawa et al.,
1985). This, so called, human serum albumin receptor has been impli¬
cated as the mechanism by which the hepatitis B virus exhibits hepato-
tropism (Tiollais _et _al. , 1981) .
In further attempts to obtain recombinant HBsAg bearing intact
and immunogenic protective epitopes, the relevant gene was cloned
into plasmid vectors and expressed in the yeast, Saccharomyces
cerevisiae (Valuenzuela, Medina, Rutter, Ammere and Hall, 1982).
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The multimeric HBsAg complexes expressed in yeast cells are similar
to the 22 nm particles and possess the complete antigenic activity
of native HBsAg (Valuenzuela et ail. , 1982) . The ability of eukary-
otic yeast cells to yield a recombinant protein bearing the protect¬
ive epitopes of HBsAg, in spite of their inability to glycosylate
proteins, may reflect the closer similarity in gene expression and
protein synthesis between yeast cells and eukaryotic mammalian cells
compared to that between the prokaryote E. coli and mammalian cells
(Old and Primrose, 1985). Chimpanzees immunised with yeast derived
recombinant HBsAg were protected from challenge with high doses of
infective hepatitis B virus (Murray, Bruce, Hinner, Wingfield et al.,
1984) after which immunisation trials were performed in humans.
In these, the antibody responses of human recipients of this
yeast derived recombinant HBsAg have been compared with the responses
of those given HBsAg extracted from plasma. No significant differ¬
ences were observed between the two in terms of quantity, quality or
specificity of antibody response (Brown, Stanley, Howard, Zuckerman
and Steward, 1986). The development of this recombinant immunogen
has been so successful that it has become available as commercial
vaccine (Engerix B, Smith, Kline and French).
A third host cell expression system has been used to express
cloned hepatitis B virus genes in mammalian cells.
The HBsAg gene has been expressed in cultured rat and mouse
cell lines (Siddiqui, 1983) as have other genes of the hepatitis B
virus (Gough and Murray, 1982). Early work by Hirschman, Price,
Garfinkel, Christman and Acs (1980) succeeded in expressing the whole
genome of the hepatitis B virus in HeLa cells. The cells showed
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marked cytopathic changes and hepatitis B core and surface antigens
were produced in culture. Under the electron microscope these could
be seen to form the 42 nm particles with central cores typical of
the intact virus (ibid). This effectively meant that a method for
studying hepatitis B virus and its effects on cells _in vitro had been
developed and also, by showing HeLa cells to be susceptible to the
cytopathic effects of the virus, provided an in vitro system for
testing sera and vaccines for the presence of live hepatitis B virus.
Thus, while the requirements for expression of an immunologi¬
cally effective recombinant protein may narrow the choice of expression
systems available, each system has its merits and it may be only by
using each system that these are revealed.
1.3.4. Bacteriophage lambda gtll expression system
a) Molecular biology
Bacteriophage lambda gtll (Agtll) is an expression vector
constructed from other Agt phage vectors and described by Young and
Davis (1983a and b) . Xgtll contains the E. coli lac Z gene and
within the B-galactosidase coding region is a unique EcoRl digestion
site, upstream of the B-galactosidase translation termination codon.
Insertion of foreign DNA into this EcoRl site inactivates the
B-galactosidase and cells bearing recombinant phage are therefore
unable to utilise the chromogenic substrate, 5-bromo-4 chloro-3-
indolyl-B-D-galactosidase (X-gal). Growth in the presence of X-gal
yields blue colonies for non-recombinant and white colonies for recom¬
binant phage (Miller, 1972) allowing identification and selection of
recombinants. Up to 8.3 kb foreign DNA can be inserted into Agtll
and leave it functional (Old and Primrose, 1985) .
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E. coli cells infected with recombinant Agtl1 express the
foreign DNA inserts as B-galactosidase fusion proteins. This ex¬
pression is under the control of prokaryotic gene signals of Eh coli
and is induced in the presence of isopropyl B-D-thiogalactopyranoside
(IPTG). If the DNA insert is in the correct orientation and reading
frame, the induced fusion protein contains a sequence of amino acids
identical to that of the native protein. Antibodies can then be used
in a screening immunoassay to select recombinants containing the DNA
sequence coding for a particular protein. Young and Davis (1983a)
first described model Agtll recombinants containing mouse o<-amylase
and chicken ovalbumin cDNAs as inserts. Then Kemp, Coppel, Cowman,
Saint, Brown and Anders (1983) applied the technique to isolating
cDNA clones coding for malarial blood stage antigens using human
serum to screen the recombinant phage. Since then,Agtll expression
libraries have been constructed using genomic or circular DNA from a
wide spectrum of parasitic organisms such as protozoa (Gill, Timms
and Kemp, 1987) , cestoda (Bowtell, Saint, Rickard and Mitchell, 1984)
and trematoda (Lanar, Pearce and Sher, 1985). In certain Eh coli
strains, Agtll phage undergoes replication by the lytic cycle cells
lysing as the phage propagates, thus forming a visible phage plaque
(Herskowitz, 1973) . In addition, the foreign DNA expressed by recom¬
binant Agtll may result in a foreign protein which is toxic to the
host cell and might kill it before sufficient amounts of the antigen
are produced. These problems do not prevent such strains being used
as hosts for Agtll during library screening; large amounts of lac
operon repressor (product of the lac 1 gene) prevent lac Z directed




formation (Huynh, Young and Davis, 1985). Only when the number of
infected cells around the plaque is reasonably large is lac Z-directed
expression induced by the addition of IPTG (ibid). In this way de¬
tectable amounts of the recombinant protein are produced and bound
by the nitrocellulose paper before being degraded where they are
available for screening with antibody (Young, Bloom, Grossikinsky,
Ivanyi e_t al. , 1985) . Since the objective of cloning genes in Agtll
is usually to obtain substantial amounts of recombinant protein,
these IS. coli strains are only suitable for library screening and
alternative strains have been developed for expression of larger
amounts of recombinant protein (Young and Davis, 1983a). These con¬
tain a mutation (hf1 A 150) which enhances the frequency of phage
lysogeny. This means that cells infected with phage do not lyse
because the phage undergoes replication by the lysogenic cycle where
phage DNA is integrated with host cell DNA and divides in synchrony
with it (Herskowitz, 1973). Thus, high cell densities of lysogens
can be cultured before inducing lac Z-directed expression of the
recombinant protein.
b) Advantages
When recombinant DNA is expressed in IS. coli, the proteins
produced are potentially unstable due to the inherent tendency of
bacteria to rapidly degrade foreign polypeptides (Charnay, Gervais,
Louise, Galibert and Tiollais, 1980; Edman, Hallewell, Valenzuela,
Goodman and Rutter, 1981). By inserting DNA into the E_. coli lac Z
gene present in Agtll the recombinant protein is produced fused to
B-galactosidase. This close association with a normal bacterial
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protein has been shown to enhance the stability of the fusion pro¬
tein (Itakura, Hirose, Crea, Riggs et a_l. , 1977) . In addition E_.
coli strains which host Agtll are mutants deficient in protein
degradation pathways (Young and Davis, 1983a). Together these
features increase the yield of recombinant protein expressed by
increasing the lifetime of the fusion protein.
Another advantage of using the E. coli lac Z gene is that
the expression is under the control of Eh coli promoters, making it
more likely that the sequence of foreign DNA will be efficiently
transcribed and translated.
In a recombinant DNA library these two characteristics of
Agtll, efficient expression and increased stability of recombinant
proteins, increase the chances of detecting any one antigen when a
large number of recombinants are screened.
More recently, since immunisation trials have been used to
test recombinant proteins as vaccines (Murray et a_l. , 1984; Winther,
Allen, Bomford and Brown, 1986; Ballou _et a_l. , 1987) , the importance
of using carrier proteins (Que, Cryz, Ballou, Fttrer et al. , 1988) and
adjuvants (Zanetti, Sercarz and Salk, 1987) has been realised. In
this respect, the B-galactosidase portion of recombinant fusion pro¬
teins can act as a carrier protein (Shuman, Silhavy and Beckwith,
1980). It has already been established that antibodies are formed
against amino acid sequences located at the amino terminus end of B-
galactosidase (ibid). The principle behind the role of a carrier
protein is based on the realisation that small antigenic determinants
with specificity for, and capacity to react with, an Ig receptor on
a B cell were not able to stimulate an antibody response on their own.
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If these small peptides were coupled to an immunogenic molecule recog¬
nised by T cells (the carrier) an antibody response to the peptide
(the hapten) could be obtained in what is known as an anti-hapten
response (Mitchison, 1971, cited by Lachmann, Strangeways, Vyakarnam
and Evan, 1986). Thus, T cells would recognise determinants on the
carrier part of the fusion protein and deliver help to B cells which
recognise the hapten (Roitt et al_. , 1985) .
The relevant features of T\ annulata and tropical theileriosis,
particularly in relation to the development of the sporozoite stage,
immunity and immunisation, have been reviewed together with the curr¬
ent application of recombinant DNA technology to the development and
production of new non-infective subunit vaccines.
The role of immunity to the Theileria sporozoite in protection
remains unclear although _in vitro evidence that an effector mechanism
exists for antisporozoite antibodies to block sporozoite infectivity
has been described.
Given the progress of malariologists along a similar line of
investigation, a research project was initiated to identify and assess
Th annulata sporozoite antigens of potential importance in stimulating
protective immunity. Regardless of whether successful vaccine mater¬
ial was obtained,it was hoped that the study would help determine what
contribution antisporozoite immunity makes to protective immunity in
vivo. If successful vaccine material was produced this would not only
provide a non-infective vaccine, or a component of such a vaccine, with
greater ease of storage and handling in tropical conditions, but might
also, based on the sporozoite stage, induce immunity giving broader
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This chapter describes the work involved in the establishment
and maintenance of the Theileria life cycle in vivo and the Theileria
parasite in vitro. The provision of parasite material, the generation
of reagents such as peripheral blood lymphocytes and _in vivo cattle
experiments were essential requirements for work described in later
chapters and the basic methods behind each of these are detailed
below.
2.1. MATERIALS
Reagents which are not fully detailed in the text are described
in Appendix I.1. and Appendix III gives the full names and addresses
of supplier companies.
2.1.1. Culture media
a) Purified deionised water
Unless otherwise specified all water used was highly purified
as follows. The water was first deionised in a MILLI RO 60 water
purification system (Millipore) and at the same time purified by
reverse osmosis. The water was then given a final polishing with
a MILLI Q water purification system (Millipore).
The final product had a resistivity of 18 megaohms, indicating
a high degree of purity.
b) Sporozoite separation media
i) Surface sterilisation of ticks: Eagles minimum essential
medium (MEM Gibco, BRL) with Hanks' salts but without L-glutamine
and sodium bicarbonate was supplemented with double strength anti¬
biotics (200 units/ml penicillin, 200 jig/ml streptomycin) and
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nystatin (100 units/ml). Sterile 7.5% sodium bicarbonate solution
(Gibco, BRL) was added until the phenol red indicator in the medium
had turned orange (pH 7.0-7.2) . This medium was used to wash ticks
during surface sterilisation.
ii) Tick grinding media: When no further purification of sporo-
zoites was to be carried out, ticks were ground in Eagles MEM
supplemented as above and containing 3.5% bovine plasma albumin (BPA,
Armour Fraction V, Sigma). This medium, known as MEM/3.5% BPA, was
filter sterilised (0.22 pm, Millipore) before the addition of nystatin
and the pH was adjusted as above.
When sporozoites were to be purified further, ticks were ground
in Hanks balanced salt solution free of calcium and magnesium ions
and without sodium bicarbonate (Gibco, BRL) containing 1% BPA (Hanks
B.S.S./1% BPA) . Double strength antibiotics were included and the
pH adjusted using sodium bicarbonate solution as above. The medium
was filter sterilised (0.22 |um) after the BPA had been added.
In later experiments when sporozoites were purified prior to
protein analysis the BPA was omitted.
iii) Stock isotonic Percoll: Sporozoites were purified by
separation on a discontinuous density gradient prepared using media
of different densities. These media were prepared using stock iso¬
tonic Percoll (SIP). SIP had the same tonicity as the medium used
to grind ticks and was made by mixing Percoll (Pharmacia), a colloid
of silica particles, with concentrated Hanks B.S.S. with or without




Hanks B.S.S. x 10 5 ml
BPA 0.5 g
Sodium bicarbonate 1 mg
(Analar, BDH)
After filtering (0.22 |im)
2 ml of the above was
added to 20 ml Percoll.
without BPA
Hanks B.S.S. x 10 2 ml
Percoll 20 ml
The pH was adjusted using
sterile 1M hydrochloric acid
until the SIP was just turning
orange from red.
iv) Percoll gradient: The media of different densities used
to form the Percoll gradient were prepared from SIP and Hanks B.S.S.
mixed in different proportions. When BPA was being included it was
present in SIP and Hanks B.S.S., likewise when excluded it was
absent from both SIP and Hanks B.S.S. The volumes of SIP and Hanks
B.S.S. required to achieve the stated step densities were different,










1.095 76.0 7.60 2.40 5
1.070 54 .0 5 .40 4.60 5
1.050 36.0 1.80 3 .20 2
1.030 18 .0 0.90 4 .10 2
BPA:
1.095 76.5 7.65 2.35 5
1.070 55.5 5.55 4.45 5
1.050 39.0 1.95 3.05 2
1.030 22 .0 1.10 3.90 2
In order to form the Percoll gradient, the above media were
layered on top of each other in order of decreasing density into a
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thick walled 40 ml glass centrifuge tube (2.5 cm diameter, MSE 40)
held at 45° to the horizontal.
c) Cell culture media
i) Foetal calf serum: Foetal calf serum (FCS, Flow Labs.)
was used to supplement the media for all Theileria and hybridoma
cell lines. As some FCS batches are unsatisfactory for Theileria
culture, particularly T. parva culture, samples of prospective FCS
batches were tested for their suitability before purchase. The
growth of a fastidious T. parva cell line in medium containing the
test FCS was compared with its growth in the medium containing the
current FCS in use over at least three passages of the culture.
Early hybridoma cultures were supplemented with FCS specially
selected for their growth (Section 3.2.4, Myoclone, Gibco, BRL).
Once well established, the hybridoma cell lines were cultured in
the same medium as used for Theileria cell lines. FCS was heat
inactivated at 56 °C for 30 minutes and stored at -20°C.
ii) Complete medium - RPMI 1640/16.7% FCS: Liquid RPMI 1640
with 25 mM Hepes (Gibco, BRL) was originally described for use in
human leucocyte culture by Moore, Gerner and Franklin (1967).
Sterile supplements were added to give complete medium containing
16.7% FCS, 2 mM L-glutamine (Gibco) and 100 units/p.g per ml of
penicillin/streptomycin. The medium was stored at 4°C. Fresh gluta-
mine was added to unused medium after two weeks. This medium was
used to culture all Theileria-infected lymphoblastoid cell lines




All filters were obtained from Millipore.
i) 0.22 pm sterile Millex-GV filter units were used for
filter sterilisation.
ii) A 22 mm diameter glass microfibre AP prefilter and a 25 mm
diameter 8 pm high porosity cellulose ester MF filter were held
together in an O ring of a Swinnex filter holder and used to obtain
an 8 pm filtrate of ground up tick supernatants. They were steri¬
lised before use by autoclaving at 15 p.s.i. for 15 minutes.
b) Culture equipment
All glassware, such as bottles, flasks and centrifuge tubes;
some reusable plasticware and other autoclavable materials were
soaked in a non residue-forming detergent (0.5-1.0% Decon 75, Decon
Labs.), rinsed three times in tap water and three times in purified
deionised water and then sterilised by autoclaving at 15 p.s.i. for
15 minutes.
Glass pipettes were soaked in 0.5-1.0% Decon 75 and then
flushed 12 times with tap water, followed by three flushes with
purified water before being sterilised by dry heat in a hot air oven
at 170^180°C for 90 minutes.
Cultures were grown in disposable plastic vessels, either in
tissue culture wells of 2 cm2 , 1 cm2 (Costar) or 0.38 cm2 (Nunc,





Three uncloned stocks of Theileria annulata were used, each
isolated from a different geographic area and named accordingly as
Ankara from Turkey (Schein _et al. , 1975) , Hissar from India (Gill,
Bhattacharyulu and Kaur, 1976) and Gharb from Morocco (Ouhelli,
1985). All three stocks were brought to the Centre for Tropical
Veterinary Medicine (CTVM) , Edinburgh, in infected ticks; H_. a_.
anatolicum infected with Hissar or Gharb stocks and H_. a., excava turn
infected with the Ankara stock. Since then they have all been
passaged and maintained in II. a., anatolicum of Indian origin
(Bhattacharyulu _et al^. , 1975) .
One stock of T. parva was used. This was the Muguga stock
described by Brocklesby, Barnett and Scott (1961) . T. parva Muguga
was obtained in the tick, Rhipicephalus appendiculatus, from the
Muguga tick colony (Bailey, 1960) and was also used uncloned.
The species and stocks used in any particular experiment are
detailed in the relevant sections.
b) Storage
The Theileria parasites were stored as cryopreserved ground
up tick stabilates and macroschizont-infected cell lines in liquid
nitrogen. The methods of cryopreservation and resuscitation are
described in Sections 2.2.5. and 2.2.6.
c) Maintenance
In vivo maintenance of T. annulata in H_. a., anatolicum and
T. parva in Rhipicephalus appendiculatus was achieved by periodic
62
passage of parasite through calves as described by Walker, Fletcher,
McKellar, Bell and Brown (1985) for T_. annulata and Bailey (1960)
for T. parva. In vitro maintenance was by culture of established
Theileria-infected cell lines which is described fully in Section
2.2.5.
2.1.4. Cattle
Purebred and crossbred Bos taurus calves from dairy breeds
and of 2-6 months old were used. These were obtained from local
farms and kept in isolation for three weeks during which time their
health was monitored and screening for Salmonella infection carried
out. The calves were weaned onto a home produced pellet diet with
ad libitum hay and water. They were kept on straw litter in tick
free buildings and each calf was identified by an ear tag number.
2.2. METHODS
2.2.1. Ticks
The practical aspects of maintaining T. parva in Rhipicephalus
appendiculatus colonies have been described by Bailey (I960) and
Branagan (1969) while others reported methods of obtaining high
infection rates in ticks (Young and Leitch, 1981). Many of the
general principles can be applied to E. a_. anatolicum as a vector
for T. annulata as detailed by Walker _et al. (1985) .
The management and manipulation of ticks to enable the pro¬
vision of large numbers of sporozoites of the required stock when
necessary was mainly carried out by Dr. Alan Walker and Mrs. June
Fletcher. Those aspects relating to this study are outlined below.
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a) Infection of nymphal ticks
One thousand to 2,000 unfed nymphal ticks were applied to,
and confined on, a calf on day 8 of a primary infection. Engorged
ticks were collected daily from day 11 (day 3 post application) with
peak numbers dropping around day 13 to coincide with rising piro-
plasm parasitaemia. Unless the calf died, nymphs continued to drop
to about day 17. Figure 6 (a-d) shows the timing of nymph appli¬
cation and nymph drop in relation to the parasitaemia. Nymphs were
moulted and stored at 28°C and 18°C respectively. The infection
rates of the resultant adults was determined using methyl green and
pyronin stains (Walker, McKellar, Bell and Brown, 1979) to stain the
Theileria parasite within the activated acini of the tick salivary
glands.
Infection rates were generally very high for T. annulata with
100% of ticks and more than 300 acini per adult tick infected.
b) Challenge of calves
Infected adult ticks were allowed to feed on calves to provide
a challenge for several calves as detailed in Section 3.2.2. Equal
numbers of female and male ticks were confined to the calves' ears
in cotton bags.
c) Provision of infective sporozoites
In order to obtain infective sporozoites,infecting adult H.
a., anatolicum were partially fed for three days on the ears of
rabbits before being removed to harvest sporozoites (Walker _et al.,
1979). This partial tick feed stimulates sporogony and allows mat¬
uration of sporoblasts to sporozoites without significant loss of
parasite into the rabbit in the tick saliva.
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2.2.2. Isolation of sporozoites
Since this thesis centres on a study of the infective sporo-
zoite, the provision of ample quantities of this stage was of prime
concern. Mature sporozoites of high infectivity in crude tick
homogenates or homogenate filtrates were suitable for infection or
challenge of calves, stabilate preparation and _in vitro infection
of peripheral blood mononuclear cells (PBM).
For IFAT antigen or sporozoite protein analysis, clean sporo-
zoite preparations free of contaminating tick proteins were required.
The basic methods of sporozoite separation described here were
developed in response to these demands by previous workers (Brown,
Stagg, Purnell, Kanhai and Payne, 1973; Brown, 1979; Walker and
McKellar, 1983).
a) Ground up tick supernatant (GUTS) and GUTS filtrate
Three day fed adult Th annula ta infected H_. a. anatolicum
were washed with water, counted and dried. To remove debris and
surface sterilise they were washed once in 1% benzalkonium chloride
(Roccal, Winthrop), three times in 70% ethanol and four times in
warmed (37°C) MEM containing double strength antibiotics and nystatin.
Ticks were left in the fourth medium wash for at least 10 minutes.
Medium for grinding ticks for GUTS or GF was MEM/3.5% BPA with
double strength antibiotics and nystatin. Ticks were usually ground
at a concentration of four tick equivalents (te) per ml and the total
volume of grinding medium to be used was divided into aliquots so that
there were several changes of medium during the grinding. Thus, ice
cold MEM/3.5% BPA was added to the ticks and they were transferred
to a mortar to be thoroughly ground using a pestle while removing and
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adding grinding medium until no intact ticks remained. The resulting
tick suspension was centrifuged at 100 G for five minutes (MSE Chil-
spin) at 4°C and the ground up tick supernatant (GUTS) recovered.
If GUTS filtrate (GF) was required, the supernatant was filtered
using an AP prefilter and 8 p. MF filter (see Section 2.1.2.).
Dilutions of GUTS or GF were made in grinding medium and the
concentration expressed as the number of tick equivalents (te)
per ml.
To assess the quality of GUTS and GF preparations, Giemsa-
stained cytocentrifuge smears (cytospins) were prepared from GUTS
or GF diluted to one te per ml and centrifuged at 110 G for five
minutes (Cytospin 2, Shandon Instruments). Figure 2 shows an
example of a cytospin of infected GF.
b) Percoll purified sporozoites
This method of separating mature sporozoites from contaminat¬
ing tick material and sporoblasts using density gradient centrifug-
ation was developed from that described by Walker and McKellar
(1983) .
When sporozoites were being purified for IFAT antigen or
immunisation of mice for monoclonal antibody production, BPA was
included in the grinding medium, SIP and step densities. When
purified for SDS-PAGE, Western blotting and surface labelling, BPA
was excluded. Section 2.1.1. describes the preparation of Percoll
gradients.
Preparation of GF to load onto the Percoll gradient followed
the same protocol as described above except that the grinding medium
was Hanks B.S.S. Eight to 10 ml GF at four te per ml (32-40 te in
Figure 2 Ground up tick supernatant filtrate from T. annulata
Ankara infected ticks.
Giemsa-stained cytospin of GF at 1 te per ml
Arrows indicate sporozoites (sp) and sporoblast (sb)
(x 1,100 magnification)





total) was carefully layered onto the gradient and the positions of
interfaces marked on the tube. The tube was then centrifuged using
a swing out rotor at 2,500 G (4,000 rpm) at 4°C. This causes sporo¬
zoites to band at the 1.070/1.095 s.g. interface leaving tick debris
above and below. Using Pasteur pipettes, GF and gradient steps
above the sporozoite band were removed. The sporozoites were
harvested into 20 ml phosphate buffered saline (PBS) and, to remove
the Percoll, the mixture was centrifuged at 1500 G (3,300 rpm) for
30 minutes at 4°C.
The sporozoite pellet was difficult to visualise and therefore
the supernatant fluid was removed by pipetting down to within 100 y.1
of the bottom of the tube. The pellet was resuspended in PBS or
Hanks/1% BPA by repeated pipetting. A cytospin was prepared in
order to assess purity and numbers of sporozoites as shown in
Figure 3.
2.2.3. Isolation of peripheral blood mononuclear cells (PBM)
Bovine PBM were required to provide target cells for sporo¬
zoite infectivity and inhibition assays or to enable infected cell
lines to be established in vitro using PBM from an experimental
animal.
The technique used for separation of PBM was based on that
described by Brown (1987). Blood was collected into heparin (20-40
units/ml) or by defibrination using glass beads (BDH). For small
volumes of blood, each 10 ml collected into sterile lithium heparin
(Vacutainer, Becton Dickinson) was diluted with 10 ml PBS and layered
directly onto 8 ml of a Ficoll Paque gradient (Pharmacia) before
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centrifugation at 800 G at the interface (2,600 rpm) for 30 minutes
at 15°C (MSE Chilspin). If larger volumes of blood were being
handled, the buffy coat was separated first by centrifuging 50 ml
volumes at 2,800 G for 20 minutes at 4°C. The buffy coat was diluted
in 9 ml PBS and layered onto 8 ml Ficoll Paque for centrifugation as
above. PBM were harvested from and below the interface and washed
twice in PBS for 10 minutes, and then five minutes, at 350 G, 15°C.
The cell pellet was resuspended in cold complete medium (RPMI 1640,
16.7% FCS) and the cell concentration determined (Coulter Electronics)
and adjusted as necessary. A Giemsa-stained cytospin was prepared
to check the quality of the separation and the cell type present.
Figure 4 shows PBM separated from defibrinated bovine blood.
2.2.4. In vitro infection of bovine PBM
Brown, Stagg, Purnell, Kanhai and Payne (1973) first infected
lymphoid cells from cattle in vitro with T. parva-infected tick
material. This advance made the assessment of the bovine humoral
response to the Theileria parasite, particularly to the sporozoite
stage (Gray and Brown, 1981; Preston and Brown, 1985) possible.
In vitro infections were carried out in 0.38 cm2 or 1 cm2
tissue culture wells, in 96 and 48 well plates respectively, accord¬
ing to the amount of material available and the purpose of the
experiment.
PBM concentration was 2-4 x 10^ cells per ml and GF was used
at between 0.25 and 2 te per ml. Wells were seeded with GF first,
then an equal or double the volume of PBM was added to each well.
Outer wells of plates were filled with sterile PBS as these wells
Figure 4 Bovine peripheral blood mononuclear cells isolated
from defibrinated blood.
Giemsa-stained cytospin of PBM at 2 x 10^ cells
per ml.
(x 550 magnification)
Figure 5 T. annulata Hissar infected lymphoblastoid cell
line.
Giemsa-stained cytospin






were susceptible to evaporation during incubation. The cultures
were then placed in a humidified incubator gassed with 5% C02 (LEEC)
and incubated at 37°C.
Medium was changed and cytospins taken at three day intervals
until 30% or more cells were infected when the cultures were trans¬
ferred to larger wells or 25 cm2 flasks. The rate of cell growth
was assessed using the inverted microscope (Diavert, Leitz, Wetzlar).
Subculture was carried out every 2-3 days at increasing dilutions
until, with established cell lines, cells were diluted 1:10 with
medium, cell concentration being maintained at levels ranging between
1 x 10^ to 2 x 10^ per ml. Figure 5 illustrates an established
T. annulata lymphoblastoid cell line.
2.2.5. Cryopreservation
a) Theileria-infected cell lines
Dimethyl sulphoxide (DMSO) has been used as a cryoprotectant
for living cells for many years (Lovelock and Bishop, 1959) and has
proved to be satisfactory for use with Theileria-infected cell lines
(Wathanga, Jones and Brown, 1985) . Cells from cultures growing at
a density of 1-2 x 10^ cells per ml were cryopreserved in complete
medium containing 10% DMSO (Analar, BDH) at a cell concentration
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of approximately 10 cells per ml in 1 ml vials (Nunc, Gibco). After
24 hours at -80°C the vials were transferred to a liquid nitrogen
bank (LR40, BOC) for long term storage. The precise method for
cryopreservation is given by Brown (1983) .
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b) Sporozoites
Ground up tick supernatant (GUTS) from infected ticks at a
concentration ranging from 1-4 te per ml was cryopreserved in the
presence of 7.5% glycerol (Analar, BDH) in MEM/3.5% BPA. Aliquots
were placed in 1 ml vials (Nunc, Gibco) and after 24 hours at -80°C
were stored in liquid nitrogen. Brown (1983) details the method
involved.
2.2.6. Resuscitation
Brown (1987) gives an account of the resuscitation of Theileria-
infected cell lines and sporozoites from cryopreservation in liquid
nitrogen. The different protocols for each reflect differences in
the properties of the cryoprotectants; DMSO and glycerol. Thus,
cell lines were thawed to 37°C and rapidly removed from the presence
of DMSO by centrifugation (200 G, 10 minutes) and resuspension in
fresh complete medium in which they were then incubated. By this
method, the estimated viability of the resuscitated cells was greater
than 90% (Wathanga et al., 1986) .
Sporozoite stabilates were also thawed rapidly in a 37°C water
bath but were then left at room temperature (20°C) to allow equili¬
bration over 15-45 minutes. When being used to infect cattle _in vivo,
several vials of a given stock were resuscitated and their contents
pooled. Aliquots were taken from this pool to inoculate calves to
ensure consistency in the infective dose. The infectivity of a
resuscitated stabilate was estimated to be about 10% of that of the
original material (Brown, 1987) .
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2.2.7. Cloning Theileria-infected cell lines
The provision of cloned parasite was not a prerequisite for
the study of sporozoite antigens. However, results were interpreted
in the knowledge that all three T. annulata stocks were likely to
contain a mixed population of parasites (Shiels _et aJL. , 1986b) .
Clones were only used in work on characterisation of the DNA of a
sporozoite recombinant (Section 6.3.3.). These clones were the
result of previous work by Wathanga (1984) and Wilkie (personal
communication) at the CTVM.
The clones were derived in several ways; Wathanga (1984) took
established cell lines and cloned them by limit dilution or by the
isolation of single cells using similar methods to those applied to
T. parva lymphoblastoid cell lines by Munderloh and Kurtti (1982)
and Nelson and Hirumi (1981). Although these clones derived from
the growth of a single cell they are not necessarily true parasite
clones since at the time of infection more than one sporozoite may
have entered a single lymphocyte. The other method used was to clone
at the time of in vitro infection of bovine PBM with sporozoites
such that increasing dilutions of sporozoites were added to a constant
number of cells in tissue culture wells until an end point was reached
after which no infection established. Here end point cultures were
presumed to be clones deriving from the infection of a single cell
with a single sporozoite.
Cloned cell lines which were used were:
i) Those derived from PBM of calf 46 -T. annulata Hissar 46
clones 2, 3 and 4; T., annulata Ankara 46 clones A, 2 and 3: These
were cloned by limit dilution or isolation of single infected cells
from an infected cell line as described by Wathanga (1984).
73
ii) Those derived from PBM of calf 139 - T. annulata Ankara
139 clones DA, D6, E5: These were cloned by end point titration
of sporozoites (G. Wilkie, personal communication).
When glucose phosphate isomerase (GPI) isoenzyme patterns of
the clones were compared with that of the parent stock pattern, they
showed segregation of the band pattern in line with that expected




Primary infection of calves was by subcutaneous inoculation
of sporozoites harvested from ticks (Section 2.2.2.) or cryopre-
served stocks of sporozoite stabilate in front of the shoulder.
The draining prescapular lymph node was one which could be readily
palpated and biopsied. The area in front of the shoulder was shaved
and a sterile syringe and 19 gauge, one inch needle used to inocul¬
ate the stabilate. Parasite stocks, doses and sites of inoculation
are given with the appropriate experiment.
b) Challenge
Challenge was effected either by subcutaneous inoculation of
sporozoite stabilate as described above or by allowing infected
adult ticks to feed on the ears of the calf. In the latter case
the draining lymph node was the left or right parotid lymph node.
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c) Monitoring of reaction
In order to follow the calves' reaction to infection or
challenge regular observations of clinical conditions and haemato-
logical and parasitological changes were made.
i) Clinical condition: From day 0 rectal temperatures were
taken daily and recorded on a day sheet. Calves were visited twice
by stockmen and 3-7 times weekly for routine experimental procedures.
The clinical features of particular note during the course of the
disease included pyrexia; inappetence; weakness; enlargement of lymph
nodes, particularly the node draining the site of inoculation; colour
of mucous membranes indicating anaemia or icterus; superficial
haemorrhages in the form of petechiae; subcutaneous oedema; hyper-
pnoea and coughing indicating pulmonary involvement; the colour and
state of faeces and urine indicating internal haemorrhage, intra¬
vascular haemolysis or impaired liver function and the degree of
dehydration as assessed by skin elasticity. Monthly liveweights
were recorded in kilogrammes. Detailed recording of clinical condition
was not made but was an important part of the monitoring process and
served as an initial indicator of the progress of the infection and
the course the disease was taking. It was also used to aid prognosis
and help decide whether a calf should be destroyed on humane grounds.
ii) Haematology: From day 0 haematological parameters were
measured at least three times a week and at certain times, for example,
at the onset or approaching the peak of piroplasm parasitaemia, were
measured daily. Jugular venous blood samples were taken into tubes
(Vacutainer, Becton Dickinson) containing the disodium salt of
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ethylenediamine tetraacetic acid (EDTA) for haematological examination
and the preparation of thin blood smears. Smears were air dried,
fixed in absolute methanol (BDH) and stained for 40 minutes in 5%
Giemsa stain (Shute, 1966) in phosphate buffer pH 7.2 (BDH). Packed
cell volume (PCV) was determined using haematocrit tubes (Harshaw
Chemicals) centrifuged at 12,000 rpm for six minutes (Biofuge A,
Heraeus Sepatech) and measured in a microhaematocrit reader (Hawksley).
Total white and red blood cell counts were measured using an
electronic particle counter (Coulter Electronics) and expressed as
the number of cells x 10J per pil and x 10 per jj.1 respectively.
iii) Parasitology: The regional lymph node draining the site
of inoculation was palpated regularly from day 4 and, at the first
sign of enlargement, was biopsied. Lymph node biopsy smears were
made, fixed and stained as described for blood. Examination of blood
and lymph node smears was carried out under oil immersion (x 50,
x 100 Fluotar lenses) using an Ortholux II microscope (Leitz, Wetzlar,
Germany).
Lymph node smears were examined for the presence of hyper¬
plastic cells (H), macroschizonts (Ma) and microschizonts (Mi) and
the presence of any one of these was rated as:
+ less than 1% of cells ) under
++ 1-5% of cells | x 100
+++ greater than 5% of cells j lens
Other features such as macrophage invasion, erthyrophagocytosis
and schizont degeneration were noted. Lymph node biopsy smears were
made daily until macroschizonts had been observed and confirmed the
following day. Thereafter, biopsy smears were examined at two day
intervals.
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Blood smears were examined primarily for the presence and number
of intraerythrocytic piroplasms. Other features such as thrombocyto-
paenia or immature red blood cells indicative of regenerative anaemia
were noted. Piroplasm parasitaemia was expressed as the percentage
of erythrocytes infected regardless of how many piroplasms were pre¬
sent within individual erythrocytes. Percentage parasitaemias were
counted to as low as 0.1%, below this parasitaemia was recorded as +
if a piroplasm was observed in approximately 200 high power fields
representing about 100,000 red blood cells, and, if none were seen,
as NPS (no parasites seen).
iv) Serology: Blood for serum was collected monthly from day 0,
serum separated and stored at -20°C. The serological test employed
was the indirect fluorescent antibody test (IFAT) described by
Burridge and Kimber (1972). IFAT was used to monitor calf antibody
levels to various stages of the parasite during experiments. The
details of the test and preparation of the antigens are described
in Sections 3.2.5. and 3.2.6.
2.2.9. Lethal infections in cattle
The purpose of establishing potentially lethal theilerial
infections in calves by inoculation of live sporozoites was to
obtain a high piroplasm parasitaemia and supply material for piro¬
plasm IFAT antigen, piroplasm protein analysis, glucose phosphate
isomerase isoenzyme studies and extraction of parasite DNA. The
other important objective was to transmit infection to ticks to
replenish stocks of H. a. anatolicum infected with T. annulata and
Rhipicephalus appendiculatus infected with T. parva.
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The calves used for tick feeding and blood collection were
often acting as controls in experiments involving other calves
undergoing infection or challenge. An example of the clinical
reaction, haematological and parasitological changes and how these
relate to the timing of tick feeding and blood collection is given
for each Theileria species and stock used during this research
(Figure 6). Table 2 gives details of the sporozoite stabilates
used and calves infected with them.













P70 Ayrshire Male T. a. Ankara 2.5 3.3 RPG
143 N Friesian Male T. a. Hissar 1.0 0.1 RPG
930 Hereford Female T. a. Gharb 2.0 4.3 LPG
931 Hereford Female T. £• Muguga 1.2 9.2 RPG
929 Hereford Male T. P • Muguga 1 .2 9.2 RPG
*Stabilate inoculated subcutaneously
PG = prescapular gland
L = left
R = right
Figure 7 shows the appearance of the lymph node draining the
site of sporozoite inoculation on day 13 of a lethal infection when
piroplasm parasitaemia was reaching a peak as illustrated in
Figure 8.
Figure 6 Lethal T. annulata and T. parva infections in calves: graphs
to show changes in body temperature, haematology
and parasitosis during the course of infection.
a Calf P70 infected with T. annulata Ankara
b Calf 143N infected with T. annulata Hissar
c Calf 930 infected with T. annulata Gharb
d Calf 931 infected with T. parva Muguga
e Calf 929 infected with T. parva Muguga
The times when tick nymphs were applied to (na) or
dropped from (nd) infected calves and blood was collected
(bid) are indicated.
Key:
I day 0, stabilate inoculated
D died or destroyed
LN regional lymph node
Ma macroschizonts observed
Mi microschizonts observed
T°C rectal temperature 4—4
wbc white blood cell count □—a
% PCV % packed cell volume •—•
% Piro % piroplasm parasitaemia O—o
days pi days post infection
Section 2.2.9. details the stabilates used to infect
these calves.

























































Figure 7 Lymph node biopsy smear on day 13 of lethal
T. annulata Hissar infection from the regional
prescapular lymph node.
Giemsa-stained cytospin showing:




( x 550 mcwnip'c<vfi'on)
Figure 8 Blood smear on day 14 of lethal T. annulata
Gharb infection.
Giemsa-stained cytospin with arrows showing
piroplasms in red blood cells at a parasit-
aemia of 89%.
Figure 9 T. annulata Hissar piroplasms purified from
piroplasm infected blood.
Giemsa-stained cytospin showing clumped
piroplasms.
( x I (100 m«anijVcft.Ti'on
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2.2.10. Isolation of piroplasms
The purification of theilerial piroplasms from bovine blood
by removal of white blood cells (Fulton and Grant, 1956) and lysis
of red blood cells (Shortman, Williams and Adams, 1972) was necessary
to provide material for SDS-PAGE and Western blotting and isolation
of parasite DNA with minimal host DNA contamination.
Up to one litre of blood was collected from a Theileria-
infected calf at the time of peak parasitaemia. Anticoagulant in
the form of 20% ACD or defibrination prevented the blood from clotting,
the latter requiring the blood to be filtered through sterile gauze.
Piroplasm parasitaemia and packed cell volume were measured so that
an estimate of the expected piroplasm yield could be made.
After centrifugation at 2,400 G for 20 minutes at 4°C the plasma
and, where possible, buffy coat were removed and PBS added to resus-
pend the packed erythrocyte layer. After three such washes in PBS
(centrifugation for 20 minutes, 4°C, 2,400 G) an estimate of the
pellet volume was made and four pellet volumes of PBS added. Mean¬
while cellulose CFll powder (Whatman) columns were prepared. Thirty-
five ml dry CFll powder was packed to about 30 ml using PBS and the
column was left to run dry. Fifty ml diluted blood was then applied
to each CFll column and the white blood cell depleted blood coming
through was kept on ice. Thirty ml of PBS washed the column through and
a sample of the pooled blood was removed for a white blood cell haemo-
cytometer count. Having ascertained that the count was less than
4
2 x 10 cells per ml the purification was continued. Blood which had
run through the CFll columns was washed twice in PBS (15 minutes,
2,000G, 4°C) and resuspended in an equal volume of PBS before mixing
83
with preheated (37°C) redblood cell lysis buffer (0.83% NH^ CI,
0.17M Tris pH 7) at a ratio of one volume blood to nine volumes
buffer. Incubation of the mixture for 3-5 minutes at 37°C changed
the colour to a clear deep red indicating complete red blood cell
lysis. The released piroplasms were collected by centrifugation
at 2,000 G, 10 minutes, 4°C and then washed three times in PBS.
The volume of the final pellet was estimated and, if the piroplasms
were not being used immediately, they were rapidly frozen in liquid
nitrogen and stored at -80°C. Cytocentrifuge smears were made from
blood after passing through the CF11 columns and post lysis to assess
the purity and quality of the piroplasms and Figure 9 shows an
example of purified piroplasms.
Table 3 gives an example for each Theileria stock of the quant¬
ity of piroplasms harvested in the above manner together with details
of factors influencing the piroplasm content of the blood.
The day of infection on which peak parasitaemia occurred
depended on both the sporozoite dose (te) and the parasite stock.
The piroplasm yield was influenced by a combination of factors includ¬
ing the volume of blood collected, the parasitaemia and the packed
cell volume.
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During infection with T. annulata the bovine host is exposed
to successive life cycle stages, each presenting many different anti¬
gens resulting in a complex assay of responses. In this study of
the potential of sporozoite antigens as immunising material, initial
work was orientated towards distinguishing the response which is
stimulated by the sporozoite from that elicited by other stages. To
this end, antibodies recognising sporzoite antigens were raised as
reagents to identify, in particular those antigens with a role in
stimulating protective immunity.
Sporozoites were first studied antigenically when Kimber,
Purnell and Sellwood (1973) carried out immunofluorescent assays
with serum from recovered cattle using cryostat sections of T. parva-
infected ticks and obtained positive reactions. Interest in the
humoral response to sporozoites developed rapidly when the sporozoite
neutralising ability of immune bovine serum was revealed (Gray and
Brown, 1981) and confirmed (Musoke et al., 1982; Preston and Brown,
1985) as reviewed in Section 1.
Mitchell (1984) discussed methods of identifying potential
targets for a protective immune response on the parasite surface. In
order to avoid random selection, purification and testing of parasite
molecules, defined and relevant antibody reagents are vital.
Hyperimmune bovine serum was an obvious source of antibody to
generate to identify sporozoite antigens and was known to be likely
to possess strong neutralising activity (Musoke et al., 1982; Preston
and Brown, 1985).
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However, the presence of antibodies to macroschizont and piro-
plasm stages in such serum (Burridge and Kimber, 1972) makes it less
satisfactory than sera from animals which have been exposed solely to
the sporozoite stage.
Two methods were used to raise antisporozoite antisera which
were intended to be restricted to the recognition of sporozoite anti¬
gens. One method was to immunise a rabbit with live T. annulata
sporozoites since in this species the parasite does not establish
infection (Neitz, 1957). This in vivo observation has been tested
by attempting to infect rabbit PBM with sporozoites in vitro without
success (C.G.D. Brown, personal communication). Although there has
been one report of macroschizont development in a New Zealand White
rabbit (Dipeolu and Ogunji, 1977) this has never been convincingly
reproduced and the rabbit immunised with live Theileria sporozoites
was considered to have been exposed to one stage only. The other
method used was to inoculate calves with irradiated sporozoites in
experiments to study the effect of different levels of irradiation
on sporozoites and their subsequent effectiveness as immunising material.
The intention was to be able to choose postimmunisation but prechallenge
antisera from calves in which patent infection with schizonts or piro-
plasms was not detected during immunisation with irradiated sporo¬
zoites, but which showed a significant degree of immunity to challenge.
A limitation to the use of rabbit or bovine polyclonal sera
alone to identify sporozoite antigens is that, by using whole organisms
to immunise, the serum obtained inevitably recognises a number of
antigens, many of which will not be relevant to protective immunity.
A problem therefore exists in distinguishing those antigens which
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stimulate antibody with sporozoite neutralising activity from others
of no functional significance.
To circumvent this problem the same strategy as used by those
studying the sporozoite stage of T. parva was adopted (Musoke et al_. ,
1984; Dobbelaere et al., 1984). Mice were immunised with T. annulata
sporozoites and hybridoma technology was applied to produce monoclonal
antibodies which recognised single antigenic determinants on these
sporozoites, enabling them to be studied individually.
This chapter describes how this battery of polyclonal and
monoclonal antibodies were generated in order to identify sporozoite
antigens.
3.2. MATERIALS AND METHODS
3.2.1. Experimental animals
Calves as described in Section 2.1.4.; 2-6 month old New
Zealand White female rabbits; inbred Balb/c female mice.
3.2.2. Immunisation protocols
a) Immunisation of calves with live virulent sporozoites
Calves 54X, 134X, N53 and N61 all underwent repeated exposure
to sporozoites. Following recovery from sporozoite stabilate immuni¬
sation (Section 2.2.8.) either due to a non lethal infection or through
drug treatment with buparvaquone (Clexon, Coopers Animal Health) at
5 mg/kg on day 14, the calves were challenged on three occasions with
live sporozoites (Sections 2.2.2. and 2.2.8.) or by adult tick feeds
(Sections 2.2.1. and 2.2.8.) as indicated in Table 4. Serum from these
calves following third challenge was considered to be hyperimmune.
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Table 4 Immunisation and challenge of calves with live virulent
sporozoites
a) Calves N53 and N61





Gharb STAB 0.2 RPG
14 buparvaquone
5 mg/kg
30 Challenge 1 Gharb STAB 0.2 LPG






93 Challenge 3 Gharb GUTS 20.0 RPG
b) Calves 54X and 134X
Day Action T. annulata stock Dose te
Inoculation
s/c
0 Immunisation Hissar STAB (54X) 4.0 RPG
Gharb GUTS (134x) oin RPG
35/41 Challenge 1 Ankara STAB 3.0) LPG
(54X) / GUTS 6.0)
(134X)
56/62 Challenge 2 Gharb GUTS (54X) 2.0 RPG
Hissar GUTS (134X) 2.0 RPG
83/89 Challenge 3 Hissar
Gharb
20 x H.a.a .






STAB = cryopreserved stabilate; GUTS = fresh GUTS
IJ.ja.a_. = infected adult H. ^a. anatolicum;
RPG = right prescapular gland; LPG = left prescapular gland
s/c = subcutaneous
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b) Immunisation of calves with irradiated sporozoites
Antisporozoite sera were obtained from calves taking part in a
series of experiments designed to test the effect of different irrad¬
iation levels on live sporozoites and their subsequent effectiveness
as immunising material. Serum was taken from four calves, each of
137
which received sporozoites irradiated by a Caesium source at a
different dose level. The details of their immunisation and subse¬
quent challenge with virulent unirradiated sporozoites are shown in
Table 5.
c) Immunisation of rabbits by infected and uninfected tick feeding
Antisporozoite serum was raised in rabbit 28 by allowing T.
annulata-infected H. a_. anatolicum adult ticks to feed on its ears on
five occasions over a six month period according to the protocol in
Table 6. In order to provide rabbit serum with antibodies to tick
components to act as a control for the serum raised in rabbit 28,
two rabbits (8 and 9) were fed on by uninfected adult H_. a_. anatolicum
as shown in Table 6.
Blood was collected for serum on days 0, 73, 168 and 189 for
rabbit 28 and days 0, 71 and 78 for rabbits 8 and 9.
d) Immunisation of mice with live sporozoites
Two Balb/c mice received repeated immunising doses of Percoll-
purified T. annulata Ankara sporozoites (Section 2.2.2.) over several
months as shown in Table 7.
The mouse which had received the final immunisation intravenously
was killed three days after its final dose and its spleen removed for
use in the production of monoclonal antibodies (see Section 3.2.4.).
Table5Immunisationofc lveswithirradia dsporozoi sdtheirubsequentha lenge Calfnumber:L21N4437102ActionIrradiationdosê ofsporozoites (Gray)D yPa asiteir site Immunisation1 Immunisation2 Immunisation3 Immunisation4 Challenge1 Challenge2Stock Dosete Stock Dosete Stock Dosete Stock Dosete Stock Dosete Stock Dosete14Ankara 2GUTS Ankara 2GUTS 49Ankara 2GUTS 90Ankara 4GUTS35 49 56 63Gharb 3GUTS Gharb 4GUTS Gharb 4GUTS Gharb 4GUTS Gharb 16xH-a_.a_. (8female, 8male)
28 77 91
Ankara





Ankara42 0.9STAB Ankara 6GUTS
STAB=cryopreservedstabilate;GUTSfresh ;H- i-ci-=adu t_.anatolicum;Ffiltr t
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Table 6 Infected and uninfected tick feeds on rabbits
a) Rabbit 28: Infected H. a. anatolicum




0 60 Gharb most 3
80 Ankara 20 ticks 5
14 120 Hissar most 3
20 ticks 5
35 60 Ankara 3
63 160 Hissar most 3
20 ticks 5
179 60 Ankara most 3
60 Hissar 20 ticks 7
b) Rabbits 8 and 9: Uninfected H. a. anatolicum
Day Tick numbers Duration of tick feed
0 120 To engorgement ( 7 days)
28 40 To engorgement ( 7 days)
56 120 To engorgement ( 7 days)
Table 7 Immunisation of mice with live sporozoites for monoclonal
antibody production




204 4.0 1 mouse intravenous
1 mouse intraperitoneal
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Blood was collected at the same time to obtain serum for IFAT. The
other mouse which had a final intraperitoneal dose was kept alive
and bled for serum on day 5 postimmunisation.
3.2.3. Hybridoma culture media
Once media had been made up they were stored at 4°C and used
within 14 days. Stock solutions of media constituents are detailed
in Appendix 1.2.2.
a) Complete medium
RPMI 1640 medium (Gibco) was supplemented with 16.7% FCS, 2 mM
L-glutamine, 100 units/lag per ml of penicillin/streptomycin, 2 |ig
per ml amphotericin B (fungizone) and 5 x 10 B-mercaptoethanol
(B-ME) .
Myoclone (Gibco), a FCS specially selected for its suitability
in supporting the growth of myeloma and hybridoma cells, was used to
supplement RPMI 1640 medium until hybridoma cell lines were cloned
and established when the RPMI 1640 complete medium used to culture
Theileria-infected cell lines was found to be satisfactory. B-ME
was included in the medium as a reducing agent to minimise the
damaging effects of oxidising agents released by dying cells and so
promote growth of healthy hybridoma cells. Penicillin, streptomycin
and fungizone were included to control bacterial, yeast or fungal
contamination in hybridoma cultures, all being of particular threat
to slowly establishing cultures or cloning work.
b) Incomplete medium
Incomplete RPMI 1640 medium was made up in the same way as
complete medium but excluding FCS.
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c) HAT or HT medium
HAT or HT medium was prepared by the addition of 4 ml 50 x HAT
or HT to 96 ml complete RPMI 1640 medium to give 2 x HAT or HT. If
1 x HAT or HT medium was required, 2 ml 50 x HAT or HT was added to
98 ml complete medium.
3.2.4. Monoclonal antibody production
a) Preparation of myeloma cells
Mouse myeloma cell line P3-X63-Ag 8 clone 653 which does not
synthesise or secrete immunoglobulin chains (Kearney et al., 1979)
was resuscitated ten days prior to the day of fusion from storage
in liquid nitrogen.
These myeloma cells were maintained in complete medium in 25
and 75 cm2 tissue culture flasks (Flow) in the logarithmic phase of
growth by subculturing every 48 hours, seeding rates being between
1 and 2 x 10^ cells per ml. The myeloma cells were passaged as above
and 24 hours later were harvested for the fusion. After two washes
in incomplete medium (200 G, 7 minutes, 15°C) the cells were resus-
pended in 10 ml fresh incomplete medium and counted using 0.2% trypan
7
blue. The total number of myeloma cells was 1.4 x 10 and all were
used for the fusion with mouse spleen cells. A Giemsa-stained cyto-
spin of the cells at this stage showed them to be healthy blastoid
cells, many exhibiting mitotic figures.
b) Preparation of mouse spleen cells
The Balb/C mouse given sporozoites intravenously three days
previously was killed by cervical dislocation and blood for serum
was taken by cardiac puncture. The spleen was removed in an aseptic
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manner, cut into small fragments and transferred into 3 ml incomplete
medium. The barrel of a sterile 20 ml syringe was used to crush the
spleen thoroughly, after which more medium was added and the suspen¬
sion was frequently pipetted to disrupt the clumps of spleen cells.
Having been allowed to stand for several minutes the cell suspension
was centrifuged at 200 G, 15°C for seven minutes. The pellet was
washed twice in incomplete medium before suspending in 10 ml fresh
incomplete medium and counting an aliquot diluted in white blood cell
O
counting fluid. 1.2 x 10 spleen cells were obtained and used for
the fusion. A cytospin showed the spleen lymphocytes to be healthy
but with only a small percentage (less than 1%) blastoid.
c) Fusion of myeloma and spleen cells
The medium and PEG solutions (Appendix 1.2.3.) were warmed to
37°C. Myeloma and spleen cells were mixed together in a conical
glass 50 ml tube and centrifuged for seven minutes, 200 G at 15°C.
The supernatant was poured off and a Pasteur pipette used to remove
the last few drops. Over the period of a minute, 0.5 ml PEG solution
1 was added to the combined cell pellet using a 1 ml pipette while
mixing with the pipette end as each drop was added.
In the same manner, 0.5 ml PEG solution 2 was added over one
minute. In the following 2-3 minutes the clumps of cells were teased
apart using the pipette tip to form a cell suspension in the PEG
mixture. To this 9 ml complete medium was added dropwise over 3-5
minutes while mixing continuously. Finally 40 ml complete medium was
mixed with the cell suspension to bring the total volume to 50 ml.
The cells were then pipetted out into 5 x 96 well flat bottomed
96
microtitre plates labelled 1-5, each well receiving 100 p.1 volume,
and the plates were incubated overnight in a humidified 37°C incubator
in 5% C02 in air.
d) Harvesting peritoneal macrophages
Balb/c mice from which peritoneal macrophages were to be
obtained were killed by cervical dislocation. The abdominal wall
was exposed by dissection in an aseptic manner. Four to five ml
ice cold incomplete medium was injected into the peritoneal cavity
and then withdrawn after several minutes, taking care to avoid
penetrating the mouse's intestine. The cells were pelleted by
centrifugation at 200 G for seven minutes at 4°C before being resus-
pended in 10 ml of the appropriate medium at 37°C and counted.
Generally peritoneal macrophages were included in the medium at a
concentration of about 2 x 10~* cells per ml whenever cultures were
established in new vessels and when cloning.
e) Post fusion protocol and initial IFAT screening
Twenty four hours after the fusion, 100 |_il of double strength
HAT medium containing 2.4 x 10^ peritoneal macrophages per ml was
dispensed into each well of plates 1-5. The plates were incubated
again at 37°C, 5% C02 .
On day 7 after the fusion, microtitre plates were examined for
any turbidity or untoward, medium colour change; red indicating excess¬
ive cell death or yellow and turbid indicating contamination. Wells
showing contamination were emptied and rinsed four times with 70%
ethanol. A partial medium change was made by carefully removing 100 (J.1
supernatant medium and replacing with 100 |_il fresh warmed 1 x HAT
medium.
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On day 9 after the fusion, plates 1-5 were screened for cell
growth under the inverted microscope. Wells in which definite focal
colonies were growing were marked. On day 11 after the fusion,
hybridoma culture supernatants were harvested from the wells marked
as showing good cell growth on day 9. One hundred and ten p.1 was
removed from each well and replaced with 110 jj.1 fresh 1 x HAT medium.
Indications that the time was appropriate for screening included cell
growth covering at least 70% of the microtitre well bottom - an
estimated 3 x 10^ cells are needed to cover the bottom of a micro¬
titre well - and medium colour change towards yellow. Four days had
passed since the medium change, ample time for secreted antibody to
accumulate.
The harvested supernatants were screened by IFAT against formalin
fixed T. annulata Ankara sporozoites.
f) Expansion of hybridoma cultures
Cultures from which the supernatants gave strong sporozoite
fluorescence in the initial IFAT screen were selected for expansion
into 1 cm2 wells. The microtitre well contents were resuspended and
100 nl was transferred to a 1 cm2 well containing 400 |il 1 x HAT
medium with peritoneal macrophages. The original microtitre well
culture was maintained by regular addition of fresh medium until the
cell cultures derived from it were established in larger vessels and
cryopreserved. Once hybridoma cells were growing well in these 1 cm2
wells, the culture supernatant was retested by IFAT for antisporozoite
activity and, if still giving a positive reaction, cloning and further
expansion were carried out. Further expansion involved the transfer
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of 1 cm2 well contents to 2 cm2 wells and thence to 25 cm2 (10 ml)
flasks. At all stages, cultures in original wells were maintained,
culture supernatants were retested for antisporozoite activity and
peritoneal macrophages were included in the medium on the initial
transfer of a culture. One cm2 wells and 25 cm2 flasks were set up
with medium containing macrophages 24 hours prior to culture trans¬
fer to allow time for medium to become conditioned. All cultures
(parents and clones) were maintained in 1 x HAT medium until trans¬
ferred to 2 cm2 cultures when 1 x HT medium was employed. Medium
changes and culture passage were made in much the same way as
described for Theileria-infected cell lines in Section 2.2.4. Once
parent and cloned hybridoma cultures had been growing for some time
(12 weeks) they were gradually changed to the same complete medium
as used for Theileria cultures and no longer required peritoneal
macrophage feeder cells.
g) Cloning hybridoma cultures
Cloning was achieved by limiting dilution (Oi and Herzenberg,
1980) in 96 well microtitre plates (0.38 cm2). The 1 cm2 culture
selected for cloning was thoroughly resuspended and the cell concen¬
tration and viability determined using trypan blue and counting cells
using a haemocytometer. Then dilutions were made down to five cells
per ml in 1 x HAT medium containing peritoneal macrophages. These
dilutions were plated out as follows (100 M-l per well) :
24 wells @ 100 cells/ml i.e. 10 cells/well
24 wells @ 50 cells/ml i.e. 5 cells/well
24 wells @ 10 cells/ml i.e. 1 cells/well
24 wells @ 5 cells/ml i.e. 0.5 cells/well
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The 24 wells which contained a representative 0.5 cell each
had the highest probability that a colony establishing originated
from a single cell and was a true clone. Therefore it was from
these wells that cloned cultures were selected. From day 7 after
cloning, microtitre plates were screened under the inverted micro¬
scope and those wells appearing to contain early clone colonies
deriving from a single cell were marked. Once nearing confluence,
the culture supernatants from at least 10 clones from each parent
cell line were screened by IFAT and positive clone cultures were
expanded in a similar manner to parent cultures.
h) Cryopreservation and resuscitation of hybridoma cultures
The methods for freezing and thawing the hybridoma cells were
identical to those followed for Theileria-infected cell lines (see
Sections 2.2.5. and 2.2.6.).
i) Harvesting monoclonal antibody
Monoclonal antibody was obtained in hybridoma culture super¬
natant or in ascites fluid from hybridomas grown intraperitoneally
in syngeneic Balb/c mice, the latter being approximately 100-fold
more concentrated in antibody. Culture supernatants were collected
after 48 or 72 hours cell growth when the culture was being passaged.
The discarded medium was centrifuged at 1,400 G for 10 minutes at 4°C
and the supernatant stored at -20°C.
To produce ascites, recipient mice were given intraperitoneal
injections of 0.5 ml pristane (2,6,10,14-tetramethylpentadecane,
Sigma) one week before intraperitoneal inoculation of 5 x 10^ live
hybridoma cells in complete medium. These cells were taken from
100
cultures in the exponential phase of growth. Hybridoma growth and
ascites production followed 1-4 weeks later and ascites tapped from
the mice was diluted in complete medium, filtered (0.22 jj.) and
stored in liquid nitrogen. Repeated freeze thawing of supernatants
and ascites was avoided.
j) Immunoglobulin class of monoclonal antibodies
Immunoglobulin class was determined using two methods,- IFAT
in which class-specific fluorescein conjugates were employed as
second antibody (goat antimouse IgG-FITC or goat antimouse IgM-
FITC, Nordic Immunologicals) at 1:40 dilutions; and an Ouchterlony
agar gel radial diffusion test (Serotec) where 75 |il undiluted
culture supernatant placed in the central well acted as antigen and
antibodies against the different mouse immunoglobulin classes and
subclasses (IgA, IgM, IgGl, IgG2a, IgG2b, IgG3) were located in
surrounding wells. After overnight incubation in a humidified
atmosphere, the presence of a white precipitation line between the
central well and an antibody well identified the monoclonal antibody
class (Ouchterlony and Nilsson, 1973) .
k) Nomenclature of hybridomas
Parent cell lines were named after the original fusion plate
and well from which they were selected, for example, plate 1 well A7
gave rise to 1A7. Clones were named firstly after their parent and
secondly after the well of the limit dilution plate from which the
clone was taken, such as 1A7/G8.
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3.2.5. IFAT antigens
All IFAT antigens were prepared on glass slides. Fifteen well
slides (Flow Lab) were used for sporozoite antigens while other
antigens were prepared on these or plain 0.8-1 nun glass slides (BDH).
Plain glass slides were cleaned in a 50:50 mixture of ether and
ethanol before use.
Antigen was applied to multiwell slides by expressing and then
removing 20 |il from each well to leave a thin film which was rapidly
air dried. On plain slides, antigen was applied as a thin even smear
covering the whole surface.
Antigen slides were wrapped and stored at -20°C in the presence
of silica gel. One slide from each batch prepared was methanol fixed
and Giemsa-stained to assess antigen quality.
Anhydrous acetone (BDH) used in antigen fixation was stored in
the presence of a 5 £ molecular sieve (Sigma)
a) Sporozoite antigen
i) Acetone fixation: Percoll-purified sporozoites (Section 2.2.2.)
washed once in PBS to remove the Percoll were resuspended in PBS con¬
taining 1% BPA at 64 te/ml, i.e. 0.5 ml PBS per 32 te Percoll prepar¬
ation. Approximately 80 multiwell slides could be prepared from
0.5 ml sporozoite suspension as described above. Slides were fixed
in anhydrous acetone for 15 minutes and allowed to dry.
ii) Formalin fixation: To 32 te of Percoll-purified sporozoites
in 1.0 ml PBS an equal volume of ice-cold 1:10 formalin (3.7% formalde¬
hyde in PBS) was added dropwise. After 10 minutes fixation, 20 ml
ice-cold PBS was added and the fixed sporozoites were pelleted by
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centrifugation at 1,500 G for 15 minutes at 4°C. The sporozoites
were washed in PBS three times centrifuging each time as described
above. The final sporozoite pellet was resuspended in 0.5 ml PBS/1%
BPA and spotted onto multiwell slides.
b) Macroschizont antigen
Preparation of macroschizont antigen was based on the technique
of Burridge and Kimber (1972) .
i) Acetone fixation: Macroschizont-infected lymphoblastoid
cells in logarithmic phase of growth at approximately 10^ cells per
ml were resuspended in medium and pelleted by centrifugation at 200 G
for 10 minutes at 4°C. The cells were washed three times, centri¬
fuging as above each time and the volume of the final cell pellet
was determined. Three volumes of PBS with 1% BPA were used to
resuspend the cells which were held at 4°C while slides were prepared.
Once the antigen had dried, slides were fixed in dry acetone for 15
minutes and then dried.
ii) Formalin fixation: Macroschizont-infected cells during the
exponential phase of growth were washed twice in PBS as described
above. After the second wash the cells were resuspended to a concen¬
tration of 5 x 107 per ml and an equal volume of ice-cold 1:10
formalin added dropwise. The cells were allowed to fix for 10 minutes
at 4°C before washing three times in PBS and finally resuspending to
7




Approximately 5 ml blood was collected from a Theileria-
infected calf with a patent piroplasm parasitaemia, preferably over
20%, into 150 ml ice-cold PBS (Burridge, 1971) . The blood suspension
was centrifuged at 400 G for 10 minutes at 4°C and the supernatant
together with the buffy coat was discarded. After resuspending the
packed erythrocytes and washing them three times in PBS, the volume
of packed erythrocytes was estimated. Two volumes of PBS with 1% BPA
were added and the suspension used to prepare IFAT antigen, generally




The indirect fluore'scent antibody test was used to assess
antibody response to the different parasite stages in immunised
calves, to assess antisporozoite antibody response in rabbits and
to screen hybridoma cultures for antisporozoite antibody production.
The method employed was based on that described by Burridge (1971)
and Burridge and Kimber (1972) .
Antigen slides were thawed from -20 to 4°C over 30 minutes
and then to room temperature over a further 30 minutes. Acetone
fixed slides were washed three times in PBS prior to use; piroplasm
slides underwent four rinses to ensure all the haemoglobin was washed
out. The slides were drained and then left to dry. Serum or mono¬
clonal antibody dilutions were made in PBS. Antigen slides were
placed in a humidified chamber and 10 |j.l of the antibody dilution
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was pipetted into the appropriate well and recorded. At least one
well on each antigen slide acted as a second antibody control and
received PBS instead of first antibody. After a 30 minute incubation
at room temperature the slides were washed in three changes of PBS
and dried. Fluorescein labelled second antibody (Appendix 1.2.1.) was
applied at a 1:80 dilution (antibovine and antirabbit conjugates)
or 1:40 (antimouse conjugate) dilution made in PBS. Twenty |ul of
diluted conjugate was pipetted onto each well and the slides were
incubated for another 30 minutes. After three PBS washes the slides
were dried and mounted using a 66% glycerol mountant before being
examined for fluorescence using a x 25 or x 40 oil immersion object¬
ive (Phaco 2 or 3) on an ultraviolet epi-illuminated fluorescence
microscope (Leitz Orthoplan, Wetzlar).
Fluorescence was graded according to intensity as shown below:




- no fluorescence, negative
The highest serum dilution still producing positive (+) fluor¬
escence was taken as the end point dilution.
b) Viable sporozoites
Surface immunofluorescence with live sporozoites was performed
to determine whether antibody was reacting with sporozoite surface
epitopes.
The method used Percoll-purified sporozoites which, after one
wash, were resuspended thoroughly in 0.5 ml PBS and dispensed in
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40-50 |il aliquots into 1.5 ml plastic centrifuge tubes, hereafter
called Eppendorf tubes (Alpha Labs). An equal volume of monoclonal
antibody as 1:100 ascites or undiluted culture supernatant or anti¬
serum (diluted to 1:10, 1:80, 1:100) was added and the mixture
incubated at room temperature for 30-45 minutes. Then 1.0 ml PBS
was added to each tube and the sporozoites were pelleted by centri-
fugation at 1,500 G on a microcentrifuge (Biofug A, Heraeus Sepatech)
for 15 minutes. The supernatant was carefully removed and each pellet
was resuspended in 50 p.1 of ice-cold 1:10 formalin solution and left
to fix for five minutes. 1.0 ml PBS was added and the resuspended
sporozoites centrifuged at 1,500 G for five minutes. Sporozoites
were washed twice with PBS in this manner. After the last wash the
supernatant was removed and the pellet resuspended in 30-50 |il of
the appropriate diluted fluorescein conjugate (Appendix 1.2.1.).
After a 60 minute incubation at room temperature the sporozoites
were washed three times in PBS as above. The final pellet was re¬
suspended in 25 |il PBS, spotted onto the wells of a multiwell slide,
dried, mounted and examined for fluorescence.
3.3. RESULTS
3.3.1. Clinical reactions of calves
The clinical reactions to immunisation(s) and challenge(s) are
shown graphically in Figure 10 (a-f). Where calves were paired, the
reaction of just one of the calves has been given.
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Calf N53 (Figure 10a)
During primary infection this calf suffered a sharp rise in
body temperature (peak 41.3°C) and piroplasm parasitaemia (peak 12.5%)
which were both halted following drug treatment. PCV, which fell to
its lowest level of 12% on day 17, rapidly recovered to normal levels
as the parasitaemia declined. Following all three challenges, body
temperature and PCV remained unchanged while Giemsa-stained biopsy
smears of the lymph node draining the site of challenge inoculum
showed transient hyperplasia but no parasitosis. A low level of
piroplasm parasitaemia remained in the blood which increased margin¬
ally on challenge, particularly following challenges 2 and 3.
Calf 54X (Figure 10b)
The general picture was similar to that of calf N53. This calf
recovered spontaneously from primary infection and not through drug
treatment and a more prolonged clinical reaction was observed with
piroplasm parasitaemia reaching a peak of 45% on day 22. On this day
PCV had fallen to 13%. Again, like calf N53, PCV and body temperature
did not rise following any of the three challenges although, unlike
N53, macroschizonts were observed as well as hyperplasia in the lymph
node biopsy following the first challenge. Piroplasms were contin¬
uously present in the blood at low levels during challenge and showed
slight increases following each of the three challenges.
Calf L21 (Figure 10c)
The first immunising dose of sporozoites irradiated at 320 Gy
established active infection in the calf as exhibited by the appear¬
ance of macroschizonts in the local lymph node on day 12 and piroplasms
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on day 15. This reaction overlapped the time of the second'immuni¬
sing dose of 320 Gy irradiated sporozoites. PCV and body temperature
values had returned to preimmunisation levels by the time the calf
was challenged and showed no changes in response to either challenge
1 or 2. Piroplasms remained at a low level.
Calves N44 and L37 (Figure lOd and e)
These calves demonstrated similar responses to immunisation
and challenge. Immunisation with irradiated sporozoites (500 or
640 Gy) caused body temperature to rise up to 40°C. This was of
short duration as were the hyperplastic reactions in the local lymph
nodes. There was no evidence of infection establishing and blood
and lymph node remained negative for parasite. When calf N44 was
challenged it became infected and exhibited a moderate degree of
clinical reaction, piroplasm parasitaemia reaching 19% as did PCV.
The calf went on to recover from this. Calf L37 was challenged twice
and underwent a relatively mild reaction to challenge 1 with piro¬
plasms at a level of 7.5%, PCV only falling to 20% and the most signi¬
ficant changes being detected in the local lymph node. The second
challenge evoked no recrudescence in parasites over the time the calf
was monitored.
Calf 102 (Figure lOf)
This calf showed even less response to immunisation with 840 Gy
irradiated sporozoites. Body temperature remained steady and only
mild hyperplasia was observed in the lymph node following the initial
immunising dose. However on challenge a severe clinical reaction
developed resulting in death 24 days after challenge.
Figure 10 Clinical reactions of calves during immunisation
and challenge with live virulent or irradiated
sporozoites.
a Calf N53 immunised with live virulent sporo¬
zoites and drug treated.
b Calf 54X immunised with live virulent sporo¬
zoites and drug treated.
c Calf L21 immunised with sporozoites irradiated
at 320 Gy.
d Calf N44 immunised with sporozoites irradiated
at 500 Gy.
e Calf L37 immunised with sporozoites irradiated
at 640 Gy.
f Calf 102 immunised with sporozoites irradiated
at 840 Gy.





D died or destroyed





% PCV % packed cell volume • •
% Piro % piroplasm parasitaemia o o
Section 3.2.2. details the immunisation and challenge








imml imm2 imm3 imm4 ch




imml imm 2 imm 3 ch1 ch 2
day




3.3.2. IFAT results: calf sera
Table 8 indicates the end point titres by IFAT for the calves'
sera tested against different stock and stage antigens during the
course of immunisation and challenge.
Calves N53, N61, 54X and 134X immunised with live virulent
sporozoites all developed titres of Vl60 to 1/640 to all three para¬
site antigens. These titres were very similar between stocks when
the IFAT reactions with different parasite stocks were tested.
Calf L21 which became infected during immunisation with 320 Gy
irradiated sporozoites but recovered, developed a very high anti-
sporozoite titre of 1/2560 postchallenge. Titres against other
parasite stages were also high.
In response to immunisation with 500 and 640 Gy irradiated
sporozoites, calves L37 and N44 developed antisporozoite titres of
1/40 and 1/160 respectively. In calf L37 an antimacroschizont titre
developed more slowly but reached the same value (*/40) as that against
sporozoites after immunisation 3. Calf N44 failed to develop a titre
against Ankara macroschizont antigen even after four immunising doses.
Neither calf showed antipiroplasm activity on. IFAT until challenge
when titres developed to all three stages of parasite antigen.
For calf N44 the prechallenge antisporozoite titre cross-reacted
well with T. annulata Hissar sporozoites ( /160) and to a degree with
Gharb sporozoites (^/40). There was also some cross-reaction produc¬
ing a low titre to Hissar macroschizont antigen (1/40).
Calf 102 which received 840 Gy irradiated sporozoites, developed
a low level sporozoite titre of 1/40 during immunisation with very
little other IFAT reaction and showed no dramatic increase in titres
before dying from the challenge reaction.
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Table 8 Reciprocal IFAT end point titres for calves immunised with live virulent or irradiated
sporozoites
Reciprocal end point titre
A H G
sp schiz piro sp schiz piro sp schiz piro
N53 -1 Preimmunisation 10 - - 10 10 - 10 10 -
live 58 Postchallenge 1 160 160 160 40 160 160 160 160 160
sporozoites 90 Postchallenge 2 160 640 640 160 640 640 640 640 640
N61 -1 Preimmunisation 40 - - 40 10 _ 40 - -
live 58 Postchallenge 1 160 160 160 40 160 - 160 160 160
sporozoites 90 Postchallenge 2 160 640 640 160 640 640 160 640 640
54X 0 Preimmunisation _ 10 - - 10 _ 10 -
live 35 Postimmunisation 160 40 160 40 40 640 40 160
sporozoites 56 Postchallenge 1 160 160 160 160 160 640 160 160
83 Postchallenge 2 640 640 640 640 640 2560 640 640
90 Postchallenge 3 640 640 640 640 640 2560 640 640
95 Postchallenge 3 640 640 640 640 640 640 640 640
134X 0 Preimmunisation - 10 _ 10 10 _ - _
live 41 Postimmunisation 40 40 160 40 40 160 40 640
sporozoites 62 Postchallenge 1 160 160 640 160 160 640 160 640
89 Postchallenge 2 160 160 640 160 160 640 160 640
101 Postchallenge 3 160 160 640 160 160 640 160 640
L21 0 Preimmunisation - - -
320 Gy 28 Postimmunisation 2 640 640
irradiated 56 Postchallenge 1 640 640 640
sporozoites 76 Postchallenge 1 2560 2560 2560 640 2560 2560
90 Postchallenge 1 10240 160
104 Postchallenge 2 2560 640 10240
N44 0 Preimmunisation 10 10 - 10 10 - 10 40 -
62 Postimmunisation 160 - - 160 40 - 40 40 -
(4 d 50 Kr)
92 Postchallenge 160 160 640 160 160 640 160 160 640
L37 0 Preimmunisation - - -
640 Gy 28 Postimmunisation 1 10 - -
irradiated 77 Postimmunisation 2 40 10 -
sporozoites 91 Postimmunisation 3 40 40 -
119 Postchallenge 1 40 40 40
127 Postchallenge 2 640 640 160
152 Postchallenge 2 160 640 160
102 0 Preimmunisation - - -
28 Postimmunisation 10 10 -
(1 x 84 Kr)
42 Postimmunisation 40 10 -
(2 x 84 Kr)
63 Postchallenge 40 10 40
A = T. annulata Ankara; H = T. annulata Hissar; G = T. annulata Gharb;
sp = sporozoite antigen; schiz = macroschizont antigen; piro = piroplasm;







3.3.3. IFAT results: rabbit sera
Sera raised in rabbits 28 and 8 by feeding Theileria-infected
or uninfected adult H_. a_. anatolicum ticks respectively were tested
by IFAT for antisporozoite activity. Titres against formalin-fixed
T. annulata Ankara sporozoite antigen are shown in Table 9 for rabbit
28. Rabbit 8 day 0 and day 78 serum gave no fluorescence even at the
lowest dilution (^/10).
3.3.4. IFAT results: mouse sera
Serum was taken from the Balb/c mice three (intravenous recip¬
ient) or five (intraperitoneal recipient) days after their final
immunising dose and was tested by IFAT against various sporozoite
antigens and against acetone fixed T. annulata Ankara schizont and
piroplasm antigen. Normal mouse serum was included as a negative
control while an antisporozoite monoclonal antibody, 4E5 (Shiels,
personal communication) was used as a positive control.
Table 10 shows the IFAT results for the above sera. Using
formalin fixed sporozoite antigen prepared from the T. annulata
Ankara with which the mice were immunised, an IFAT titre of /160
was observed for the intraperitoneal recipient. This was greater
1
than the titre of /40 obtained for the mouse immunised intravenously,
while normal mouse serum gave no fluorescent reaction. A low titre
to Ankara macroschizont antigen was detected in both immunised mice.
Neither showed any antipiroplasm reaction by IFAT (data not shown).
Table9IFATresults:s rafromrab itednby.annulatainf ctedHy lomtick DayofReciproc lIFATtitres serumFormalinfix dsporozoiteFormalinfixemacr schizontAcet nei dpi opl sm 0 7364010 16816010 18964040 Allantigens:T.an ulataAnkara -Nodetectableti re(l ssthanVlO)Serafromrabbit28
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4E5 culture supernatant 1 + + + + + -
4 + - + + + -
Normal mouse serum 10 + + + + + +
40 - - + - + -
i/p immunised mouse serum 10 + + + + + +
40 + + + + + +
160 - + + + + +
640 - + - + + +
2560 - - - - -
i/v immunised mouse serum 10 + + + + + +
40 + + + + + +
160 - + + + + -
640 - - - - - -
2560 - - - - - -
A = T. annulata Ankara
H = T. annulata Hissar










3.3.5. IFAT results: monoclonal antibodies
a) Primary screen
On day 9 after the fusion, 26% of the microtitre wells con¬
tained cultures with distinct colonies growing. The culture super-
natants of 74 of these were taken for testing for antisporozoite
activity using formalin fixed T. annulata Ankara sporozoite antigen.
Twenty of the 74 supernatants gave strong fluorescence of
sporozoites and the cultures corresponding to these 20 were expanded,
cloned and cryopreserved.
b) Stable clones
Following cloning and loss of some secreting cultures, 19 stable
cloned hybridoma cell lines were established secreting antisporozoite
monoclonal antibodies. One non-secretor, 4C7/G7, was retained for
use as a control hybridoma cell line.
Table 11 shows the IFAT reactions of these 19 monoclonal anti¬
bodies when tested against sporozoite, macroschizont and piroplasm
stages of T. annulata Ankara and sporozoites of T. annulata Gharb.
Figure 11 shows examples of the fluorescence obtained with mono-
clonals recognising formalin fixed T. annulata Ankara sporozoites.
Antisporozoite activity appeared to cross-react well with
sporozoites of the Gharb stock from Morocco; all 19 of the mono-
clonals reacting positively with this antigen.
No fluorescence of piroplasms was observed with any of the
antisporozoite monoclonals; several did cross-react with the macro-
schizont-infected lymphocyte antigen of T. annulata Ankara giving a
variety of fluorescence patterns.
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Table 11 IFAT results: monoclonal antibodies tested against
different stages and stocks of T. annulata
Monoclonal - IFAT antigen
antibody Ankara Gharb Ankara Ankara









































































4C7/G7 supernatant from non-secreting hybridoma cell line
1C7 antimacroschizont Mab (Shiels et al. , 1986a)
7B10 anti-infected lymphocyte surface Mab (Shiels et al., 1986b)
4E5 antisporozoite Mab (B. Shiels, personal communication)
sp = sporozoite antigen; schiz = macroschizont antigen;
piro = piroplasm antigen; f = formalin fixed; a = acetone fixed
Figure 11 Immunofluorescence of formalin fixed T. annulata
Ankara sporozoites in the IFAT using monoclonal
antibodies:
a) 4B11 (x 440 magnification)
b) 1A7 (x 1,500 magnification)
These clearly show that the use of monoclonals
4B11 and 1A7 in the IFAT results in fluorescence






3.3.6. Immunoglobulin class of monoclonal antibodies
Two antisporozoite monoclonal antibodies, 1A7/G8 and 4B11/C12,
were subjected to IFAT and the Ouchterlony test to determine their
immunoglobulin class as described. By both methods the two mono-
clonals were found to be of immunoglobulin class M (IgM). Figure 12
shows the appearance of the Ouchterlony test result.
3.3.7. Surface immunofluorescence of sporozoites
Live Percoll-purified T. annulata Ankara sporozoites were used
in surface IFAT against several monoclonal antibodies and antisera
and the reactions obtained are detailed in Table 12.



















28 day 0 1/80
day 73 1/80
A = ascites; S = supernatant
7B10 = control monoclonal antibody (Shiels et al., 1986a)
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- weaker than 4B11/C12
Figure 12 Precipitation lines in the Ouchterlony test used





C 4H5 IgG2 control IgG2 monoclonal
(Shiels _et ad. , 1986a)







The calves in which hyperimmune serum was raised (N53, N61,
54X, 134X) all became immune during their primary infection as shown
by the subsequent lack of reaction to challenge on three occasions
and the development of IFAT titres to all three parasite stages;
sporozoite, schizont and piroplasm. Antisporozoite titres were
established after infection but either remained static or showed
only a four-fold rise after three challenges. This suggests that
the re-exposure to sporozoites was not sufficient to boost the calves'
humoral response to sporozoites dramatically. It is possible that
more long term and repeated sporozoite inoculation is required to
obtain a convincing anamnestic response. For example, workers
studying Plasmodium falciparum, and wishing to use antibody with
restricted specificity to sporozoite and liver stages, obtained serum
from an individual constantly exposed to malaria over 20 years while
under chloroquine prophylaxis. This subject exhibited extremely high
antibody titres to sporozoites as assessed by IFAT (Guerin-Marchand,
Druilhe, Galey, Londono _et a_l. , 1987) .
During challenge of the calves it is likely that the proportions
of each antibody class stimulated were changing. This may not have
been reflected in IFAT titres but may be of enormous functional
significance. Musoke et_ _al. (1982) found that antisporozoite antibody
class following a primary infection was almost exclusively IgM while
serum from cattle boosted two to three times showed antisporozoite
activity to be predominantly IgG. They used solid phase radio-immuno-
assay to detect antibody so titres are hard to compare directly with
those detected by IFAT. However' their results show that there was as
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much variation in antibody titre between calves within a group as
between titres exhibited by individual calves after primary infection
and after repeated exposure to sporozoite challenge. Thus some
calves had antibody titres after primary infection equivalent to
titres exhibited by hyperimmune calves. It seems that IFAT titres
alone may not be a good indication of hyperimmunity to sporozoites.
The calves involved in the irradiated sporozoite experiments
present a complicated spectrum of reactions and IFAT titres. In
simple terms, the results can be interpreted as showing that the
lowest level of sporozoite irradiation studied here (320 Gy, calf L21)
may have reduced the infective dose but nevertheless did not prevent
the calf from becoming infected and then recovering to behave in a
fashion much like one of the hyperimmunised calves above during chall¬
enge .
Srivastava and Sharma (1977) reported prolonged incubation
periods and less severe disease in two groups of calves receiving
T. annulata sporozoites irradiated with 50 or 100 Gy. However two
out of three calves still died in each group, all of which became
infected and their observations could be attributed more to reduction
in the infective dose as observed in calf L21 than to true attenuation
of the parasite.
Similarly, Purnell _et ad. (1974) studied the effect of inoculat¬
ing cattle with suspensions derived from T. parva infected Rhipicephalus
appendiculatus irradiated over a wider range of 0-600 Gy. At lower
irradiation doses (200 Gy or less) , calves became infected by the
inoculated parasites and were immune to challenge. Of two calves which
showed no reaction to the first inoculum, one died on challenge and
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the other survived challenge undergoing only a mild reaction. Above
250 Gy irradiation, parasites failed to infect cattle in all but one
case which died. These cattle remained susceptible to challenge.
Thus, only one animal could be considered to have become immune without
showing clinical reaction, and therefore perhaps without infection
establishing. There was no good evidence for attenuation of sporo-
zoites and the observations made by Purnell, Ledger and Obatre (1972)
that increasing doses of irradiation produced increasing numbers of
morphologically abnormal parasites in acini may account for the
reactions by indicating a progressive reduction in parasite numbers
inoculated.
In this study a high level of irradiation (840 Gy, calf 102)
reduced sporozoite infectivity and effective immunogenicity leaving
the calf susceptible to challenge with live sporozoites.
Between these two extremes, calves L37 and N44 received sporo¬
zoites irradiated at intermediate dose levels and while infection did
not appear to establish in either calf during immunisation on the
basis of absence of detectable schizonts in repeated biopsies of the
local'lymph node and low or undetectable levels of antibody to schizont
and piroplasm stages, neither calf died on challenge. L37 underwent
a mild clinical reaction and N44 a moderate one before recovery. This
is compared to the reaction of two control calves challenged with the
same stabilate inoculum which either died or demonstrated severe
clinical signs (data not shown). If one accepts that infection was
not established in calves L37 and N44 the implication is that the
irradiated sporozoites alone were able to stimulate a protective immune
response. In vitro studies on irradiated Plasmodium berghei sporozoites
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have revealed that some retain the ability to infect cultured hepa¬
toma cells and transform to the trophozoite stage but are unable to
develop further into the schizont (Sigler, Leland and Hollingdale,
1984). Preliminary in vitro observations on the invasion of bovine
lymphocytes by irradiated T. annulata sporozoites in this laboratory
have indicated that a similar phenomenon may be occurring (Brown,
1981) in which case both humoral responses to sporozoites and cell
mediated responses to the trophozoite-infected cell may have been
elicited in calves N44 and L37. The relative importance of each
has yet to be determined but if sporozoite surface proteins on
irradiated sporozoites remain functional as regards infectivity,
those involved in stimulation of neutralising antibody, which may be
the same proteins, are also likely to be intact. Serum taken after
immunisation with irradiated sporozoites but before challenge in calf
N44 cross-reacted well between the immunising T. annulata Ankara stock
and T. annulata Hissar and, to a lesser extent with T_. annulata Gharb,
while there was minor antimacroschizont and no antipiroplasm response
detectable. The observation that cross-reaction between sporozoites
of different parasite stocks is present where there is virtually no
cross-reaction between life cycle stages within the same stock suggests
that the protective immunity generated may be restricted to sporozoite
challenge and leave animals susceptible to challenge with macroschizont
infected cells though this would not be a risk during natural challenge.
Whether this sporozoite stock cross-reactivity correlates with cross-
immunity remains to be determined. The specificity of protective
immunity produced by irradiated Plasmodium berghei sporozoites has been
investigated by Nussenzweig, Vanderberg, Most and Orton (1969) and they
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showed that the immunological differences between sporozoites and
blood forms of one Plasmodium species may be greater than those
between sporozoites of different species. Although their observ¬
ation refers to species rather than stocks of the same species as
in this study, the principle applies to both. Also, cross-immunity,
where it occurred, between sporozoite species was unrelated to the
cross-immunity between the respective blood stages. Immunity was
stage specific; challenge of sporozoite immunised mice with homologous
blood stage parasite resulted in no significant degree of protection.
Therefore, the sera from calves N53, N61, 54X, 134X and L21
could be classified as hyperimmune sera reflecting exposure to all
parasite stages. Sera from calves N44 and L37 provided what could
tentatively be described as stage specific immune sera, apparently
only exposed to sporozoites. Calf 102, inoculated with sporozoites
receiving the highest doses of irradiation, was susceptible to chall¬
enge and failed to develop significant IFAT titres to any stage; its
serum could, therefore, provide a useful comparison for sera from
the other animals.
The rabbits immunised by tick feeding predictably gave strong
or negligible antisporozoite IFAT reactions according to whether
infected or uninfected ticks had fed. The serum from rabbit 28
represents sporozoite specific antiserum with a high titre without
the complication of possible trophozoite development since sporo¬
zoites do not infect rabbits (Neitz, 1957; C.G.D. Brown, personal
communication). It follows that sporozoites remain extracellular
and exposed to the immune system for longer than in cattle and, in
consequence, high levels of antisporozoite antibody were likely to
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develop. At the same time the slow release of sporozoites into the
dermis during tick feeding probably serves as a very effective method
of antigen delivery to an area rich in cells of the immune system
which have infiltrated the site of tick attachment (Gill and Walker,
1985; Walker and Fletcher, 1986).
The immunisation regime followed for the mice and for monoclonal
antibody production appeared to elicit disappointingly low levels of
antisporozoite antibody in the mouse used for the fusion which was
inoculated intravenously. Since this mouse's serum was taken only
three days post-inoculation, the low IFAT titre may be due to the
fact that the anamnestic response was still in its early stages.
A higher antisporozoite IFAT titre was exhibited by serum from the
mouse receiving its sporozoite dose intraperitoneally. Serum was
taken later from this mouse and antibody levels may have had time
to rise in response to the final inoculation. However, low antibody
levels at the time of spleen removal need not imply that poor numbers
of antisporozoite secreting hybridomas will be obtained. Indeed the
opposite may be true. There is evidence that recently activated B
cells or plasma cell precursors, as yet non-secreting, fuse prefer¬
entially (Goding, 1980) and for this reason fusion is recommended on
day 3 after the final immunisation (Oi, Jones, Goding, Herzenberg and
Herzenberg, 1978) . The mouse had "rested" for several months after
the initial immunisation and was then boosted with an intravenous
sporozoite dose as recommended by Goding (1980). Other workers
(Pearson et al., 1980) have found that the intravenous route for the
final immunisation results in high numbers of specific hybrids because
memory lymphocytes are selectively stimulated in the spleen.
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The fusion itself involved a spleen:myeloma cell ratio of 10:1
which has achieved good results previously, although ratios anywhere
between 1:1 and 10:1 seem to be satisfactory (Oi et al., 1978; Galfre,
Howe, Milstein, Butcher and Howard, 1977) .
Nineteen cloned antisporozoite monoclonal antibodies were
established from this fusion which may appear rather few -considering
that 15 parent cultures were cloned. However, during expansion,
cloning and culture of these hybridomas, many cultures previously
identified as antisporozoite being antibody secretors suddenly stopped
secreting. Prior to cloning, this can easily result by overgrowth
of secretors by non-secreting hybridomas especially as antibody pro¬
duction, by its use of cell resources, makes a secreting hybridoma
cell line less able to compete for growth with non-secretors (Goding,
1980). Early cloning is helpful in this respect but cessation of
secretion is still a frequent occurrence, particularly if hybrids
are stressed by unfavourable culture conditions. Reasons for loss
of antibody secreting ability in a cloned cell line may be loss of
chromosomal material (Goding, 1980) or instability in gene expression
(Pearson et al_. , 1980; Galfre and Milstein, 1981) . To minimise the
risk of losing positive hybridoma cell lines, conditions were opti¬
mised; medium changes were partial and frequent, all overgrowth
avoided, peritoneal macrophages were used to condition the medium
and act as feeder cells and, once HAT medium was no longer required,
cells were grown in HT medium for at least a week until the amino-
pterin and its effects had gone.
The IFA test was chosen to screen for antisporozoite antibody
activity because, like enzyme linked immunosorbent assays, it is quick
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to perform, simple and sensitive although it is a subjective test.
These are important criteria to consider when large numbers of hybrid
supernatants are to be tested and make IFAT and ELISA preferable to
more laborious techniques such as coprecipitation of radio-labelled
parasite components. IFAT has the additional advantage of allowing
visualisation of the site of antibody recognition.
Antisporozoite activity of all 19 established monoclonal anti¬
bodies was observed more easily when formalin fixed sporozoite anti¬
gen was used rather than acetone fixed antigen. Since formalin
fixation is reputed to stabilise surface membrane antigens while
preserving antigenicity (Nantulya and Doyle, 1977) this may indicate
that most of the monoclonals were reacting with epitopes on the sporo¬
zoite surface. Acetone tends to have a much more destructive effect
on cell surface membranes and allows them to become partially permeable
to immunoglobulin (Biberfeld, Biberfeld, Molnar and Fagraeus, 1974).
This makes it a less suitable fixative when testing for antibodies
directed against surface epitopes.
The monoclonal antibodies were raised against the Ankara stock
of T. annulata and all showed cross-reaction with T. annulata Gharb
sporozoites by IFAT. Musoke et al. (1984) also found monoclonal
antibody cross-reaction between sporozoites of several Th parva
stocks and suggested that a common protective antigenic determinant
may be present in all T. parva stocks.
Cross-reaction with other life cycle stages was observed to a
lesser extent. None of the monoclonals staining piroplasms and only
three giving schizont fluorescence, two of which were very weak.
Several others showed a weak and less localised fluorescence of the
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infected cell cytoplasm. This may have been a non-specific reaction
although there are precedents for antigenic cross-reaction between
parasite life cycle stages (Hope, Hall, Simmons, Hyde and Scaife,
1984; Shiels _et al., 1986b; Szarfman, Lyon, Walliker, Quakyi et al.,
1988) .
The immunoglobulin class for monoclonal antibodies (Mabs) ,
1A7/A8 and 4B11/C12 was determined as IgM. To obtain IgM and not
IgG monoclonal antibodies after a long immunisation schedule may be
reconciled with the fact that a high early IgM peak is stimulated in
an anamnestic response (Roitt, 1980). Much shorter protocols for
raising T. parva sporozoite recognising antibodies have produced an IgM
(Musoke et al., 1984) and an IgG3 (Dobbelaere et al., 1984) monoclonal.
Finally, surface immunofluorescence of sporozoites was convin¬
cingly obtained when-the same two Mabs (1A7/G8 and 4B11/C12) and
hyperimmune rabbit and bovine sera were reacted with purified live
sporozoites. This indicated that the monoclonals and at least some
antibodies in the polyclonal sera recognise epitopes exposed on the
surface of sporozoites. Thus, sporozoite coat proteins of T. annulata
are immunogenic.
The IgG3 monoclonal antibody against T. parva sporozoites has
also been shown to recognise a surface antigen (Dobbelaere, Shapiro
and Webster, 1985) although the monoclonal derived from the use of
crude freeze thawed T. parva sporozoites as immunising material
rather than intact live sporozoites as in this study.
With the antibodies raised as described above, it was possible
to continue to determine if the antibodies could be shown to be pro¬
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The main aim of this study was to identify sporozoite antigens
capable of eliciting a protective response. Since the IFAT used in
the initial assessment of antisporozoite activity by antisera or
monoclonal antibodies gives no indication of the functional ability
of an antibody as regards its role in protection, another method of
assessment was necessary.
The choice of method was influenced by the absence of a con¬
venient laboratory animal model for the Theileria parasite (Irvin,
Brown and Crawford, 1972; Irvin, Purnell, Brown and Cunningham, 1975) .
If such a model were available, _in vivo passive transfer experiments
would be an option as employed by Potocnjak et al. (1980) investigat¬
ing the protective activity of monoclonals against a malarial sporo¬
zoite surface antigen.
The mouse has also been used for passive transfer experiments
to assess monoclonals recognising the surface of the invasive tachy-
zoite stage of Toxoplasma gondii (Johnson, McDonald and Neoh, 1983;
Kasper, Currie and Bradley, 1985).
The protective potential of immune serum has classically been
judged by similar passive transfer experiments and also by evidence
of passive immunity in the offspring of immune mothers as observed
in the young of mice immunised with irradiated malarial sporozoites
(Orjih, Cochrane and Nussenzweig, 1981). Passive transfer of anti¬
sporozoite antibodies to infants occurs in areas where malaria is
endemic (Nardin, Nussenzweig, Bryan and McGregor, 1981) . Passive
transfer experiments using serum from animals immune to theilerial
infection have been described (Koch, 1903; Theiler, 1907; Robson et
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al. , 1961; Muhammed et al., 1975) with conflicting results being
reported. The possibility of transfer of protective antibodies to
calves in colostrum has also been studied (Burridge and Kimber, 1973;
Cunningham et al., 1988) without yielding convincing results. How¬
ever, antisporozoite antibody levels were not specifically measured
in any of these studies and their implications as regards antisporo¬
zoite immunity are unclear.
Assay methods involving a combination of in vivo and in vitro
components in which antibody is incubated with the infective parasite
prior to inoculation into susceptible animals have been developed
in several parasite-host systems. Nussenzweig, Vanderberg and Most
(1969a) prevented infection of susceptible mice with malarial sporo-
zoites by incubating them in serum from mice immunised with irradi¬
ated sporozoites. Using a similar protocol, those working .on the
T. parva sporozoite have detected neutralising activity by sera con¬
taining antisporozoite antibodies from cattle and rabbits (Musoke _et
al. , 1982) and by an antisporozoite monoclonal antibody (Dobbelaere,
et al., 1984).
To assess a large number of sera or monoclonals against sporo¬
zoites of T. annulata or T. parva in this way would require the use
of many cattle making the exercise excessively expensive, laborious
and, perhaps, unethical. Therefore an entirely in vitro screening
assay was chosen.
Since 1973 there has been a system for reproducibly infecting
bovine PBM with sporozoites _in vitro (Brown _et al. , 1973) . Into this
system Gray and Brown (1981) and later others (Musoke et_ ad. , 1984;
Dobbelaere et al., 1984; Preston and Brown, 1985) were able to
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introduce antibodies to create a sporozoite inhibition assay. Inhi¬
bition of invasion assays have been used to test antibodies in vitro
against parasites such as Toxoplasma gondii for some time (Jones,
Len and Hirsch, 1975) while malarial sporozoite inhibition assays
(Hollingdale et al., 1982; Hollingdale, Nardin, Tharavanij, Schwartz
and Nussenzweig, 1984) only became possible at the same time as the
in vitro cell culture systems were developed (Hollingdale, McCullough,
Leef and Beaudoin, 1981) .
All assays of this type work on the same principle, whereby
the infective stage is incubated with antiserum or monoclonal anti¬
body and then allowed access to the appropriate target cells under
conditions in which infection would normally occur. This is followed
by a quantitative assessment of the infection rate. By including
suitable controls the degree of inhibition can be determined for any
one antibody.
This chapter describes the further development and application
of a sporozoite inhibition assay which was used to demonstrate the
sporozoite neutralising activity of immune bovine serum (Preston and
Brown, 1985) to assess the antibodies described in Section 3. The
aim was to use the assay to discriminate and select antisporozoite
antibodies with potential protective capacity from others by screen¬
ing for the functional ability to block sporozoite invasion of PBM
in vitro.
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4.2. MATERIALS AND METHODS
4.2.1. Sporozoites
Theileria annulata sporozoites from Ankara, Gharb or Hissar
stocks were obtained as GUTS filtrate (GF) as described in Section
2.2.2. GF was used at a concentration of 0.25-2.0 te/ml in MEM/
3.5% BPA.
4.2.2. Peripheral blood mononuclear cells (PBM)
PBM from a susceptible cow or calf were separated using the
Ficoll-Paque method (Section 2.2.3) . The cells were used at a
concentration of 2-4 x 10°/ml in complete medium (RPMI 1540/16.7%
FCS) .
4.2.3. Antibodies
Antisera were thawed from storage at -20°C and used undiluted
and diluted */4, */8 / Vl6.
Monoclonal antibodies (Mabs) were used either as undiluted
fresh culture supernatant taken from hybridoma culture after 2-4
days' growth, or as diluted ascites from hybridoma inoculated mice.
Ascites was diluted to VlO, VlOO, VlOOO for inclusion in
the assays.
Dilutions were made in complete tissue culture medium and,
where necessary, antibody solutions were filter sterilised using a
0.22 p. filter (Millex G-V, low protein binding, Millipore) .
4.2.4. Sporozoite inhibition assay
Inhibition assays were carried out in one cm2 wells of 48 well
tissue culture plates (Costar).
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For each sporozoite:antibody combination, 0.25 ml GF was mixed
with an equal volume of antibody in four replicate wells except in
initial Mab screening assays when two or three replicate wells were
set up. These were allowed to incubate at 37°C, 5% C02 for one hour.
In a few assays involving monoclonal antibodies, complement was added
in the form of rabbit serum (Gibco) after 30 minutes incubation
following which plates were incubated a further 30 minutes. Then
1-2 x 106 PBM in 0.5 ml complete medium were added to each well and
incubation continued. It should be noted that since sporozoites and
antibody were mixed 1:1, the effective concentration of antibody was
half the stated concentration.
4.2.5. Controls
Controls were included in each assay by incubating sporozoites
either with medium alone, with medium containing no antibody (e.g.
supernatant from 4C7/G7 a non-secreting hybridoma) or with antibody
lacking antisporozoite activity.
Preimmunisation sera acted as controls for antisporozoite sera
while the controls for antisporozoite monoclonal antibodies were
monoclonals raised against something other than sporozoites. These
were:
7B10: which reacts with the surface of the infected lymphocyte
(Shiels et. al. , 1986a)
IE 11_ which react with the macroschizont (Shiels et al., 1986b)
1C7' (IE11 cross-reacts with sporozoites)
3D6D3: an anti-Taenia saginata IgM monoclonal donated by
Dr. L.J. Harrison
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4.2.6. Assessment of inhibition
To assess the blocking action of the antibodies, 50 p.1 samples
were taken from the resuspended contents of each of the wells in
order to prepare Giemsa-stained cytospins.
Cytospins were taken from each well any time from day 2, usually
on day 4 and later in some cases. Two hundred cells were counted
from each cytospin to obtain the percentage of trophozoite or macro-
schizont infected cells. Percent inhibition was calculated by com¬
paring the median percentage infection for the control monoclonal or
antiserum (x) with that for the test monoclonal or antiserum (y) in
the equation:
x — y
% inhibition = x 100
x
Where sample numbers permitted (n > 4) , results were analysed
using the Mann-Whitney U Test for non-parametric data (Siegel, 1956).
Results for a test antibody described as significantly different,
differ at the P < 0.05% level from the results of the appropriate
control antibody.
4 .3. RESULTS
Median percentage infection rates and range values from which
the figures were constructed and the statistical analyses were made
are tabulated in Appendix II.
4.3.1. Sporozoite neutralising activity: bovine antisera
a) Hyperimmune sera from calves immunised with live virulent sporo-
zoites
i) N53 and N61: These two calves were hyperimmunised with re¬
peated doses of live virulent infective sporozoites. During primary
137
infection they were treated with buparvaquone and recovered. Figure
13a shows the sporozoite neutralising activity of their serum during
the course of their hyperimmunisation. A substantial degree of inhi¬
bition was observed in the serum from both calves after being exposed
to two doses of sporozoites (day 58). This increased after a third
sporozoite inoculation (day 90) but the increase was only significant
for calf N61. Although serum from day 107, two weeks after a fourth
dose of live sporozoites, showed a slightly reduced neutralising
action this was not found to be significantly different from day 90's
serum for either calf.
ii) 54X and 134X: These two calves were also hyperimmunised
by repeated inoculation of live virulent sporozoites. They recovered
naturally from the primary infection. Figure 13b shows the strong
(100%) neutralising effect of their hyperimmune sera. Cultures con¬
taining 134X sera were maintained for 18 days at which time there was
still no sign of infection observed in any well containing day 101
serum.
b) Sera from calves immunised with irradiated sporozoites
Selected sera from calves L21, N44, L37 and 102, which had been
immunised with sporozoites irradiated at different dose levels, were
tested for sporozoite neutralising activity. The assay included sera
taken before immunisation, after immunisation but before challenge
and, where available, after challenge with virulent sporozoites. Pre-
and post-immunisation sera from N53 were included as a positive control.
Figure 13c shows the different levels of infection and inhibition
obtained. Undiluted sera from all calves inhibited 100% of sporozoite
Figure 13 Sporozoite inhibition assays to test bovine sera.
Bar charts showing median % infection and inhi¬
bition levels in assays to test sera from:
a) Calves N53 and N61 hyperimmunised with live
virulent sporozoites after recovery follow¬
ing drug treatment.
b) Calves 54X and 134X hyperimmunised with
live virulent sporozoites after recovering
naturally.
c) Calves L21, N44, L37 and 102 (and calf N53
as a control) immunised with irradiated
sporozoites.
Open bars represent assays using undiluted
sera.
Shaded bars represent assays using serum
diluted 1/4.





























infectivity irrespective of the irradiation dose of the sporozoites
they received. In those calves which survived, this inhibition re¬
mained at a high level after challenge. The level of inhibition was
reduced by dilution of the sera, the degree of reduction not being
significantly different between calves.
4.3.2. Sporozoite neutralising activity: rabbit antisera
a) Antisporozoite serum from rabbit 28 against two T. annulata
stocks
Rabbit 28 was immunised by repeatedly feeding _T. annulata-
infected H. a. anatolicum ticks on its ears. Preimmune and immune
sera were included in a neutralisation assay using sporozoites from
Ankara and Gharb stocks. Figure 14a indicates that immune serum from
rabbit 28 possessed strong blocking activity against both parasite
stocks, such that even a 1/16 serum dilution inhibited 100% of sporo¬
zoite infectivity and prevented infection from establishing. Both
preimmune and immune sera, when undiluted, showed a potent non-specific
action on sporozoite invasion. Therefore, rabbit sera were diluted
to at least 1/4 for inclusion in subsequent inhibition assays.
b) Antisporozoite serum from rabbit 28 compared with serum from
rabbit 8
Rabbit 8 was also fed on repeatedly by adult H_. a^. anatolicum
but, unlike rabbit 28, the ticks were uninfected. Thus, sera from
rabbit 8 were supplementary controls for the possibility of a non¬
specific neutralising effect resulting from anti-tick responses.
In this way (Figure 14b), serum diluted 1/4 showed significant inhi¬
bition for both rabbits although the inhibition by rabbit 28 serum
(100%) was much stronger than that by rabbit 8 serum (41%) after they
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had been fed on by ticks. When the same sera were diluted to */8
the neutralising activity of rabbit 8 serum (20.8%) was no longer
significant while that of rabbit 28 serum remained at a high level
(98.9%) .
c) Effect of heat inactivation on sporozoite neutralising activity
Sporozoites of a third T. annulata stock, Hissar, were used in
an assay to assess the effect of heat inactivation on day 0 and immune
sera from rabbit 28. The sera were heat inactivated for 30 minutes
at 56°C and used at a */4 dilution. Figure 14c was derived from
results obtained after just 48 hours culture. At this time after
infection normal infected cells may still contain parasites at the
trophozoite stage. Therefore, infection levels were taken to include
both trophozoite and schizont-infected cells.
A high level of infection had established by day 2 in the cul¬
tures containing day 0 sera. Heat inactivated day 0 serum allowed
a significantly higher level of infection to develop (41%) than un¬
treated day 0 serum (19%) . However, heat inactivation of immune day
73.serum had no detectable effect on its sporozoite neutralising
activity; both untreated and heat inactivated day 73 serum abolished
sporozoite infectivity.
d) Assessment of sporozoite blocking versus inhibition of lympho¬
cyte transformation activity
In this experiment a sporozoite inhibition assay was set up in
duplicate. One tissue culture plate was set up in the normal manner;
day 0 and day 73 sera from rabbit 28 were added to sporozoites one hour
before PBM were added. The other plate was set up with sporozoites
Figure 14 Sporozoite inhibition assays to test rabbit
sera.
Bar charts showing median % infection and
inhibition levels in assays to test sera
from:
a) Rabbit 28 fed on by infected ticks
Tested vs. T. annulata Ankara (i) and
Gharb (ii) sporozoites.
b) Rabbit 28 and rabbit 8 (fed on by
uninfected ticks)
Tested vs. T. annulata Ankara sporozoites
c) Rabbit 28
Tested vs. T. annulata Hissar sporozoites
Sera used: normal and heat inactivated
d) Rabbit 28
Tested vs. T. annulata Hissar sporozoites
Sera added: as normal on day 0 of culture














































and PBM but sera were not added until 24 hours later. After a further
48 hours (total 3 days) incubation,cytospins were made from all wells
and Figure 14d shows the results obtained. As before, immune (day 73)
serum from rabbit 28 added on day 0 of the assay, completely blocked
sporozoite infectivity. When added on day 1 of the assay this serum
had no significant effect on the level of infection establishing
compared to cultures containing day 0 serum added on day 1. Cultures
to which serum was added on day 1 developed a higher level of in¬
fection than those containing serum from day 0 but the difference was
not found to be significant.
4.3.3. Sporozoite neutralising activity: antisporozoite monoclonal
antibodies
a) Primary screen of 19 antisporozoite monoclonals
All 19 secreting hybridoma cell lines selected on the basis of
giving positive fluorescence of formalin fixed sporozoites in the
IFAT were screened for functional ability to neutralise sporozoite
infectivity. Four wells were set up for each sporozoite:Mab combin¬
ation. Complement (rabbit serum,Gibco) was added to two of these
as described in Section 4.2.4. to a concentration of 1:10 in the
sporozoite:Mab mixture. This proved toxic to all cultures, resulting
in cell death. Consequently, results are only presented of the eval¬
uation of sporozoite invasion inhibition without complement.
Table 13 shows the results obtained.
b) Secondary screen of selected antisporozoite monoclonals
After the preliminary screen, 12 Mabs were selected for retest-




Table 13 Primary screen of antisporozoite monoclonal antibodies
for sporozoite neutralising activity
, Median % infection4" ++
Monoclonal antibody % inhibition
n = 2
4B11/C12 S 1.0 85*
A 2.5 62*
4A7/A8 S 12.5 -92
A 2.0 69*
5D1/D11 S 2.0 69*
A 5.5 15
5F1/E11 S 6.5 0
A 1.0 85*
1A7/G8 S 3.5 46*
4A7/E8 S 5.5 15
4A7/B12 S 5.5 15
4D3/E8 s 9.0 -38
5F1/H11 S 5.5 15
4B11/E9 S 0.5 92*
4A7/D10 s 6.5 0
4A7/E12 s 4.5 31
4B11/B12 s 0.5 92*
4B11/G11 s 2.0 69*
4G5/C10 s 2.0 69*
5F1/G12 s 6.5 0
4B11/H12 s 1.0 85*
5D1/D12 s 2.5 62*
1B4/B12 s 1 .0 85*
i7Bl 0 s 5.0 23
A 6.5 0
: 1E1 1 s 3.0 54*
!4C7/G7 s 5.0 23
^Medium only 6.5 0
Sporozoites: T?. annulata Ankara, 0.25 te/well
S = undiluted supernatant from 4 day hybridoma cultures
A = ascites diluted 1:100
+ = on day 4 of assay
++ = calculated against medium only
* ="Mab neutralising over 45% sporozoite infectivity
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Various changes were made in the experimental detail to try
and ensure that observed effects were not artefacts:
i) Rabbit complement at a 1:10 working dilution had proved too
toxic to be of use and was included at 1:20 in this experiment.
ii) Supernatants were taken from 2-day rather than 4-day hybri-
doma cultures since the latter might contain a higher proportion of
dying cells releasing factors into the medium. These could affect
sporozoite infectivity in a non-specific manner.
iii) To try and obtain a higher level of infection in control
cultures by day 4, more concentrated GF was used.
Table 14 shows the results. Again no data is shown for the
effect of complement since even a 1:20 dilution proved too toxic with
very few cells becoming infected.
c) Tertiary screen of selected antisporozoite monoclonals
Of the six Mabs appearing in the first two screening experiments
to possess some ability to block sporozoite invasion into PBM (at
least 55% inhibition compared with control Mab), three were selected
to re-examine this inhibitory activity.
Again, changes were made to experimental detail to try and
improve the inhibition assay:
i) PBM were isolated from the blood of a calf since the PBM
from the mature cow used previously appeared to be less susceptible
to infection with sporozoites than cells from less mature animals.
ii) GF was used at two dilutions.
iii) Mab ascites was used at three dilutions.
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Table 14 Secondary screen of selected antisporozoite monoclonal
antibodies for sporozoite neutralising activity
Monoclonal antibody
Median % infection"*" % inhibition
























































































Sporozoites: lb annulata Ankara, 0.3 te/ml
+ = on day 4 of assay
* = Mab neutralising over 55% of sporozoite infectivity
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iv) As well as control Mabs, 7B10 and 1E11, Mabs 5D1/D11 (ascites)
and 5D1/D12 (supernatant) were included as controls. These two Mabs
were produced during the same fusion as the test Mabs and gave posi¬
tive results with sporozoites on IFAT but had not possessed signifi¬
cant blocking action in the previous two experiments.
Complement was not added to any wells.
Table 15 shows the results obtained.
Inhibition rates were low in this experiment with supernatants
being inactive. For day 4 cultures, the infection rate was high in
the cultures containing 0.25 te GF. Thus, in these cultures the
blocking activity of all but the strongest ascites (1:10) may have
been masked.
d) Sporozoite neutralising activity of two antisporozoite mono-
clonals, 4B11/C12 and 1A7/G8
Two antisporozoite Mabs, 4B11/C12 and 1A7/G8, were selected for
further testing. They had most consistently exhibited a substantial
degree of sporozoite neutralising activity.
Assay i): The Mabs were used individually and in combination
to see whether an additive inhibitory effect was obtained. The calf
sera were included to provide a positive control. Figure 15 illu¬
strates the results.
Ascites at 1:10 and 1:100 dilutions demonstrated strong block¬
ing activity for both individual monoclonals 4B11/C12 (80-93%) and
1A7/G8 (45-87%). When used together, the inhibition rates did not
increase substantially (61-93%). The culture supernatant of control
Mab 7B10 allowed such low levels of infection (Appendix II) to esta¬
blish that it was not possible to detect significant inhibition in
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Table 15 Tertiary screen of selected antisporozoite monoclonal





vs. 7B10 vs. 5D1
GF 0.25 te/well
4B11/C12 A 1:10 26.0 52* 61*
A 1:100 57.5 -20 10
A 1:1000 52.0 3 8
S 38.0 22 7
1A7/G8 A 1. : 10 33 .5 38 50*
A 1 : 1 00 40.0 1 7 37
A 1 : 1000 42.5 21 25
S 42.5 13 -4
4B11/E9 S 50.5 -3 -23
GF 0.05 te/well
-
4B11/C12 A 1 : 1 00 9.5 58* 69*
S 16.0 -45 0
1A7/G8 A 1 : 1 00 11.0 51* 64*
S 13.5 -23 16
4B11/E9 S 23.5 -114 -47
Sporozoites: T. annulata Ankara
A = ascites
S = undiluted culture supernatant
+ = on day 4 of assay
* = Mab neutralising over 50% of sporozoite infectivity
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cultures containing supernatants from 4B11/C12 and 1A7/G8. It was
realised, at this point, that the use of 7B10 as the control mono¬
clonal might have been making the calculated inhibition values lower
than they really were. Preston et al. (1986) actually report that
the inclusion of Mab 7B10 in the medium of schizont-infected cultures
severely limits the growth of these cultures. Although not actually
inhibiting sporozoite invasion of lymphocytes, 7B10 may have reduced
the subsequent growth of cells which had become infected.
Assay ii): Culture supernatants from Mabs 4B11/C12 and 1A7/G8
were retested for neutralising activity in an assay using different
controls; Mab 1C7 which recognises a macroschizont antigen (Shiels
et al., 1986b) and an IgM class Mab raised against Taenia saginata.
This assay was performed in microtitre wells as it was part of a
larger inhibition assay (see Section 7.3.2.). Fifty |il GF (0.05 te)
and 50 |il undiluted Mab supernatant were mixed in each well before
adding 100 (FL PBM (2 x .10^ cells) 60 minutes later. The bar chart
in Figure 15b indicates the infection and inhibition rates which
resulted.
4B11/C12 and 1A7/G8 supernatants both showed convincing and
significant degrees of sporozoite inhibition; 97% and 77% respect¬
ively. While the anti-schizont Mab, 1C7, inhibited 35% of infecti-
vity it was not found to be significantly different from the control
Mab.
To illustrate the appearance of cultures from which cell counts
were made in a sporozoite inhibition assay, Figure 16 shows a Giemsa-
stained cytospin of a culture in which sporozoite invasion a) was and
b) was not blocked.
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Figure 15 Sporozoite inhibition assays to test antisporo-
zoite monoclonal antibodies.
Bar charts showing median % infection and %
inhibition levels in assays to test monoclonals
1A7/G8 and 4B11/C12.
a) individually and in combination:
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Figure 16 Cultures of bovine peripheral blood mononuclear
cells resulting from incubation of sporozoites
in neutralising antibody (a) or antibody with
no neutralising effect (b) .
Giemsa-stained cytospins taken on day 3 of a
sporozoite inhibition assay:
a) uninfected mononuclear cells; 100% inhibition
of sporozoites (x 550 magnification)
b) macroschizont infected cells; no inhibition
of sporozoites (x 1,100 magnification)
Arrows indicate macroschizonts in infected cells.
Figure 17 Trophozoite infected bovine peripheral blood
mononuclear cells 48 hours after in vitro
infection.
Giemsa-stained cytospins showing two examples







In using an _in vitro assay to assess inhibition of sporozoite
invasion into target cells by antibody, such an assay must satisfy
certain demands. These can be considered in terms of predictability
and reliability.
a) Predictability
The assay should be standardised so that known positive and
negative controls yield consistent levels of inhibition and infection
respectively. Into such a standardised system, test antibodies could
be introduced and compared with others as interassay variation would
be minimal. This predictability, or lack of it, was one of the areas
where difficulties were encountered in these sporozoite inhibition
assays. Three sources of variation were present.
i) Sporozoites: The quantum of infection per well was expressed
as the number of tick equivalents. This is an accepted way of indi¬
cating the concentration of a filtrate (GF) of ground up tick super¬
natant (Brown, 1983). Since sporozoites were not counted, the number
placed in each well could, and did, vary between different GF pre¬
parations, differences in the infection rate of ticks being one cause
of this variation. It might therefore seem logical to institute
sporozoite or infected salivary gland acini counts (Irvin, Boarer,
Dobbelaere, Mahan, Masake and Ocama, 1981) and adjust GF to contain
a standard number of sporozoites per unit volume in a manner similar
to that carried out for sporozoites of Plasmodium falciparum and
Plasmodium vivax by Hollingdale et al. (1984). However, this would
in no way assure standard sporozoite infectivity, other factors play
as important a role in determining sporozoite infectivity. One of
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these, sporozoite maturity, is affected by the duration of the tick
feed (Purnell and Joyner, 1968; Purnell, Brown, Cunningham, Burridge
et al. , 1973); the age of the tick and the tick's efficiency at feed¬
ing (Young and Leitch, 1981; Walker _et ad., 1985). This last effect
itself is governed by a host of other factors. These include the
degree of inbreeding in the tick population; the resistance of ticks
shown by the rabbit on which the ticks are feeding, be it innate or
immunological as may occur if the rabbit has been used for a tick
feed on a previous occasion (Brossard, 1977; Chiera, Newson and
Cunningham, 1985); and the level of T. annulata infection in the sal¬
ivary glands. Very high infection rates can adversely affect the
tick's survival and ability to feed (Schein and Friedhoff, 1978;
Walker et al_. , 1985) . Sporoblasts are presumed to be non-infective
and immature sporozoites less infective than those which have reached
full maturity in the salivary gland. Variation in any of the above
can alter the range of maturity within the sporozoite population and
thus influence the infectivity.
Finally, parasite stocks and, within stocks, different batches
of infection appear to differ noticeably in their innate infectivity
for PBM.
Given this variation it would be of significant benefit to
develop a sporozoite inhibition assay which uses cryopreserved stabi-
late as a source of sporozoites. The infectivity could be ascertained
by titration beforehand and the same batch could be used for a whole
series of inhibition assays. At present, however, cryopreservation
of sporozoites in glycerol reduces the infectivity to about 10% of
that of the fresh material (Brown, 1987). While this leaves the
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stabilate very adequate for the in vivo infection of calves and
still allows establishment of in vitro infected cultures, the early
infection rates of such cultures are low and they establish slowly.
This would make valid assessment of inhibition of sporozoite invasion
difficult as early differences between cultures containing test and
control antibodies would be minimal.
ii) Antibodies: The concentration of antibody in monoclonal
ascites and culture supernatant was not determined and may have
fluctuated between preparations although they were checked for anti-
sporozoite activity by the IFAT prior to use.
iii) Peripheral blood mononuclear cells: The target cell popu¬
lation, PBM, varies in an individual animal and between animals as
they mature and as they encounter pathogens and allergens (Schalm,
1965) .
The proportions of various cell subsets changes accordingly.
Changes in the number of MHC class II positive antigen presenting
cells and B lymphocytes could influence the number of cells becoming
infected dramatically, since both these cell types are preferentially
infected by T. annulata sporozoites (Spooner et a_l. , 1988) . Variation
in infectibility of PBM from different animals using the same sporo¬
zoite material has been repeatedly observed in this laboratory (C.G.D.




Reliability refers to the degree of certainty with which a
reduced level of infection can be considered to be due to inhibition
of sporozoite invasion by antibody. Some aspects which influence
the reliability of the results are discussed below.
i) Effects independent of antibody: Preston and Brown (1985)
described an antibody independent effect of immune bovine serum which
caused retardation of trophozoite development into macroschizonts.
Investigations into the factors responsible for this effect have
incriminated a heat resistant, low molecular weight constituent of
serum (P.M. Preston, personal communication) which may be tumour
necrosis factor (Cerami and Beutler, 1988). Undoubtedly this effect
contributed to the degree of inhibition caused by hyperimmune bovine
sera (Section 4.3.1.a) although its importance was not specifically
investigated. Whether serum taken from calves immunised with irrad¬
iated sporozoites exhibits this effect is not known. Some of the
irradiated sporozoites enter lymphocytes (Brown, 1981) as demonstrated
for irradiated Plasmodium berghei sporozoites, some of which still
entered cultured hepatoma cells but failed to develop further (Sigler,
Leland and Hollingdale, 1984) . Thus, it is possible that the anti-
trophozoite effect described above could be stimulated in these calves
also. The immune serum from rabbit 28 which was fed on by infected
ticks did not exhibit such an antitrophozoite effect: when serum was
added to day 1 assay cultures no inhibition was observed.
Other evidence that non-antibody factors influence results
comes from Experiment 4.3.2.C) where heat inactivation of sera from
rabbit 28 left the inhibiting activity of day 73 serum unimpaired
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but allowed a much greater level of infection to develop in cultures
containing heat inactivated day 0 serum. Destruction of complement,
and possibly other toxic proteins by heat inactivation was likely to
be responsible for this effect which enhanced the difference between
the day 0 and day 73 sera.
ii) Effects associated with antibody: This refers to a reduction
in the level of infection caused by antibody exerting its effects
without preventing sporozoite entry into cells. Mazier et al. (1988)
and Hollingdale (1987) observed that in sporozoite inhibition assays,
malarial sporozoites evading antibody neutralisation and invading
hepatocytes failed to undergo further exoerythrocytic development.
They suggested that this was due to the action of antibody bound by
the sporozoite and carried into the hepatocyte. Unquantified obser¬
vations of a similar nature were made during this study. Certainly
in cultures where immune sera or monoclonals 4B11/C12 and 1A7/A8 were
used, cells containing undeveloped sporozoites were visible in day 4
cytospins even in cultures where no infection established.
There are several possible explanations for these observations.
Antibody bound by the parasite before entry which does not have an
immediate effect preventing invasion but inhibits further development
could do so by causing lysis or structural changes in the sporozoite.
Antibody-induced changes were observed by electron microscopy of
malaria sporozoites incubated with immune sera (Cochrane, Aikawa,
Jeng and Nussenzweig, 1976). Another way in which antisporozoite
antibody could continue to have an inhibitory effect would be if the
sporozoite coat, shed during entry to the mononuclear cell (Webster
et al. , 1985) remains on the cell surface for some time. This was
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seen to be the case for the T_. parva sporozoite surface coat
(Dobbelaere et al., 1985a) and, if true for T. annulata also, could
provide an antibody target on the infected cell. Finally, antibody
may be able to penetrate the infected cell. Non-parenchymal cells
of the liver have been shown to take up immune complexes in vivo in
mice by phagocytosis (Hopf, Schaefer, Hess and Meyer zum Bllscherfelde,
1981). Since the sporozoites infect cells of the immune system which
bear Fc receptors (Spooner et al., 1988; Male, Champion and Cooke,
1987) it is possible that antibodies could gain access to the intra¬
cellular parasite.
The other example of an antibody acting to reduce infection
levels in these assays was Mab 7B10 which recognises an antigen on
the surface of T. annulata-infected mononuclear cells. Mab 7B10 is
already known to exert an inhibitory effect on the growth of T.
annulata-infected lymphocytes (Preston _et ad., 1986) although how
this is mediated is not known.
iii) Time interval between infection and assessment of inhi¬
bition: This interval should be as short as possible to minimise the
impact of effects unrelated to inhibition of sporozoite invasion but
not so brief that the difference between negative and positive results
is not detectable, particularly if only a low level of infection is
achieved in control cultures. Producing a high infection rate in
control cultures to yield early results was highly desirable but two
problems arose with this approach. One was that the sporozoite sus¬
pension (GF) contains tick proteins, such as enzymes and gut contents,
with potentially toxic effects. When more concentrated GF was used
these caused cell death making the assay useless. Also, if cells
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are multiply infected with sporozoites they often die (C.G.D. Brown,
personal communication). The second problem was that an excessive
number of sporozoites could overcome the inhibitory capacity of the
antibody present.
Hollingdale (1987) describes a sporozoite invasion inhibition
assay where inhibition is assessed after just three hours using a
Mab to stain and count intracellular malarial sporozoites which are
morphologically distinguishable from free sporozoites. There is no
such immediate and obvious change in the morphology of interiorised
theilerial sporozoites visible by light microscopy, although using
transmission electron microscopy, Jura, Brown and Kelly (1983)
describe rapid transformation into the trophozoite stage. In Giemsa-
stained preparations confusion existed both in distinguishing intra¬
cellular sporozoites from those attached to the exterior of cells
and in confidently recognising the trophozoite stage. Figure 17
shows two examples of readily identifiable trophozoites but fre¬
quently they were not so clearly seen.
Winger et al. (1978) took smears of erythrocytes at 20 and 40
hours post-infection to assess Babesia divergens merozoite inhibition
rates while Dobbelaere et al. (1984) and Musoke et al. (1984)
assessed T. parva sporozoite inhibition rates from cytospins taken
from days 3 and 5 respectively.
In this study, the majority of inhibition assays were assessed
on day 4 after in vitro infection when infection levels were high
enough to detect differences but before differences were obscured by
secondary effects.
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It might appear that the use of, for example, tritiated
thymidine incorporation as a measure of proliferation in a culture
rather than visual counts of infected cells would be more reliable
in assessing inhibition. However, there is a significant degree of
lymphoproliferation in an early in vitro infected culture which
occurs without the blasting cells being infected. Visual counting
of Giemsa-stained cytospins distinguishes these uninfected cells
from infected ones, whereas radioactive nucleotide precursor incor¬
poration would not (Preston and Brown, 1985) .
It is clear from the results obtained that the _in vitro assay
used in this study was capable of detecting different levels of
sporozoite neutralising activity by antibodies. These are discussed
below, bearing in mind the influence of the above points on their
interpretation.
All sera from hyperimmunised calves (N53, N61, 54X and 134X)
which received repeated doses of live virulent sporozoites, exhibited
strong activity inhibiting sporozoite invasion of PBM as previously
reported by others for similar antisera raised against both T.
annula ta (Preston and Brown, 1985) and T. parva (Musoke et a_l. , 1982) .
Calves N53 and N61 recovered from primary infection through the
use of a theilericidal drug, buparvaquone, administered on day 14 of
infection. Taylor (1985) assayed serum levels of buparvaquone after
administration at therapeutic doses to calves and found that they
were minimal after 16 days and absent 32 days after administration.
Thus the inhibitory activity of serum from day 58 post-infection used
in the sporozoite inhibition assay would not have been due to the
presence of persisting levels of buparvaquone in the serum.
159
The postimmunisation sera from all calves immunised with
irradiated sporozoites appeared to be very effective in neutralis¬
ing sporozoite infectivity, regardless of the irradiation dose to
which the immunising sporozoites had been exposed. Surprisingly,
the sporozoite neutralising capacity did not correlate with the
susceptibility of these calves to theileriosis on challenge. Calf
102, which appeared fully susceptible to challenge (Section 3.3.1.),
exhibited strong neutralising activity in postimmunisation serum
after receiving sporozoites irradiated at 840 Gy. The implications
of these results must affect the interpretation of inhibition assays
involving theilerial sporozoites.
If the protection afforded to calves N44 and L37 by immunis¬
ation with irradiated sporozoites was entirely dependent on antibody
mediated neutralisation of sporozoites, one would expect serum from
calf 102 to have lacked such-activity. As this was not the observed
result, the calves which survived challenge may have owed their
immunity to a secondary mechanism which was not operating in calf 102
and was unrelated to neutralisation of sporozoites. Indeed, compared
to immunisation with live sporozoites, immunisation with irradiated
sporozoites may be a poor method of eliciting antisporozoite anti¬
bodies which neutralise _in vivo. Alternatively, if sporozoite
neutralisation was a significant effector mechanism in vivo, the
ability of serum from calf 102 to inhibit sporozoite neutralisation
in vitro may be an artefact resulting from the conditions of the
assay. To consider this point further: the virtual absence of detect¬
able antisporozoite antibodies in the serum of calf 102 after immuni¬
sation when tested by IFAT (Section 3.3.2.) or Western blotting
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(Section 5.3.3.) implies either that the in vitro neutralisation
observed reflected an antitrophozoite transformation action inde¬
pendent of antibody or that antisporozoite antibodies present were
of low affinity and therefore remained undetected by the above
methods. In vivo contact of antibody with sporozoites would be
brief owing to the rapid entry of sporozoites into their host cells
(Fawcett et al., 1982; Jura et al., 1983) , whereas the in vitro
assay allowed relatively prolonged contact between sporozoites and
serum. Thus, antibodies of low affinity in the serum of calf 102
would not have time to neutralise ^Ln vivo but might appear effective
in vitro. The immunoglobulin class of antisporozoite antibody might
also be responsible for differences in the _in vivo effectiveness of
humoral response between calves. If antisporozoite antibody present
in the serum of calf 102 was not only of low affinity but also pre¬
dominantly IgM, the in vivo neutralising capability of such antibody
might be restricted since IgM antibody is largely confined to the
intravascular pool (Roitt _et al^ , 1985) and might penetrate to the
site of the tick bite less easily than antibody of other immuno¬
globulin classes. However, Musoke et al. (1982) reported that a
change in the predominant immunoglobulin class of bovine sporozoite
neutralising antibodies, from IgM to IgG with repeated sporozoite
challenge correlated with an increase in the in vitro sporozoite
neutralising activity of the antisera. In view of the fact that the
in vitro activity of serum from calf 102 was no weaker than other
calves' sera, differences in antibody class were probably not involved.
Another explanation for _in vitro neutralising activity being
observed in serum from calf 102 is that calf 102 might recognise
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different sporozoite antigens from the other calves; antigens which
are accessible to antibody in the prolonged period of incubation
used in the _in vitro but not _in vivo because they are poorly repre¬
sented on the sporozoite surface.
Further experiments are required to determine the true explan¬
ation and to assess whether calves N44 and L37 were immune to chall¬
enge due to Jui vivo neutralisation of sporozoites, or due to a
secondary mechanism perhaps cell mediated, or a combination of the
two.
Sporozoite inhibition assays to test the rabbit sera showed
that rabbit 28 developed a strong sporozoite neutralising activity
after being fed on by infected ticks. That this effect was primarily
mediated by a response directed against sporozoite and not tick
antigens is shown by the much lower level of inhibition exerted by
serum from rabbit 8 which was fed on by uninfected ticks. This
slight inhibitory activity became insignificant when the serum was
diluted further, whereas the diluted serum from rabbit 28 maintained
strong sporozoite neutralising activity. One can speculate that
antibody to tick proteins which develops in the serum of rabbits fed
on by ticks (Gill, Boid and Ross, 1986) was responsible for the
slight inhibition observed. If sporozoites bind small quantities
of tick protein to their surface, antibody recognising these tick
proteins might cause sporozoite aggregation or interfere with normal
sporozoite invasion of cells, thus reducing their infectivity in a
non-specific manner.
Sporozoite neutralisation by serum from rabbit 28 was effective
against all three T. annulata stocks, as expected since tick batches
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infected with each of the three stocks had fed on its ears (see
Section 3.2.2.). This neutralising ability was not complement
dependent and was unaffected by heat inactivation of the serum. Heat
inactivation did have a significant effect in allowing a higher
level of infection to establish in cultures containing day 0 serum.
This was presumably due to the destruction of other heat labile
noxious substances. By performing an experiment in which serum from
rabbit 28 added on day 1 of the assay was compared with a normal
assay, the sporozoite inhibition was shown to be due to the action
of serum within the first 24 hours of the assay. Thus, it is evi¬
dent that, for this rabbit serum, inhibition of sporozoite invasion
rather than of lymphocyte transformation was the mechanism involved.
This was not unexpected since the rabbit was considered to have been
exposed to the sporozoite stage only.
The assays to test the antisporozoite monoclonals led to the
selection of two Mabs which had shown the most consistent and signi¬
ficant levels of sporozoite inhibition; Mab 4B11/C12 (61-100%) and
Mab 1A7/G8 (46-87%). In view of the results with the irradiated
sporozoite recipient sera, doubt may be cast on the validity of this
assay as a means of selecting Mabs which identify potentially pro¬
tective antigens. However, significance can be attached to the fact
that some antisporozoite Mabs showed no inhibitory action. Neither
monoclonal neutralised sporozoite infectivity as strongly as hyper¬
immune bovine sera or rabbit 28 serum. This could be because, by
definition, they each only recognise a single epitope, whereas the
polyclonal sera could be identifying several target antigens to
achieve neutralisation. In addition, hyperimmune bovine serum
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possesses antilymphocyte transformation activity (Preston and Brown,
1985) which contributes to the final level of inhibition observed.
The degree of inhibition by a monoclonal antibody can, in part,
be a reflection of the assay sensitivity. Certainly T. annulata
is an easier parasite with which to establish infected cell lines
than T. parva for which cell feeder layers (Brown, 1983) or filler
cells and growth factors (Baldwin, Malu and Grootenhuis, 1988) are
required. It follows that it is likely to be harder to demonstrate
complete blocking of T. annulata compared to T. parva sporozoites.
Both Dobbelaere et al. (1984) and Musoke et_ ad. (1984) show complete
blocking of T. parva sporozoite infectivity with high levels of
their antisporozoite Mabs. The merozoite invasion blocking antibody
of Winger et al. (1987) showed a maximum of 76% inhibition when
calculated in the same manner as in these assays and this was con¬
sidered to be a significant degree of inhibition. Thus, the inhi¬
bition rates obtained with Mabs 4B11/C12 and 1A7/G8 should not be
considered as too low to be of significance.
In conclusion, therefore, an in vitro assessment of the
functional ability of a range of antisporozoite antibodies was made
and led to the selection of two monoclonal antibodies showing sub¬
stantial levels of sporozoite neutralising activity.
These monoclonals have advantages over polyclonal sera in that
the sporozoite epitope which is recognised by each antibody and which
mediates their inhibitory activity can be readily identified. Both
the monoclonals and the rabbit 28 serum are particularly useful in
that they exert their inhibitory activity entirely through recog¬
nition of sporozoite epitopes without the complication of effects
Figure 18 Possible modes of action of antibody or serum
factors in sporozoite inhibition assays.
a antibody binding to sporozoites: aggregation,
lysis, structural changes leading to loss of
infectivity.
b antibody binding to sporozoites: interfering
with recognition, attachment and/or entry
into target cells.
c antibody entering host cells after sporo¬
zoite entry: sporozoite death or failure
to develop further.
d antibody bound to sporozoites carried into
cell: sporozoite death or failure to develop
further.
e serum factor (? tumour necrosis factor) acting
on trophozoite infected cells: inhibition of
transformation.
f antibody binding surface of macroschizont







































on lymphocyte transformation observed with polyclonal bovine sera.
Figure 18 illustrates the possible modes of action of the different
antibodies used in the inhibition assays described in this chapter.
Since monoclonals, 4B11/C12 and 1A7/G8 may identify potenti¬
ally protective sporozoite surface antigens, the next aim in this
study was to characterise these antigens and compare them to those
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The indirect fluorescent antibody test reactions and sporo-
zoite neutralising abilities of a range of antisporozoite antibodies
have been reported in the previous two chapters. However, these give
little indication of how the antigens recognised by these different
monoclonals and antisera relate to each other. To determine this,
and to define the antigens recognised by Mabs 1A7/G8 and 4B11/C12
(hereafter known as 1A7 and 4B11) more fully, the techniques of
protein separation and antigen detection were applied to sporozoite
proteins.
Two methods of antigen characterisation were used. The first
used the technique known as Western blotting. In this, the proteins
of whole sporozoites were separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE), the principles of
which are described by Hames and Rickwood (1981) and Walker (1986).
Then antigens were detected by antibodies after their transfer to,
and immobilisation on, nitrocellulose paper (Towbin, Staehelin and
Gordon, 1979; Walker, 1986).
The second method used the techniques of surface labelling and
immunoprecipitation and involved radioiodination of sporozoite surface
proteins (Fraker and Speck, 1978; Howard, Kaushall and Carter, 1982)
prior to their incubation with antibody to form immune complexes.
These were precipitated from unbound protein, separated by SDS-PAGE,
and their position detected directly using autoradiography to visual¬
ise the presence of radioactive iodine molecules.
There are many good reasons for determining the molecular weight
of parasite proteins of interest. Statement of molecular weight is
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the standard manner in which a protein is described and reported.
Once the molecular weight is known, comparisons can be made regard¬
ing whether different parasite stocks or parasite stages which react
with the antibody by another method of immunodetection, such as
immunofluorescence or the enzyme linked immunosorbent assay (ELISA),
bear the relevant epitope on proteins of the same size.
Knowledge of molecular weight also reveals whether different
antibodies giving identical reactions by other methods are identi¬
fying the same antigenic determinants of the parasite, although this
can be done without resorting to protein analysis. For example,
Musoke et al. (1984) showed that five monoclonal antibodies recog¬
nised the same antigenic component of T. parva sporozoites by using
a competitive inhibition ELISA. It is of interest to know whether
antisera raised in different species or by different immunisation
procedures react with different or similar parasite components.
Early work to characterise theilerial antigens by Wagner, Brown,
Duffus, Kimber et al. (1974) and Allsopp, Wagner, Matthews and Kariavu
(1977) was hampered by two problems; the difficulty in obtaining
protein free of bovine contaminants and the considerable range of
molecular weights of the antigens obscuring subtle strain differences.
Since then, both immune precipitation (Allsopp, 1981; Creemers, 1981,
1983) and immunoblotting techniques (Shapiro, Fujisaki, Morzaria,
Webster et aT., 1987) have been used with some success to identify
macroschizont and piroplasm antigens.
The same methods have been used to analyse theilerial sporozoite
proteins of T. parva (Dobbelaere, Shapiro and Webster, 1985b; lams,
Hall and Musoke, 1988) and T. annulata (B. Shiels, personal communication).
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The purpose of the work described here was to define the mole¬
cular weight of sporozoite antigens recognised by the different anti-
sporozoite antibodies, to define how the antibody reactivities related
to each other and to investigate the nature of antigens detected by
monoclonals 1A7 and 4B11.
5.2. MATERIALS AND METHODS
Formulations of materials mentioned in the text are given in
Appendix 1.3.
5.2.1. Preparation of protein samples for SDS-PAGE
a) Percoll-purified sporozoites
Thirty two te of sporozoites, prepared using media excluding
BPA, were purified on a Percoll gradient (Section 2.2.2.). Sporo¬
zoites from all three T. annulata stocks were used. Two bands of
material were harvested from the gradient; a band taken from the
1.07/1.095 s.g. interface containing the purified sporozoites (Sample
1) and a band taken from the 1.03/1=05 s.g. interface containing
sporozoites, immature sporoblasts and tick debris (Sample 2) . Figure
19 shows the samples harvested diagramatically.
Each was washed once in 20 ml PBS containing protease inhibitors
(Appendix 1.3.5.) by centrifugation at 1,500 G for 30 minutes at 4°C.
The pellets were thoroughly resuspended in 0.75 ml PBS containing
protease inhibitors and then 0.25 ml of x 4 reducing SDS sample buffer
containing B-ME was added before heating the samples at 100°C for five
minutes. Samples were aliquoted and stored at -80°C. Depending on
sporozoite density, as assessed from a Giemsa-stained cytospin, 30-
100 (il of sample (1-3 te) was used per gel track.
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Figure 19 Material harvested from Percoll gradient









For non-reduced samples, 50 ul of the resuspended pellet was
added to 50 (il x 1 non-reducing SDS sample buffer containing iodo-
acetamide. The mixture was heated at 100°C for five minutes and the
whole 100 jj.1 volume used for one gel track. Except where specified
otherwise, samples were run in a reduced form.
Early preparations of Percoll-purified sporozoites were made
with BPA in the media and without the inclusion of protease inhibitors.
For reasons which are explained shortly the protocol was amended to
rectify these points.
b) Uninfected Percoll preparation
To act as a control antigen, uninfected GF from 32 x three day
fed uninfected H. a. anatolicum adult ticks was separated on a Percoll
gradient. Material was collected from exactly the same positions as
above and were called samples 3 and 4 (Figure 19). They were treated
in exactly the same manner to be run under reducing conditions only.
c) Ground up tick supernatant (GUTS)
Uninfected and T. annulata Hissar infected GUTS were prepared
at a concentration of 10 te per ml using MEM without BPA as the grind¬
ing medium. The aliquoted samples were stored at -80°C and 1 te
separated on each gel track, under reducing conditions.
d) Purified piroplasms
A 0.5 ml pellet of T. annulata Ankara piroplasms prepared in
the manner described in Section 2.2.10. was resuspended in 2 ml PBS
containing protease inhibitors. An equal volume of x 1 reducing SDS
sample buffer was added and the mixture was heated at 100°C for five
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minutes. The sample was passed rapidly in and out of a 21 gauge
needle to shear the DNA and reduce the viscosity of the sample. Ten
Hi was used per gel track.
e) Rabbit and bovine blood
Samples were prepared from rabbit and bovine blood. Whole
blood was collected into tubes containing EDTA (Vacutainer, Becton
Dickinson) and for each gel track 1 |il of whole blood was diluted
with 23 Hi PBS containing protease inhibitors. Eight |il of x 4
reducing SDS sample buffer was added to this and the sample was
heated at 100°C five minutes before cooling and loading onto the gel.
5.2.2. SDS-PAGE
Separation of proteins in the above samples was achieved using
SDS-PAGE on 7-20% acrylamide gel slabs (Studier, 1973). The tech¬
nique was used to study total protein profiles, to provide proteins
separated by molecular weight for immunoblotting and to analyse the
products of surface labelling and immunoprecipitation. The practical
aspects are described by Zingales (1984), Goding and Handman (1984)
and Walker (1986). Briefly, 7-20% polyacrylamide gradient gels were
prepared by mixing 20 ml of 7% and 20 ml of 20% acrylamide solutions
via a concentration gradient gel pourer and peristaltic pump, having
added 26 Hi of 10% ammonium persulphate (BDH) and 6 Hi of N,N,N',N'-
tetramethylethylenediamine (TEMED, BDH) to each of the two gel con¬
centrations to cause polymerisation of the acrylamide. The resulting
gels (19 cm x 13.7 cmx 0.15 cm) were overlaid with a 3 cm stacking
gel. The low acrylamide concentration (4.5%) of this stacking gel
allows proteins to concentrate before reaching the lower resolving gel
(Laemmli, 1970).
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Samples of 10-100 pi were loaded into wells in the stacking gel
and electrophoresis was carried out in electrophoresis tank buffer
(Appendix 1.3.1.) at 80 volts until the bromophenol blue dye of the
sample buffer had reached the end of the gel. This took 16-20 hours.
5.2.3. Protein detection in SDS-PAGE gels
In order to visualise the positions of protein bands after
electrophoresis and to fix the proteins in position in the gel, two
protein staining methods were used.
a) Coomassie blue stain
Proteins were stained for 2-4 hours in a filtered solution of
Coomassie brilliant blue R (Sigma), 0.1% w/v in destain solution, at
room temperature. Gels were destained overnight to visualise the
proteins.
b) Silver stain (Morrisey , 1981)
This was the main method used to visualise sporozoite proteins
in gels. It is more sensitive than Coomassie blue which is unable
to .detect bands containing less than 100 ng protein (Goding and
Handman, 1984) .
Gels were incubated for 30 minutes in each of solutions 1, 2
and 3 (Appendix 1.3.2.). They were then washed in purified water
overnight. After a 30 minute incubation in 0.1% w/v silver nitrate
(Sigma), the gels were rinsed in purified water and then developer
(Appendix 1.3.2.) before being left in developer until bands had
appeared (about 20 minutes). The reaction was stopped with 5 ml of
2.3 M citric acid (BDH) per 100 ml developer. After rinsing in puri¬
fied water over 30 minutes, gels were photographed.
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5.2.4. Western blotting
Practical details of performing Western blots are given by
Towbin et al. (1979), Moriearty (1984) and Walker (1986). Solutions
and reagents are detailed in Appendix 1.3.3.
Proteins separated by SDS-PAGE were electrophoretically trans¬
ferred onto 0.45 (am nitrocellulose paper (Schleicher and Schuell)
in blotting buffer using an Ancos semi-dry electroblotter (Dako Ltd.)
at 200 mA, 12 volts for 90 minutes. When transfer had occurred, the
track containing the molecular weight markers was cut off and the
proteins visualised by staining in 0.1% amido black (Sigma) in de-
stain. The rest of the nitrocellulose paper (blot) was placed in
blocking buffer containing 5% skimmed milk (Marvel, Carnation) for
four hours to block non-specific protein binding sites on the nitro¬
cellulose paper (Johnson, Gautsch, Sportsman and Elder, 1984). The
blot was then divided as necessary and incubated overnight in anti¬
serum or monoclonal antibody. Rabbit sera were diluted to 1:200 and
bovine sera to 1:100 in blocking buffer with 5% skimmed milk, while
Mabs were used as undiluted culture supernatants. The blot was then
washed in seven changes of PBS over 90 minutes before being .incubated
for two hours with the appropriate horseradish peroxidase conjugated
second antibody at a dilution of 1:1000 (anti-bovine) or 1:2000
(anti-rabbit and anti-mouse) in blocking buffer with 5% skimmed milk.
The blot was then washed in PBS as above. The positions of antigen-
antibody complexes were detected by incubating the blot in substrate
for the peroxidase enzyme. To do this, the blot was placed in sub¬
strate solutions 1 and 2 (Appendix 1.3.3.) mixed together and colour
development allowed to occur over the next 5-20 minutes. The blot was
finally rinsed in purified water.
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5.2.5. Determination of protein molecular weights
Molecular weights were calculated by reference to the mobili¬
ties of the protein standard mixture of the low molecular weight
range (Appendix 1.3.5.) . All molecular weights are given in kilo-
daltons (kdal, Stryer, 1981) and are estimates.
5.2.6. Radiolabelling of sporozoite surface proteins
The method described here for labelling of surface proteins
with radioactive iodine 125 (*25j) using a chloroamide, iodogen is
based on that followed by Howard et al. (1982) with modifications
as noted below.
Forty te of GF from both uninfected and T. annulata Ankara
infected ticks were separated on Percoll gradients. BPA was excluded
from all the media. Bands were harvested from 1.03/1.05 s.g. and
1.07/1.095 s.g. interfaces of the infected Percoll preparation
(samples 1 and 2) and from the 1.03/1.05 s.g. interface of the unin¬
fected Percoll separation (sample 3). The samples were washed as
described in Section 5.3.1. except that protease inhibitors were
excluded from the PBS. After washing, each pellet was resuspended
in 300 |il PBS. Glass bijoux bottles had previously been coated
internally with 60 y.g iodogen (1, 3 ,4 ,6-tetrachloro-3-alfa , 6-alfa-
diphenylglycoluril, Sigma) by evaporation of 600 p.1 of 100 hg/ml
iodogen in chloroform.
The three samples (1-3) were each placed in a rinsed iodogen-
coated bijou and 300 |iCi (3 |il) of 125j (as sodium iodide in dilute
sodium hydroxide solution, pH 7-11, free from reducing agents,
Amersham International PLC) was added to each. The bijoux were
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agitated at room temperature for 10 minutes and then the contents of
each were transferred to labelled 1.5 ml Eppendorfs and 1.0 ml PBS
containing protease inhibitors, used to rinse the bijou, was added.
The samples were centrifuged for 12 minutes at 1,500 G (4,500 rpm)
on a microcentrifuge. The supernatants containing free iodine were
discarded and each pellet was resuspended in 1.2 ml PBS containing
protease inhibitors and recentrifuged. Two further washes were made
as above.
Each pellet was then resuspended in 750 jal lysis buffer
(Appendix 1.3.5.) and freeze thawed three times in liquid nitrogen.
One jj.1 of each sample was placed in a plastic vial (Sarstedt) and
radioactivity was measured using a gamma counter (Nuclear Enterprises
NE 1600).
Trichloroacetic acid (TCA, Sigma) precipitation was carried out
to see what proportion of the measured radioactivity derived from
labelled protein. This involved measuring the radioactive counts
per minute (cpm). for 4 (j.1 of each sample, adding 100 |j.l of normal
rabbit serum diluted 1:10 in PBS, and then filling the vial with 10%
TCA. The tubes were centrifuged for five minutes at 2,500 G and 4°C
and the supernatant discarded before counting the pellets. The
proportion of radioactivity remaining indicated the efficiency of the
radiolabelling process.
To determine which proteins had been labelled with ^^1, each
sample was separated by overnight SDS-PAGE on a 7-20% acrylamide gel.
For each gel track, 100,000 cpm were diluted in 30 )il PBS containing
protease inhibitors, added to 10 pil x 4 SDS sample buffer and heated
at 100°C for five minutes.
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5.2.7. Immunoprecipitation of rddiolabelled proteins
Four replicate vials were prepared for each sample, all contain¬
ing 100,000 cpm. For each sample (1-3), each of the four vials was
mixed with a different antibody as shown below:
Mab 1A7 400 u.1
Mab 4B11 400 |il
Normal mouse serum 3 |il + 397 pil immunoprecipitation
diluent (Appendix 1.3.4.)
Mab anti-Taenia saginata 400 (j.1
The Mabs were used as undiluted culture supernatants. The
contents were mixed, covered in Parafilm (American Can Company) and
left at 4°C for three hours. To each vial, 3 p.1 normal mouse serum
(except to those already containing normal mouse serum) , 50 ptl immuno¬
precipitation diluent and 4 5 p.1 goat anti-mouse antiserum (prepared
by Dr. L.J. Harrison and referred to by Harrison and Parkhouse, 1986)
were added. Vials were incubated at 4°C overnight to allow preci¬
pitate to form.
Five hundred p.1 of diluent was added to each vial and they
were centrifuged for 10 minutes at 1,200 G, 4°C. The supernatants
were discarded, taking care to leave the precipitate intact. A few
drops of diluent were added to resuspend the precipitate by vortexing
(Whirlimixer, Fisons) before adding another 1.0 ml diluent to wash
the precipitate by centrifuging as above. This was repeated three
times or until counts of radioactivity remained similar from one wash
to the next. At this point each precipitate was resuspended in 20 |J.l
PBS and 10 p.1 of x 1 reducing SDS sample buffer was added. The samples
were heated at 100°C for five minutes, cooled and separated by SDS-PAGE
on a 7-20% gradient gel.
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5.2.8. Gel drying and autoradiography
Polyacrylamide gels on which surface labelled or immuno-
precipitated proteins had been separated were stained in 0.1% Coo-
massie blue and destained to visualise the non-radioactive molecular
weight markers. Then the gels were soaked for 45 minutes in 1% gly¬
cerol, 10% acetic acid in purified water before being dried for two
hours onto porous cellophane using a gel slab dryer (Biorad Labs.).
Autoradiographs of the dried gels were obtained by exposing them at
-80°C to x-ray film (Agfa-Gevaert Curix RPI [100 NIF]) using fast
tungstate intensifying screens (Ilford). They were developed (Kodak
D19 developer) and then fixed (Ilford Hypam Fixer, diluted 1 in 4).
5.3. RESULTS
Two problems were encountered in the preparation of sporozoites
for SDS-PAGE analysis which were overcome as described. The first
was that, if BPA was included in the media during purification, it
was bound by the sporozoites to such a degree that washing failed to
remove it. This dramatically influenced and obscured the true pro¬
tein profile of the sporozoites since most of the protein present
was BPA (Figure 20a, track 2). Western blots also gave poor results
at this stage. Therefore, subsequent sporozoite preparations were
made excluding any extraneous protein, in particular BPA, from media
and from the Percoll gradient (Figure 20a, track 1). To ensure that
sporozoite infectivity was not lost without the BPA, which would imply
detrimental effects on sporozoite proteins, infectivity titrations
were carried out for GF and Percoll preparations (for in vitro infec¬
tion method see Section 2.2.4.) and the results are shown in Table 16.
Figure 20 Effects of bovine plasma albumin and protease
inhibitors on the analysis of sporozoite
antigens.
a) Silver stain of sporozoite proteins separated
by SDS-PAGE after purification of sporozoites
using:
track 1 media excluding bovine plasma albumin
track 2 media including bovine plasma albumin
b) Western blot of sporozoite proteins detected
by monoclonal antibody 1A7 after purification
of sporozoites in the:
track 1 absence of protease inhibitors
track 2 presence of protease inhibitors
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Table 16 In vitro titration of infectivity of sporozoites prepared
without BPA.
Sporozoites Dilution






































































GF: 2 te per well
- ten-fold dilutions made from these
Percoll: 2 te per well)
ND = Not done; TaH = T. annulata Hissar; TaG = T. annulata Gharb
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Sporozoite infectivity remained high in spite of the absence of
BPA, the Percoll preparation (T. annulata Hissar) being about ten¬
fold less infective than the equivalent GF at the same concentration
which is in agreement with previous work (C.G.D. Brown, personal
communication).
The other problem was that, initially, samples prepared for
SDS-PAGE were susceptible to cleavage by endogenous proteases or,
more likely, proteases derived from tick saliva or salivary glands
(Gill et al., 1986). To prevent this proteolytic action, samples
were always washed, resuspended and diluted in PBS containing prote¬
ase inhibitors. Figure 20b shows the effect of including protease
inhibitors on the sporozoite antigen(s) recognised by Mab 1A7 on a
Western blot (track 2). Without the inhibitors 1A7 appeared to
recognise proteins of lower molecular weights (track 1).
5.3.1. Sporozoite proteins
Figure 21 shows the protein profiles of material prepared from
infected (T. annulata Ankara) and uninfected Percoll preparations.
The points of note are:
a) Pure sporozoites (track 1) and sporozoites/sporoblasts
contaminated with tick debris (track 3) had a very similar protein
content as detected by silver staining. This is in spite of the
greater maturity and purity of the sporozoites in track 1 compared
to track 2 which is shown by the appearance of each preparation on
Giemsa-stained cytospins (Figure 22a and b).
b) Track 4 of Figure 21 contains proteins from the 1.03/1.05
s.g. interace of an uninfected Percoll preparation (Figure 22c).
182
These were tick derived proteins, many of which can be seen to be
present in track 3 and even track 1 also. This preparation acted
as a valuable control since protein bands visible in tracks 1 and 3
but absent in track 4 may be considered as sporozoite/sporoblast in
origin. The molecular weights of such proteins are given below and
their positions are indicated in Figure 21.










Thus nine parasite specific proteins are visible, two of which
appear to be present predominantly on mature sporozoites (proteins 2
and 4 of molecular weight 111 and 70 kdal respectively), the rest
being common to both preparations from an infected Percoll separation.
c) The final feature of Figure 21 is the virtual absence of
protein from material harvested from the 1.07/1.095 s.g. interface
of an uninfected Percoll separation (track 2).
When protein profiles of infected and uninfected GUTS were
compared (Figure 23) there were no visible differences in their pro¬
teins. The proteins of sporozoites of each T. annulata stock puri¬
fied on a Percoll gradient were compared after SDS-PAGE separation
and silver staining (Figure 24) and, at this level of sensitivity, no
differences could be observed between the different stocks.
Figure 21 Sporozoite and tick proteins harvested from T.
annulata Ankara infected and uninfected GUTS
filtrate separated on Percoll gradients.
Silver stain of proteins harvested from:
track 1 1.07/1.095 s.g. interface of infected
Percoll preparation; sample 1
track 2 1.07/1.095 s.g. interface of uninfected
Percoll preparation; sample 4
track 3 1.03/1.05 s.g. interface of infected
Percoll preparation; sample 2
track 4 1.03/1.05 s.g. interface of uninfected
Percoll preparation; sample 3
The positions of sporozoite proteins 1-9 are
indicated with arrows.
Figure 22 Material harvested from T. annulata Ankara
infected and uninfected GUTS filtrate after
separation on Percoll gradients.
Giemsa-stained cytospins showing:
a) Sample 1: sporozoites from 1.07/1.09 s.g.
interface of an infected Percoll preparation.
b) Sample 2: sporoblasts, sporozoites and tick
debris from 1.03/1.05 s.g. interface of an
infected Percoll preparation.
c) Sample 3: tick debris from 1.03/1.05 s.g.





























Figure 23 Proteins of crude uninfected GUTS and T.
annulata Hissar infected GUTS.
Silver stain of proteins after separation by
SDS-PAGE of:
track 1 T. annulata Hissar infected GUTS
track 2 uninfected GUTS
Figure 24 Proteins of Percoll-purified sporozoites from
different T. annulata stocks.
Silver stain of proteins after separation by
SDS-PAGE Of:
track 1 T. annulata Hissar sporozoites
track 2 T. annulata Gharb sporozoites




5.3.2. Sporozoite antigens detected by antisporozoite monoclonal
antibodies
Figure 25 summarises the reaction of Mab 4B11 with sporozoite
proteins. This monoclonal recognised a sporozoite protein around
17 kdal in size in both Percoll-purified sporozoite and infected
GUTS (tracks 1 and 3). This antigen was not sensitive to reduction;
the same size protein was detected in non-reduced samples (track 2)
and there was no reaction of 4311 with tick proteins in uninfected
GUTS (track 4). The same antigen was recognised in all three stocks
of T. annulata (tracks 1, 5 and 6). When larger quantities of sporo-
zoites were used per gel track 4B11 reacted strongly with the 17 kdal
antigen and to a minor extent with an antigen of 20 kdal (track 5).
When Mab 1A7 was reacted with Percoll-purified sporozoites
four protein doublets were observed at molecular weights of approxi¬
mately 54, 63, 70 and 85 kdal (Figure 26). These molecular weights
are approximate. They were obtained by extrapolation from calibration
curves made by plotting the molecular weights of protein standards
against their relative mobilities on semilogarithmic paper. Since
a "line of best fit" had to be drawn, the molecular weight determined
for a band might not concur with that expected from visual inspection
of the blot. Apart from this, there were differences between blots,
which are discussed later, in the mobility of the protein group de¬
tected by Mab 1A7 although the multiple pattern remained very consist¬
ent. The same multiple band pattern was detected in purified sporo¬
zoites from all three stocks of T. annulata (Figure 26, tracks 2, 3
and 6), the only differences being the 85 kdal doublet which, in the
Gharb stock, occurred at 80 kdal. When crude GUTS was used as the
Figure 25 Sporozoite antigen recognised by antisporozoite
monoclonal antibody 4B11.
Western blots of different antigens reacted with
monoclonal 4B11. The antigens were:
track 1 Percoll-purified T. annulata Hissar
sporozoites: proteins reduced
track 2 Percoll-purified T. annulata Hissar
sporozoites: proteins non-reduced
track 3 T. annulata Hissar infected GUTS
track 4 uninfected GUTS
track 5 Percoll-purified T. annulata Ankara
sporozoites
track 6 Percoll-purified T. annulata Gharb
sporozoites
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antigen, 1A7 detected the same proteins and an additional protein
band of higher molecular weight at 104 kdal (Figure 26, track 4).
No antigens were detected when 1A7 was reacted with uninfected T.
annulata Hissar GUTS (Figure 26, track 1) or samples from 1.03/1.05
and 1.07/1.095 s.g. interfaces of an uninfected Percoll separation
(Figure 27, tracks 1 and 3 respectively).
Figure 27 compares the antigens detected by 1A7 in samples 2
(sporozoites, sporoblasts and tick debris, track 2) and 1 (sporo-
zoites, track 4) of a Percoll separation of T. annulata Ankara sporo¬
zoites. The antigens were identical in position, the only difference
between them being that the intensity of the three lower molecular
weight bands in track 2 is less than in track 4.
The uninfected controls used were true controls in all but one
aspect: the nymphs from which the infected adult ticks derived, en¬
gorged on infected bovine blood, whereas those providing uninfected
adults engorged on rabbit blood. To ensure that the reactions of
1A7 and 4B11 with sporozoites were not, in part, due to traces of
bovine blood proteins, a Western blot was carried out to react the
two Mabs with rabbit and bovine blood separated on a 7-20% acrylamide
gel. Figure 28 (tracks 3-6) shows the complete absence of specific
reaction with either antibody. No reaction was seen when proteins
of T. annulata Ankara piroplasms were separated by SDS-PAGE (Figure
29, track 1) and blotted before incubating with 1A7 (track 2). Immune
bovine serum, from a calf which recovered from sporozoite immunisation,
was included as a positive control (track 4) with day 0 serum from
the same calf giving no reaction (track 3).
Figure 26 Reactivity of antisporozoite monoclonal antibody
1A7 with sporozoite proteins.
Western blots of different antigens reacted with
monoclonal 1A7. The antigens were:
track 1 uninfected GUTS
track 2 Percoll-purified T. annulata Hissar
sporozoites
track 3 Percoll-purif ied T_. annulata Gharb
sporozoites
track 4 T. annulata Hissar infected GUTS
track 5 Material from 1.07/1.095 s.g. interface
of an uninfected Percoll preparation
track 6 Percoll-purified T. annulata Ankara
sporozoites
Figure 27 Reactivity of monoclonal antibody 1A7 with
material harvested from infected and uninfected
Percoll preparations.
Western blot of antigens reacted with monoclonal
1A7:
track 1 Sample 3 from 1.03/1.05 s.g. interface
of uninfected preparation
track 2 Sample 2 from 1.03/1.05 s.g. interface
of infected preparation
track 3 Sample 4 from 1.07/1.095 s.g. interface
of uninfected preparation















Figure 28 Absence of reactivity of monoclonal antibodies
1A7 and 4B11 with rabbit or bovine blood proteins.
Western blot showing Mabs 1A7 (tracks 3 and 4)
and 4B11 (tracks 5 and 6) reacted with:
track 3 rabbit blood
track 4 bovine blood
track 5 rabbit blood
track 6 bovine blood
Tracks 1 and 2 show the Coomassie blue stained
proteins of rabbit and bovine blood respectively
after separation by SDS-PAGE.
Figure 29 Absence of reactivity of antisporozoite mono¬
clonal antibody 1A7 with piroplasm protein.
Western blot of T. annulata Ankara piroplasm
proteins reacted with:
track 2 monoclonal 1A7
track 3 preimmune bovine serum
track 4 Theileria immune bovine serum
(positive control)
Track 1 shows Coomassie blue stained piroplasm




The anti-Taenia saginata Mab used as a control in previous
experiments gave no reaction with Percoll-purified sporozoites on
Western blots (data not shown).
5.3.3. Sporozoite antigens recognised by rabbit and bovine antisera
Polyclonal sera from rabbits and calves were reacted in Western
blots with T. annulata Ankara Percoll-purified sporozoites. Figures
30-32 illustrate representative samples of the results obtained.
Whenever possible, tracks reacted with 1A7 and 4B11 were included so
that the relative positions of bands revealed by monoclonal and
polyclonal antibody could be determined.
None of the negative controls gave reactions on the blots.
These controls included day 0 sera for each calf, serum from calf 45T
which was immune to Hyalomma ticks (supplied by Dr. A.R. Walker),
serum from rabbit 8 which had been fed on by uninfected ticks and
an antimacroschizont Mab, 1C7 (Shiels et al., 1986b). The lack of
reactivity of sera from the tick immune calf (Figure 30, track 12)
and rabbit 8 (Figure 32, track 4) with the separated proteins suggests
that the bands revealed by sera from animals exposed to infected ticks
or infected tick material represented sporozoite and not tick antigens.
A 17-20 kdal antigen in a similar position to that recognised
by Mab 4B11 was detected by hyperimmune serum from calves 134X (Fig¬
ure 30, track 10) and N61 (Figure 30, track 5), by serum from calves
102 and L37 (Figure 31, tracks 3 and 4) immunised with irradiated
sporozoites and by day 73 serum from rabbit 28 (Figure 32, track 2)
which was fed on by infected ticks.
Figure 30 T. annulata Ankara sporozoite antigens recognised
by sera from calves hyperimmunised with sporo-
zoites.
Western blots of Percoll-purified T. annulata
Ankara sporozoite proteins reacted with anti¬
bodies :
track 1 Mab 4B11
track 2 Calf N53 Day 0
track 3 Day 107
track 4 Calf N61 Day 0
track 5 Day 107
track 6 Mab 1A7
track 7 Mab 4B11
track 8 Mab 1C7
track 9 Calf 134X Day 0
track 10 Day 101
track 11 Calf 45T Day 0
track 12 immune to Hyalomma ticks
Details of immunisation of calves is given in
Section 3.2.2.
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Figure 31 T. annulata Ankara sporozoite antigens recognised
by sera from calves immunised with live virulent
(54X) or irradiated (L21 , N44, L37 and 102) sporo-
zoites.
Western blots of Percoll-purified T. annulata
Ankara sporozoite proteins reacted with antibodies:
track 1 Mab 1A7
track 2 Calf 54X day 95 immunised with live
virulent sporozoites
track 3 Calf L37 day 91 immunised with irradiated
sporozoites (640 Gy)
track 4 Calf 102 day 43 immunised with irradiated
sporozoites (840 Gy)
track 5 Calf N44 day 63 immunised with irradiated
sporozoites (500 Gy)
track 6 Calf N44 day 92 challenged with live
sporozoites
track 7 Calf L21 day 104 challenged with live
sporozoites
track 8 Calf L21 day 49 immunised with irradiated
sporozoites (320 Gy)
track 9 Calf L21 day 0
Figure 32 T. annulata Ankara sporozoite antigens recognised
by sera from rabbits fed on by infected (rabbit 28)
or uninfected (rabbit 8) Hyalomma ticks.
Western blots of Percoll-purified T. annulata
Ankara sporozoite proteins reacted
track 1 rabbit 28 day 0
track 2 rabbit 28 day 73
track 3 rabbit 8 day 0
track 4 rabbit 8 day 71
track 5 antisporozoite Mab 1A7
track 6 antisporozoite Mab 4B11
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These blots show that there was variation in the position and
relative intensity of the four sporozoite protein doublets detected
by Mab 1A7 and in one blot the high molecular weight (104 kdal) pro¬
tein could be detected in Percoll-purified sporozoites (Figure 31,
track 1). In spite of this, the general pattern of reactivity was
consistent. The variations were believed to be due to differences
between Percoll preparations in maturity and purity of the sporozoites
and perhaps also as a consequence of technical factors. They do not
cast doubt on the validity of the multiple reaction of 1A7 with sporo¬
zoite antigens. When the antigens recognised by calf and rabbit sera
are compared with those recognised by Mab 1A7, antisporozoite serum
from rabbit 28 and hyperimmune serum from calf 134X are seen to have
detected bands which correlate well with those recognised by 1A7 on
the same blot (Figure 32, tracks 2 and 5 and Figure 30, tracks 6 and
10). Serum taken after challenge from calf L21, recipient of 320 Gy
irradiated sporozoites (Figure 31, track 7) and hyperimmune sera from
calves 54X (Figure 31, track 2), N53 and N61 (Figure 30, tracks 3 and
5) reacted with some but not all of the proteins detected by 1A7.
Of the other antigens recognised by the antisporozoite antisera,
summarised in Table 17, those of molecular weight 122-126, 100, 36
and 27 kdal are of particular interest in that they were detected by
at least four different immune antisera.
5.3.4. Surface labelling and immunoprecipitation
Five major and three minor proteins were labelled by 125j j_n
sample 1, the sporozoite preparation (Figure 33a, track 1). Their
molecular weights are given in Table 18 together with an indication
of their origin.
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All sera are postimmunisation
• = band detected
Figure 33 a) * ^Iodine labelled surface proteins of samples
Ir 2 and 3 from Percoll gradients of GUTS
filtrate.
Autoradiograph of proteins separated by SDS-PAGE
track 1 sample 1 from 1.07/1.095 s.g. interface
of infected Percoll gradient
track 2 sample 2 from 1.03/1.05 s.g. interface
of infected Percoll gradient
track 3 sample 3 from 1.03/1.05 s.g. interface
of uninfected Percoll gradient.
b) Immunoprecipitation of radiolabelled proteins
by antisporozoite and control monoclonal anti¬
bodies .



























1 2 3 1 2 3 4 5 6 7 8 9 10 11 12
196
Table 18 Molecular weights and likely origin of radiolabelled









81 + + tick
75 - sporozoite
57 -? -? sporozoite?
42 -? -? sporozoite?
38 + + tick
(15) + sporozoite/sporoblast
(13) + sporozoite/sporoblast
() = minor; + = present; - = absent
The efficiency of radioiodination by the iodogen method was
measured by TCA precipitation. The percentage of radioactivity due
to labelled protein in each sample was:
Sample Content (predominant) %_
1 Sporozoite proteins 81
2 Sporozoite, sporoblast and tick proteins 74
3 Tick proteins 68
Immunoprecipitation of the radiolabelled proteins showed a
number of proteins to be non-specifically precipitated even by controls
(anti-Taenia saginata Mab and normal mouse serum, Figure 33b, tracks
1 and 2). However Mab 1A7 can be seen to have specifically precipi¬
tated a protein of 61 kdal from sporozoite material (Figure 33b,
track 3). This may correspond to the 57 kdal radiolabelled protein
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observed in track 1, Figure 33a. Mab 4B11 precipitated a protein
of around 17 kdal in both sporozoite (Figure 33b, track 4) and
impure sporoblast/sporozoite material (Figure 33b, track 8). This
precipitated protein probably corresponds to the 15 kdal radio-
labelled protein observed in tracks 1 and 2, Figure 33a.
5.4. DISCUSSION
In the studies described it was possible to identify sporo¬
zoite specific proteins in both lysates of whole sporozoites and
surface labelled sporozoite preparations. Certain of these sporo¬
zoite proteins were specifically identified by Mab 4B11 and 1A7 in
both types of preparation. Sporozoite proteins were shown to be
recognised by antisporozoite rabbit serum and certain immune bovine
sera, some of which identified proteins of similar molecular weights
to those detected by the two Mabs.
Nine sporozoite specific proteins were visible on a silver
stained polyacrylamide gel on which whole sporozoites had been
separated, while between four and six proteins were radiolabelled
on the sporozoite Surface. The molecular weights of sporozoite pro¬
teins detected by these two methods do not correlate exactly. One
reason for this may be that the purified sporozoite preparation con¬
tained a number of tick proteins which appeared to bind to the sporo¬
zoite surface in the same manner as observed for BPA. These tick
contaminants probably obscured the visualisation of some sporozoite
proteins while other sporozoite proteins may have been present in
small amounts and remained undetected even by silver staining. Pro¬
teins which possessed similar but not identical weights as assessed
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by the two methods (e.g. the 54 kdal silver stained protein and the
57 kdal radiolabelled protein, see Table 17) may actually represent
the same sporozoite protein. The estimations of molecular weight
of a single protein on different occasions may give slightly differ¬
ent results. This should be borne in mind for all the results
obtained and is a good reason for comparisons between antibody reactions
to be made only between results obtained on the same blot. Fish (1975)
details a number of technical causes of variation and inaccuracy in
molecular weight estimation by SDS-PAGE and suggests that the SDS
itself can introduce variability if different commercial preparations
of the chemical are used.
The silver stained proteins of the infected and uninfected
GUTS were predominantly tick and rabbit (from the tick's blood meal)
in origin and obscured any sporozoite proteins which may have been
present.
No differences could be observed between the proteins of Percoll-
purified sporozoites from different T. annulata stocks separated by
SDS-PAGE and silver stained. This ties in with the close similarity
of the reaction of Mabs 1A7 and 4B11 with different stocks.
The Western blot results show that the epitopes recognised by
the two antisporozoite Mabs, 1A7 and 4B11 were different from one
another, were both present on sporozoite proteins, and were absent
from uninfected material. Both Mabs recognised antigenic determinants
common to all three stocks of T. annulata.
This correlates with the cross-reactivity between T. annulata
stocks when the monoclonals were assessed by IFAT and suggests that
there are antigens present on the surface of the sporozoite which may
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be cross-protective. This possibility has been found to exist for
T. parva also and was demonstrated by cross-reactivity in the IFAT
and by neutralisation of the infectivity of sporozoites from differ¬
ent stocks (Dobbelaere et al., 1984; Musoke _et al., 1984). The major
17 kdal antigen recognised by Mab 4B11 (Figure 25) probably corres¬
ponds to protein 9 on silver stained gels (Figure 21) and to the 15
kdal radiolabelled sporozoite protein (Figure 33). The latter is
further evidence that 4B11 is directed against a sporozoite surface
protein. The 4B11 17 kdal antigen was recognised by certain anti-
sera. It appears to have been the only protein detected by post-
immunisation serum from calves L37 (640 Gy sporozoites) and 102 (840
Gy sporozoites, Figure 31). Calf 102 was fully susceptible to chall¬
enge with virulent sporozoites while calf L37 underwent a mild reaction
and recovered. Thus, presence of antibody to the 4B11 antigen did
not in this instance necessarily indicate immune status although it
was an antigen recognised by sera from two calves hyperimmune to
sporozoites (N61 and 134X, Figure 30) and from rabbit 28 which was
immunised by repeated feeding of infected ticks (Figure 32). Nor
does presence of antibody to the 4B11 antigen correlate with sporo¬
zoite neutralising activity since sera from some calves which exhi¬
bited potent sporozoite blocking activity (54X, N53, N44, Figures 30
and 31) failed to recognise this antigen.
Mab 1A7 recognised a more complex antigen than Mab 4B11 and
showed a multiple reaction with sporozoites. This indicates that 1A7
recognises an epitope which resides on each member of a group of pro¬
teins of different molecular weights. There are several possible
explanations of the nature of the proteins bearing the 1A7 epitope
which are illustrated in Figure 34:
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a) The epitope may reside, and may be repeated, on a protein
which undergoes processing as the sporoblast, and then sporozoite,
matures. Evidence which supports this explanation includes the
detection of a higher molecular weight protein (104 kdal) in infected
GUTS. GUTS contains a proportion of the least mature sporozoites
and sporoblasts in which the 104 kdal protein may be the precursor
of the lower molecular weight proteins. There is evidence that
immature sporozoites and sporoblasts express the T. parva sporozoite
antigen recognised by monoclonal antibody with sporozoite neutralis¬
ing activity, at low levels on day 0-2 of the tick feed. From day 3
(sporozoites are harvested on day 4 or 5 from T. parva-infected
Rhipicephalus appendiculatus) the antigen, or its precursors, are
synthesised at a rapid rate (Dobbelaere _et ad., 1985a) which coin¬
cides with the time when maximal parasite proliferation occurs
(Dobbelaere et al_. , 1983) . A similar situation may exist for T.
annulata. When infected ticks were removed on day 3, sporoblasts
and sporozoites of this parasite may have contained protein bearing
the 1A7 epitope at differing degrees of maturity. This has been
observed to be the case for a sporozoite surface antigen of Plasmodium
knowlesi (_P. knowlesi) where the relevant monoclonal antibody recog¬
nises three proteins of different molecular weights when P_. knowlesi
sporozoites are immunoprecipitated (Ellis, Ozaki, Gwadz, Cochrane est
al. , 1983) . The two higher molecular weight proteins were found by
immunoelectron microscopy to be intracellular precursors, while the
lower molecular weight protein was present on the surface of sporo¬
zoites as the mature form of the antigen (Fine, Aikawa, Cochrane and
Nussenzweig, 1984) . The immunoprecipitation of a single 61 kdal
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protein by Mab 1A7 also supports this explanation although this was
only a preliminary result. The 61 kdal protein is likely to be the
same protein as that represented by the 63 kdal band observed in
blots with 1A7. This was, therefore, the mature form of this sporo-
zoite antigen and, as such, was present on the sporozoite surface.
Differences in intensity of the protein bands detected by 1A7 between
blots might have been due to different levels of sporozoite maturity
in different Percoll separations. It is, however, surprising that
a blot of sporoblast containing material reacted with 1A7 did not
differ more from that obtained with purified sporozoites (Figure 27),
and that the 104 kdal protein was not apparent in the sporoblast
containing preparation.
b) Since the parasite stocks were not cloned, the possibility
exists that the multiple reaction of 1A7 was due to the presence of
a mixed population of sporozoites. Sporozoites in each population
may bear the epitope on a protein of a different size. If this were
the whole explanation, one would not have expected to see such simi¬
lar patterns of reactivity with 1A7 as was evident between the differ¬
ent stocks (Figure 26) and the higher molecular weight protein observed
in GUTS remains unexplained. However, Shapiro et al. (1987) and Hall,
Williamson, Shiels, Brown and Tait (1988) report that Mabs recognising
macroschizonts of T_. parva and T. annulata respectively, react with
different sized proteins in different parasite stocks and there may
be a similar phenomenon in sporozoites.
c) The different sized proteins detected by 1A7 could represent
independent but related gene products within a parasite population
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which are expressed together in sporozoites, each containing an
amino acid sequence which forms the 1A7 epitope.
d) There may be partial epitope identity between different
proteins or additional binding capacity of 1A7 causing cross-reactivity.
Ghosh and Campbell (1986) have reviewed multispecificity in monoclonal
antibodies and while this is a possible explanation, the fact that
there was no reaction with uninfected material and only one surface
labelled protein was immunoprecipitated by 1A7.points to this mono¬
clonal being specific.
e) The group of proteins recognised by Mab 1A7 may represent
glycoproteins, related only as a result of the attachment of similar,
or identical, oligosaccharide chains rather than shared amino acid
sequences (Ramasamy and Reese, 1985) .
However, the T. parva sporozoite antigen recognised by neutral¬
ising Mab has been found to be almost certainly protein in nature,
being susceptible to proteolytic but not exoglycosidase digestion
(Dobbelaere et_ al. , 1985b) .
f) Sporozoites purified for SDS-PAGE were washed and resus-
pended in the presence of protease inhibitors and were immediately
and rapidly solubilised under denaturing conditions, before being
separated by SDS-PAGE or stored at -80°C. Under such conditions it
was hoped that the action of proteases could be discounted as a
reason for the multiple bands detected by Mab 1A7.
Additional experiments would be required to distinguish the
true reason for the multiple reactivity of Mab 1A7 with sporozoite
proteins. Information derived from work described later in this
thesis helps to indicate the most likely explanation.
Figure 34 Possible explanations for multiple reaction
of Monoclonal 1A7 with sporozoite proteins.
Key:
DNA
complementary DNA - "~~- - _ -
messenger RNA
protein
Mab 1A7 epitope A
processing
203
nucleus cytoplasm sporozoite surface
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The iodogen method was chosen for radioiodination of the
surface molecules of the sporozoite because it is relatively rapid
and simple. In addition, there is no requirement for extraneous
protein or damaging chemicals such as hydrogen peroxide or reducing
agents, as when the lactoperoxidase technique is employed (Howard
et al., 1982). In addition, the iodogen is a large, sparingly
water-soluble molecule (Zingales, 1984) which acts to catalyse the
radioiodination of tyrosyl residues of proteins from its position
on the inner surface of the reaction vessel. Therefore, over the
short period (10 minutes) for which the iodogen was in contact with
the sporozoites, labelling of surface molecules should have occurred
with minimal penetration and labelling of cytoplasmic proteins
(Howard et ^al. , 1982) . The iodogen method achieved a good level of
radioiodination with at least 68% of the radioactivity present being
due to labelled protein.
The proteins immunoprecipitated by Mabs 1A7 and 4B11 have been
discussed above. Dr. B. Shiels (personal communication) detected
three sporozoite proteins of different sizes with a single anti-
sporozoite monoclonal antibody, 4E5, by surface labelling and immuno-
precipitation. These three proteins were of a higher molecular weight
than those detected by 1A7 but suggest that the sporozoite may be
composed of groups of immunologically related molecules. Similarly,
lams _et a^. (1988) provide evidence that the same is true for the
proteins of Th parva sporozoites. They show that the reaction of
antisporozoite bovine serum with sporozoites in Western blots is the
result of antibodies identifying several groups of proteins, all
members within a group containing a similar amino acid sequence within
their structure.
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The 1A7 epitope was recognised by serum from calf 134X, hyper¬
immune to sporozoites (Figure 30), and serum from rabbit 28, exposed
to infected ticks (Figure 32). Sera taken after challenge from calf
L21, recipient of 320 Gy irradiated sporozoites, and hyperimmune sera
from calves 54X, N53 and N61, all immunised with virulent sporozoites,
are more difficult to assess with respect to their reaction with the
epitope recognised by 1A7. They reacted with some, but not all, of
the proteins detected by 1A7. Whether this means that they were
detecting different epitopes which happen to reside on the same
proteins or whether these sera did contain antibody to the 1A7 epi¬
tope but exhibited variable affinity for the epitope depending on
the particular protein on which it is located, is not clear.
What is clear is that the antibody reactions between calves
immunised in a similar manner may differ markedly,- 54X and 134X show
different reactions from those of N53 and N61 as well as differing
from each other. Except for calf L21, calves immunised with irrad¬
iated sporozoites showed little or no reaction with sporozoites by
Western blotting. This lack of reactivity may be due to the Western
blot technique or to low antibody affinity or simply to the absence
of adequate antisporozoite antibody, in spite of the fact that calf
N44 developed an antisporozoite IFAT titre of Vl60 after immunisation.
Assuming that the method of antibody detection was not at fault, it
seems that immunisation with irradiated sporozoites is a much less
effective method of raising antisporozoite antibodies than the use
of live virulent sporozoites.
The small numbers of calves in these experiments make it diffi¬
cult to be very conclusive, not only about the irradiated sporozoite
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experiments, but also about the reaction of different hyperimmune
sera with sporozoite proteins. Regarding the latter, it seems that
there is variation between calves' responses when exposed to the
same sporozoites. In view of the outbred genetic background of the
calves, they were likely to be of different BoLA (bovine MHC) types
(Spooner, Oliver, Sales, McCoubrey et al., 1979) . When compared to,
for example, inbred laboratory mice in which the H2 (murine MHC)
type is much more confined, it is perhaps not surprising that the
potential of calves to respond to a particular antigenic determinant
could prove less predictable.
The observation that the epitopes recognised by 1A7 or 4B11
may not be consistently recognised by immune bovine sera does not
preclude their development as potential protective proteins. The
presentation of one or both of these antigens in*an appropriate manner,
purified and in adequate amounts, in excess of the quantity of the
antigen which would be presented in sporozoites, could elicit a
sporozoite neutralising response. If this response could be shown
to play a role in protection, a viable alternative to vaccination
with live parasite would be available. In order to be able to test
this possibility, large quantities of the epitopes recognised by 1A7
and 4B11 were required. Therefore work was initiated to obtain one
or both of the epitopes as a recombinant protein. This is described
in the next chapter.
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CHAPTER SIX
SELECTION AND ANALYSIS OF RECOMBINANTS
EXPRESSING A SPOROZOITE EPITOPE
Page
6.1. INTRODUCTION 208
6.2. MATERIALS AND METHODS 210
6.2.1. Equipment, buffers and solutions 210
6.2.2. Bacterial strains and cloning vectors 211
6.2.3. Genomic library of T. annulata 212
6.2.4. Genomic library screening 213
6.2.5. DNA extraction methods 215
6.2.6. Subcloning DNA inserts 220
6.2.7. Restriction endonuclease digestion and agarose
gel electrophoresis 222
6.2.8. Radiolabelling of DNA inserts 223
6.2.9. Southern blot analysis 224
6.2.10. Northern blot analysis 226
6.2.11. Generation of lysogens 227
6.2.12. Lysogen colony screening 228
6.2.13. Recombinant protein analysis 229
6.3. RESULTS 230
6.3.1. Genomic library screening 230
6.3.2. Insert sizes in recombinant phage and plasmid
clones 232
6.3.3. Southern blot analysis 232
6.3.4. Northern blot analysis 239





The application of antibody reagents and an _in vitro screening
assay to identify sporozoite antigens which are, or could be, targets
for a protective immune response has been described in earlier chap¬
ters. This led to the selection of two antisporozoite monoclonal
antibodies, 4B11 and 1A7 with sporozoite neutralising activity and
the characterisation of the epitopes they recognise. While inform¬
ation is only available from an _in vitro sporozoite neutralisation
assay, the relevance of these sporozoite epitopes to the stimulation
of protective immunity in the bovine host remains a matter for spec¬
ulation. Therefore, it was considered important to direct work
towards the production of sufficient material bearing the sporozoite
epitopes to use in immunisation trials in cattle.
Two alternatives were available by which to obtain such immun¬
ising material. One was to purify the relevant antigens directly
from sporozoites. This approach has been used to isolate antigens
from Babesia bovis (Wright, Mirre, Rode-Bramanis, Chamberlain et _al.,
1985) and Anaplasma marginale (Palmer, Barbet, Davis and McGuire,
1986) to test in cattle. The limitations of this approach are mainly
concerned with the large number of infected ticks that would be
required to provide sufficient sporozoites from which to purify
antigens. The nature of the 1A7 antigen(s) would also tend to com¬
plicate this approach. Since several proteins bear the relevant
epitope a decision would have to be made whether to extract all these
proteins or just one representative. The stability of the sporozoite
antigens is not known although they appear to be susceptible to pro¬
teases. Obviously protein degradation would further decrease antigen
yield.
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A second alternative by which to obtain proteins in quantity
has become available with the development of techniques in gene mani¬
pulation. This alternative is the use of DNA recombinant technology
to clone and express the theilerial DNA coding for the sporozoite
epitope. The recombinant proteins expressed are then available in
large amounts for testing in cattle.
The use of lambda phage gtll (\gtll) as a cloning vector for
DNA fragments and the expression of these fragments in Eh coli
(Young and David, 1983a and b) has been reviewed already. A Xgtll
expression library constructed using genomic DNA from T. annulata
(Dr. F.R. Hall, personal communication) was available for use. Such
libraries expressing recombinant parasite antigens have been screened
with monoclonal (Dame et al., 1984) or polyclonal (Kemp et al., 1983;
Lanar et al., 1985; Gill jst a_l. , 1987) antibodies. The value of
selecting recombinants by immunological screening of the expressed
proteins over screening by nucleic acid hybridisation is two-fold.
The antibody reagents are readily available and, by screening for the
desired end product, selected recombinants are known to contain the
parasite DNA insert in frame and in the correct orientation. Also,
the amino acid sequence expressed must have retained epitope identity
and reactivity with the screening antibody.
Both complementary DNA (cDNA, Enea et_ _al. , 1984) and genomic
DNA (Dame et al., 1984) have been used to prepare expression libraries
from which Plasmodium falciparum sporozoite genes have been cloned.
A cDNA library has the advantage of being parasite stage specific
since it only represents the DNA which is expressed in the life cycle
stage from which it was prepared. This biases the library towards
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expression of stage specific antigens and so increases the chances
of cloning such an antigen gene. However, the same property dimin¬
ishes the general value of a cDNA library, as a separate library would
be required for each parasite stage being studied. In view of this
constraint and the consideration that it might be difficult to obtain
adequate amounts of messenger RNA from sporozoites to make a cDNA
library, a genomic expression library of T. annulata was screened with
the antisporozoite Mabs, 4B11 and 1A7.
The prime objective of the work described in this chapter was
to isolate recombinants containing theilerial DNA sequences coding
for the sporozoite epitopes recognised by antisporozoite monoclonals
4B11 and 1A7. In doing this, a thorough analysis was made of the
nature of the recombinants obtained in order to define them and to
ensure their validity. This analysis is described.
It is of interest both in relation to the production of immun¬
ising material and also in furthering the understanding of the DNA
encoding the sporozoite epitope, the RNA transcribed from it and the
polypeptide translation products.
6.2. MATERIALS AND METHODS
The majority of methods used followed established protocols
detailed by Maniatis, Fritsch and Sambrook (1982) and Huynh, Young
and Davis (1985) with modifications or additions as described below.
6.2.1. Equipment, buffers and solutions
Any stock solutions or buffers not detailed in the text are
listed in Appendix 1.4.
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Glassware and other equipment was sterilised as described in
Section 2.1.2. except when being used for work with RNA. In RNA
experiments, all glassware and equipment was baked in a hot air oven
(180°C, 3 hours). Where baking was not feasible, the equipment was
soaked in purified water containing 0.1% diethylpyrocarbonate (DEP,
Sigma) then autoclaved. Solutions and buffers were sterilised by
autoclaving (15 p.s.i., 15 minutes) or filtration (0.22 pm, Millipore).
For RNA experiments, solutions and buffers were made up using DEP
treated purified water and autoclaved.
6.2.2. Bacterial strains and cloning vectors
a) Bacterial strains
i) Y1090: A restriction negative, ampicillin resistant strain
of Eh coli described by Young and Davis (1983b) was used as the host
cell forXgtll for screening and purifying recombinant phage.
ii) Y1089: An ampicillin resistant strain of Eh coli was used
to prepare lysogens of wild type Xgtll and recombinant \gtll clones.
Y1089 was particularly suitable for generating lysogens because it
contains a deficiency in the Ion protease which increases the stabi¬
lity of the recombinant fusion protein. It also has a mutation (hfl A
150) which enhances the frequency of phage lysogeny (Young and Davis,
1983b; Huynh _et al. , 1985) .
iii) JM 83: An Eh coli K-12 strain developed by Messing (1979)
was used as the host cell for transformation by the plasmid vector,
puC 18.
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b) Cloning vectors ,,
i) Lambda phage gtl1: Young and Davis (1983a) detail the con-
ii) Plasmid puC 18: Norrander, Kempe and Messing (1983) des¬
cribe the construction of this bacterial plasmid which also contains
the lac Z gene and a single EcoRl site.
c) Storage
Bacterial host strains and plasmid transformed cells taken from
the logarithmic phase of growth were mixed with an equal volume of
sterile glycerol. These were stored at -80°C. Short term storage
of Y1090 cells was at 4°C in 10 mM magnesium sulphate. Recombinant
phage were stored in phage medium (SM) saturated with chloroform at
4°C. For long term storage at -80°C, phage were snapfrozen while
in SM containing 7% dimethylsulphoxide (DMSO).
6.2.3. Genomic library of T. annulata
The genomic library screened was prepared by Dr. Roger Hall
of the Wellcome Unit for Molecular Parasitology, University of Glasgow.
The library was made from genomic DNA isolated from purified piroplasms
of T. annulata Hissar. DNA was mechanically sheared to obtain random
fragments of approximately 300 basepairs (bp) to four kilobases (kb)
in size. The DNA was methylated with EcoRl methylase to protect it
from restriction endonuclease digestion. EcoRl linkers were then
ligated to the theilerial DNA and digested with EcoRl. These DNA
fragments (representing approximately 0.2 p.g theilerial DNA) were
which contains the lac Z gene and a unique EcoRl
site.
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ligated using T4 DNA ligase into the EcoRl site of Xgtll. Phage DNA
was packed _in vitro into phage particles and the presence of 70%
recombinant plaques was detected by their lack of B-galactosidase
activity (Miller, 1972). This was confirmed by the presence of DNA
inserts on EcoRl digestion.
6.2.4. Genomic library screening
The enzyme linked immunoassay method used essentially followed
a protocol described by Young, Bloom, Grossinsky, Ivanyi, Thomas
and Davis (1985).
a) Unamplified library screening
Y1090 cells were grown to mid-logarithmic phase (optical den¬
sity 0.5 at 600 nm wavelength) in LB medium containing 100 M-g/ml
ampicillin, 10 mM magnesium sulphate (MgSO^) and 0.2% maltose (all
from Sigma). The cells were pelleted by centrifugation at 1,500 G
for 10 minutes at 4°C and resuspended in one tenth of the original
culture volume of 10 mM MgSO^.
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Four x 10 phage particles from the unamplified library were
mixed with 0.9 ml Y1090 cells in four replicate tubes and incubated
at 42°C for 20 minutes. To each tube, 50 ml of liquid (37°C) top
agar containing 10 mM MgSO^ and 100 nq/ml ampicillin were added.
After mixing gently each was poured onto the dry, level surface of
a 24 x 24 cm tray containing bottom agar. Once the top agar had set
the four plates were incubated at 42°C for four hours until phage
plaques were clearly visible. Nitrocellulose paper filters previously
soaked for two hours in 10 mM isopropyl B-D-thiogalactopyranoside
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(IPTG, Sigma), dried and labelled, were overlaid onto the plates.
The plates were incubated for a further two hours at 37°C. Then the
filters were carefully removed and rinsed briefly in Tris/saline
buffer (TS) pH 8.0 before being blocked for one hour using 5% oval¬
bumin (Sigma) in TS. Meanwhile the agar plates were stored at 4°C.
The filters were incubated overnight at 20°C in a mixture of the two
antisporozoite monoclonal antibodies, either as ascites diluted 1
in 200 in TS/5% ovalbumin containing 0.01% sodium azide (Sigma) or
as undiluted culture supernatant. Next, filters were worked in four
changes of TS/0.05% Tween 80 and two changes of TS, for five minutes
each wash. Second antibody (sheep anti-mouse immunoglobulin, SAPU)
conjugated to horseradish peroxidase was used at a 1:300 dilution in
TS/5% ovalbumin and filters were incubated in this for two hours at
20°C. They were then washed in the same manner as described pre¬
viously. Finally, to visualise any recombinant phage plaques binding
monoclonal antibody, peroxidase substrate solution was added to the
filters. After colour had developed, filters were washed in two chan¬
ges of purified water and allowed to dry. Positively staining plaques
were distinguished from background negative plaques by the darker
brown colour they developed. Using the filter as a template guide,
the plaques on the agar plates corresponding to the positive plaques
on the filters were removed using the butt end of a sterile Pasteur
pipette and placed in 1 ml SM containing 25 jj.1 chloroform (BDH) for
storage at 4°C.
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b) Cloning positive phage
The phage plaques which had been picked were rescreened three
times until pure phage clones were obtained which gave positive re¬
actions with Mab 1A7. To do this, 100 |!l SM containing approximately
103 phage particles was mixed with 100 jj.1 Y1090 cells, incubated at
42°C for 20 minutes and plated onto circulate agar plates (Petri
dishes, Sterilin, 8.0 cm diameter) using 2.5 ml top agar. The
plaque immunoassay then followed the protocol described above. Once
cloned phage were available, they were screened with a panel of
anti-theilerial monoclonal antibodies.
6.2.5. DNA extraction methods
a) Parasite DNA
To avoid mechanical shearing of parasite DNA during extraction
all mixing was carried out by gentle tube rotation and pipette ends
were cut off to give a wide bore opening.
i) Piroplasm: A number of different methods were used to ex¬
tract and purify DNA from piroplasms of Theileria. The method des-
scribed here is simple but was found to yield high molecular weight
DNA of adequate purity for restriction endonuclease digestions and
Southern blotting.
A 0.6 ml pellet of theilerial piroplasms purified from red
and white bovine blood cells as described in Section 2.2.10. was
resuspended in 8.9 ml TE pH 7.6. SDS was added to 1% and the mixture
was slowly homogenised with three strokes of the homogeniser. The
volume of the homogenate was made up to 50 ml with TE and mixed
gently. An equal volume of phenol was added and mixed for 20 minutes
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followed by centrifugation at 20°C, 8,000 G (Sorvall Superspeed
RC-2, Dupont Instruments) for 15 minutes. The aqueous phase was
removed and mixed with an equal volume of phenol:chloroform (2:1)
for 20 minutes and recentrifuged as above. This time the aqueous
phase was mixed with an equal volume of chloroform for five minutes
and centrifuged at 15°C, 2,000 G for 10 minutes. The final volume
of the aqueous phase was measured after its removal to a clean tube
and 4 M sodium chloride solution was added to a final concentration
of 0.1 M. Two and a half volumes of ice-cold 100% ethanol were
immediately added and mixed by swirling. Using a Pasteur pipette the
precipitated DNA was spooled out of the ethanol into a glass centri¬
fuge tube and washed in 70% ethanol. The DNA was dried, redissolved
in 5 ml TE pH 7.6 and stored at 4°C.
ii) Macroschizont-infected lymphoblastoid cell lines: Cells fro©
50 ml of T. annulata Hissar and Ankara infected cell lines in the
logarithmic phase of growth were pelleted by centrifugation at 800 G,
4°C for 15 minutes. Three times the pellet volume of lysis buffer
(100 mM Tris, 240 mM potassium chloride, 35 mM magnesium chloride)
was added to each and they were resuspended by gentle vortexing.
Twenty percent SDS was added to a final concentration of 4% and the
cell lysate was mixed with the end of a pipette. Four ml TE pH 7.6
was added to each and they were left mixing for 30 minutes. Phenol/




One hundred |_il SM containing approximately 10^ phage particles
were incubated with 100 p.1 Y1090 cells (prepared as described for
genomic library screening) for 20 minutes at 42°C. 2.5 ml top agar¬
ose was added and the cells plated onto LB medium solidified with
1% agarose and incubated overnight at 42°C to obtain confluent lysis
of the bacterial cells by the phage. SM (5 ml per plate) was added
and the plates left shaking at 20°C for two hours. The SM contain¬
ing phage was removed and centrifuged at 8,000 G, 10 minutes, 4°C
(Highspeed 18 MSE). RNase A (DNase free) and DNase 1 were added to
the decanted supernatant to a concentration of 1 pg/ml and the
solution was incubated at 37°C for 30 minutes. An equal volume of
SM containing 20% polyethylene glycol (molecular weight 6,000) and
2 M sodium chloride was added and, after mixing, allowed to stand
for one hour at 0°C. To recover the precipitated phage, the solution
was centrifuged at 10,000 G, 20 minutes, 4°C. The supernatant was
discarded and the drained pellet resuspended in 0.5 ml SM by vortex-
ing. Having transferred the solution to an Eppendorf tube, 5 |j.l of
10% SDS and 5 u.1 of 0.5 M EDTA pH 8.0 were added and incubation carried
out at 68°C for 15 minutes. The solution was extracted twice with
phenol:chloroform (1:1) and once with chloroform, retaining the
aqueous phase each time. To the last aqueous phase, an equal volume
of isopropanol (May and Baker) was added. The mixture was stored
at -70°C for 20 minutes, thawed and centrifuged for 15 minutes at
15,000 G. The resulting pellet was chained and washed with 70% ice-
cold ethanol and then dried. Fifty (il TE pH 8.0 was added to re-
dissolve the pellet which was then stored at -20°C.
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c) Recombinant plasmid
The alkaline lysis method of DNA extraction was used (Maniatis
et al., 1982) .
i) Small-scale: The cells from 1.5 ml of an overnight plasmid
culture (37°C in LB medium containing 100 hg/ml ampicillin) were
pelleted by centrifugation. One hundred |il of ice-cold 50 mM glucose,
10 mM EDTA, 25 mM Tris CI pH 8.0 (Solution 1) was added and the pellet
was resuspended by vortexing. After five minutes at 20 °C, 200 |_l1
0.2 N sodium hydroxide, 1% SDS (Solution 2) was added and the mixture
was gently mixed by inversion. After five minutes at 0°C, 150 (il
ice-cold 5 M potassium acetate was added and the sample was incubated
for five minutes at 0°C. After centrifugation at 10,000 G for five
minutes, the supernatant was extracted with an equal volume of phenol:
chloroform (1:1) and the phases were separated by centrifugation for
two minutes at 10,000 G. The aqueous phase was precipitated with two
volumes of ethanol, then washed and dried as above. Fifty (j.1 TE
pH 8.0 containing DNase free pancreatic RNase A (20 ng/ml) was added
and the pellet was resuspended by vortexing for storage at -20°C.
ii) Large-scale: To obtain large amounts of recombinant plasmid,
amplification in rich medium was carried out. Twenty five ml LB
medium containing 100 (ig/ml ampicillin was inoculated with 0.1 ml
of a plasmid culture grown overnight. This culture was grown at
37°C to late logarithmic phase (OD 0.6 at 500 nm) and was then used
to inoculate 500 ml prewarmed (37°C) LB medium containing ampicillin.
After exactly 2\ hours growth at 37°C, 2.5 ml chloramphenicol (34 mg/
ml) were added to give a working concentration of 170 p.g/ml. This
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culture was incubated at 37°C for 16 hours and then cells were har¬
vested by centrifugation at 2,000 G, 4°C for 10 minutes. The pellet
was resuspended in 100 ml ice-cold STE and pelleted again as above.
The pellet was resuspended in 10 ml solution 1 (see above) contain¬
ing 5 mg/ml lysozyme (Sigma) and left to stand for five minutes at
20°C. Twenty ml fresh solution 2 was added and mixed by gentle
inversion then left to stand for 10 minutes on ice. To this, 15 ml
of ice-cold 5 M potassium acetate was added and mixed by inverting
sharply, then left on ice for 10 minutes. The mixture was centri-
fuged at 12,000 G, 4°C for 30 minutes and the supernatant obtained
was mixed with 0.6 volumes of isopropanol. After 15 minutes at 20°C,
this was centrifuged at 12,000 G, 20°C for 30 minutes and the super¬
natant discarded. The pellet was washed with 70% ethanol at room
temperature then dried and redissolved in 8.0 ml TE pH 8.0.
The purification of closed circular DNA was achieved by centri¬
fugation to equilibrium in caesium chloride - ethidium bromide gradients.
One g of Caesium chloride (Boehringer Mannheim) was dissolved into
each ml solution. In order to stain the DNA, 0.8 ml of a 10 mg/ml
solution of ethidium bromide (Sigma) was added to each 10 ml of
solution and mixed well. The tubes were kept covered with foil.
Centrifugation to equilibrium was performed in an MSE Superspeed 65
Ultracentrifuge using a fixed rotor (MFT 70.10 43114-125) for 36 hours
at 45,000 rpm, 20°C.
After centrifugation the gradient was examined by ultraviolet
light. The lower of two visible bands was harvested by inserting a
20 gauge, one-inch needle through the tube wall. An equal volume of
isoamyl alcohol (Sigma) was added to the harvested DNA and centrifuged
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at 1,500 G, 20°C for three minutes. The bottom aqueous phase was
retained and re-extracted four times with isoamyl alcohol until the
pink colouration of ethidium bromide was no longer visible. The
final aqueous phase was dialysed overnight against several changes
of TE pH 8.0.
The volume of the dialysed DNA solution was measured and 0.1
volume of 3 M sodium acetate (pH adjusted to 5.2 using glacial acetic
acid) was added followed by precipitation with two volumes of 100%
ethanol. The precipitate was recovered by centrifugation, washed
with 70% ethanol and then dried. The pellet was redissolved in
200 |il TE pH 8.0 and the DNA was stored at -20°C.
d) Estimation of DNA concentration
DNA concentrations were estimated by measuring the absorbance
of the DNA sample at 260 nm using a spectrophotometer (Pye Unicam
8-100) , an absorbance of 1 OD representing a concentration of 40 jig/
ml.
6.2.6. Subcloning DNA inserts
The theilerial DNA inserts present in selected recombinant
Xgtl1 were subcloned into the plasmid vector puC 18.
a) Ligation
For a target:vector ratio of 3:1, 600 ng of recombinant Agtl 1
were mixed with 10 ng of plasmid puC 18 after both had been digested
with restriction endonuclease EcoRl (see Section 6.2.7.). The mixture
was diluted to 50 |il using TE pH 8.0, having adjusted the salt concen¬
tration to 0.2 M using 4 M sodium chloride. Two and a half volumes
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of ice-cold 100% ethanol were added and the DNA mixture was left for
two hours at -70°C. Then the precipitated DNA was pelleted by centri-
fugation at 10,000 G for 10 minutes in a microcentrifuge. The pellet
was washed with 70% ethanol and dried well before resuspending in
3.5 |il sterile water, 1 |il x 5 ligase buffer (BRL) and 0.5 p.1 (0.5
units) T4 DNA ligase enzyme (BRL) and incubated at 12-15°C for two
hours.
b) Preparation of competent bacteria
JM83 cells were made competent for transformation with plasmid
DNA by incubation in calcium chloride. Cells in the logarithmic
phase of growth at 37°C at a low cell density (5 x 10^ cells/ml),
were chilled on ice and pelleted by centrifugation (4,000 G, 5 minutes,
4°C). The cell pellet was resuspended in half the original culture
volume of ice-cold 50 mM calcium chloride and 10 mM Tris CI pH 8.0
and incubated at 0°C for 15 minutes. The cells were pelleted as
above and resuspended in 15 of the original culture volume of the
same calcium chloride solution, then stored at 4°C for 12-24 hours.
c) Transformation
Two hundred (j.1 of competent JM83 cells were mixed with the
ligation reaction mixture and incubated on ice for one hour. They
were heat-shocked at 42°C for exactly two minutes and immediately
chilled for two minutes. Then, 0.5 ml LB medium (without ampicillin)
was added and incubated at 37°C for 30 minutes. Ten |il 1 M IPTG and
50 M.1 2% X-gal (5-bromo-4-chloro-3-indolyl B-D-galactopyranoside,
Sigma) in N,N-dimethyl formide (Sigma) were added to the cells before
plating onto four LB agar plates containing 100 |J.g/ml ampicillin.
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These were incubated at 37°C for 16 hours. Blue colonies represented
cells which had been transformed by non-recombinant plasmid as they
were still able to utilise X-gal, the chromogenic substrate for the
B-galactosidase enzyme (Miller, 1972). White colonies were selected
as containing possible recombinant plasmids.
6.2.7. Restriction endonuclease digestion and agarose gel eletro-
phoresis
The conditions required for digestion by each restriction endo¬
nuclease are detailed in Appendix 1.4.10.
In general digestions were carried out in small buffer volumes
(less than 30 jj.1 ) for five hours, or, occasionally overnight for
about 16 hours. Endonucleases were used in excess; 2-10 units per
reaction. The DNA contents per reaction (one reaction per agarose
gel track) were approximately 1 |ig for recombinant phage and plasmid,
2 |ig for Theileria piroplasm DNA and 10 jj.g for Theileria macroschizont
infected cell line DNA and bovine DNA (from calf thymus, Sigma).
Twenty |j.g/ml pancreatic RNase A (free of DNases) was added to di¬
gestions of phage and plasmid DNA to improve the action of the endo¬
nuclease .
Agarose gel electrophoresis was used to separate DNA fragments
to analyse the products of endonuclease digestion or prior to Southern
blotting or extraction of an insert from the gel. A horizontal slab
gel system was used as described by McDonell, Simon and Studier (1977).
In this system good resolution and accurate relative mobilities of
DNA are obtained. 0.8-1.0% agarose gels were prepared by melting
agarose (Type 1, low EEO, Sigma) in TBE x 1 (Appendix 1.4.6.) con¬
taining 1 ng/ml ethidium bromide (Sigma).
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Samples (10-30 |il per track) were prepared for electrophoresis
by addition of loading buffer (x 6, Appendix 1.4.8.)- Standard DNA
markers (1 kb ladder, BRL), diluted in TE pH 8.0, were prepared in
the same way. One p.g standard DNA was used per track except for
Southern blotting when 0.02 |ig was used.
Submarine gels were electrophoresed in TBE x 1 containing 1 |jg/
ml ethidium bromide.
Electrophoresis of large gels for Southern blotting was carried
out for 16-20 hours at 20 mA while gels for the separation of inserts
from recombinant phage or plasmid were run at 60 mA, 100 V for 1-1i
hours. Visualisation of DNA bands was possible under ultraviolet
light illumination (312 nm, U-V transilluminator, Vilber Lourmat)
because of the presence of fluorescent ethidium bromide which inter¬
calates with DNA; as little as 1 ng of DNA can be detected by direct
examination of a gel in ultraviolet light (Sharp, Sugden and Sambrook,
1973) . DNA size in gels or blots was estimated by reference to DNA
markers of known size in a standard 1 kb DNA ladder (BRL) electro¬
phoresed in the same gel as the sample DNA.
6.2.8. Radiolabelling DNA inserts
The inserts subcloned into plasmid puC 18 were used to probe
Southern and Northern blots. They were extracted free of plasmid
DNA and labelled using a commercial kit (Polymeraid - RH (TM),
P and S Biochemicals) by a technique described by Feinberg and Vogel-
stein (1983, 1984). EcoRl digested recombinant plasmid DNA was
separated using a 0.9% low melting point agarose gel (Sigma). The
desired bands were visualised under U-V illumination and removed with
a minimum amount of extraneous agarose. The samples were diluted in
water (1.5 ml/g agarose) and boiled for seven minutes to denature the
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DNA and melt the agarose. After incubating at 37°C for 10 minutes,
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25 ng DNA was radiolabelled using 25 M-Ci phosphorus-dCTP (3000 Ci/
mmole, Amersham International). The reaction was incubated at 20°C
for five hours and was stopped by the addition of reaction termination
buffer (dCTP, EDTA) . Ninety M-l STE (Appendix 1.4.7.) and 10 |ig
sonicated salmon sperm DNA (Sigma) as carrier DNA were added and the
total sample loaded onto a 1.0 cm high spun column (Biogel P6DG,
Buorad, in STE) and centrifuged to separate unincorporated nucleo¬
tides from labelled DNA. The column was washed once with 100 p.1 STE
and the radioactivity of the collected sample was measured in a liquid
scintillation counter (Packard Tri-carb, 4430) . DNA fragments were
Q
labelled to an activity of 4-6 x 10 cpm/|ig DNA.
6.2.9. Southern blot analysis
The technique of Southern blotting was developed by Southern
(1975) and allows the identification of specific DNA sequences within
a complex mixture of DNA fragments. Fragments separated by agarose
gel electrophoresis are transferred to nitrocellulose paper which is
then probed with a radioactively labelled defined DNA sequence which
will hybridise to homologous sequences.
Following electrophoresis, agarose gels were treated as follows
(Appendix 1.4.16. for solutions). To depurinate the DNA and so aid
the transfer of larger DNA fragments, the gel was soaked in 0.25 M
hydrochloric acid for 15 minutes. The DNA was denatured by soaking
for 60 minutes in three changes of alkali denaturing solution and then
soaked for 60 minutes in three changes of neutralising solution pH 7.5.
Transfer of the DNA to nitrocellulose paper or nylon membrane (Hybond-N,
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Amersham International) Was achieved using the Southern blotting
technique detailed by Maniatis et al_. (1982) . Blotting occurred
by the capillary movement of a high salt buffer from the gel to the
nitrocellulose paper or nylon membrane over five hours. When trans¬
fer was complete the nitrocellulose or nylon blot was dried at 37°C
for 20 minutes and then baked in a vacuum oven at 80°C for one hour,
to bind the DNA.
The nitrocellulose or nylon blot was prehybridised for 18 hours
at 65°C by incubation in Southern blot hybridisation buffer contain¬
ing 100 |J.g/ml denatured sonicated salmon sperm DNA to block non¬
specific binding sites. Hybridisation was carried out by incubating
the blot for at least 18 hours at 65°C in the same buffer containing
the appropriate P labelled DNA insert. Before addition, labelled
probes were denatured by boiling for 10 minutes. Enough labelled
probe was added to give a radioactivity of 10^ cpm/ml hybridisation
buffer and 4 ml buffer was used per 100 cm2 of blot. Standard DNA
markers (1 kb ladder) radiolabelled in exactly the same manner as
the DNA inserts were also added to each blot.
Blots were washed at 65°C for one hour in two changes of 2 x
SSC, 0.1% SDS and for one hour in two changes of 0.2 x SSC, 0.1% SDS.
At this temperature and at the salt concentrations used during hybrid¬
isation and washing, conditions were suitable for the hybridisation
of homologous sequences. One blot of T. parva DNA was hybridised
at 59°C and the one hour wash in 0.2 x SSC was omitted to provide
lower stringency conditions.
When washed, blots were examined for hybridisation by autoradio¬
graphy using x-ray film (Kodak XOMAT AR5) and fast tungstate
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intensifying screens (Ilford), films being exposed at -70°C. Films
were developed as described in Section 5.2.8.
6.2.10. Northern blot analysis
Northern blotting is based on the same principle as Southern
blotting except that it is RNA which is electrophoresed, transferred
to nitrocellulose paper and probed (Thomas, 1980). The salivary
gland RNA used for the Northern blot was extracted by Dr. Roger Hall
from 100 uninfected and 100 infected (T. annulata Ankara) tick sali¬
vary glands from 11. a^. anatolicum ticks which had been feeding on
a rabbit for two days (Walker _et al_. , 1985) . Briefly, salivary
glands were dissected directly into 4 M guanidium thiocyanate, 50 mM
Tris pH 7.5, 10 mM EDTA, 1% B-mercaptoethanol. The glands were homo¬
genised and precipitated with 0.75 volumes of 100% ethanol. The
material was pelleted, resuspended in the above solution and repre-
cipitated with ethanol. The pellet was then homogenised in 50 mM
EDTA, phenol, chloroform and the aqueous phase extracted with ether.
The RNA was isolated by overnight precipitation on ice in 3 M sodium
acetate pH 5.5. RNA concentration was measured using a spectrophoto¬
meter as for DNA. For Northern blot analysis the method described
by Gehring, Shiels, Northemann, de Bruijn et al. (1987) was followed.
Solutions are detailed in Appendix 1.4.17. Twenty (J.g of total RNA
was used for each gel track. This RNA was denatured at 55°C for
15 minutes in a solution of 50% formamide (BRL), 2.2 M formaldehyde
(BDH), 20 mM MOPS, 5 mM sodium acetate (Sigma), 0.5 mM EDTA, pH 7.0
before being separated in a 1.4% agarose gel containing 0.74% form¬
aldehyde in MOPS buffer. RNA was transferred to a nylon membrane by
electroblotting followed by UV fixation.
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The Northern blot was treated for 30 minutes in Northern blot
hybridisation buffer at 55°C before adding "^P-labelled Xgtll-SRl
insert (10^ cpm/ml buffer) . Hybridisation was performed overnight
at 55°C. The blot was washed for 60 minutes in four changes of
hybridisation buffer at 55°C and exposed to x-ray film as described
above.
6.2.11. Generation of lysogens
In order to obtain larger quantities of the recombinant pro¬
teins expressed by Xgtll-SRl and \gtl1-SR2, recombinant lysogens
were prepared in E_. coli strain Y1089 as follows.
Y1089 cells were grown to mid-logarithmic phase of growth
(OD 0.6 at 600 nm) in LB medium containing 100 (ig/ml ampicillin
(LBm + amp), 10 mM MgSO^ , 0.2% maltose, and then harvested by centri-
fugation at 1,500 G for 10 minutes at room temperature. The cell
pellet was resuspended to its original volume in 10 mM MgSO^ and
incubated at 37°C for five minutes. To enhance the chances of lyso-
geny occurring, cells were mixed with recombinant phage at a ratio
8of 1:1. Thus in each case, 1 ml of Y1089 cells containing 5 x 10
O
cells was added to 5 x 10 phage particles and they were incubated
together for one hour at 32°C to allow adsorption to occur. Cells
were pelleted by centrifugation for 10 minutes at 1,200 G and resus¬
pended in 2 ml LBm + amp containing 10 mM MgSO^. After incubating
at 32°C for 30 minutes the cells were pelleted again and this time
8 i
were resuspended in 1 ml 10 mM MgSO^ to which 5 x 10 A CI phage
particles were added. Acl is a phage which disregards the hfl mutation
and will infect and lyse cells which are not already infected by other
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phage. Its inclusion during lysogen generation reduced the number
of unwanted non-lysogens growing. A CI was kindly provided by Dr. M.
Goman.
The cells were incubated with A CI at 32°C for another 30 min¬
utes before pelleting once again and resuspending in LBm + amp. The
cells were diluted using LBm + amp and spread onto LB agar plates
at a density of approximately 200 cells per plate having included
Aci in the medium at a 1:1 ratio.
Plates were incubated overnight at 32°C.
Single colonies which had grown overnight were streaked onto
two replicate agar plates (containing ampicillin), one of which was
incubated overnight at 32°C and the other at 42°C, in order to test
for temperature sensitivity. At 32°C the temperature sensitive phage
repressor is functional, therefore cells growing at 32°C but not at
42°C were assumed to be lysogens.
Lysogens of both recombinant and wild type Agtll were generated
in this way.
6.2.12. Lysogen colony screening
To check that the recombinant Agtl1 lysogens produced expressed
the recombinant protein recognised by Mab 1A7, a rapid colony screen
was carried out.
Lysogen clones were grown at 32°C to mid-logarithmic phase
from an overnight culture in LBm + amp. Cells were then plated onto
agar at a density of 200 cells per plate. Two plates of each lysogen
were grown overnight.
229
For each lysogen, two agar plates were prepared; one with a
layer of top agar containing ampicillin (100 ng/ml) and 20 mM IPTG,
the other with a layer of top agar containing ampicillin only.
Untreated nitrocellulose paper filters were laid on the lysogen
colonies and then lifted off and placed, with the colonies upper¬
most, on the prepared agar plates. One filter for each lysogen was
placed on a plate containing 10 mM IPTG, the other filter on a plate
without IPTG. Plates containing IPTG were grown at 42°C while the
others were grown at 32°C, both for two hours. Then all filters
were removed and the colonies lysed in situ by incubating them in
chloroform vapour for 15 minutes.
The filters were then treated in exactly the same manner as
were the filters used for genomic library screening, in order to
react the colonies with Mab% 1A7 and 4B11 and then visualise this
reaction.
6.2.13. Recombinant protein analysis
To determine the molecular weights of recombinant proteins
produced by the recombinant Agtl1 clones selected, lysogens were
used to prepare larger quantities of the proteins for SDS-PAGE and
Western blotting.
Two ml of an overnight lysogen culture was added to 8 ml fresh
LBm + amp and grown at 32°C to mid-logarithmic phase. The lysogen
was then induced by raising the temperature to 42°C and adding IPTG
to a 10 mM concentration. After 80 minutes of induction the cells
were pelleted by centrifugation at 2,000 G, 30°C for six minutes.
A time course induction experiment had been carried out to determine
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the optimal time for harvesting the induced lysogens (see Section
6.3.5.). The pellet was resuspended in 0.75 ml PBS containing 1 mM
PMSF and 0.25 ml x 4 SDS sample buffer and then lysed by boiling for
five minutes. The induced lysates were separated by SDS-PAGE on 7%
or 10% gels, 50-100 p.1 lysate per gel track. Lysates not used
immediately were stored at -20°C.
Transfer of the separated proteins to nitrocellulose paper,
reaction with antibody and detection of the reaction were carried
gen was used as a control antigen while antisporozoite monoclonal
4B11 and anti-B-galactosidase serum acted as antibody controls.
As part of the study of the recombinant proteins, the reacti¬
vity of lysogens with the antisporozoite antisera used in previous
chapters was examined by Western blotting. Again, the techniques
used are fully described in Section 5.2.4.
6.3. RESULTS
6.3.1. Genomic library screening
After cloning and rescreening a number of plaques which app¬
eared positive in the initial screen, two recombinant phage clones
were purified which reacted positively with Mab 1A7. These were named
Agtll-SRl and Agtl 1-SR2. Both clones gave positive staining plaques
with Mab 1A7 but not with 4B11 (Figure 35) or any other anti-
theilerial monoclonal antibodies raised against the sporozoite and
other stages.
out as described previously (Section 5.2.4.). Wild
Figure 35 Genomic library screening: detection of a T.
annulata sporozoite antigen gene fragment
cloned inAgtll and expressed in E. coli.
Plaque immunoassay of pure or impure \gtll-
SRl phage. Plaques gave positive reactions
with Mab 1A7 and negative reactions with
Mab 4B11.
Figure 36 DNA insert sizes of recombinant plasmid or
phage.
EcoRl digestions of recombinant plasmid or phage
DNA separated by agarose gel electrophoresis to
show insert sizes of:
Track Insert size
1 puC 18-SR2a 1 .3 kb
2 puC 18-SR2b 1.7 kb + 100 bp
3 puC 18-SRl 330 bp
4 A gtl1-SR2 1.3 + 1.7 kb + 100
5 Agtl1-SRl 330 bp
Insert sizes are indicated with arrows and were




vs. 4B11 vs. 1A7
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6.3.2. Insert sizes in recombinant phage and plasmid
EcoRl digestions of DNA purified from recombinant clones
Xgtl1-SR1 and Xgtl1-SR2 when separated by agarose gel electrophor¬
esis, revealed that Xgtl1-SRl contained a single insert of 330 base
pairs (Figure 36, track 5) while Xgtl1-SR2 contained three inserts
of 1.7 kb, 1.3 kb and 100 base pairs (Figure 36, track 4), indi¬
cating the presence of two internal EcoRl digestion sites. The
inserts were successfully cloned from Xgtl1 to puC 18 (Figure 36,
tracks 1-3) with the 1.3 and 1.7 kb inserts ofXgtll-SR2 being
cloned separately into two different plasmid clones named puC 18-
SR2a and b respectively. By chance, the 100 bp insert was randomly
ligated into the same clone as the 1.7 kb insert.
6.3.3. Southern blot analysis
Figure 37 shows ethidium bromide stained DNA fractionated in
an agarose gel. Figure 38 shows the corresponding Southern blots
derived from three replicates of the gel probed with the inserts from
the recombinants puC 18-SR1 (100 bp insert, C i) and ii)), puC 18-
SR2a (1.3 kb insert, A) and pUC 18-SR2b (1.7 kb insert, B). There
was no hybridisation to bovine DNA by any of the inserts (track 5).
All three inserts hybridised to both stocks (Ankara and Hissar) of
T?. annulata (tracks 3 and 4) . The hybridisation to genomic Theileria
DNA was similar between SR2b and SRI, while SR2a and SR2b hybridised
to different bands. Hybridisation to the gtll-SRl and gtll-SR2
inserts (tracks 1 and 2) shows that SRI and SR2b cross-hybridised to
each other but SR2a hybridised only to itself. There was no hybrid¬
isation to the small 100 bp insert by any of the three probes.
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Figure 37 EcoRl digestions of recombinant phage, theilerial
and bovine DNA separated by agarose gel electro¬
phoresis .
Tracks represent DNA from:
track 1 ^gtll-SR2
track 2 ^gtll-SRl
track 3 T. annulata Ankara piroplasms
track 4 T. annulata Hissar piroplasms
track 5 bovine thymus gland
Track 6 contains kb markers (20 ng).
The adjacent markers visible (1 |ig) were present
to indicate that the separation of DNA fragments
had occurred and were removed before the DNA was
transferred from this agarose gel to nitrocellu¬
lose paper (Figure 38).
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Figure 38 Southern blot hybridisation of recombinant plasmid
clone inserts to bovine, theilerial and phage DNA.
Plasmid inserts SRI (Ci and Cii), SR2a (A) and
SR2b (B) hybridised to EcoRl digested DNA blotted




track 3 T. annulata Ankara piroplasms
track 4 T?. annulata Hissar piroplasms
track 5 bovine thymus gland
Track 6 contains kb ladder markers.
Cii) represents Ci) exposed to X-ray film for
10 days rather than 24 hours to reveal hybrid¬
isation of the SRI insert to theilerial DNA.
kb









Figure 39 shows that the puC 18-SR1 insert hybridised to three
bands of DNA in EcoRl digested T_. annulata piroplasm DNA from both
Ankara and Hissar stocks at about 3.3, 4.8 and 6.0 kb (tracks 1 and
2) but did not show any reaction with T. parva piroplasm DNA (track
3) . The T_. parva containing track was probed at 59°C and washed at
a lower stringency (2 x SSC) than the blots with T. annulata DNA.
Although the three DNA bands hybridised are similar in position in
Ankara and Hissar stocks, their relative intensity differs between
the stocks.
When different restriction endonucleases were used to digest
Ankara (Figure 40, tracks 1-3) or Hissar (Figure 40, tracks 4-7)
piroplasm DNA, different patterns of hybridisation are observed.
Hind III digested DNA probed with the puC 18-SR1 insert (Figure 40,
tracks 1, 2 and 6) reveals four hybridisation bands of 3.5, 4.8,
5.8 and 6.3 kb. The bands are the same size in Ankara and Hissar
DNA. When Pst 1 digested Hissar DNA (Figure 40, tracks 4 and 5) was
probed three bands are observed at 3.1 and 3.5 kb and a high band
at greater than 10 kb.
A Southern blot was performed using EcoRl digested DNA from
cloned T. annulata Ankara and Hissar infected cell lines (Section
2.2.7.) to compare the hybridisation pattern with that obtained with
parent cell lines and piroplasm DNA when probed with the puC 18-SR1
insert. T_. annulata Ankara DNA contained three hybridising bands
in both macroschizont-infected cell line (Figure 41, track 12) and
piroplasm (track 5) derived DNA. All of the Ankara cloned cell lines
gave just a single band. The 3.3 kb band was represented in four
clones; 139-D4, 139-E5, 46-A and 46-2 (tracks 7,8,9 and 11); the
Figure 39 Southern blot hybridisation of recombinant DNA
insert from puC 18-SR1 to T. annulata and
parva piroplasm DNA.
EcoRl digested piroplasm DNA from:
track 1 T. annulata Ankara
track 2 T. annulata Hissar
track 3 T. parva Muguga
probed with ~^P labelled 330 bp insert of puC 18-
SRl .
Figure 40 Southern blot hybridisation of recombinant DNA
insert from puC 18-SR1 to T. annulata piroplasm
DNA digested with different restriction endo-
nucleases.
T. annulata Ankara (tracks 1-3) and Hissar
(tracks 4-7) piroplasm DNA digested with:
Hind III tracks 1, 2 and 6
EcoRl tracks 3 and 7
Pst I tracks 4 and 5
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Figure 41 Southern blot hybridisation of puC 18-SR1 insert-
to genomic DNA from cloned and uncloned parasite
material.
EcoRl digested DNA from T. annulata:
track 1 Hissar 46-4 )
track 2 Hissar 46-3 - cloned cell lines
track 3 Hissar 46-2 |
track 4 Hissar 46-parent cell line
track 5 Ankara piroplasms
track 6 Ankara 139-D6
track 7 Ankara 139-D4
track 8 Ankara 139-E5
track 9 Ankara 46-A
- cloned cell lines
track 10 Ankara 46-3
track 11 Ankara 46-2
track 12 Ankara 46-parent cell line
probed with "^P labelled puC 18-SRl insert.
Figure 42 Northern blot hybridisation of puC 18-SR1 insert
to total RNA from infected and uninfected tick
salivary glands.
Total RNA separated by agarose gel electrophor¬
esis, blotted and probed with ^2p labelled
puC 18-SRl insert. RNA was obtained from:
tracks 1 and 3 uninfected H. _a. anatolocum
salivary glands
tracks 2 and 4 T. annulata Ankara infected
H_. a., anatolicum salivary glands
Tracks 3 and 4 represent tracks 1 and 2 exposed
to X-ray film over a longer period.
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4.8 kb band by two clones; 139-D6 and 46-3 (tracks 6 and 10) and
the 6.0 kb band by none. The Hissar reaction is less clear, the
4.8 kb band is barely visible in the Hissar infected parent cell
line DNA (track 4). However the Hissar clones, 46-4, 46-3 and 46-2
clearly show only one band of 3.3 kb to have hybridised with no
evidence of a higher band (tracks 1-3). The blot shown was performed
by Len Metcalfe while working at the Wellcome Unit for Molecular
Parasitology.
6.3.4. Northern blot analysis
Northern blot analysis (Figure 42) revealed a major RNA band
of 3.1 kb to be expressed specifically in infected tick salivary
glands (track 2). No hybridisation is seen in RNA from uninfected
glands (track 1). On exposing the Northern blot longer, higher
molecular weight bands of 6.4 and 4.9 become visible in infected
salivary gland RNA (track 4), still with no reaction in uninfected
salivary gland RNA (track 3).
6.3.5. Lysogen generation and recombinant protein analysis
Lysogens harbouring recombinant Agtl1 phage and wild type
Agtll phage were successfully produced in Y1089. Of 100 single
colonies tested for temperature sensitivity for each recombinant A gtll,
42% and 36% were lysogens of \gtll-SRl and Agtll-SR2 respectively
and failed to grow at 42°C. The lysogen colony screen confirmed the
reactivity of the recombinant lysogens with Mab 1A7 when induced to
express recombinant protein with IPTG. Figure 43 shows an example
from this screen. lysogen and uninduced
Figure 43 Colony screen of recombinant lysogen Agt11-SR1.
The upper segment shows induced Agtl1-SRI lysogen
colonies reacting positively with monoclonal
antibody 1A7.
The lower segment shows uninduced Agtl1-SR1
lysogen colonies failing to react with mono¬
clonal 1A7.
An enzyme linked immunoassay was used to
reveal positive or negative antigen-antibody
reactions.
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Figure 44 Time course of induction for lysogen \ gtl1-SR1.
a) Coomassie blue stained acrylamide gel of
Xgtll-SRl lysogen lysates from cultures
induced for 15, 30, 45, 60, 75 and 90
minutes (tracks 1-6).




recombinant lysogens failed to react with Mab 1A7 and no reaction
was obtained when induced recombinant lysogens were incubated with
other Mabs, 4B11, 7B10 and 4H5 (data not shown). The time course
for recombinant lysogen induction showed that the level of recombin¬
ant protein increased sharply in the first 60 minutes and did not
change appreciably in the following 30 minutes. An 80 minute incu¬
bation time was selected for use in subsequent experiments. Figure
44 shows a Coomassie stained acrylamide gel (a) and corresponding
Western blot (b) of lysogen samples taken during the induction process.
Figure 45 shows induced lysogen and Y1089 lysates analysed by
protein stains of SDS-PAGE gels and by Western blotting. Specific
protein bands were induced of 135 kdal inXgtll-SRl lysogen (tracks
2 and 10) and of 115 kdal in wild typeXgtll lysogen (track 11) , the
latter representing induction of the B-galactosidase enzyme. In
\gtll-SR2 lysogen (track 1) and Y1089 (track 3) no unique bands were
visible. Western blots of the same material show several features.
Mab 1A7 reacted with a specific protein in both Xgtll-SRl and Xgtll-
SR2 lysogens of 135 and 147 kdal respectively (tracks 5 and 4) but
recognised no proteins in wild type Xgtll lysogen (track 13) or Y1089
(track 6). Mab 4B11, acting as a negative antibody control, gave
no such reaction (tracks 7-9). When A gtl 1-SR1 and wild type lysogens
were incubated in serum possessing anti-B-galactosidase activity,
bands were detected at 135 and 115 kdal respectively (tracks 14 and 15) .
The reactivity of the bovine and rabbit antisera used in earlier
chapters, with the recombinant protein expressed byAgtll-SRl lysogen
is illustrated in the Western blots in Figures 46 and 47a and compared
with their reactivity with B-galactosidase expressed by wild type
Figure 45 Analysis of recombinant proteins of ^gtll-SRl
andAgtll-SR2 expressed in E. coli.
Coomassie blue stained gels showing induced





track 11 wild type Agt11
Western blots of the same material reacted
with antibody:
track 4 A gt 11-SR2]
track 5 Agtll-SRlji - VS . monoclonal 1A7
track 6 Y1089
track 7 \gtu-SR2;
track 8 Agtii-SRi;1 - vs. monoclonal 4B11
track 9 Y1089 :
track 12 Agtll-SRl
i- vs. monoclonal 1A7
« ^




track 15 wild type i~ sidase serum
Figure 46 Reactivity of selected antibodies with \ gtll-
SR1 recombinant protein.
Western blot of induced lysates of Agtll-SRl










track 10 Calf N44 day 92 challenged with live
virulent sporozoites
track 11 Calf 45T day 0




Calf 53 day 0
Calf 53 day 107 hyperimmunised with
live virulent sporozoites
Calf 61 day 0
Calf 61 day 107 hyperimmunised with
live virulent sporozoites
Calf N44 day 0
Calf N44 day 63 immunised with





























Figure 47 Reactivity of antisporozoite antibodies with
Agtll-SRl recombinant protein and wild type
Agtll B-galactosidase
a) Western blot of induced Agtll-SRl lysogen
reacted with antibodies:
track 1 Calf L37 day 63 immunised with irrad¬
iated sporozoites (640 Gy)
track 2 Calf L37 day 0
track 3 Calf L21 day 91 challenged with live
virulent sporozoites
track 4 Calf L21 day 63 immunised with irrad¬
iated sporozoites (320 Gy)
track 5 Calf L21 day 0
track 6 Calf 102 day 43 immunised with irrad¬
iated sporozoites (840 Gy)
track 7 Calf 102 day 0
track 8 Calf 134X day 101 hyperimmunised with
live virulent sporozoites
track 9 Calf 134X day 0
track 10 Calf 54X day 95 hyperimmunised with live
virulent sporozoites
track 11 Calf 54X day 0
track 12 Mab 1A7
track 13 Rabbit 77 day 66 (see Section 7.3.3.)
anti-B-galactosidase serum
track 14 Rabbit 28 day 73 after fed on by infected
ticks
track 15 Rabbit 28 day 0
b) Western blot of induced wild type Agtll
reacted with the same antibodies.
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\gtll lysogen (Figure 47b). The essential points of interest are
that all calves, except L37, immunised with sporozoites by repeated
inoculation of either virulent live sporozoites or irradiated sporo¬
zoites developed a reaction to the same 135 kdal protein expressed
in Agtll-SRl lysogen as recognised by Mab 1A7, albeit less strongly
than Mab 1A7. This reactivity was not observed in day 0 sera, nor
in serum from a calf shown to be immune to uninfected ticks (Figure
45, track 12). Rabbit 28 developed very strong recognition of the
135 kdal protein (Figure 47a, track 14); day 73 serum taken after
immunisation by infected ticks feeding gave as strong a reaction to
this protein as Mab 1A7 (Figure 47a, track 12). The corresponding
serum from rabbit 8, which was immunised by uninfected ticks feeding,
gave no reaction at all with this protein (data not shown).
Figure 47b shows that identical sera to those used in Figure 47a,
when 'reacted with the induced wild type Agtll lysogen, do not recog¬
nise the B-galactosidase protein at 115 kdal.
Monoclonals raised against the infected lymphocyte surface
7(4H5) and the macroschizont (1C7) also fail to recognise the 135 kdal
recombinant.protein (Figure 46, tracks 2 and 3).
6.4. DISCUSSION
The two recombinants,Agtl1-SRl and Agtl1-SR2, selected from
the genomic library expressed proteins which contained the epitope
recognised specifically by antisporozoite Mab 1A7. There was no
cross-reaction with 4B11 or other monoclonals raised against the
sporozoite, nor with monoclonals raised against other stages of the
parasite.
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No recombinants expressing the epitope recognised by 4B11
were detected. This may have been due to the absence of any recom¬
binants containing the appropriate gene sequence in the correct
orientation and reading frame. Another reason might be that a
recombinant may have been expressing the appropriate amino acid
sequence but either essential protein folding or post translational
modification, absent in IS. coli, were required to form the epitope
showing reactivity with 4B11.
Although ^gtll-SRl and \gtll-SR2 both contain theilerial DNA
coding for the 1A7 epitope they are not identical; the insert sizes
show that Xgtl1-SR2 has a greater theilerial DNA content.
Since the genomic library was constructed from piroplasm DNA
there was a small risk that a few bovine white blood cells not
removed during piroplasm purification might have contaminated the
library with fragments of bovine DNA.
g
The bovine genome (10 kb) is approximately 100 times larger
n
than the Theileria genome (10' kb) so very few white cells could
introduce some bovine DNA recombinants. To ensure that the selected
recombinants did not contain bovine DNA which, due to some artefact,
coded for a protein reacting positive with 1A7, bovine DNA was in¬
cluded in a Southern blot probed by the puC 18 inserts (Figure 38).
None of the inserts hybridised to bovine DNA, confirming that their
DNA is parasite and not host derived. The agarose gel on which the
digested DNA was separated (Figure 37) shows that the piroplasm DNA
did not have bands in common with bovine DNA. Thus, at this level
of sensitivity, the piroplasm DNA was not significantly contaminated
with bovine.
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The same Southern blot as above shows that the 330 bp sequence
of Xgtll-SRl must be contained in the large 1.7 kb insert of Agtll-
SR2 since these two inserts cross-hybridised with each other. This
correlates with their similar hybridisation pattern on probing theil-
erial DNA, which differed from that of the 1.3 kb insert. Figure 48
shows the interrelationship of Xgtll-SRl and Xgtll-SR2 diagrammati-
cally.
The genomic library from which these recombinants were sel¬
ected was constructed using DNA fragments created in a random fashion
(Section 6.2.3.). This makes it possible for just fragments of a
gene to be cloned and also unlikely that whole genes will be cloned
discrete from adjacent theilerial DNA from a non-coding region or
another gene. The recombinant protein analysis shows that the ex¬
pressed fusion proteins contain theilerial portions which are smaller
than any of the native sporozoite proteins bearing the 1A7 epitope.
It is clear from this that the 1.7 kb and 330 bp gene sequences
coding for this epitope are only portions of a larger gene.
Since there are no internal EcoRl digestion sites in the puC
18-SRl insert, the presence of three bands in Ankara and Hissar DNA
probed with this insert indicates that there are three copies of the
DNA sequence in both stocks. These parasite stocks are not cloned
so the three gene fragment copies could represent the presence of
a mixed population with three different genomes. Alternatively there
could be three copies of this gene fragment within a single genome,
or even a combination of the two situations.
The hybridisation pattern of cloned macroschizont-infected cell
line DNA probed with the puC 18-SRl insert (Figure 41) affords
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Figure 48 Relationship between the inserts in clones lambda
gtll-SRl and lambda gtll-SR2 which both express
the epitope recognised by Mab 1A7.
The numbers refer to lengths in kb.
The letter r designates EcoRl restriction sites.
The arrow denotes the direction of transcription.
The shaded segment represents the gene sequence
of the Xgtll-SRl insert.
I 0.3 |
r r
L lac z R
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preliminary evidence that the former is t,rue and that the three bands
observed in parent cell line and piroplasm DNA are the result of res¬
triction fragment polymorphism in a mixed parasite population and are
not multiple gene copies. The bands were segregated to single copies
in the clones. The 6.0 kb band was not present in any clone of either
Ankara or Hissar. This may just reflect its apparently low represen¬
tation in the uncloned parent cell lines (Figure 41, tracks 4 and 12) ,
if more clones had been available for testing it would probably have
been detected. Restriction fragment polymorphism is a distinguishing
feature of some repetitive antigens of Plasmodium falciparum (Coppel,
Saint, Stahl, Langford et al., 1985a; Kemp, Coppel,Stahl, Bianco ei;
al., 1986). Workers cloning and expressing Plasmodium circumsporo-
zoite epitopes in a similar manner to this study have found single
gene copies of the DNA coding for this epitope on Southern blots in
Plasmodium cynomolgi (Enea _et aT., 1984a), Plasmodium knowlesi (Ellis
et al., 1983) and Plasmodium falciparum (Dame et al., 1984). In a
similar manner to theAgtll-SRl insert, a cDNA clone encoding a
Babesia bovis antigen detected two bands in genomic DNA from an un¬
cloned isolate while two other isolates showed a single band (Gill
et al., 1987) . This suggests that the cDNA clone gene sequence may
belong to a polymorphic locus of Babesia bovis.
The DNA sequence of the SRl insert was originally derived from
T. annulata Hissar genomic DNA. The Southern blots show that the
sequence is also present in Ankara DNA and further work has confirmed
that Gharb DNA shows the same hybridisation pattern (data not shown).
This correlates with the observation that Mab 1A7 reacts with all
three stocks by IFA and Western blotting. Use of this gene sequence
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as a DNA probe would not differentiate uncloned T. annulata stocks
and would group clones derived from these stocks differently from
groups resulting from GPI analysis. However, T. parva DNA did not
appear to contain the DNA representing the SRI insert even when
hybridised under conditions allowing hybridisation of a sequence
showing incomplete homology. This feature is in common with observ¬
ations that the DNA sequence coding for the repetitive epitope of
the circumsporozoite protein of Plasmodium is not shared between
species of that parasite (Enea est al., 1984b).
The Northern blot analysis (Figure 42) gave good evidence to
indicate that the DNA sequence of the puC 18-SR1 insert was specifi¬
cally expressed in the infected and not the uninfected tick salivary
glands. A very strong signal was apparent from the 3.1 kb RNA trans¬
cript. By day 2 of a tick feed, which is when salivary glands were
harvested for RNA extraction, sporogony will have occurred under the
stimulus of the tick feeding (Schein and Friedhoff, 1978) resulting
in peak synthesis of the sporozoite surface antigens. During this
short time there will have been sudden and rapid expression of the
DNA encoding these antigens and therefore the mRNA species respons¬
ible for the protein synthesis will be well represented. Indeed,
the methyl green and pyronin stain demonstrates the maximal presence
of RNA on day 2, since RNA stains a blue colour with this technique
(Walker et. a_l. , 1979) . The higher molecular weight RNA bands of 6.4
and 4.9 (Figure 42) visible on longer exposure may represent precur¬
sors of the 3.1 kb sequence or may, since the RNA was extracted from
uncloned parasite, be transcripts from other copies of the sequence.
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The analysis of the _in vivo RNA transcripts has been extended
by hybridising the insert of Agtll-SRl to RNA from macroschizont and
piroplasm stages of the life cycle. The results indicate that the
expression of this gene is confined to sporoblast and sporozoite
stages (Dr. F.R. Hall, personal communication). Dr. Roger Hall has
also performed preliminary experiments to study the translation
products of infected salivary gland RNA. Immunoprecipitation of
these products with serum raised against the Agtll-SRl fusion protein
(see Section 7.3.3.) revealed a single high molecular weight protein
band of over 100 kdal. This could represent the 104 kdal sporozoite
protein observed in Western blots of crude infected tick homogenates
(Figure 26). Its presence suggests that the multiple reaction of Mab
1A7 with sporozoites is, at least partly, due to processing of a high
molecular weight precursor molecule.
The validity of the two recombinants selected by Mab 1A7 from
the genomic library has been confirmed by showing the presence of
the cloned theilerial DNA sequence in the genome (Figure 39) and by
demonstrating stage specific expression of the DNA (Figure 42). This
analysis of the DNA cloned in the two recombinants was carried out
concurrently with an analysis of the recombinant proteins they express
in _E. coli.
Since the initial selection of Agtll-SRl and\gtll-SR2 was
conducted by screening for expression of the recombinant protein,
the selected recombinants were known to contain the theilerial DNA
sequence in the correct transcriptional orientation and translational
frame (Young and Davis, 1983a).
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Lysogens were generated in J3. coli strain Y1089 in order to
obtain larger quantities of the recombinant proteins. As the results
show (Figure 45) , Agtll-SRl and Agtll-SR2 express recombinant pro¬
teins of 135 and 147 kdal respectively, each of which bear the sporo-
zoite epitope recognised specifically by Mab 1A7. \ gtll-SR2 recom¬
binant protein was not visible on Coomassie blue-stained gels.
However, it may have been marked by a host cell protein occurring
at the same site. Partly for this reason,Agtl1-SRl was used for all
future work. These recombinant proteins are expressed fused to B-
galactosidase which has a molecular weight of 115 kdal. This means
that a 115 kdal portion of the expressed fusion protein is bacterial
in origin, leaving theilerial peptide portions of 20 (Agtll-SRl) and
32 (Agtll-SR2) kdal. The DNA insert isolated from Agtl1-SRl which
was described earlier was only 330 bp in size, with a theoretical
coding capacity of only about 11-12 kdal. An anomaly thus exists
between the sizes of the DNA insert and the theilerial peptide portion.
This has been investigated by Dr. Roger Hall who sequenced the DNA
of theAgtll-SRl insert and obtained the predicted amino acid sequence
(Figure 49). This amino acid sequence contains a protein coding
region relatively high in proline (10% overall with one stretch of
25% between amino acids 20 to 64). Such high proline content has
previously been reported to retard protein migration on SDS-PAGE
(Young et al., 1985; Carrol and Laughon, 1987) and may explain the
apparently large size of the fusion protein.
The reactivity of the rabbit and bovine antisera with the A gtl1-
SR1 fusion protein (Figures 46 and 47) was interesting since it indi¬
cates that animals exposed to sporozoites produce antibodies which
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Figure 49 Nucleotide sequence of the 330 base pair SRI insert
and the predicted amino acid sequence
GAA TTC CTA GTG AAG GAT GTA AGC GAA GAA CAG GDD GGA
Glu Phe Leu Val Lys Asp Val Ser Glu Glu Gin Val Gly
ATA GGA GAT TTA AGT GAC CCG AAT AGC AGA ACA CCA AAT
lie Gly Asp Leu Ser Asp Pro Asn Ser Arg Thr Pro Asn
GCA AAA CCA GCC GAA CTT GGA CCT TCA CTA GTG ATA CAA
Ala Lys Pro Ala Glu Leu Gly Pro Ser Leu Val lie Gin
AAT GTA CCA TCA GAC CCC TCA AAA GTG ACA CCA ACA GAG
Asr Val Pro Ser Asp Pro Ser Lys Val Thr Pro Thr Glu
CCT TCA AAT TTG CCA CAA GTA CCA ACA ACA GGG CCG GGG
Pro Ser Asn Leu Pro Gin Val Pro Thr Thr Gly Pro Gly
AAC GGG ACG GAT GGA ACA ACA ACA GGA CCA GGT GGA AAC
Asn Gly Thr Asp Gly Thr Thr Thr Gly Pro Gly Gly Asn
GGG GAA GGA GGC AAA GAT TTG AAG GAA GGA GAA AAG AAA
Gly Glu Gly Gly Lys Asp Leu Lys Glu Gly Glu Lys Lys
GAA GGA TTA TTT CAA AAG ATC AAA AAC AAA CTC TTG GGC
Glu Gly Leu Phe Gin Lys lie Lys Asn Lys Leu Leu Gly
TCA GGA TTC GAA GTC ACA AGA ATTC
Ser Gly Phe Glu Val Thr Arg lie
The two EcoRl sites are indicated by a dotted line above the
sequence. The proline residues are underlined to emphasise their
high frequency. The reading frame is shown in phase with B-galacto-
sidase.
Sequence determination was entirely the work of Dr. Roger Hall.
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recognise this fusion protein. This response was not observed in
animals exposed to uninfected ticks. Since the fusion protein con¬
tains a major bacterial component the same sera were reacted with B-
directed against the theilerial or bacterial component of the fusion
protein. It would not be surprising for calves to develop antibodies
to a range of E_. coli proteins since this is a major inhabitant of
the gastrointestinal tract and pathogenic E_. coli strains are one
of the most common causes of enteritis in young calves (Blood,
Henderson and Radostits, 1979). In fact, the calves and rabbit
specifically identified the sporozoite portion of the fusion poly¬
peptide. This was surprising since in Western blots in which the
same sera were reacted with purified sporozoites only a few of the
calves and rabbit 28 identified the same sporozoite epitope as Mab
1A7. The reaction of calf sera with this epitope was weak compared
to that of Mab 1A7 and rabbit 28. This may be reason why it was not
observed in Western blots with sporozoites where, proportionally,
the quantity of epitope present would have been much smaller.
Uncertainty must still surround the role of this sporozoite
epitope as a component of an antigen stimulating protective immunity.
Calf 102, immunised by repeated inoculation of irradiated sporozoites,
was shown to be susceptible to challenge infection, yet shows some
reactivity with the 135 kdal protein as well as _in vitro sporozoite
neutralisation. Whether this response was not adequately stimulated
in calf 102 to confer protection or whether, in other calves, the
response was too weak and occurred incidental to protection is open
to question.
galactosidase from to see if the reactivity was
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The obvious means of resolving these questions was first to
immunise animals with theXgtll-SRl fusion protein in order to obtain
antibody responses which would react with the sporozoite epitope as
strongly as Mab 1A7; then to challenge the immunised calves with
virulent sporozoites and observe whether any degree of protection
was afforded. The next chapter describes work towards and including
such an immunisation trial.
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Prior to cloning and expression of parasite antigen genes with
a view to producing material for an effective subunit vaccine, pre¬
liminary work will normally have been performed to suggest that the
antigen has the potential to stimulate an effective immune response.
Evidence of the latter may result directly from immunisation trials
with the purified antigen (Hall, Hyde, Goman, Simmons et a_l. , 1984)
or indirectly from experiments which indicate that antibody recog¬
nising the antigen is, or could be, protective (Potocnjak et al.,
1980; Nardin, Nussenzweig, Nussenzweig, Collins et al. , 1982;
Hollingdale et^ al_. , 1984; Dobbelaere et al. , 1984; Musoke jet a_l. ,
1984; Winger et aT., 1987). Another feature used to indicate an
antigen's importance, which is perhaps the least reliable, is de¬
tection of.reactivity with polyclonal immune serum (lams et al,
1988; Goff, Davis, Palmer, McElwain ^et al., 1988) .
Once selected antigens have been produced as genetically
engineered recombinant proteins they are available in large quant¬
ities for immunisation trials. These trials have two purposes;
firstly to determine whether the purified recombinant protein is
immunogenic when inoculated, and secondly, to assess whether the
response, if one is obtained, is protective.
In parasite systems where a laboratory animal model is readily
available, preliminary trials can combine these two activities with
those animals responding to the recombinant protein being challenged
with live parasite. For some parasites there is no laboratory animal
model and the definitive host would be either too costly, or too
controversial to use without considerable justification from
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preliminary experiments (for example: cattle, chimpanzees, human
\
volunteers). In such situations the assessment of immunogenicity
and of methods of antigen presentation can be initially investigated
in an alternative species. In these species some idea can be gained
of the potential protective function of the recombinant protein by
coupling the in vivo response with _in vitro methods similar to those
described for assessing the role of a parasite antigen. One such
example is the work carried out in mice to test a potential Plasmodium
falciparum recombinant sporozoite vaccine for use in man. The serum
from immunised mice was first tested for reactivity with sporozoites
in the IFAT and then tested for its ability to neutralise sporozoite
infectivity for human hepatocytes _in vitro (Mazier _et al_. , 1986) .
The aim of the work described in this chapter was to carry out
immunisation trials in mice and rabbits using theXgtll-SRl fusion
protein and then to extend the work _in vivo by immunising the natural
bovine host of T. annulata with the protein and challenging with a
lethal dose of homologous sporozoites to test whether any degree of
protective immunity has resulted.
The experiments described include a detailed assessment of the
response of immunised mice and rabbits in order to select an appro¬
priate method for presenting the material to calves. This assessment
included the use of IFAT, Western blotting and in vitro sporozoite
inhibition assays. It was intended to determine whether animals had
responded to the immunising material; if they had, whether the response
was directed towards sporozoite and/or bacterial portions of the fusion
protein and, lastly, whether their response demonstrated functional
ability in blocking sporozoite infectivity in vitro.
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A method for immunising calves was only selected afteir satis¬
factory results had been obtained in all these aspects. Likewise,
not until similar results had been obtained in immunised calves,
were they subjected to challenge with virulent parasite.
In this way it was hoped that an objective and meaningful
assessment could be made of the immunising and protective ability
of this recombinant sporozoite epitope.
7.2. MATERIALS AND METHODS
7.2.1. Experimental animals
a) Mice
Ten Balb/c female mice over eight weeks old. Mice were identi¬
fied as 1-10.
b) Rabbits
Six New Zealand White female rabbits aged at least three months
old. Rabbits were identified as 1608, 1609, 73, 75, 77 and 11.
c) Calves
Six castrated male calves of Friesian x Holstein or Friesian x
Ayrshire breeds, aged at least two months old at the start of the
experiment. Ear tag numbers were 10T, 34A, 14T, 37A, 41P and 38A.
7.2.2. Immunising material
a) Extraction
Animals were immunised with either the\gtll-SRl recombinant
protein or with typeAgtll B-galactosidase (except rabbit 11).
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Both these proteins were extracted in an identical manner from
SDS-PAGE gels. Thirty ml of induced lysogens (for induction method
see Section 6.2.13.) of Xgtll-SRl or wild typeXgtll were harvested
by centrifugation for six minutes at 2,200 G, 30°C (ME Mistral 3000) .
The pellets were drained and resuspended in 2.25 ml PBS containing
1 mM PMSF. 0.75 ml SDS sample buffer (x 4) was added and the lyso¬
gens were heated at 100°C for five minutes and then stored at -20°C.
After running a gel to ensure that good lysogen induction had
been achieved, two 7% polyacrylamide gels were loaded with each lyso¬
gen. 1.5 ml lysogen was used per gel. After overnight electrophor¬
esis to separate the reduced proteins, a 1 cm wide longitudinal strip
was cut from the centre of each gel and stained for one hour in 0.1%
Coomassie blue. After destaining for one hour these acted as templates
so that a horizontal strip (approximately 0.1 x 12.5 x 0.9 cm) con¬
taining the desired protein (Xgtll-SRl at 135 kdal or Xgtl1-B-galacto-
sidase at 115 kdal) could be cut out of each gel.
The gel strips were macerated, then 4-8 ml PBS was added and
the mixture was left to elute overnight at 4°C. The acrylamide was
spun down at 2,500 G, 10°C for 30 minutes and the supernatant was
removed. This undialysed material was used to immunise mice and
rabbits 1608 and 1609.
A more efficient method was used for protein elution to obtain
material for the second and third calf immunisations using an electro-
eluter (Model 422 Electro-eluter, Biorad). In this, gel strips were
subjected to electroelution for five hours at 10 mA per electro-
elution tube in ammonium bicarbonate buffer (0.395% NH^HCO^, 0.1% SDS) .
The eluted and concentrated protein was collected in buffer from just
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above a dialysis membrane (35 kdal pore size). Material, from
either elution technique, used to immunise rabbits 73, 75 and 77
and calves was dialysed overnight. The eluted protein in solution
was dialysed against two litres of PBS at 4°C (if extracted mechani¬
cally) or 20°C (if extracted by electroelution to prevent the NH4HCO3
crystallising out of solution).
The dialysed solution was then used for immunisation.
b) Protein estimation
One hundred p.1 of each protein extraction was taken before or
after dialysis to measure protein concentration using the BCA Protein
Assay Reagent microprotocol method (Pierce Chemical Company).
c) Adjuvant
When adjuvant was used, an equal volume of sterile complete or
incomplete Freund's adjuvant (Gibco) was mixed with the dialysed
aqueous protein solution until an emulsion formed.
7.2.3. Immunisation regimes
Table 19 summarises the details of the immunisation protocol
followed for each experiment.
Rabbit 11 was immunised with Dermatophilus congolensis antigen
combined with Freund's adjuvant as indicated in Table 19. This
immunisation was performed by Ian Heron and Dr. Alex Morrow who
kindly donated serum from before and after the rabbit was immunised.
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7.2.4. Routine monitoring
a) Mice and rabbits
Day 0 serum and serum from day 10 after second and third doses
were obtained from all mice and rabbits. Rabbits were bled from the
marginal ear vein and mice from the tail vein. On day 10 after
their third immunising dose mice were killed and bled out from the
heart.
b) Calves
Blood was taken for serum once every two weeks from day 0
and on day 94, 10 days after the last immunising dose. EDTA blood
was taken once weekly from day 0 for routine haematology. At the
same time, rectal temperatures were measured and the calves were
given a general clinical examination during which the reaction at
the site of the injection was monitored.
7.2.5. Assessment of response to immunisation
Sera from all animals were tested in an identical manner.
Four methods of assessing the animals' responses to immunisation were
used:
as antigen.
2. Western blots using Percoll-purified T. annulata Ankara
sporozoites as antigen.
3. IFAT using formalin-fixed T. annulata Ankara sporozoite
antigen.
4. In vitro sporozoite inhibition assays.
The methods for all the above have been described in detail in
previous chapters.
1. Western blots using Xgtl1-SR1 or wild
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7.2.6. Challenge of calves
All six calves were challenged 18 days (day 102 of the experi¬
ment) after the third immunising dose by subcutaneous inoculation
anterior to the left shoulder of 1.0 tick equivalents (0.5 ml) from
pooled stabilates of T. annulata Hissar. The order of calf inocul¬
ation was as follows:
14T, 10T, 4 IP, 37A, 34A, 38A
A series of experiments to titrate the infectivity of a T.
annulata Hissar sporozoite stabilate _in vivo had already been per¬
formed at CTVM during the previous year (C.G.D. Brown, personal
communication). Table 20 shows the dose dependent effect on various
clinical parameters which occurred. Since the infectivity of this
pool of stabilates was proven and titrated it was selected as chall¬
enge material for this experiment. On the basis of the previous
results obtained (Table 20) calves were given a 1.0 te dose which
was considered likely to be a lethal challenge to at least 50% of
the susceptible calves.
7.2.7. Monitoring reaction to challenge
All measurements and observations were made from day -1 of
challenge (day 101 of experiment).
a) Rectal temperature
Rectal temperatures were recorded daily.
b) Haematology and piroplasm parasitaemia
EDTA blood was taken on alternate days up to day 8 when it was
taken daily until the first piroplasms and peak piroplasm parasitaemia
were observed after which alternate day sampling was resumed.
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Table 20 In vivo infectivity titration of the T. annulata Hissar




(t.e.) number 1st Ma 1st Piro 1st Temp. Death
10 Friesian S24 7 9 8 15
Friesian S21 3 9 7 17
Friesian S33 5 -9 6 21
Friesian IP 4 9 6 17
0.1 Hereford 910 7 11 10 -
Hereford 908 7 11 10 -
Friesian S39 9 9 15 22
Friesian 143N 7 10 10 21
0.001 Friesian 909 14 11 17 26
Ayrshire S56 14 12 15 -
Ayrshire S57 13 12 18 -




The left prescapular lymph node was palpated daily. From
day 4, lymph node biopsies of the left prescapular lymph node were
taken daily until the first macroschizonts had been detected and
confirmed the following day. Thereafter sampling was carried out
on alternate days.
d) Clinical examination
The clinical condition of calves was assessed at the same
time as samples were taken as described in Section 2.2.8.
The parameters measured included:
rectal temperature
hyperplasia )




white blood cell count
red blood cell count
7.3. RESULTS
7.3.1. Immunising material
Figure 50a shows Coomassie stains and the corresponding Western
blots of representative samples of extracted ^gtll-SRl fusion protein
used to immunise rabbits and mice. Both \gtll-SRl protein and \ gtll-
B-galactosidase extracted to immunise calves are illustrated in
Figure 50b.
These proteins were obtained free of the vast majority of host
cell proteins and represented about 90% of the total protein presented
to animals at immunisation. The Western blots show that extracted
Figure 50 Purity and immunoreactivity of extracted
Agtl 1-SR1 fusion protein and wild typeAgtll
B-galactosidase
Coomassie stained gels:
a) tracks 1 and 2
b) tracks 1-4
and corresponding Western blots:
a) tracks 3 and 4
b) tracks 5-8
a) Material used to immunise mice and rabbits:
tracks 1 and 3 crude Xgtl1-SRl lysogen lysate
tracks 2 and 4 extracted Xgtl1-SRl fusion
protein.
b) Material used to immunise calves:
tracks 1 and 5 crude Xgtl 1 lysogen lysate
tracks 2 and 6 extracted Xgtll B-galactosidase
tracks 3 and 7 crude Xgtl1-SRl lysogen lysate
tracks 4 and 8 extracted Xgtl1-SRl fusion
protein
Tracks 3 and 4 were reacted with Mab 1A7
Tracks 5-8 were reacted with anti Xgtl1-SRl
fusion protein serum (see Section 7.3.3.)-
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and Agtl1-B-galactosidase retained reactivity with serum possessing
anti-B-galactosidase activity (Figure 50b, track 6).
7.3.2. Mice
mice 9 and 10 remained as unimmunised controls.
a) Reaction with immunising material
After two immunising doses, 4/8 mice had produced antibodies
not shown) and after three doses, 6/8 mice had responded as judged
by reactivity with the same 135 kdal protein recognised by Mab 1A7
on a Western blot (Figure 51a). Sera taken from non-immunised mice
(Figure 51a, tracks 2 and 3) or mice before immunisation (data not
shown) showed no reactivity with this protein.
b) Reaction with sporozoites
The same sera failed to show significant reactivity with T.
annulata Ankara sporozoites either by IFAT or Western blotting.
Figure 51b illustrates the extremely weak reaction of the serum of
mouse 7 after immunisation with sporozoites (track 2). No other sera
detected any sporozoite proteins and no sera developed a detectable
antisporozoite IFAT titre (data not shown).
c) In vitro sporozoite inhibition
Immunised and control mice sera were used at dilutions of Vl,
V4 and /16 in inhibition assays carried out in microtitre wells
(see Section 4.3.3.).
Mice 1-8 were immunised with Agtl 1 -SRI fusion protein while
fusion protein used as immunising material (data
Figure 51 Reactivity of mice sera with \gt11-SR1 fusion
protein and sporozoites.
a) Western blot of induced \gtl1-SRI lysogen
lysate reacted with antibodies:
track 1 Mab 1A7
tracks 2-11 postimmunisation sera from mice
1-10
b) Western blot of T. annulata Ankara sporo¬
zoites reacted with antibodies:
track 1 Mab 1A7
track 2 mouse 7 before immunisation
track 3 mouse 7 after immunisation
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Figure 52 Sporozoite inhibition assay to test sera from
mice immunised with Xgtll-SRl fusion protein.
Bar charts showing median % infection and %
inhibition levels in assays to test sera from
pairs of mice.
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Mice were paired and their sera mixed for testing for sporo-
zoite blocking activity as only small amounts of serum were avail¬
able. Figure 52 shows the results obtained.
Of the mice which produced antibodies to theXgtll-SRl fusion
protein, only pairs 1+5 and 6+8 showed significant inhibition of
sporozoite infectivity; inhibiting 60 and 65% infectivity respect¬
ively at 1/4 serum dilution. This effect was not observed by the
same sera diluted further to 1/16. Pair 4+7 had no significant
effect on sporozoite invasion even though mouse 7 serum was the only
one with any sign of reactivity with sporozoites on a Western blot.
Mouse pair 2+3 which produced no detectable antibody response to the
immunising material also lacked sporozoite neutralising activity.




Rabbits 1608 and 1609 were immunised with the extracted X gtll-
SRl fusion protein on three occasions by multiple intradermal inoc¬
ulations. Sera taken from these rabbits after two and three immun¬
ising doses failed to show a response to the fusion protein at 135
kdal in a Western blot (Figure 53) or to sporozoites by IFAT (data
not shown). In view of this lack of response no Western blot or
inhibition assay with sporozoites was performed.
b) Intramuscular inoculation with Freund's adjuvant
Rabbits 73, 75 and 77 all received intramuscular inoculations
of the extracted Xgtl1-SRl fusion protein combined with complete or
272
incomplete Freunds adjuvant on three occasions. Rabbit 11 received
two doses of Dermatophilus antigen in complete or incomplete Freunds
adjuvant.
i) Reaction with immunising material: Serum taken 10 days after
the third immunisation (second immunisation of Dermatophilus antigen
in rabbit 11) demonstrated anti-Xgtl1-SR1 fusion protein activity
as strong as that of Mab 1A7 in rabbits 73, 75 and 77 (Figure 54a,
tracks 1, 3, 5 and 7). This activity was absent in day 0 sera from
the same rabbits (Figure 54a, tracks 2, 4 and 6) and in postimmuni-
sation serum from rabbit 11 (Figure 55b, track 8). Some of the anti-
against the bacterial component of the fusion protein since they all
reacted with the 115 kdal B-galactosidase protein in Western blots of
induced wild typeXgtll lysogen (Figure 50, tracks 5 and 6; Figure 56a,
track 7, data shown for rabbit 77 only).
ii) Reaction with sporozoites: Postimmunisation sera from rabbits
73, 75 and 77 reacted with the same four protein doublets on sporo¬
zoites as Mab 1A7 (Figure 54b, tracks 2-4). Again the recognition of
the bands was as strong as Mab 1A7 showed with sporozoites on the same
blot (Figure 27, track 4). An IFAT using these sera against formalin-
fixed T. annulata Ankara sporozoite antigen confirmed that postimmuni-
sation sera from rabbits 73, 75 and 77 recognised sporozoites. The
postimmunisation IFAT titre from the three rabbits had risen from 1/10
to 1/160 giving a titre comparable to that of rabbit 28 after it was
fed on by infected ticks as Table 21 indicates. Rabbit 11 serum had
no detectable IFAT titre against sporozoites. Table 21 shows the lack
fusion protein was directed
Figure 53 Reactivity of sera from rabbits inoculated intra-
dermally with Agtl1-SR1 fusion protein.
Western blot of Xgtll-SRl induced lysogen lysate
reacted with antibodies:
track 1 Mab 1A7
track 2 Rabbit 1608 day 0
track 3 Rabbit 1608 day 28
track 4 Rabbit 1608 day 38
track 5 Rabbit 1609 day 0
track 5 Rabbit 1609 day 28
track 7 Rabbit" 1609 day 38
Figure 54 Reactivity of sera from rabbits inoculated
intramuscularly with<\gtl1-SR1 fusion protein
in Freund's adjuvant.
Western blots of:
a) Xgtll-SRl lysogen reacted with:
track 1 Mab 1A7
track 2 Rabbit 73 day 0
track 3 Rabbit 73 day 66
track 4 Rabbit 75 day 0
track 5 Rabbit 75 day 66
track 6 Rabbit 77 day 0
track 7 Rabbit 77 day 66
b) T. annulata Ankara sporozoites reacted with:
track 1 Rabbit 73 day 0
track 2 Rabbit 73)
track 3 Rabbit 75
track 4 Rabbit 77
- day 55
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of significant reactivity of day 0 and postimmunisation sera from
rabbit 77 against macroschizont and piroplasm antigens of T. annulata
Ankara in the IFAT, thus the anti-Xgtl1-SR1 fusion protein response
appeared to be specific to sporozoites. The response predominantly
consisted of antibodies of immunoglobulin class IgG with a less marked
but detectable IgM component. This was assessed by using two second
antibodies, one goat antirabbit (GAR) IgG (Fc) and goat antirabbit
IgM (Fc), before a third rabbit antigoat antibody conjugated with
fluorescein.
iii) Sporozoite inhibition assays: Figure 55a shows that all
three rabbits immunised with the\gtll-SRl fusion protein exhibited
strong sporozoite inhibiting activity such that up to 100% inhibition
was achieved by serum diluted to ^/4. Even serum diluted to 1/8
caused marked neutralisation of sporozoite infectivity, the levels of
blocking at both dilutions were similar to those obtained with serum
from rabbit 28 which was fed on by infected ticks. Control rabbit 11
which was immunised with Dermatophilus antigen failed to affect sporo¬
zoite invasion to any significant degree. To investigate the nature
of the sporozoite inhibiting activity of these anti-^gtl1-SRl fusion
protein sera, further assays were performed. Figures 55b and c illu¬
strate the results of these assays, all of which used serum from
rabbit 77 since this rabbit had shown the strongest sporozoite neutral¬
ising action. This neutralisation was active against all three stocks
of T. annulata; Ankara, Gharb and Hissar with no significant differences
between the degree of action on each stock. Control rabbit 11 had no
effect on sporozoite invasion in any of the stocks. Heat inactivation
of rabbit 77 serum reduced the strength of the neutralising activity
Figure 55 Sporozoite inhibition assays to test sera from
rabbits immunised with the X gtll-SRl fusion
protein combined with Freund's adjuvant.
Bar charts showing median % infection and %
inhibition levels in assays to test sera from:
a) Rabbits 73, 75, 77 and 11 against T. annulata
Ankara sporozoites
Open bars: serum dilution 1/4
Closed bars: serum dilution 1/8
b) Rabbits 77 and 11 against T. annulata
Gharb (i) and Hissar (ii) sporozoites
c) Rabbit 77 against T. annulata Hissar
sporozoites.
i) Sera used: normal and heat inactivated
ii) Sera added: day 0 and day 1 of culture
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but still left it highly significant (Figure 55c). When serum from
rabbit 77 was added 24 hours after in vitro infection of PBM with
sporozoites, there was no effect on the level of infection established
(Figure 55c).
7.3.4. Calves
Six calves were used in a preliminary immunisation trial. Two
calves (10T and 34A) were immunised with A gtl1-SR1 fusion protein,
two (14T and 37A) were immunised with Agtl1-B-galactosidase and two
(41P and 38A) were kept as unimmunised controls.
a) Reaction to immunising material
Western blots showing the reaction of Agtl1-SRI (Figure 56b)
and wild type Agtl1 (Figure 56c) lysogens with sera taken from the
six calves on day 94 give results which correlate with the material
each calf had received. Thus, calves 10T and 34A detected the 135
kdal band representing theAgtll-SRl fusion protein (Figure 56b,
tracks 5 and 6); calves 14T and 37A detected the 115 kdal band repre¬
senting B-galactosidase (Figure 56a, tracks 3 and 4) and calves 41P
and 38A detected neither of these (Figure 56a and b, tracks 1 and 2).
It is interesting to note that calves 10T and 34A did not recognise
the 115 kdal protein in wild type Agtl1-SRI in addition to the 135
kdal protein inAgtll-SRl. Also the anti-B-galactosidase activity
of calves 14T and 37A only gave a faint reaction with the 135 kdal
protein in gtll-SRl. The extracted B-galactosidase used to immunise
calves 14T and 37A, obviously contained some contaminating proteins
since these calves detect some other bacterial proteins of similar
molecular weight to B-galactosidase in both wild type and recombinant
1 lysogens.
Figure 56 Reaction of calf sera with immunising material.
a) Western blot: calf sera vs. wild type ^gt11
lysogen.




2 Calf 4ip) non-immunised controls
3 Calf 37a)
- immunised controls (B-gal)4 Calf 14T)
5 Calf 34A)
6 Calf 10T)
7 Rabbit 77 immunised (Agtll-SRl)
- immunised (Agtll-SRl)
8 Rabbit 11 immunised control (Dermato-
philus antigen)
9 Mab 1A7




The intramuscular inoculation sites became palpably and visibly
swollen, the degree of swelling was maximal between days 7 and 14
after each immunising dose was administered. No skin ulceration
occurred and the calves were not otherwise affected.
b) Reaction to sporozoites
Although the Western blot in Figure 57 is of poor quality, it
clearly shows that, like rabbits 73, 75 and 77, postimmunisation sera
from calves 10T and 34A (tracks 3 and 4) which received Agtl1-SRI
fusion protein reacted with the same group of sporozoite proteins as
Mab 1A7 (track 6). Control immunised calves (tracks 1 and 2) or non-
immunised calves (track 5, data shown for calf 4IP only) did not
recognise any sporozoite bands. Interestingly, there is some vari¬
ation in the relative intensity of bands detected between calves 10T,
34A and Mab 1A7. In particular, the 104 kdal protein, which was pre¬
viously a feature of Western blots using crude infected tick homo-
genate, was stained very intensely by serum from calf 34A (Figure 57,
track 3) .
Calves 10T and 34A were also shown to recognise sporozoites
by using the IFAT. Antisporozoite titres against formalin fixed
T. annulata Ankara sporozoites rose from 1/10 to V160 compared to
1/40 in calves after immunisation with B-galactosidase and 1/10 in
unimmunised controls.
c) Sporozoite inhibition assay
Again, as demonstrated by anti-Agt11-SRl fusion protein sera
from rabbits 73, 75 and 77, postimmunisation serum from calves 10T
and 34A alone had a marked sporozoite neutralising ability which was
Figure 57 Reactivity of calf sera with T. annulata Ankara
sporozoites
Western blot of sporozoite proteins reacted with
antibodies:
track 1 Calf 37a;
track 2 Calf 14tl
I - immunised controls (B
track 3 Calf 34a;
track 4 Calf iot:|- immunised (Agtll-srl)
track 5 Calf 4 ip non-immunised control
track 6 Mab 1a7
Calf sera all day 94.
The arrows indicate the positions of sporozoite
proteins recognised by Mab 1A7 (track 6).
280
281
Figure 58 Sporozoite neutralisation assay to test
sera from immunised and control calves.
Bar charts showing median % infection
and inhibition levels.
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absent from the other four calves' sera also taken on day 94. This
is illustrated in Figure 58.
d) Reaction to challenge
On day 102 of the experiment, 18 days after four of the calves
had received their final immunising doses, all six calves were chall¬
enged with virulent T. annulata Hissar sporozoites and their subse¬
quent reaction was monitored (see Sections 7.2.6. and 7.2.7.).
Figure 59 shows the clinical reactions of the calves illustrated
graphically and Table 22 summarises the salient comparative features
of these reactions.
All six calves became infected with Th annulata with the appear¬
ance of macroschizonts in the local lymph node between 4-7 days and
piroplasm infected red blood cells between 9-10 days postinfection.
Three calves underwent a severe reaction and were destroyed in extremis
(calves 34A, 14T and 3 7A) . The other three calves all survived, two
(41P and 38A) having suffered a severe reaction and one (10T) only
a moderate clinical reaction.
•The calves which were destroyed had been immunised with either
B-galactosidase (14T and 37A) orXgtll-SRl fusion protein (34A) com¬
bined with Freunds adjuvant. At post mortem, 35-39 days after the
last immunisation, the intramuscular injection sites were examined.
They consisted of localised areas of fibrosis with no significant
abscessation or necrosis.
Figure 59 Clinical reactions of immunised and control calves
on challenge with live virulent sporozoites.
a) Rectal temperatures (T°C) and presence of
macroschizonts and microschizonts in the
regional lymph node (heavy lines).
The upper of the heavy lines represents
macroschizonts.
The lower of the heavy lines represents
microschizonts.
b) White blood cell counts (wbc)
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7.4. DISCUSSION
The experiments described have assessed the immunogenicity of
theXgtll-SRl fusion protein in both naturally resistant and suscept¬
ible hosts of T. annulata. When administered to calves and rabbits
in Freund's adjuvant, a strong antibody response was stimulated which
recognised sporozoites and neutralised their infectivity _in vitro.
However, the calves remained susceptible to challenge with live
virulent sporozoites.
The fusion protein used as immunising material remained immuno-
reactive after extraction and separation from the majority of host
cell proteins. High levels of purity were not considered an essential
requirement for raising high titres of monospecific antibody against
the sporozoite epitope. Indeed, Coppel, Brown, Mitchell, Anders and
Kemp (1984) used crude bacterial lysates of induced lysogens to raise
antibodies to a mature blood stage antigen of Plasmodium falciparum.
However, others recommend that small quantities of a single immunogen
are more likely to induce populations of antibody with high specifi¬
city and affinity, and consequently, sensitivity for the injected
substance (Eisen and Siskind, 1974). Therefore fused polypeptides
are more usually purified before being used to prepare polyclonal
antisera (Coppel, Cowman, Lingelbach, Brown et al., 1983).
In each experiment different host responses were obtained.
Without the use of an adjuvant, rabbits inoculated intradermally
failed to mount an antibody response at all and mice inoculated intra-
peritoneally responded to bacterial but not sporozoite portions of
the fusion protein. When the protein solution was dialysed against
PBS, combined with Freunds adjuvant and inoculated into an intramuscular
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site, strong antibody responses were obtained in both rabbits and
calves. Interestingly, sera from these rabbits contained antibodies
against both bacterial and sporozoite portions of the fusion protein
while the calves only recognised the smaller sporozoite portion. The
IFAT confirmed the Western blot data and significant titres against
sporozoite antigen were only observed in sera which detected a sporo¬
zoite band pattern similar to the reaction of Mab 1A7.
To explain these differences there are several aspects to con¬
sider which include: the species of animal immunised, the route of
administration, the immunising dose and the use of adjuvant.
The properties of the expression system used in this study were
detailed in the literature review. One of several reasons for select¬
ing the system was that the' theilerial peptide would be expressed
fused to a bacterial protein. The latter could then act as a protein
carrier to enhance the immunogenicity of the smaller peptide by stim¬
ulating an antihapten response (Lachmann et al., 1986). The failure
of rabbits inoculated intradermally to mount a humoral response against
the fusion protein most likely reflected a problem in the method of
antigen presentation, in particular, the absence of adjuvant. Although
inoculation into an intradermal site exposes the immunogen to antigen
presenting dendritic cells and macrophages, Vaitukaitis (1981) who
described the intradermal immunising technique employed in this study,
did recommend the inclusion of Freunds adjuvant. Alternatively, it
is possible that only a cellular response was made or that T suppressor
cells were activated and reduced the B cell response stimulated (Roitt
et al., 1985).
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There are a number of possible explanations for the restricted
humoral response of the mice which failed to recognise the sporozoite
epitope, even though they exhibited a strong response to the bacterial
portion of the fusion protein. The principle behind the role of a
carrier protein involves linked recognition of the carrier protein by
T cells and of the smaller peptide or hapten by B cells (Roitt et ad. ,
1985). Mice as a species only recognise a restricted number of T
helper cell determinants on B-galactosidase in spite of the large
size of this protein (Krzych, Fowler, Miller and Sercarz, 1982). If
the sporozoite epitope was not optimally placed in relation to these
determinants, the anti-hapten response may not occur. If this was the
case, the hope would be that this phenomenon occurs in mice only.
However, there is already a precedent in cattle for antibodies raised
against a fusion protein failing to recognise the foreign peptide
portion. The failure of a recombinant Babesia bovis antigen to pro¬
tect cattle against challenge with virulent parasite was attributed
to this (Timms, Barry, Gill, Sharp and de Vos, 1988). Whether the
cattle were exhibiting the same phenomenon as the mice or whether
the method of antigen presentation was at fault was not known.
A second consideration to explain the results is the genetic
background of the animals. This can restrict the combination of
determinants recognised at either the T or B cell level and can limit
the antibody responses of mice (Katz, Maizells, Wicker, Miller and
Sercarz, 1982). Winther, Allen, Bomford and Brown (1986) thought this
an unlikely reason for their failure to obtain an antibody response
to recombinant foot and mouth disease viral protein 1 fused to B-galacto¬
sidase. They had used a variety of mouse H2 haptotypes and, in all,
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a proportion failed to recognise the viral portion of the fusion
polypeptide. Epitope specific suppression has been described by
Herzenberg, Tokuhisa and Herzenberg (1980) who found that priming
animals with the carrier protein before inoculation of the carrier -
hapten, led to hapten specific suppression. If naturally occurring
anti-B-galactosidase antibodies were present in the mice prior to
immunisation, a similar effect could occur, however, none of the
day 0 mice sera contained detectable levels of such antibody.
Given that an antibody response to the B-galactosidase portion
was obtained, the mouse results were unlikely simply to be due to an
inadequate immunising dose. Certainly, increasing the dose level had
no effect on the response to the foot and mouth disease viral protein
(Winther _et al. , 1986) .
The explanation for the mouse response is, therefore, unresolved
and could simply be due to an inappropriate method of antigen present¬
ation. An entirely different method used for immunising calves and
rabbits did result in a strong and specific antibody response to the
sporozoite epitope.
Although Freund's adjuvant is not a realistic alternative for
use in a commercial vaccine it was chosen because of its proven abil¬
ity to potentiate immune responses in cattle. Wells, Emery, Hinson,
Morrison and Murray (1982) demonstrated that, of nine different adju¬
vants, complete Freund's stimulated antibody production and delayed
type hypersensitivity against a variant specific surface antigen of
Trypanosoma brucei most effectively. Also, successful immunisation
trials to protect cattle against Anaplasma marginale infection (Palmer
et al. , 1986) and virulent Babesia bovis (Wright et al_. , 1985) both
used purified antigens combined with Freund's adjuvant.
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Several beneficial properties of Freund's adjuvant may have
helped stimulate the antibody response observed in the rabbits and
calves. The antigen in emulsion is stabilised and resistant to
dispersal and so acts as a depot from which antigen is slowly re¬
leased, exposing the antigen to the immune system over a prolonged
period of time. The oil adjuvant stimulates an inflammatory response
at the inoculation site increasing vascular and lymphatic flow,
attracting cells of the immune system and increasing the circulation
of lymphoid cells. In addition, the heat killed Mycobacterium
tuberculosis in complete Freund's adjuvant activates macrophages to
produce factors enhancing the immune response (Allison and Byars,
1986) .
The calves' antibody response was directed entirely towards
the sporozoite portion of the fusion protein, suggesting that the B-
galactosidase was being recognised by T helper cells and was acting
as a carrier protein without stimulating the production of antibodies
to itself. This is a valuable characteristic for a carrier protein.
It is observed to occur with the purified protein derivative of
tuberculin and repeated intradermal injections of tuberculin in the
diagnostic Mantoux test do not give rise to tuberculin sensitivity
allowing the test to be used on multiple occasions (Lachmann et al_. ,
1986) .
The sporozoite inhibition assay results were particularly excit¬
ing since sera from rabbits and calves immunised with the\gtll-SRl
protein retained the functional ability of Mab 1A7 in neutralising
sporozoite infectivity for bovine PBM in vitro. This neutralising
action was of a similar order of strength as that of serum from
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hyperimmune cattle and was both stronger and more consistent than
exhibited by Mab 1A7. Thus, specific interaction of antibody with
the sporozoite epitope recognised by Mab 1A7 was confirmed to be
responsible for the inhibition of sporozoite infectivity in vitro.
The activity was found to operate against all three stocks of T.
annulata used in this study. This is of importance because, if
functional in vivo, the protective mechanism may afford broad spect¬
rum immunity.
Additional inhibition assays using the rabbit antisera showed
the main inhibitory action to be complement independent: the degree
of inhibition was only slightly reduced by heat inactivation.
Addition of serum on day 1 of the assay had no effect on the number
of infected cells establishing and suggests that, as expected, the
inhibitory effect was directed at the invasive sporozoite stage
rather than at transforming infected cells. When Mazier et al. (1986)
used antibody against recombinant peptides of Plasmodium falciparum
sporozoites in an _in vitro inhibition assay they detected a continued
inhibitory effect on the development of exoerythrocytic forms from
sporozoites which had managed to penetrate cultured hepatoma cells.
Some of the inhibitory effect in these experiments may result from
the action of antibody carried into the cell when the sporozoite in¬
vades. This possibility was discussed in Section 4.4.
Gysin, Barnwell, Schlesinger, Nussenzweig and Nussenzweig (1984)
also found that antibody produced artificially to the sporozoite sur¬
face of the monkey parasite, Plasmodium knowlesi, by immunising rabbits
with a synthetic peptide, possessed sporozoite neutralising activity.
They demonstrated this by inoculating monkeys with sporozoites which
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had been incubated in serum containing the antipeptide antibody,
these monkeys then failed to develop patent infections.
T. annulata Hissar sporozoites were chosen as the challenge
stock for the calf immunisation trial. Strictly speaking, they
represented a homologous challenge since the recombinant protein
Agtll-SRl was derived from a genomic library constructed using T.
annulata Hissar piroplasm DNA, although Mab 1A7, which was used to
screen the library, was raised against T. annulata Ankara sporozoites.
Prior to challenge, only calves 10T and 34A possessed anti-
sporozoite antibody and strong sporozoite neutralising activity.
Disappointingly, on challenge there was no difference between their
clinical reactions and those of the control calves which could not
be put down to the normal variation observed between individual sus¬
ceptible calves (Sergent _et cLL. , 1945) . Calf 34A exhibited a very
similar pattern of disease to calves 14T and 37A. While calf 10T
showed a much lower level of parasitaemia and a relatively minor fall
in PCV compared to the other five calves. Little significance can
be attached to its recovery in that calves 38A and 4IP also survived.
This 50% survival rate was unexpectedly high having selected an
infective dose judged from previous experience to be between 10-1000
x LD50. Indications that calf 10T was going to suffer only a moderate
clinical reaction did not appear until after the first piroplasms
were detected. Since the immune mechanism being studied was expected
to act principally at the sporozoite stage, one would predict that
evidence of a protective effect would be seen soon after infection
as a delayed prepatent period (days to first macroschizonts in the
regional lymph node and days to temperature rise above 39.5°C) and
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fewer macroschizonts in the regional lymph node. Such observations
would have indicated that the infective dose had been reduced by the
neutralising antibody and would reflect the dose-dependent nature of
Theileria infection in cattle (Cunningham, Brown, Burridge, Musoke
et al. , 1974; Radley, Brown, Burridge, Cunningham _et al_. , 1974;
Purnell, 1974). Unfortunately this dose dependency is not always
a consistent feature of T. annulata and sporozoite stabilate can
still kill individual cattle at doses which fail to infect others
(Samish and Pipano,- 1981) . However, Gill, Bhattacharyulu, Kaur and
Singh (1981) monitored host responses in cattle infected with graded
stabilate doses or tick numbers and were confident that the severity
of reaction to T. annulata was dose dependent.
Obviously it is difficult to draw general conclusions from an
immunisation trial with only two calves in each experimental group
and using a single method of immunisation and challenge. Under the
conditions of this experiment, immunisation with theXgtll-SRl recom¬
binant protein was not successful in protecting calves against tropi¬
cal theileriosis. Whether this failure reflects the fact that anti¬
body responses to sporozoites only play a minor role in protective
immunity or whether modifications in the methods of immunisation or
challenge would demonstrate theAgtll-SRl protein as an effective






8.1. SELECTION OF A SPOROZOITE EPITOPE 297
8.2. ANTIGEN PRESENTATION 300
8.3. ROLE OF ANTISPOROZOITE HUMORAL IMMUNITY 306
8.4. FUTURE PROSPECTS 309
296
The identification of an epitope on the surface of Theileria
annulata sporozoites and its production as a recombinant protein,
culminated in the failure to stimulate a detectable degree of pro¬
tective immunity in calves immunised with this protein, in spite of
the strong sporozoite neutralising activity developed by their sera.
The identification of sporozoite antigens and the cloning and
expression of the gene sequence coding for a selected sporozoite
epitope were described and discussed in earlier chapters. For this
reason, the discussion here concentrates on the influence of antigen
presentation on the success or failure of a potential recombinant DNA
vaccine and also on the role of antisporozoite immunity and whether
such immunity is unable to confer protection in vivo.
A review of the literature revealed the uncertainty which surr¬
ounds the role of antisporozoite immunity. Early reports of pro¬
tection conferred by passive transfer of serum (Koch, 1930b; Robson
et al., 1961) have not been repeated successfully (Theiler, 1970;
Muhammed et ad. , 1975) . Cell mediated immunity has been shown to play
a major role in conferring protection to infection with Theileria
(Emery,1981; Emery _et al., 1981; Preston et al., 1983). However, since
the discovery that hyperimmune bovine serum blocks sporozoite infecti-
vity in vitro very effectively (Gray and Brown, 1981; Musoke et al.,
1982), the sporozoite stage has been the subject of much interest.
Techniques for maximising sporozoite yields from infected ticks (Walker
et al., 1985) and for their purification (Walker and McKellar, 1983)
have made sporozoite material accessible in sufficient quantities to
consider, for example, the preparation of sporozoite IFAT antigen
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This is important; no such antigen was available for the antisporo-
zoite status of bovine sera used in the passive transfer experiments
mentioned above to be assessed. Together with the development of
hybridoma technology and genetic engineering, new tools have become
available and have been applied to a study of the sporozoite stage,
allowing defined antigenic material to be assessed and produced in
order to investigate the possibility of developing a subunit non-
infective vaccine based on this stage.
8.1. SELECTION OF A SPOROZOITE ANTIGEN
In vitro assays similar to that employed in this study have been
used as the basis for selection and assessment of antibody recognising
invasive stages of other protozoan parasites (Musoke et al., 1984;
Dobbelaere et al., 1984; Hollingdale et aJL. , 1984; Winger et al., 1987;
Whitmire _et al., 1988) . Monoclonal antibodies or antisera which re¬
duce, or completely block, the infectivity of the parasite they recog¬
nise are considered to be recognising antigens of potential importance
in stimulating an immune response. This was the rationale behind the
use of such an assay in this study, particularly as hyperimmune bovine
serum had previously been shown to neutralise sporozoite infectivity
in vitro (Gray and Brown, 1981; Musoke et _al., 1982; Preston and
Brown, 1985) . Considerable importance has been attached to this
sporozoite blocking activity of Theileria immune serum. It was thus
disconcerting to observe, when testing serum from calves receiving
multiple doses of irradiated sporozoites, that the serum of calf 102
which had been immunised with sporozoites irradiated at the highest
dose but which was susceptible to challenge, was highly effective in
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blocking sporozoite infectivity _in vitro. The implications and
possible explanations of this result were fully discussed in Chapter
4. Serum from calves which had been immunised with irradiated sporo-
zoites without becoming patently infected recognised only a single
sporozoite antigen (Calves L37 and 102) , or none at all (Calf N44) ,
in Western blots. If this was not a fault of the Western blot tech¬
nique, the implication is that irradiated sporozoites are a relatively
poor method of eliciting antisporozoite antibodies compared to expos¬
ure to fully virulent live sporozoites: sera from the rabbit which
was fed on by infected ticks and from hyperimmunised calves gave
strong multiple reactions with sporozoite proteins on Western blots.
It is clear that in vitro sporozoite neutralisation alone does not
necessarily indicate prediction of an effective immune response.
Nevertheless Mabs 1A7 and 4B11 were selected on the basis of in vitro
sporozoite neutralisation since they appeared to be potentially of
greater interest than other Mabs which failed to block sporozoite
infectivity. Inhibition assays using the anti-^gtl1-SRI sera showed
the inhibitory effect to act within the first 24 hours, presumably
on sporozoite invasion. Extrapolating from this, the assumption was
that, by binding to the sporozoite antigen, Mabs 1A7 and 4B11 inter¬
fered with the sporozoites' recognition, attachment or entry into
the host cells. However, in vivo testing of the antigens recognised
by these Mabs was made a priority early on. As described in Chapter 5,
recognition of the epitopes detected by Mabs 1A7 and 4B11 by immune serum
was variable. Recognition by immune serum raised in the definitive host,
in this case, cattle, is not a prerequisite for a parasite antigen
to be chosen for testing as vaccine material, although it is a useful
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feature as it indicates that the natural host of the parasite is
capable of responding to the epitope involved. Goff £t al. (1988)
identified Babesia bovis merozoite surface antigens with Mabs and
considered the recognition of these antigens by immune bovine serum
to be evidence that the antigens could be considered important in
stimulating protective immunity. Mitchell (1984) points out that
novel parasite antigens of negligible immunogenicity to the natural
host when presented as a component of the parasite during infection,
might be recognised by monoclonal antibodies. If such antigens were
isolated from the parasite and presented in a suitable manner to the
host, a response absent during natural infection might be elicited
and consequently a novel effector mechanism might confer protection
to challenge with live parasites.
It was fortuitous that it was the sporozoite epitope recognised
by Mab 1A7 which was obtained as a recombinant protein. This recom¬
binant was shown to contain a gene sequence which was sporozoite
specific in expression and highly conserved; as such it was common
to sporozoites from all stocks of T. annulata which were tested.
These features of the 1A7 epitope, together with the strong
sporozoite neutralising activity of sera from rabbits immunised with
the expressed recombinant protein bearing the epitope, meant that it
was considered worthwhile and necessary to determine whether immunis¬
ation of calves with this protein would protect them against a lethal
challenge with sporozoites of Theileria annulata.
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8.2. ANTIGEN PRESENTATION
In this study, cattle were presented with a polypeptide bearing
a sporozoite epitope capable of stimulating a sporozoite neutralising
antibody response. Given alone such a vaccine would have no means
of amplifying either itself or the immune response mounted against
it. In addition, even if a protein fragment, such as this sporozoite
protein possesses specificity as demonstrated by its reactivity with
specific antibody, it may lack essential antigenic determinants which
confer immunogenic potency on the native protein structure from which
it derives.
For these reasons, which apply to many new forms of immunogen
being tested as vaccines, the features of antigen presentation which
influence whether and how an effective and durable immune response is
induced are coming under closer scrutiny (Kaye, 1987).
Different strategies can be adopted to manipulate the immuno¬
genic properties of an immunogen and the application of these to the
recombinant protein used to immunise calves is discussed below.
Soluble small proteins or peptides bearing few, or even single,
epitopes administered alone are generally non-immunogenic and require
the use of adjuvant (Deans, Knight, Jean, Waters et al., 1988) or
conjugation to carrier proteins (Itoh, Takai, Ahnuma, Kitajima et al.,
1986) for an immune response to be stimulated.
Adjuvants particularly influence whether the immune response
elicited is predominantly cell mediated or humoral and the isotype
of antibody produced (Allison and Byars, 1986). The use of a carrier
protein is important in directing the attention of the immune system
to particular epitopes, in stimulating linked T and B cell responses
and in conferring memory (Zanetti et al., 1987) .
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The isotype of antisporozoite antibody in the immunised calves
may have influenced the effectiveness of the antibodies in vivo.
IgG was certainly stimulated since the peroxidase conjugate used in
Western blots was antibovine IgG, but the IgG subclass was not deter¬
mined. Whether other antibody isotypes were present was also not
determined. Musoke et al. (1982) found that the IgG2 containing
fraction of T. parva hyperimmune bovine serum possessed most of the
neutralising activity. Opsonisation by antibody, without the involve¬
ment of complement is mediated particularly efficiently by IgG2
antibody (McGuire, Musoke and Kurtti, 1979) which is also able to
fix bovine complement. These effector mechanisms would tend not to
be detected in _in vitro assay because of the absence of phagocytic
cells but might afford greater activity _in vivo than that predicted
from the in vitro assay. Complete Freund's adjuvant (CFA) stimulates
predominantly IgG2 antibody in the guinea pig while incomplete FA
stimulates mainly IgGl (White, 1976). If the same is true in cattle,
one would have expected both IgGl and IgG2 to have been elicited since
both CFA and IFA were used during immunisation. Thus the appropriate
immunoglobulin isotype should have been present.
The carrier protein used can also influence antibody isotype.
Bacterial polysaccharides, such as tetanus toxin, have been conjugated
to proteins from organisms such as Haemophilus influenzae type b
(Chu, Schneerson, Robins and Rastogi, 1983) with the specific inten¬
tion of changing the isotype of antibody. Use of tetanus toxin in¬
duced the formation of protective IgG antibody to the Haemophilus
influenzae component and also induced immunological memory whereas,
without this carrier protein, IgM antibody providing poor protection
was elicited and memory was poor.
302
Reasons for the humoral response of the immunised calves
failing to confer protection may relate to the absence of accessory
immune responses resulting in a lack of cooperation between B, T
and antigen presenting cells. The antibody response detected in
the calves could be interpreted as being the result of highly regu¬
lated collaboration between T helper and B cells, possibly together
with modulation from T suppressor cells (Zaretti et al_. , 1987) .
Without assaying for T helper cell function one can only speculate
on how the response was obtained and how modifying the presentation
of the epitope might have made the immune response more effective
in protection. T helper cell determinants on the B-galactosidase
molecule were presumably recognised by the calves and gave rise to
the antihapten response to the sporozoite epitope. Different carriers
fused to a purified recombinant protein encoding the immunodominant
region of the Plasmodium falciparum circumsporozoite protein were
tested in rabbits (Que et. al. , 1988) , Cholera toxin and Pseudomonas
aenigihosa toxin A conjugates to the protein made the circumsporozoite
portion significantly more immunogenic (ibid). Previous trials in
human volunteers using reported inoculations of the same purified
recombinant protein had only generated partial protection in those
given high doses (Ballou et a_l. , 1987) . Increased immunogenicity
using different non-toxic conjugated carrier proteins may be an aim
for future immunisation trials using theAgtll-SRl fusion protein.
Immunogenicity may be increased through more favourable spacing of
T helper and B cell determinants or simply by providing a greater
number of determinants for interaction.
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Inadequate T cell responses to the carrier protein were not
thought to be a problem in the calves in that they produced anti¬
bodies reacting strongly with the sporozoite epitope. Lack of T
cell determinants on the sporozoite portion of the molecule could,
however, have had profound effects on the effector mechanisms
stimulated (Zaretti et a(L., 1987) . No work has been reported on the
cell mediated responses to sporozoites of Theileria. Extrapolating
from studies of the immune response of humans to the circumsporozoite
protein of Plasmodium falciparum (Campbell, Paleologo, Franke,
Ratiwayanto <rt all. , 1988), it is likely that a recombinant protein,
such as A gtl1-SRI which represents only a small portion of the larger
antigenic molecule on the sporozoite from which it derives may lack
B and T cell determinants crucial to the development of a significant
immune response. The fewer T helper cell determinants on the sporo¬
zoite portion of the fusion protein, the more likely one is to see
genetic restriction of the bovine T cell response to the immunising
material. Such genetic restriction has been shown to occur in the
response of mice to the repeat region of the circumsporozoite protein
of Plasmodium falciparum (Del Giudice, Cooper, Merino, Verdini et
al., 1986) and there is circumstantial evidence that the same is
true of man (Campbell et ad., 1988). Absence of crucial T helper
determinants may have limited the magnitude or affinity of the anti¬
body response to the A gtl1-SRI sporozoite epitope making neutralising
antibody less likely to be functional in vivo, establishment of memory
may also have been poorer. An in vitro assay for detecting T helper
determinants on proteins has been developed by Lamb and Young (1987) . In
this, native sporozoites or recombinant proteins separated by SDS-PAGE
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and blotted onto nitrocellulose paper could be tested individually
for their ability to stimulate proliferation of T helper cell lines
established from Theileria immune cattle. By using a larger portion
or the whole of the native molecule to immunise, a more effective
immune response might be elicited, although care may be required to
avoid determinants recognised by T suppressor cells. The co-existence
of T suppressor and T helper determinants in an antigen can lead to
non-immunogenicity as the T suppressor cells stimulation prevents
establishment of all the T helper cells '(Jensen, Pierce and Kapp,
1984). Fortunately, the two types of determinant are usually well
separated (Sercarz, Yowell, Turkin e_t _al. , 1978) allowing the portions
containing suppressor determinants to be cut out.
Even when the appropriate B and T cell determinants are present
on the immunogen, the correct balance of humoral and cell mediated
responses still needs to be recruited. CFA is capable of stimulating
both humoral and cell mediated responses while IFA tends to result
in antibody production only (Allison and Byars, 1986),
The physico-chemical properties of the recombinant protein it¬
self may be important. Proteins which have been denatured are fre¬
quently more immunogenic than the native molecules, assuming the
epitopes remain intact, because the hydrophobic inner domains of
the molecules are exposed and the molecules aggregate (Dresser and
Mitchison, 1968).
The use of a virus which replicates in mammalian cells as the
expression vector is another alternative for production of this sporo-
zoite recombinant. For example, if vaccinia virus were used for this
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purpose it would provide an efficient method of antigen delivery
and circumvent the need for carrier proteins and adjuvants (Smith,
Cheng and Moss, 1986) . Obviously the protective capacity of immune
response would still be influenced by the availability of T and B
cell determinants on the recombinant protein produced.
Recombinant vaccinia virus contains foreign DNA spliced onto
a vaccinia promoter and introduced into a region of the vaccinia
genome not essential for virus replication (Panicali and Paoletti,
1982; Mackett, Smith and Moss, 1982). Vaccinia virus holds certain
attractions as a vector for a recombinant vaccine. Firstly, the
vaccinia virus can accept a relatively large quantity of foreign DNA
(Smith and Moss, 1983), thus the whole sporozoite antigen gene could
be cloned together with antigen genes from other stages of the para¬
site, or even other pathogens (Perkus, Piccini, Lipinskas and Paoletti,
1985). Secondly, the replication of recombinant vaccinia virus in
cells of the host not only amplifies the quantity of recombinant pro¬
tein presented but can also result in expression of the recombinant
protein on the surface of the infected cells (Smith et al^. , 1986) .
Immunisation with vaccinia virus recombinants has already been shown
to stimulate production of protective antibody against hepatitis B
(Moss, Smith, Gerin and Purcell, 1984) and rabies (Wiktor, McFarlan,
Reagan, Dietzschold _et al., 1984) viruses. Expression on the surface
of infected cells means that protective antigens can be identified
together with the MHC of the host, an ideal situation for stimulating
cell mediated immune responses. This would, perhaps, make vaccinia
a suitable choice for cloning the gene coding for the 4H5 antigen on
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the surface of T. annulata-infected cells (Shiels et al., 1985a;
Preston et al., 1986) . With these advantages in mind, the circum-
sporozoite genes of Plasmodium knowlesi and Plasmodium falciparum
have been cloned and expressed in vaccinia virus and the recombin¬
ant products elicited specific antibody to the native circumsporo-
zoite protein in rabbits (Smith, Godson, Nussenzweig, Nussenzweig
et al. , 1984; Smith et ^al. , 1986).
8.3. ROLE OF ANTISPOROZOITE HUMORAL IMMUNITY
If one accepts that a suitable sporozoite epitope was selected
for the immunisation trial and presented to the calves in an adequate
manner and, assuming crucial T cell responses were not missing, the
immune response was potentially protective, then the factors which
may have prevented the response from being effective must be consid¬
ered.
The main action of antisporozoite antibody in theileriosis is
believed to be inhibition of sporozoite invasion (Preston and Brown,
1985). If effects mediated by antibody occur after sporozoite in¬
vasion through recognition of antigen shed during invasion but remain¬
ing on the surface of the infected cell (Dobbelaere et a_l. , 1985a)
or by the action of antibody bound to sporozoites which still managed
to enter cells (Mazier et al., 1986; Hollingdale, 1987), these are
shortlived and have not actually been demonstrated as effector mech¬
anisms in bovine theileriosis. Thus, for the antisporozoite immunity
to operate, the sporozoites must be exposed to antibody before they
can enter cells. The length of time sporozoites are exposed to anti¬
body in part depends on where the target cell becomes infected since,
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wherever it is, the process is rapid once they have made contact
with the cells (Fawcett et al., 1982; Jura et al., 1983).
By the time the number of sporozoites entering the bovine host
is reaching its maximum, a cellular reaction has developed at the
site of the Hyalomma tick bite. Gill and Walker (1985) describe this
reaction in rabbits and noted that the nature of the cells present
depended on whether the animal had been exposed to ticks on previous
occasions; with repeated tick infestation the proportion of mono¬
nuclear cells, some of which can be infected by T_. annulata sporo¬
zoites, increases. Thus, the tick attachment site may provide readily
available host cells in the immediate vicinity of sporozoite entry,
again leaving little opportunity for antibody to act. The presence
of infectable cells at the tick attachment site should, however, be
interpreted with caution. The cells recruited may include stimulated
B cells and plasma cells actively secreting antisporozoite antibody;
an anamnestic response only taking three days to develop (MacLeod,
1953) .
Thus tick feeding may decrease or increase the likelihood of
antisporozoite antibody being effective. If the latter, subcutaneous
inoculation of sporozoite stabilate might have been an unrealistic
method of challenging the immunised calves. Establishment of a tick
bite lesion and a slow "trickle" of sporozoites into the host over
5-6 days (Bhattacharyulu et al., 1975) may be necessary to allow anti¬
sporozoite antibody to neutralise sporozoite infectivity in vivo.
In this respect, antisporozoite immunity in theileriosis may have an
advantage over the same in malaria where the mosquito inoculates
sporozoites directly into the bloodstream over just a few seconds
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(Manwell, 1968). In the calf immunisation trial described in this
thesis, sporozoite stabilate was chosen as the method of challenge
because, in view of the small number of calves in each group, the
challenge needed to be as uniform as possible. Tick challenge is
inevitably more variable than stabilate challenge as individual ticks
vary in infectivity. This was clearly shown by Cunningham, Brown,
Burridge, Irvin et al. (1973) when they compared the infectivity and
virulence of a T- parva sporozoite stabilate with the classical 10
tick challenge which had been used previously.
Where bovine mononuclear cells become infected with sporozoites
is still open to speculation and it is possible that sporozoites
reach the lymph node draining the site of the tick bite before enter¬
ing host cells. Profuse amounts of saliva are produced by the feed¬
ing tick and the excess fluid is drained by the lymphatic system via
the regional lymph node (Theis, Franti, Engel and Littrell, 1976) .
Large numbers of lymphoid cells are available for sporozoites to in¬
fect within the lymph node, although if a proportion of these are
secreting antisporozoite antibody, the sporozoites may be exposed
to higher levels of inhibitory antibody in this environment.
Alternatively, it is conceivable that PBM are predominantly
infected while in the tick mouthparts. The tick feeds using a pump¬
ing action such that mononuclear cells could enter the mouthparts as
the tick ingests blood, become infected and then be returned to the
bovine host with a pulse of saliva. Tatchell, Carnell and Kemp (1972)
describe this feeding action in ticks. Such an infection mechanism,
if it occurs, would severely restrict the access of antibody to sporo¬
zoites .
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There are, therefore, a number of reasons why antisporozoite
antibody may have failed to inhibit sporozoite invasion in vivo even
when very effective _in vitro blocking had been obtained.
If challenge with ticks instead of sporozoite stabilate inocul¬
ation allowed a proportion of the sporozoites entering the bovine
host to be neutralised, this would serve to reduce the infective dose.
Given the dose dependent nature of Theileria infection discussed in
Chapter 7 (Cunningham et al., 1974; Gill et al., 1981), this could
permit a successful immune response and recovery.
8.4. FUTURE PROSPECTS
Further work is necessary to define the contribution of anti¬
sporozoite immunity to protection against tropical theileriosis. An
assessment of whether antisporozoite immunity becomes more effective
in cattle under heavy tick challenge in an endemic area would be of
great interest and analysis of sera from such cattle would be valu¬
able in this respect. At the same time, the use of inactivated sporo¬
zoites to immunise calves, followed by correlation of their IFAT and
Western blot reactions and _in vitro sporozoite neutralising activity
with their reaction to challenge would help elucidate the role of
antisporozoite immunity. Serum from cattle repeatedly immunised with
freeze thawed T. parva sporozoites was used to select recombinants
coding for sporozoite epitopes considered as potentially protective
(lams et ad., 1988) . This serum was described as possessing _in vitro
sporozoite neutralising activity but no indication was given of the
immune status of the cattle to ECF (ibid).
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It may be worthwhile performing further immunisation trials
using the Agtll-SRl protein, and also the polypeptide expressed by
the whole gene which has now been cloned (Dr. F.R. Hall, personal
communication). Larger numbers of cattle, a variety of immunisation
regimes and challenge with ticks or titrated doses of sporozoites,
may allow a more realistic assessment of protective capacity of the
response stimulated and may reveal a degree of protective immunity
resulting from the action of antibody directed against this parti¬
cular sporozoite epitope.
To stimulate more complete immunity may then require the use
of the sporozoite recombinant as part of a "cocktail" vaccine together
with antigens from other stages. For example, antigens on the surface
of parasitised mononuclear cells recognised by genetically restricted
cytotoxic T lymphocytes (Preston et al., 1983; Hall, 1988). Such an
antigen might be the 4H5 antigen on the surface of infected cells
(Shiels et. jal. , 1986a) which mediates complement lysis of these cells
(Preston ^t aT. , 1986) . In this way, a number of immune mechanisms
would be activated to simulate the protective immune responses elicited
during active infection with T. annulata.
Particularly in the case of tropical theileriosis in which
anaemia is a component of the pathogenesis, it would also be exciting
to attempt to immunise against the merozoite stage of the parasite.
An approach could be used similar to that adopted in this study. The
merozoite is the only stage in the bovine host, other than the sporo¬
zoite, which is invasive and extracellular for a period of time.
Coppel, Favaloro, Crewther, Burkot et al. (1985b) describe a blood
stage antigen of Plasmodium falciparum which shares determinants with
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the sporozoite coat protein. Whether similar antigens common to
sporozoite and merozoite stages occur in T. annulata and whether
they would be relevant to stimulating protective immunity has yet to
be investigated.
Bearing in mind that epidemiological tools may contribute to
disease control, the work described in this study may have yielded
reagents of use in this area. Monoclonal antibody 1A7 or the gene
fragment cloned inAgtll-SRl may prove useful for other purposes,
such as a gene probe for identification of infection in tick saliv¬
ary glands. This depends on whether a detection system can be
established which is less cumbersome and more accurate than existing
methods for assessing the rate of tick infection (Walker et al_. , 1979) .
Even if this study has not resulted in the production of an
effective subunit sporozoite vaccine for tropical theilbriosis, some
insight has been afforded into the role of antisporozoite immunity,
the sporozoite antigens involved and the dubious relevance of in
vitro neutralisation assays to in vivo protection. In addition,
the analysis of the cloned Agtl1-SR1 recombinant demonstrated the
presence of a mixed parasite population showing polymorphism of the
SRI locus. The expression of the gene fragment was stage specific,
occurring only in sporoblast and sporozoite stages and thus affords
a model system for studying the control of differential gene trans¬
cription in this important parasite.
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I . 1 . REF. CHAPTER 2
1.1.1. Anticoagulants
a) Heparin
Preservative free heparin (Porcine intestinal mucosa Grade I,
Sigma) was dissolved in sterile phosphate buffered saline, pH 7.3,
at 1,000 units per ml. The solution was filter sterilised (0.22 |im,
Millipore) and stored at 4°C. Heparin was used at a concentration of
20-40 units per ml blood.
b) Acid citrate dextrose solution (ACD, Dacie and Lewis, 1975)
Trisodium citrate dihydrate (Analar, BDH) 22 g
Citric acid, monohydrate (BDH) 8 g
Dextrose (D-glucose, Analar, BDH) 25 g
Purified water up to one litre
The solution was autoclaved (15 p.s.i., 15 minutes) and stored at
20°C. For use, five volumes of blood were added to one volume of ACD.
1.1.2. Phosphate buffered saline (PBS)
Phosphate buffered saline, pH 7.3 and free of calcium and mag¬
nesium ions, was prepared according to the formulation below (Oxoid,
1979) and autoclaved at 15 p.s.i. for 15 minutes.
Sodium chloride (Analar, BDH) 8.0 g
Potassium chloride (BDH) 0.2 g
Disodium hydrogen phosphate, anhydrous (BDH) 1.15 g
Potassium dihydrogen phosphate (BDH) 0.2 g




Ten g of Giemsa powder (Azur-eosin-methylene blue, Merck) was
ground with 540 ml glycerol (Analar, BDH) and kept at 60°C for one
hour with intermittent shaking. Once cooled to room temperature,
840 ml methanol (Analar solvent methanol, BDH) was added and the
mixture was shaken vigorously and then left stirring overnight.
2.75 g Azur II (Merck) was added and stirring continued for another
night. This concentrated solution was filtered (Whatman No. 4) and
stored in a dark bottle. For use,a 5% solution was made up in
phosphate buffer (GURR 6550, BDH) pH 7.2.
1.1.4. Penicillin - Streptomycin
A stock antibiotic solution (x 1,000) containing 100,000 units
per ml of sodium benzylpenicillin (Crystapen, Glaxovet) and 100,000
hg per ml of streptomycin sulphate (Glaxo) in purified water was
stored in aliquots at -20°C. The working concentration was 100 units/
|ig per ml solution.
1.1.5. Nystatin
A stock fungistat solution (x 100) containing 10,000 units per
ml of nystatin (Gibco) in purified water was stored in aliquots at
-20°C. The working concentration was 100 units per ml solution.
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1.2. REF. CHAPTER 3
1.2.1. IFAT materials
a) Formalin fixative
A 1:10 formalin (3.7% formaldehyde solution) was made by adding
10 ml of 37% formaldehyde solution (Analar, BDH) to 90 ml PBS pH 7.3
and storing at 4°C.
b) Fluorescein conjugated second antibody
Second antibody conjugated to fluorescein (FITC) was supplied
(Nordic Immunologicals) as a lyophilised powder and was reconstituted
in purified water. The conjugate was stored in 50 |il aliquots at
-20°C. The conjugates used were:
rabbit antibovine IgG (Fc and Fab) = RAB/FITC
goat antirabbit Ig (IgGl, IgG2, IgA, IgM, Fc and Fab) = GAR/Ig/FITC
rabbit antimouse Ig (IgGl, IgG2a, IgG2b, IgG3, IgA, IgM, Fc and Fab)
= RAM/lg/FITC
These were diluted in PBS before use at 1:80 dilution (RAB/FITC,
GAR/Ig/FITC) or 1:40 (RAB/lg/FITC).
c) IFAT Mountant
A 66% glycerol mountant was used to mount slides to be examined
for fluorescence. This was prepared by mixing 10 ml 50 mM Tris CI
buffer (pH 9.2) with 20 ml glycerol.
1.2.2. Hybridoma culture medium constituents
a) B-mercaptoethanol
A sterile 0.1 M stock B-mercaptoethanol (B-ME) solution was
prepared by adding 0.7 ml commercial B-ME (Sigma) to 99.3 ml purified
water. As supplied, 1 ml B-ME is equivalent to 1.12 g, thus the
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molar weight 78.13 g is equivalent to 69.76 ml. This stock B-ME
was stored in aliquots at -20°C and diluted x 2,000 in medium for
use at the working concentration of 5 x 10-^ M.
b) Amphotericin B
Amphotericin B (fungizone, Gibco) was supplied as a stock sol¬
ution of 1 mg/ml and was stored at -20°C. For use it was diluted x 500
in medium to achieve the working concentration of 2 pg/ml.
c) Foetal calf serum
Myoclone (Gibco), a selected foetal calf serum, was heat inacti¬
vated at 56°C, 30 minutes and stored at -20°C. It was used to
supplement RPMI 1640 medium at a level of 16.7%.
d) HAT and HT supplements
Hypoxanthine - Aminopterin - Thymidine (HAT) and Hypoxanthine -
Thymidine (HT) supplements (Gibco) were supplied as sterile 50 x
concentrated solutions containing:
hypoxanthine 65 mg
aminopterin (HAT only) 0.95 mg
thymidine 19.5 mg
per 100 ml
The aminopterin, once diluted to 1 x in medium was at its
_7
active concentration of 4 x 10 M.
1.2.3. Fusion solutions
a) PEG 1
Polyethylene glycol solution 1 (PEG 1) was made up of 41.6%
PEG and 15% DMSO in incomplete medium (no FCS). 20.8 g PEG (molecular
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weight 6,000, BDH) was diluted in 20 ml warm (37°C) incomplete RPMI
1640 medium and made up to 42.5 ml. The solution was autoclaved
and, once cool, 7.5 ml DMSO was added.
b) PEG 2
PEG 2 was a 25% PEG solution made up by dissolving 6.25 g
PEG in 12 ml warm incomplete medium and making up the volume to
25 ml before autoclaving.
PEG solutions 1 and 2 were made up the day before the fusion .
1.2.4. Counting fluids
a) White blood cell counting fluid (Dacie and Lewis, 1975)
2% acetic acid (BDH) was used as a diluent for the mouse
spleen cell count prior to fusion since it lyses red blood cells.
b) Trypan blue
0.2% Trypan blue (Sigma) in PBS pH 7.3 was used to stain non¬
viable cells for myeloma and hybridoma cell counts.
1.3. REF. CHAPTER 5
1.3.1. SDS - Polyacrylamide gel electrophoresis
a) Stock 30% acrylamide solution
Acrylamide (Sigma)
N,N methylene bisacrylamide (Sigma)
Mixed bed ion exchanger (Duolite MB6113, BDH)
Purified water to 500 ml





b) Lower Tris x 4
*Tris (Sigma) 36.4 g
+SDS (Sigma) 0.6 g
Purified water to 200 ml
pH changed to 8.8 using concentrated HC1 (BDH)
*Tris = trishydroxymethylamine
+SDS = sodium dodecyl sulphate
c) Upper Tris x 4
Tris 12.12 g
SDS 0.8 g
Purified water to 200 ml
pH changed to 6.8 using concentrated HC1
d) Stacking gel (4.5% acrylamide)
Upper Tris x 4 50 ml
30% acrylamide 30 ml






Purified water to 200 ml











EDTA (disodium salt, Sigma)
SDS













45 mg (18.5 mM)
223 mg (3 0 mM)
1.0 g (5% w/v)
0.45 ml (2.5% w/v)



















g) Electrophoresis tank buffer (pH 8.3)
Tris 3.03 g 25 mM
Glycine (BDH) 14.14 g 0.192 M
SDS 1.0 g 0.1%
Purified water to 1,000 ml
All the solutions above were stored at -20°C except tank buffer





Glacial acetic acid (BDH) 10%
in purified water
b) Silver stain solutions











Gluteraldehyde (Taab Labs) 5.0%
Sodium tetraborate (BDH) 1.9%
in purified water
iii) Developer:
Sodium carbonate (BDH) 3 g
37% formaldehyde (Analar, BDH) 50 M-l
Purified water to 100 ml
1.3.3. Western blotting
a) Blotting buffer
For use with semi-dry Ancos blotter (Dako Ltd.)
Electrophoresis tank buffer 100 ml
Technical methanol (BDH) 100 ml
Purified water 300 ml
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b) Blocking buffer x 10
Tris 60.5 g 50 mM
Sodium chloride (BDH) 87.0 g 150 mM
EDTA 3.72 g 1 mM
Nonidet P40 (Sigma) 5.0 ml 0.005%
Gelatin (BDH) 25.0 g 2.5%
Thiomersal 2.0 g 0.2%
Purified water to 1 ,000 ml
pH changed to 7.4 using concentrated HC1
c) Peroxidase conjugated second antibody
Horseradish peroxidase conjugated second antibody was supplied
(Nordic Immunologicals) as a lyophilised powder. This was recon¬
stituted in 1 ml water and then diluted with 4 ml PBS containing
0.05% Tween 20 (Sigma). 75 |ul aliquots were stored at -20°C. The
conjugates used were:
goat antibovine IgG (heavy and light chains) = GAB/PO
goat antirabbit IgG (heavy and light chains) = GAR/lgG (H+L)/PO
goat antimouse Ig (IgGl, IgG2a, IgG2b, IgG3, IgA, IgM, Fc and Fab)
= GAM/lg/PO
d) Substrate solutions
i) Tris buffered saline (TBS):
Tris 4.85 g 20 mM
Sodium chloride 58.48 g 500 mM
Purified water to 2,000 ml
pH changed to 7.5 with concentrated HC1
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ii) Solution 1: 60 (il of ice-cold 30% hydrogen peroxide
(Analar, BDH) added to each 100 ml TBS just prior to use.
iii) Solution 2: 60 mg 4-chloro-l-napthol (Sigma) dissolved
in 20 ml ice-cold technical methanol.
1.3.4. Surface radioiodination and immunoprecipitation
a) Lysis buffer
PBS (pH 7.2) containing protease inhibitors and 1% Nonidet P40
(non-ionic detergent).
b) Immunoprecipitation diluent buffer
Prepared from stock solutions
Tris buffer 2.0 M pH 8.0 10 ml 20 mM
Sodium chloride 0.5 M 100 ml 50 mM
Nonidet P40 10% 20 ml 0.2%
1.3.5. General
a) PBS containing protease inhibitors
N-tosyl-l-lysine chloromethylketone (TLCK, Sigma) 2.5 mg
N-tosyl-l-phenylalanine chloromethylketone (TPCK, Sigma) 5.0 mg
PBS pH 7.2 99 ml
PBS was stirred overnight and then stored at 4°C. Just prior
to use 1 ml 100 mM phenylmethyl-sulphonylfluoride (PMSF, Sigma) was
added.
b) Molecular weight markers
A commercial mixture of six molecular weight protein standards
were used covering the low molecular weight range (Pharmacia). The
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contents of one vial were reconstituted in 1.0 ml 1 x SDS sample
buffer and heated at 100°C for five minutes. Aliquots were stored
at -20°C and 10 y.1 was used per gel track.
The protein standards present were phosphorylase b (94 kdal),
bovine serum albumin (67 kdal), ovalbumin (43 kdal), carbonic anhy-
drase (30 kdal), soyabean trypsin inhibitor (20 kdal) and -lactal-
bumin (14 kdal).
1:4 REF. CHAPTER 6
1.4.1. Antibiotics
a) Ampicillin (Sigma)
Stock solution of 100 mg/ml of the sodium salt of ampicillin
in water. Sterilised by filtration and stored at -20°C. Working
concentration of 100 pg/ml.
b) Chloramphenicol (Sigma)
Stock solution of 34 mg/ml in 100% ethanol stored at -20°C.
Working concentration of 170 pg/ml.
1.4.2. Media
a) Luria-Bertani (LB) medium
Per litre:
Bactotryptone (Difco) 10 g
Sodium chloride (BDH) 10 g
Yeast extract (Difco) 5 g
pH to 7.5 with sodium hydroxide
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b) Solid media
"Bottom" agar or agarose plates were prepared by the addition
of 15 g agar (Bactoagar, Difco) or agarose (type 1, Sigma) per litre
of LB medium prior to autoclaving. After cooling to 55°C, ampicillin
was added to a concentration of 100 iig/ml and the plates were poured.
"Top" agar or agarose was prepared by adding 7 g of agar or
agarose to each litre of LB medium.
1.4.3. For working with bacteriophage
a) Maltose (Sigma)
20% maltose prepared in water and filter sterilised was stored
at -20°C and used at a working concentration of 0.2%.
b) SM (phage buffer)
Per litre:
Sodium chloride 5.8 g
Magnesium sulphate (MgSO^, Tl^O, BDH) 2.0 g
1M Tris buffer pH 7.5 50 ml
2% gelatin (BDH) 5 ml
1.4.4. Genomic library screening
a) Tris-saline buffer (TS)
Per litre:
Sodium chloride 8.77 g 0.15 M
Tris base 1.21 g 10 mM
pH 8.0
361
b) Substrate solution s
Imidazole buffer pH 7.4 10 mM (Sigma) 4.5 ml
Dianisidine dihydrochloride 5 mg/ml (Sigma) 2.25 ml
Hydrogen peroxide (Analar, BDH) 0.45 ml
Purified water 38.0 ml




Tris buffer pH 7.6 10 mM
EDTA pH 8.0 1 mM
pH 8 .0
Tris buffer pH 8.0 10 mM
EDTA pH 8.0 1 mM
1.4.6. TBE (Tris-borate electrophoresis buffer)
Working solution:
Tris - borate 0.089 M
boric acid 0.089 M
EDTA 0.002 M
x 10 stock solution, per litre:
Tris base 108 g
boric acid (Sigma) 55 g
0.5M EDTA pH 8.0 40 ml
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1.4.7. STE
Tris buffer pH 8.0 10 mM
Sodium chloride 100 mM
EDTA pH 8.0 1 mM
1.4.8. Gel loading buffer (type III)
6 x buffer:
bromophenol blue (Sigma) 0.25%




1.4.9. Buffers for restriction endonuclease digestion
Strength of salt buffer
Low Medium High
Sodium chloride - 50 mM 100 mM
Tris buffer pH 7.5 10 mM 10 mM 50 mM
Magnesium chloride 10 mM 10 mM 10 mM
Dithiothreitol 1 mM 1 mM 1 mM
1.4.10. Conditions for restriction endonuclease digestion
Restriction enzyme Temperature Buffer salt concentration
Eco Rl 37°C High
Pst 1 37°C Medium
Hind III 37°C Medium
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1.4.11. Phenol
Phenol was either obtained as a liquid commercial preparation
(BRL Ultrapure) or from crystalline phenol by redistillation at
160°C. Liquid phenol was stored wrapped in foil at -20°C under 1 .0 M
Tris buffer pH 8.0. Antioxidant, 8-hydroxyquinoline (Sigma) was
added to a concentration of 0.1%.
Before use the phenol was extracted several times with 0.1 M
Tris buffer pH 8.0 or was equilibrated with the buffer to be used,
e.g. TE pH 7.6, TE pH 8.0.
1.4.12. DNase free RNase
A stock solution of pancreatic RNase (RNase A, Sigma) at
10 mg/ml was prepared in 10 mM Tris buffer pH 7.5 and 15 mM NaCl.
To destroy any DNase activity this was heated to 100°C for 15
minutes, cooled and then stored at -20°C.
1.4.13. DNase
A stock solution of DNase (DNase 1, Sigma) at 1 mg/ml was
prepared in sterile deionised purified water and stored at -20°C.
1.4.14. 5M Potassium acetate pH 4.8
5M Potassium acetate (Sigma) 60.0 ml
Glacial acetic acid (BDH) 11.5 ml
Purified water 28.5 ml
This mixture results in a 3 M solution with respect to potassium
and a 5 M solution with respect to acetate.
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1.4.15. Preparation of dialysis tubing
Dialysis tubing (Medicell International Ltd.) cut into suit¬
able lengths was boiled in two litres of 2% sodium bicarbonate,
1 mM EDTA for 10 minutes, rinsed thoroughly and boiled again with
purified water. The tubing was cooled and stored at 4°C. Before
use the tubing was rinsed with purified water.
1.4.16. Southern blot hybridisation
a) Acid depurinating solution
0.25 M hydrochloric acid (HC1, BDH) made by the addition of
10.4 ml concentrated HC1 to 490 ml purified water.
b) Alkali denaturing solution
Per 2 litres:
Sodium chloride 1.5 M 175.32 g
Sodium hydroxide (BDH) 0.5 M 40 g
c) Neutralising solution
Per 2 litres:
Tris buffer pH 8.0 1 M 242.2 g
Sodium chloride 1.5 M 175.32 g
d) 20 x SSC
Per litre:
Sodium chloride 175.3 g
Sodium citrate (Sigma) 88.2 g
pH adjusted to 7.0 with 10 N sodium hydroxide
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e) Hybridisation buffer (Southern blots)
For 100 ml
1M Sodium phosphate buffer pH 7.4 50 ml
20% SDS 35 ml
Purified water 14 ml
Denatured (boiled) sonicated






1.4.17. Northern blot hybridisation
a) MOPS buffer
MOPS + pH 7.0 (Sigma) 4 0 mM
Sodium acetate (Sigma) 10 mM
EDTA 1 mM
b) Hybridisation buffer (Northern blot)
PIPES* pH 6.8 (Sigma) 50 mM
Sodium chloride 1 M
Sodium phosphate (Sigma) 50 mM
EDTA 1 mM
SDS 5%
MOPS = morpholinopropanesulphonic acid
*PIPES = 1,4-piperazine diethanesulphonic acid
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APPENDIX II
Median % infection and range values for sporozoite
inhibition assays in Chapters 4 and 7
The bar histogram figure numbers to which
pond are indicated
these values corres-





(range) n = 4








13b Calf 54X 4 0.25 0 25.0 (23.5-31.5)
94 0.0 (0.0-0.5)






7 1/16 0 31.0 (22.5-33.0)
101 0.0 (0.0-0.0)
11 1/64 0 19.5 (18.5-24.0)
101 0.0 (0.0-0.0)













L21 8 0 70.8 (63.5-77.0) 59.3 (43.0-60.5) 37.0
49 0.0 (0.0-0.0) 12.8 (8.0-16.5) 4.0 (1.0-9.0)
104 0.0 (0.0-0.0) 5.3 (4.0-11.5) 9.3 (4.5-14.5)
N44 8 0 53.5 (46.0-78.0) 33.8 (21.5-51.5) 24.0 (19.0-24.0)
63 0.0 (0.0-0.5) 6.3 (0.5-9.0) 11.3 (5.5-14.5)
92 0.0 (0.0-2.0) 3.0 (0.05-5.5) 5.0 (4.0-5.0)
L37 8 0 67.3 (48.5-81.5) 22.0 (19.0-25.0) 23.0 (11.5-25.0)
91 0.0 (0.0-0.0) 3.3 (1.0-7.5) 4.0 (3.0-6.0)
N53 8 0 63.0 (54.0-68.0) 43.0 (26.0-50.0) 36.0 (24.0-49.0)
107 0.0 (0.0-0.0) 4.5 (1.0-8.0) 7.0 (4.0-9.0)
102 3 0 21.0 (10.5-27.0) 29.5 (24.0-35.0) ND
42 0.0 (0.0-0.5) 5.0 (3.0-10.5) ND
N53 3 0 18.8 (17.0-35.0) 48.0 (43.0-54.0) ND
107 0.8 (0.0-1.0) 21.3 (13.0-25.0) ND
Sporozoites: T. annulata Ankara, 0.25 te GF per well































































19.3 0.0 41.0 0.0





















4B 11/C12 A 1:10 3.0 (2.0-5.0)
A 1: 100 3.0 (3.0-4.5)
S 3.0 (1.5-7.0)
1A7/G8 A 1: 10 7.5 (4.5-8.0)
A 1:100 8.5 o h-* o
S 20.5 (16.0-23.5)
4B11/C12 A 1:10 2.0 (2.0-3.5)
+ A 1:100 6.0 (4.5-7.0)
1A7/G8 S x 2 4.0 (1.5-6.5)
7B10 A 1: 10 15.0 (14.0-20.5)
A 1: 100 15.5 (15.0-37.0)
S 10.0 orHT—11oCO
S x 2 4.0 (4.0-5.0)
Calf 134X sera day 0 23.5 (21.0-24.5)
day 101 0.0 (0.0-0.0)
GF 1/16 te/well
4B11/C12 A 1:10 1.5 (1.0-2.5)
A 1:100 0.5 (0.5-1.5)
S 0.5 (0.5-1.5)
1A7/G8 A 1: 10 1.0 (0.5-1.5)
A 1:100 1.0 (0.5-1.5)
S 10.5 (8.0-23.5)
4B11/C12 A 1: 10 0.5 (0.5-0.5)
+ A 1: 100 0.5 (0.0-1.0)
1A7/G8 S x 2 1.0 (0.5-1.0)
7B10 A 1 : 10 7.5 (4.5-8.0)
A 1:100 7.5 (7.5-11.0)
S 1.0 (0.5-1.5)
S x 2 0.5 (0.5-4.5)
Calf 134X sera day 0 2.5 (1.0-6.0)
day 101 0.0 (0.0-0.0)
Sporozoites: T. annulata Ankara
Infection rates assessed on day 4 of culture










anti Taenia saginata 39.5 (25.0-44.0)
Sporozoites: T. annulata Ankara, 0.05 te GF per well
Infection rates assessed on day 4 of culture
Figure 52





Mouse 1 + 5 4.0 (1.0-6.0) 32.3 (27.0-34.0)
4 + 7 12.5 (5.0-15.0) 22.8 (20.0-30.0)
6 + 8 3.5 (2.0-7.0) 14.5 (5.0-28.5)
2 + 3 14.5 (10.0-25.0) 18.0 (11.0-28.0)
9 + 10 10.0 (9.0-18.0) 21.0 (9.0-33.0)
Sporozoites: T. annulata Ankara, 0.05 te per well
Infection rates assessed on day 4 of culture
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Figure 55a
Median % infection (range) n = 4




73 0 22.3 (16.0-30.5) 25.5 (21.5-36.5)
66 0.5 (0.0-0.5) 2.0 (2.0-3.0)
75 0 20.3 (13.5-25.5) 32.0 (23.0-50.0)
66 0.0 (0.0-0.5) 1.0 (0.5-2.0)
77 0 20.5 (15.5-29.5) 21.0 (13.5-25.5)
66 0.0 (0.0-0.0) 0.3 (0.0-2.0)
11 0 22.0 (17.0-32.0) ND
38 17.3 (11.5-25.5) ND
28 0 19.5 (16.0-26.5) 27.3 (20.5-29.5)
73 0.0 (0.0-0.0) 0.3 (0.0-1.5)
Sporozoites: T. annulata Ankara, 0.25 te per well
Infection rates assessed on day 4 of culture
Figure 55b
T. annulata
,, , r „ . _ , .
_ Median % infection (range)
,, . Serum stock .
Rabbit n = 4
day' 0.25 te per ^ . _ _ _ ^ ..
,, Day 4 of culture Day 7 of culturewell
77 0 21.0 (13.0-41.5) 59.0 (49.5-63.5)
66 0.0 (0.0-0.0) 0.0 (0.0-0.5)
Gharb
11 0 40.8 (25.5-42.5) 55.0 (52.0-71.0)
38 39.8 (24.0-47.0) 63.5 (43.0-73.5)
77 0 21.0 (17.5-28.0) 60.0 (55.5-64.5)
66 0.5 (0.0-0.5) 1.3 (1.0-2.0)
Hissar
11 0 29.8 (26.5-30.5) 46.0 (45.5-62.5)







Day of Median % infection











77 0 Added as usual
66 on day 0 of assay
17.0 (10.0-22.0)
0.0 (0.0-0.0)
77 0 Added to cultures
66 on day 1 of assay
11.0 (7.5-18.5)
17.8 (16.0-20.0)
Sporozoites: T. annulata Hissar, 0.3 te per well
*Median % infection includes trophozoite and schizont infected






Median % infection (range)
n = 4
10T 0 13.8 (10.5-19.0)
94 0.0 (0.0-0.0)
34A 0 14.0 (10.5-20.0)
94 0.5 (0.0-0.5)
14T 0 17.8 (14.0-22.5)
94 12.5 (8.5-26.5)
37A 0 11.8 (10.0-13.5)
94 17.3 (11.5-20.0)
4 IP 0 14.3 (11.5-15.0)
94 18.8 (16.5-24.0)
38A 0 12.0 (10.5-13.5)
94 15.5 (13.0-16.0)
Sporozoites: T. annulata Ankara
Infection rates assessed on day 2 of culture




Manufacturers' and suppliers' names and addresses
Agfa Professional Photographic Division, 27, The Great West Road,
Bentford, Middlesex, T88 9AX, England.
Alpha Laboratories, 40, Parkham Drive, Eastleigh, Hampshire, SP5 4NV,
England.
American Can Company. Suppliers: Gallenkamp Ltd., Belton Road West,
Loughborough, Leicestershire, England.
Amersham International PLC, Lincoln Place, Green End, Aylesbury,
Berkshire, England.
Anderman and Company Ltd., 145, London Road, Kingston-on-Thames,
Surrey, KT2 6NH, England.
BDH Ltd., Broom Road, Poole, Dorset, BH12 4NN, England.
Beeton Dickinson UK Ltd., York House, Empire Way, Wembley, Middlesex,
England.
Bethesda Research Laboratories. Suppliers: Gibco Ltd.
Biorad Laboratories Ltd., Caxton Way, Watford Business Park, Watford,
Hertfordshire, England.
BOC Ltd., 150, Polmadie Road, Glasgow, G5 OHN, Scotland.
Boehringer Mannheim (BCL), Bell Lane, Lewes, East Sussex, BN7 1LG,
England.
Carnation, 36, Park Street, Croydon, Surrey, CR9 ITT, England.
Costar. Suppliers: Northumbria Biologicals Ltd., South Nelson Indus¬
trial Estate, Cramlington, England.
Dako Ltd., 22, The Arcade, The Octagon, High Wycombe, Buckinghamshire,
England.
Decon Laboratories Ltd., Ellen Street, Portslade, Brighton, BN4 1EQ,
England.
Difco Laboratories, P.O. Box 149, Central Avenue, West Moseley, Surrey,
England.
Fisons Scientific Apparatus Ltd., Bishop Meadow Road, Loughborough,
Leicestershire, England.
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Gibco Ltd., P.O. Box 35, Washington Road, Abbotsinch Industrial
Estate, Paisley, PA3 4EP, Scotland.
Glaxovet Ltd., Greenford, Middlesex, UB6 OHE, England.
Heraeus Equipment Ltd., Unit 9, Wates Way, Brentwood, Essex, CM15 9TB,
England.
Ilford Ltd., Mobberley, Cheshire, England.
Koch Light Laboratories Ltd., Poyle, Colbrook, Buckinghamshire,
England.
Kodak Ltd., Hemel Hempstead, England.
LEEC Ltd., Private Road 7, Colwick, Nottingham, NG4 2AJ, England.
Leitz Instruments Ltd., 48, Park Street, Luton, LUl 3HP, England.
Merck, Darmstadt, West Germany. (Suppliers: BDH).
Millipore (UK) Ltd., The Boulevard, Ascot Road, Croxley Green,
Watford, W01 8YW, England.
MSE Scientific Instruments, Manor Royal, Crawley, Sussex, RH10 2QQ,
England.
Nordic Immunological Laboratories Ltd., P.O. Box 544, Maidenhead,
Berkshire, England.
Nuclear Enterprises Ltd., Bankhead Meadway, Edinburgh, EHll 4EY,
Scotland.
NuncIon. Suppliers: Gibco Ltd.
Oxoid Ltd., Wade Road, Basingstoke, RG24 OPW, England.
P and S Biochemicals Ltd., 38, Queensland Street, Liverpool, L7 3JG,
England.
Packard Instruments Ltd., Manulife House, 13-17, Church Road, Caver-
sham, Berkshire, RG4 7AA, England.
Pharmacia Ltd., Pharmacia House, Midsummer Boulevard, Milton Keynes,
England.
Pierce Chemicals. Suppliers: Life Science Laboratories Ltd.,
Sedgewick Road, Luton, LU4 9DT, England.
Promega Biotech. Ltd. Suppliers: P and S Biochemicals Ltd.
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Pye Unicam Ltd., York Street, Cambridge, CB1 2PX, England.
Sarstedt Ltd., 68, Boston Road, Leicester, LE4 1AW, England.
Schleicher and Schuell. Suppliers: Anderman and Company Ltd.
Scottish Antibody Production. Unit (SAPU) , Law Hospital, Carluke,
Lanarkshire, ML8 5BS, Scotland.
Serotec, 22, Bankside Station Approach, Kidlington, Oxford, 0X5 1JE,
England.
Shandon Southern Products Ltd., 93, Chadwick Road, Astmoor, Runcorn,
Cheshire, England.
Sigma Chemical Company Ltd., Fancy Road, Poole, Dorset, BH17 7NH,
England.
Sorvall. Suppliers: Dupont (UK) Ltd., Wedgewood Way, Stevenage,
Hertfordshire, SGI 4QN, England.
TAAB Laboratory Equipment, 3, Minerva House, Calleva Industrial Park,
Aldermaston, England.
Whatman Labsales Ltd., Unit 1, Coldred Road, Parkwood, Maidstone,
Kent, ME15 9XN, England.
Winthrop Laboratories, Winthrop House, Surbiton-upon-Thames, Surrey,
England.
